
<html lang="en"     class="pb-page"  data-request-id="7a8fe20e-473e-4cab-bd7e-cbfb50364d8a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.0c00102;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-10"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis" /></meta><meta name="dc.Creator" content="Guiyan  Han" /></meta><meta name="dc.Creator" content="Na  Liu" /></meta><meta name="dc.Creator" content="Chenglan  Li" /></meta><meta name="dc.Creator" content="Jie  Tu" /></meta><meta name="dc.Creator" content="Zhuang  Li" /></meta><meta name="dc.Creator" content="Chunquan  Sheng" /></meta><meta name="dc.Description" content="Invasive fungal infections (particularly candidiasis) are emerging as severe infectious diseases worldwide. Because of serious antifungal drug resistance, therapeutic efficacy of the current treatm..." /></meta><meta name="Description" content="Invasive fungal infections (particularly candidiasis) are emerging as severe infectious diseases worldwide. Because of serious antifungal drug resistance, therapeutic efficacy of the current treatm..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 29, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00102" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00102" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00102" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00102" /></link>
        
    
    

<title>Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00102" /></meta><meta property="og:title" content="Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0013.jpeg" /></meta><meta property="og:description" content="Invasive fungal infections (particularly candidiasis) are emerging as severe infectious diseases worldwide. Because of serious antifungal drug resistance, therapeutic efficacy of the current treatment for candidiasis is limited and associated with high mortality. However, it is highly challenging to develop novel strategies and effective therapeutic agents to combat drug resistance. Herein, the first generation of lanosterol 14α-demethylase (CYP51)-histone deacetylase (HDAC) dual inhibitors was designed, which exhibited potent antifungal activity against azole-resistant clinical isolates. In particular, compounds 12h and 15j were highly active both in vitro and in vivo to treat azole-resistant candidiasis. Antifungal mechanism studies revealed that they acted by blocking ergosterol biosynthesis and HDAC catalytic activity in fungus, suppressing the function of efflux pump, yeast-to-hypha morphological transition, and biofilm formation. Therefore, CYP51-HDAC dual inhibitors represent a promising strategy to develop novel antifungal agents against azole-resistant candidiasis." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="Invasive fungal infections (particularly candidiasis) are emerging as severe infectious diseases worldwide. Because of serious antifungal drug resistance, therapeutic efficacy of the current treatment for candidiasis is limited and associated with high mortality. However, it is highly challenging to develop novel strategies and effective therapeutic agents to combat drug resistance. Herein, the first generation of lanosterol 14α-demethylase (CYP51)-histone deacetylase (HDAC) dual inhibitors was designed, which exhibited potent antifungal activity against azole-resistant clinical isolates. In particular, compounds 12h and 15j were highly active both in vitro and in vivo to treat azole-resistant candidiasis. Antifungal mechanism studies revealed that they acted by blocking ergosterol biosynthesis and HDAC catalytic activity in fungus, suppressing the function of efflux pump, yeast-to-hypha morphological transition, and biofilm formation. Therefore, CYP51-HDAC dual inhibitors represent a promising strategy to develop novel antifungal agents against azole-resistant candidiasis." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0013.jpeg" /></meta><meta name="twitter:title" content="Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00102"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00102">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00102&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00102&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00102&amp;href=/doi/10.1021/acs.jmedchem.0c00102" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 5341-5359</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00192" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c00231" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Guiyan Han</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Guiyan Han</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Guiyan++Han">Guiyan Han</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Na Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Na Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Na++Liu">Na Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chenglan Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chenglan Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</div><div class="loa-info-affiliations-info">School of Pharmacy, Ningxia Medical University, 1160 Shengli Street, Yinchuan 750004, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chenglan++Li">Chenglan Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jie Tu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jie Tu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jie++Tu">Jie Tu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhuang Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhuang Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhuang++Li">Zhuang Li</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Chunquan Sheng</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chunquan Sheng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#384b505d565f5b49784b55554d165d5c4d165b56"><span class="__cf_email__" data-cfemail="81f2e9e4efe6e2f0c1f2ececf4afe4e5f4afe2ef">[email protected]</span></a>. Phone/Fax: +86 21 81871205.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chunquan++Sheng">Chunquan Sheng</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9489-804X" title="Orcid link">http://orcid.org/0000-0001-9489-804X</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00102&amp;href=/doi/10.1021%2Facs.jmedchem.0c00102" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 5341–5359</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 29, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>4 February 2020</li><li><span class="item_label"><b>Published</b> online</span>29 April 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 May 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00102" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00102</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5341%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DGuiyan%2BHan%252C%2BNa%2BLiu%252C%2BChenglan%2BLi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D10%26contentID%3Dacs.jmedchem.0c00102%26title%3DDiscovery%2Bof%2BNovel%2BFungal%2BLanosterol%2B14%25CE%25B1-Demethylase%2B%2528CYP51%2529%252FHistone%2BDeacetylase%2BDual%2BInhibitors%2Bto%2BTreat%2BAzole-Resistant%2BCandidiasis%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5359%26publicationDate%3DMay%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00102"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1129</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">14</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00102" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Guiyan&quot;,&quot;last_name&quot;:&quot;Han&quot;},{&quot;first_name&quot;:&quot;Na&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Chenglan&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Jie&quot;,&quot;last_name&quot;:&quot;Tu&quot;},{&quot;first_name&quot;:&quot;Zhuang&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Chunquan&quot;,&quot;last_name&quot;:&quot;Sheng&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;29&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;5341-5359&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00102&quot;},&quot;abstract&quot;:&quot;Invasive fungal infections (particularly candidiasis) are emerging as severe infectious diseases worldwide. Because of serious antifungal drug resistance, therapeutic efficacy of the current treatment for candidiasis is limited and associated with high mortality. However, it is highly challenging to develop novel strategies and effective therapeutic agents to combat drug resistance. Herein, the first generation of lanosterol 14α-demethylase (CYP51)-histone deacetylase (HDAC) dual inhibitors was designed, which exhibited potent antifungal activity against azole-resistant clinical isolates. In particular, compounds 12h and 15j were highly active both in vitro and in vivo to treat azole-resistant candidiasis. Antifungal mechanism studies revealed that they acted by blocking ergosterol biosynthesis and HDAC catalytic activity in fungus, suppressing the function of efflux pump, yeast-to-hypha morphological transition, and biofilm formation. Therefore, CYP51-HDAC dual inhibitors represent a promising strategy to de&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00102&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00102" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00102&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00102" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00102&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00102" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00102&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00102&amp;href=/doi/10.1021/acs.jmedchem.0c00102" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00102" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00102" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00102%26sid%3Dliteratum%253Aachs%26pmid%3D32347094%26genre%3Darticle%26aulast%3DHan%26date%3D2020%26atitle%3DDiscovery%2Bof%2BNovel%2BFungal%2BLanosterol%2B14%25CE%25B1-Demethylase%2B%2528CYP51%2529%252FHistone%2BDeacetylase%2BDual%2BInhibitors%2Bto%2BTreat%2BAzole-Resistant%2BCandidiasis%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D10%26spage%3D5341%26epage%3D5359%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291362" title="Antimicrobial agents">Antimicrobial agents</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290649" title="Antifungal activity">Antifungal activity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/10" title="Go to Volume 63, Issue 10"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/jmcmar.2020.63.issue-10/20200528/jmcmar.2020.63.issue-10.largecover.jpg" alt="Go to Volume 63, Issue 10"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/medium/jm0c00102_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00102&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Invasive fungal infections (particularly candidiasis) are emerging as severe infectious diseases worldwide. Because of serious antifungal drug resistance, therapeutic efficacy of the current treatment for candidiasis is limited and associated with high mortality. However, it is highly challenging to develop novel strategies and effective therapeutic agents to combat drug resistance. Herein, the first generation of lanosterol 14α-demethylase (CYP51)-histone deacetylase (HDAC) dual inhibitors was designed, which exhibited potent antifungal activity against azole-resistant clinical isolates. In particular, compounds <b>12h</b> and <b>15j</b> were highly active both <i>in vitro</i> and <i>in vivo</i> to treat azole-resistant candidiasis. Antifungal mechanism studies revealed that they acted by blocking ergosterol biosynthesis and HDAC catalytic activity in fungus, suppressing the function of efflux pump, yeast-to-hypha morphological transition, and biofilm formation. Therefore, CYP51-HDAC dual inhibitors represent a promising strategy to develop novel antifungal agents against azole-resistant candidiasis.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38101" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38101" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Invasive fungal infections (IFIs) are emerging as severe infectious diseases worldwide, mainly because of the increasing number of immunocompromised people.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Patients undergoing organ transplantations, clinical treatments in intensive care units (ICUs), and immunosuppressive and chemotherapeutic therapies and infected with human immunodeficiency virus (HIV) are highly vulnerable to IFIs.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> It is reported that about 300 fungal pathogens could cause human infections, among which <i>Candida</i> species are responsible for the most important pathogenic factors of IFI cases and cause over 400,000 life-threatening infections per year worldwide with a mortality of 46–75%.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5−8)</a> Traditional antifungal agents including polyenes, azoles, echinocandins, and flucytosine have been widely used for the treatment of invasive candidiasis (IC), leading to severe drug resistance (particularly azole-resistance), reduced antifungal efficacy, and high mortal rate.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12">(9−12)</a> Therefore, the development of new antifungal agents against azole-resistant IC is highly desirable and challenging.<a onclick="showRef(event, 'ref10 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref13">(10,13)</a></div><div class="NLM_p">Lanosterol 14α-demethylase (CYP51) is the target of azole antifungal agents (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A), such as fluconazole (FLC), itraconazole (ITC), and voriconazole (VOR). Azoles block the biosynthesis of ergosterol in fungal cell membranes through inhibiting CYP51 and exert fungistatic activity.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The main molecular mechanisms of azole resistance include the overexpression of CYP51, mutations in the CYP51 structure, upregulation of efflux pumps, and formation of fungal biofilm.<a onclick="showRef(event, 'ref3 ref4 ref14'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref14">(3,4,14)</a> Histone deacetylases (HDACs), a family of epigenetic enzymes, widely exist in eukaryocytes. By removing acetyl groups from histones and other proteins, HDACs play an important role in gene regulation, transcription, and posttranscriptional modification, which has been extensively investigated as antitumor targets.<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15−17)</a> Recently, fungal HDACs were found to play a key role in the development of drug resistance including azoles.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18−20)</a> In addition, several fungal biological features and virulence are functionally influenced by HDACs.<a onclick="showRef(event, 'ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23">(21−23)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/medium/jm0c00102_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design rationale of CYP51/HDAC dual inhibitors. (A) Chemical structures of azole antifungal agents; (B) chemical structure and binding mode of posaconazole (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5SFA">5SFA</a>); (C) design of CYP51/HDAC dual inhibitors by pharmacophore fusion.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00102&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The potential applications of HDAC inhibitors in the antifungal therapy have been preliminarily confirmed.<a onclick="showRef(event, 'ref15 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref15 ref24 ref25">(15,24,25)</a> For example, HDAC inhibitors vorinostat (SAHA) and trichostatin A were reported to possess synergistic effects with FLC against azole-resistant fungi.<a onclick="showRef(event, 'ref19 ref26'); return false;" href="javascript:void(0);" class="ref ref19 ref26">(19,26)</a> These findings provide a basis for the design of multitargeting agents to combat with severe azole resistance. Moreover, <i>in vivo</i> antifungal potencies and antifungal mechanism of action of the azole/HDAC inhibitor combination still remain to be explored.</div><div class="NLM_p last">A multitargeting molecule may have the advantages of the synergistic effect and antiresistant efficacy, which also may be limited by a higher molecular weight, potential host toxicity of hitting multiple mechanisms.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> Thus it is highly challenging to design a multitargeting molecule with desired druglike profiles. Previously, we designed Janus kinase 2 (JAK2)/HDAC dual inhibitors that could simultaneously treat leukemia and IFIs.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> JAK2/HDAC dual inhibitors synergized with FLC both <i>in vitro</i> and <i>in vivo</i> to treat resistant fungal infections. Inspired by these results, we envisioned that direct antifungal activity against resistant IFIs could be achieved by the design of CYP51/HDAC dual inhibitors. Herein, the first generation of CYP51/HDAC dual inhibitors was designed to treat azole-resistant candidiasis. Compared with azole antifungal agents, the dual inhibitors revealed potent inhibitory activities against azole-resistant <i>Candida</i> species. Particularly, compounds <b>12h</b> and <b>15j</b> exhibited excellent <i>in vitro</i> and <i>in vivo</i> antifungal activity to treat resistant IC, whose antifungal and anti-resistant mechanisms were preliminarily clarified.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45872" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45872" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Design of CYP51/HDAC Dual Inhibitors</h3><div class="NLM_p last">Previously, we have performed a systemic structure-based design and structure–activity relationship (SAR) studies of azole CYP51 inhibitors<a onclick="showRef(event, 'ref29 ref30 ref31 ref32 ref33 ref34 ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31 ref32 ref33 ref34 ref35 ref36 ref37">(29−37)</a> and also designed a series of HDAC-based multitargeting inhibitors,<a onclick="showRef(event, 'ref16 ref17 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref38 ref39 ref40">(16,17,38−40)</a> providing a basis for the rational design of CYP51/HDAC dual inhibitors. Herein, the CYP51/HDAC dual inhibitors were designed by merging the key pharmacophores of CYP51 and HDAC inhibitors. Generally, the classical HDAC inhibitor (<i>e.g.,</i> SAHA) includes a surface recognition cap (SRC) group, a linker, and a zinc-binding group (ZBG, such as hydroxamic acid). A linker with a certain length and ZBG are known as the key pharmacophores of HDAC inhibitors, while diverse scaffolds can be designed as SRC groups.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41,42)</a> The key pharmacophores of typical CYP51 inhibitors consist of a triazole ring (coordination with heme iron atom of CYP51) and difluorophenyl (or dichlorophenyl) ring (interaction with the hydrophobic pocket of CYP51), while diverse side chains with different lengths could be accommodated in the active site of CYP51.<a onclick="showRef(event, 'ref29 ref43'); return false;" href="javascript:void(0);" class="ref ref29 ref43">(29,43)</a> Recently, the crystal structure of <i>Candida albicans</i> CYP51 in complex with posaconazole was solved (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B).<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> The binding mode of posaconazole indicates that the length of azoles generally correlates well with CYP51 inhibitory activity, and longer side chains can form additional interactions with the substrate access channel in CYP51. On the basis of the above analysis, the type A CYP51/HDAC dual inhibitors was designed by introducing a linker and hydroxamic acid ZBG on the structure of FLC (compounds <b>7a–c</b> and <b>8a–c</b>). Then, diverse <i>N</i>-methylbenzylamine containing linkers were investigated (types B and C) based on our previous experience in the design of CYP51 inhibitors (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> To validate the design rationale, compound <b>15j</b> was selected to be docked into the active site of CYP51. The results revealed that it shared a similar binding mode with posaconazole with the ZBG and linker group inserted into the channel of CYP51 (Figure S3 in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00102/suppl_file/jm0c00102_si_001.pdf" class="ext-link">Supporting Information</a>).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Chemistry</h3><div class="NLM_p">The synthesis of the target compounds <b>7a–c</b>, <b>8a–c</b>, <b>12a–j</b>, and <b>15a–t</b> are depicted in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<named-content content-type="anchor" rid="sch2" type="simple"></named-content><a class="ref internalNav" href="#sch3" aria-label="3">3</a>, and the target compounds were obtained as racemates according to the optical rotation. Starting materials <b>1a</b>, <b>1b</b>, and <b>9a–f</b> are commercially available, while starting materials <b>9g–j</b>, <b>13a–q</b>, oxirane <b>4</b>, and intermediate <b>10</b> were synthesized according to the reported procedure.<a onclick="showRef(event, 'ref37 ref45 ref46 ref47 ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref37 ref45 ref46 ref47 ref48 ref49 ref50">(37,45−50)</a></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/medium/jm0c00102_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00102&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 12 h, yield 75–83%; (b) (i) 4 M HCl in dioxane, anhydrous CH<sub>3</sub>OH, rt, 1 h; (ii) HCONHNH<sub>2</sub>, Et<sub>3</sub>N, CH<sub>3</sub>OH, rt, 18 h, yield 45–59%; (c) K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 12 h, yield 16–31%; (d) NH<sub>2</sub>OH·HCl, KOH, CH<sub>3</sub>OH, rt, 5 h, yield 73–84%.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/medium/jm0c00102_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00102&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 2 h, yield 63–84%; (b) (i) 50% TFA in anhydrous CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h; (ii) K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 12 h; (iii) NH<sub>2</sub>OH·HCl, KOH, CH<sub>3</sub>OH, rt, 5 h, yield 30–55%.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/medium/jm0c00102_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00102&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) RNH<sub>2</sub>·HCl, Ti (<i>i</i>-propoxyl)<sub>4</sub>, Et<sub>3</sub>N, anhydrous CH<sub>3</sub>OH, rt, 12 h; (ii) NaBH<sub>4</sub>, rt, 30 min, yield 84–96%; (b) (i) K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 12 h; (ii) NH<sub>2</sub>OH·HCl, KOH, CH<sub>3</sub>OH, rt, 5 h, yield 34–56%.</p></p></figure><div class="NLM_p">Substitution of phenols <b>1a</b> and <b>1b</b> by brominated compounds gave nitriles <b>2a–c</b>, followed by the addition of the cyano group with CH<sub>3</sub>OH in the acidic condition, and on further cyclization with formylhydrazine in the presence of trimethylamine (Et<sub>3</sub>N), intermediates <b>3a–c</b> were obtained. Then, oxirane <b>4</b> was treated with intermediates <b>3a–c</b> in <i>N</i>,<i>N</i>-dimethylformamide (DMF) using K<sub>2</sub>CO<sub>3</sub> as the base to give intermediates <b>5a–c</b> and <b>6a–c</b>. Because intermediates <b>5a–c</b> and <b>6a–c</b> are structurally similar, their structures were further confirmed by 2D-NMR (Figure S1 in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00102/suppl_file/jm0c00102_si_001.pdf" class="ext-link">Supporting Information</a>). Finally, they were treated with freshly prepared hydroxylamine in basic CH<sub>3</sub>OH to afford target compounds <b>7a–c</b> and <b>8a–c</b>, respectively (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><div class="NLM_p">Target compounds <b>12a–j</b> were synthesized using compounds <b>9a–j</b> as the starting materials (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Briefly, compounds <b>9a–j</b> were nucleophilic-substituted by intermediate <b>10</b> in the presence of K<sub>2</sub>CO<sub>3</sub> to give intermediates <b>11a–j</b>. Then, further deprotection of intermediates <b>11a–j</b> in the presence of trifluoroacetic acid (TFA), followed by ring opening of oxirane <b>4</b> and the direct treatment with freshly prepared hydroxylamine in basic CH<sub>3</sub>OH afforded target compounds <b>12a–j</b>.</div><div class="NLM_p last">Target compounds <b>15a–t</b> were synthesized according to the procedures outlined in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Starting from a reductive amination of aldehydes <b>13a–q</b> in the presence of primary amine and sodium borohydride, intermediates <b>14a–t</b> were obtained, which further reacted with oxirane <b>4</b> by the ring opening reaction and treated with freshly prepared hydroxylamine in basic CH<sub>3</sub>OH to afford target compounds <b>15a–t</b>.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> <i>In Vitro</i> Antifungal Activities and SAR</h3><div class="NLM_p">Initially, the <i>in vitro</i> antifungal activities of target compounds were evaluated using the CLSI (M27-A3) microdilution method<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> because the assays for evaluating fungal CYP51 and HDAC inhibitors are rather limited. Then, highly potent antifungal compounds will be selected for validation and investigation of the mechanism of action. Azole-sensitive <i>C. albicans</i> and <i>Cryptococcus neoformans</i> and four azole-resistant <i>C. albicans</i> and <i>Candida tropicalis</i> clinical isolates were used in the assay. The antifungal activities are expressed as MIC<sub>80</sub> (the minimum inhibitory concentration with inhibition over 80%) values and azole antifungal agents FLC, ITC, VOR, and HDAC inhibitor SAHA were used as the positive drugs.</div><div class="NLM_p">Initially, linkers and ZBG were attached directly to FLC (compounds <b>7a–c</b> and <b>8a–c</b>, type A inhibitors). As shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, most of the target compounds exhibited weak to moderate activities to both azole-sensitive and azole-resistant <i>C. albicans</i> (MIC<sub>80</sub> range: 8–64 μg/mL). In contrast, FLC, ITC, VOR, and SAHA were inactive against azole-resistant strains. The results preliminarily validated the anti-resistance profiles of the designed compounds.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. <i>In Vitro</i> Antifungal Activities of Compounds <b>7a–c</b> and <b>8a–c</b> (MIC<sub>80</sub>, μg/mL)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/medium/jm0c00102_0008.gif" alt="" id="GRAPHIC-d7e784-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" align="center">Azole-sensitive <i>C. alb.</i><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="3" align="center">Azole-resistant <i>C. alb.</i><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" align="center">Azole-resistant <i>C. tro.</i><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" align="center">Azole-sensitive <i>C. neo.</i><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Compd.</th><th class="colsep0 rowsep0" align="center" char="."><i>m</i></th><th class="colsep0 rowsep0" align="center" char="."><i>n</i></th><th class="colsep0 rowsep0" align="center">SC5314</th><th class="colsep0 rowsep0" align="center">0304103</th><th class="colsep0 rowsep0" align="center">7781</th><th class="colsep0 rowsep0" align="center">4108</th><th class="colsep0 rowsep0" align="center">5008</th><th class="colsep0 rowsep0" align="center">H99</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7a</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7b</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7c</b></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8a</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8b</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8c</b></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FLC<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ITC<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">0.125</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">VOR<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">0.125</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">0.0625</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SAHA</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Abbreviations: <i>C. alb.</i>, <i>Candida albicans</i>; <i>C. tro.</i>, <i>Candida tropicalis</i>; <i>C. neo.</i>, <i>Cryptococcus neoformans</i>; FLC, fluconazole; ITC, itraconazole and VOR, voriconazole.</p></div></div></div><div class="NLM_p">To improve the antifungal activities, type B inhibitors featured as the <i>N</i>-methylaminomethylphenyltriazolone linker were designed and assayed (compounds <b>12a–j</b>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Compounds <b>12a–e</b> with an alkyl linker (from 3 to 7 carbon atoms) generally showed moderate antifungal activity. When the linker was extended to 8 carbon atoms (compound <b>12f</b>), antifungal activity was obviously improved. Further incorporation of the phenyl group into the alkyl linker (compounds <b>12g</b> and <b>12h</b>) led to a slight increase of the inhibitory activity against azole-resistant isolates. The introduction of the oxygen atom into the alkyl linker (compounds <b>12i</b> and <b>12j</b>) had little impact on the antifungal activity.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. <i>In Vitro</i> Antifungal Activities of Compounds <b>12a–j</b> (MIC<sub>80</sub>, μg/mL)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/medium/jm0c00102_0009.gif" alt="" id="GRAPHIC-d7e1112-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/medium/jm0c00102_0010.gif" alt="" id="gr8" /></img><div></div></div><div class="NLM_p">To further explore the importance of the triazolone group for the antifungal activities, type C inhibitors were designed by removing the triazolone group and variation of N-substitutions and the linking site of the phenyl group (compounds <b>15a–t</b>, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Interestingly, removing the triazolone group resulted in the improvement of the antifungal activity (compounds <b>15a–f</b>). In particular, compounds <b>15d</b>, <b>15e</b>, and <b>15f</b> showed excellent antifungal activities against both azole-sensitive and resistant fungal pathogens (MIC<sub>80</sub> range: 0.125–1 μg/mL). The replacement of the linker oxygen atom by the amide (compounds <b>15g</b> and <b>15h</b>) led to decreased antifungal activity. In contrast, the introduction of an additional oxygen atom into the linker of compound <b>15f</b> was favorable for the antifungal activity. Compound <b>15j</b> showed potent inhibitory activity against azole-sensitive <i>C. albicans</i> (MIC<sub>80</sub> = 0.125 μg/mL) and <i>C. neoformans</i> (MIC<sub>80</sub> = 0.5 μg/mL). Importantly, it was still highly active against four azole-resistant clinical isolates with MIC<sub>80</sub> values in the range of 0.25–0.5 μg/mL, whereas FLC, ITC, VOR, and SAHA were totally inactive. Furthermore, compound <b>15j</b> was investigated by time-kill curve assays, which exhibited fungistatic activity against azole-resistant <i>C. albicans</i> at 16 μg/mL (Figure S2 in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00102/suppl_file/jm0c00102_si_001.pdf" class="ext-link">Supporting Information</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. <i>In Vitro</i> Antifungal Activities of Compounds <b>15a–t</b> (MIC<sub>80</sub>, μg/mL)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/medium/jm0c00102_0011.gif" alt="" id="GRAPHIC-d7e1191-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/medium/jm0c00102_0012.gif" alt="" id="gr9" /></img><div></div></div><div class="NLM_p">On the basis of compound <b>15j</b>, the extension of a carbon atom between the phenyl group and hydroxamic acid (compound <b>15k</b>) had negative effects on the antifungal activity. The meta (compounds <b>15i–n</b>) or ortho (compounds <b>15o–q</b>) substitution of the linker on the phenyl group also led to obvious decrease of the antifungal activity. Finally, when the N-methyl group of compound <b>15j</b> was replaced by ethyl (<b>15r</b>), isopropyl (<b>15s</b>), or cyclopropyl (<b>15t</b>), significant decrease of the antifungal activity was observed.</div><div class="NLM_p last">Among the target compounds, compounds <b>12h</b> (type B inhibitors) and <b>15j</b> (type C inhibitors) were chosen for further biological evaluations and mechanism studies on the basis of structural diversity and inhibitory activities against azole-resistant fungi. Initially, <i>in vitro</i> cytotoxicity of compounds <b>12h</b> and <b>15j</b> were assayed. They exhibited relatively weak cytotoxicity against human cell lines A549 (human lung carinoma cell line) and HUVEC (human umbilical vein endothelial cell line) with the IC<sub>50</sub> values in the range of 3.9–16.1 μg/mL (6.7–25.4 μM), which were about 2–16 times higher than the MIC<sub>80</sub> values against azole-resistant fungi (Table S1 in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00102/suppl_file/jm0c00102_si_001.pdf" class="ext-link">Supporting Information</a>).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Compounds <b>12h</b> and <b>15j</b> Inhibited Biosynthesis of Ergosterol in Azole-Resistant <i>C. albicans</i></h3><div class="NLM_p">Ergosterol, a predominant sterol of fungal cell membranes, plays an important role in maintaining the stability and function of cell membranes. Azoles inhibit fungal CYP51 and block the production of ergosterol, which cause the accumulation of other sterols such as lanosterol, eburicol, and obtusifoliol, and then cause damage of fungal cell membranes and exert fungistatic activity.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Fungal CYP51s are membrane-bound proteins, which are difficult to be purified for biological assays.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> As an alternative, the analysis of sterol composition of fungal cell membranes has been widely used to evaluate the activity of CYP51 inhibitors.<a onclick="showRef(event, 'ref54 ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref54 ref55 ref56">(54−56)</a> Therefore, the influences of compounds <b>12h</b> (0.5 μg/mL) and <b>15j</b> (0.5 μg/mL) on the sterol composition of azole-resistant <i>C. albicans</i> were explored by gas chromatography–mass spectrometry (GC–MS) with FLC (0.5 μg/mL) as the positive control (Figure S4 in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00102/suppl_file/jm0c00102_si_001.pdf" class="ext-link">Supporting Information</a>). The sterol profiling of the FLC group revealed that ergosterol was still the main sterol of the <i>C. albicans</i> cell membrane (74.97%), which was similar to that of the negative control group without the drug treatment. The results indicated that FLC was inactive against resistant <i>C. albicans</i> isolates possibly because of the poor inhibition of CYP51 and low damage to the cell membrane. In contrast, after the treatment of compounds <b>12h</b> and <b>15j</b>, the relative amount of ergosterol was decreased to 61.48 and 18.44%, respectively. Moreover, the amounts of lanosterol in these two groups were higher than the negative control group and FLC-treated group, suggesting that compounds <b>12h</b> and <b>15j</b> effectively blocked the demethylation of lanosterol (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).The results were also consistent well with the MIC<sub>80</sub> values, which indirectly indicated that compounds <b>12h</b> and <b>15j</b> could significantly inhibit CYP51 in resistant <i>C. albicans</i> cells.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Sterol Composition Analysis of <i>C. albicans</i> 0304103 Cells Treated by Compounds <b>12h</b>, <b>15j</b>, and FLC</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">sterol composition (%)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">sterol</th><th class="colsep0 rowsep0" align="center" char=".">retention time (min)</th><th class="colsep0 rowsep0" align="center" char=".">no drug</th><th class="colsep0 rowsep0" align="center" char=".">FLC</th><th class="colsep0 rowsep0" align="center"><b>12h</b></th><th class="colsep0 rowsep0" align="center"><b>15j</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">unknown sterol (1)</td><td class="colsep0 rowsep0" align="char" char=".">13.82</td><td class="colsep0 rowsep0" align="char" char=".">2.91</td><td class="colsep0 rowsep0" align="char" char=".">3.06</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ergosterol</td><td class="colsep0 rowsep0" align="char" char=".">14.06</td><td class="colsep0 rowsep0" align="char" char=".">75.21</td><td class="colsep0 rowsep0" align="char" char=".">74.97</td><td class="colsep0 rowsep0" align="left">61.48</td><td class="colsep0 rowsep0" align="left">18.44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">unknown sterol (2)</td><td class="colsep0 rowsep0" align="char" char=".">14.50</td><td class="colsep0 rowsep0" align="char" char=".">6.77</td><td class="colsep0 rowsep0" align="char" char=".">7.5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">unknown sterol (3)</td><td class="colsep0 rowsep0" align="char" char=".">14.96</td><td class="colsep0 rowsep0" align="char" char=".">4.78</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">obtusifoliol</td><td class="colsep0 rowsep0" align="char" char=".">15.12</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">7.59</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">unknown sterol (4)</td><td class="colsep0 rowsep0" align="char" char=".">15.26</td><td class="colsep0 rowsep0" align="char" char=".">1.29</td><td class="colsep0 rowsep0" align="char" char=".">1.17</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lanosterol</td><td class="colsep0 rowsep0" align="char" char=".">15.78</td><td class="colsep0 rowsep0" align="char" char=".">4.15</td><td class="colsep0 rowsep0" align="char" char=".">3.94</td><td class="colsep0 rowsep0" align="left">25.29</td><td class="colsep0 rowsep0" align="left">8.57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">unknown sterol (5)</td><td class="colsep0 rowsep0" align="char" char=".">15.90</td><td class="colsep0 rowsep0" align="char" char=".">4.87</td><td class="colsep0 rowsep0" align="char" char=".">4.66</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">eburicol</td><td class="colsep0 rowsep0" align="char" char=".">16.68</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">13.22</td><td class="colsep0 rowsep0" align="left">65.4</td></tr></tbody></table></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Compounds <b>12h</b> and <b>15j</b> Inhibited Fungal HDACs</h3><div class="NLM_p">Until date, the assay for determining inhibitory activity against fungal HDAC is still rare. Herein, we developed a whole fungal cell HDAC enzymatic assay to test whether compounds <b>12h</b> and <b>15j</b> were fungal HDAC inhibitors. Briefly, the protoplasts of <i>C. albicans</i> were prepared using snailase. Then, the protoplasts were treated with different concentrations of compounds <b>12h</b>, <b>15j</b>, SAHA and FLC, and the HDAC substrate was added subsequently. Finally, the fluorescence intensity deriving from the decomposition of the HDAC substrate in different groups was monitored to evaluate the inhibitory activities of fungal HDACs (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). The results revealed that compounds <b>12h</b> and <b>15j</b> could inhibit the activities of whole fungal cell HDAC with an IC<sub>50</sub> value of 1.3 and 0.16 μM, respectively, while SAHA exhibited weaker inhibition activity (IC<sub>50</sub> = 1.5 μM) and FLC was totally inactive. In contrast, compounds <b>12h</b> and <b>15j</b> exhibited relatively weaker inhibitory activity against whole human cell HDACs with an IC<sub>50</sub> value of 6.8 and 2.7 μM, respectively, whereas SAHA inhibited whole human cell HDACs more strongly than compounds <b>12h</b> and <b>15j</b>. Similarly, compounds <b>12h</b> and <b>15j</b> all inhibit HDAC1 and HDAC6 with weaker activity than SAHA.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. HDAC Enzyme Inhibition Activities (IC<sub>50</sub>, μM)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compounds</th><th class="colsep0 rowsep0" align="center">whole fungal cell HDAC</th><th class="colsep0 rowsep0" align="center">whole human cell HDAC</th><th class="colsep0 rowsep0" align="center" char=".">HDAC1</th><th class="colsep0 rowsep0" align="center" char=".">HDAC6</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">12h</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">6.8</td><td class="colsep0 rowsep0" align="char" char=".">0.28</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">15j</td><td class="colsep0 rowsep0" align="left">0.16</td><td class="colsep0 rowsep0" align="left">2.7</td><td class="colsep0 rowsep0" align="char" char=".">0.69</td><td class="colsep0 rowsep0" align="char" char=".">0.60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SAHA</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">0.85</td><td class="colsep0 rowsep0" align="char" char=".">0.056</td><td class="colsep0 rowsep0" align="char" char=".">0.024</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FLC</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Compounds <b>12h</b> and <b>15j</b> Inhibited Azole-Resistant <i>C. albicans</i> by Downregulating the Expression of CYP51 and Efflux Pump Related Genes</h3><div class="NLM_p">It was widely accepted that one of the most important mechanisms of azole resistance in <i>C. albicans</i> is mutation or increase of CYP51 (encoded by <i>ERG11</i>), causing the reduced affinity of azoles to CYP51.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> In addition, the upregulation of efflux pump and increased efflux of drugs from cells is another ubiquitous mechanism of azole resistance. A number of genes were associated with fungal efflux pump, such as <i>CDR1</i>, <i>CDR2</i>, <i>MDR1</i>, and so forth.<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57,58)</a> In order to better understand the antiresistant mechanism of compounds <b>12h</b> and <b>15j</b> in <i>C. albicans</i> cells, the relative expression levels of four resistance related genes (<i>i.e., ERG11</i>, <i>CDR1</i>, <i>CDR2</i>, and <i>MDR1</i>) were investigated using real-time reverse transcription-polymerase chain reaction (RT-PCR) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A) using FLC as the control. It could be observed that the expression of four genes was increased significantly under the stimulation of FLC, which might be the important reason for the obvious resistance of <i>C. albicans</i> 0304103 to FLC. Interestingly, decrease or even reversal of the gene expression was observed after the treatment of dual CYP51/HDAC inhibitors as compared to the FLC group. Compound <b>12h</b> led to significant decrease on the expression levels of <i>ERG11</i>, <i>CDR1</i>, and <i>CDR2</i>, while compound <b>15j</b> resulted in the downregulation of <i>ERG11</i>, <i>CDR1</i>, <i>CDR2</i>, and <i>MDR1</i> genes.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/medium/jm0c00102_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Relative expression levels of azole-resistance related genes of <i>C. albicans</i> 0304103 after the treatment of FLC, compounds <b>12h</b> and <b>15j</b> at the concentration of 32 μg/mL for 16 h. Relative fold changes represent changes in the expression levels of the treated group as compared with the blank control. (B) Extracellular fluorescence intensity of Rh6G treated by compounds <b>12h</b>, <b>15j</b>, and FLC. These results were represented as the mean ± standard deviation using three dependent experiments. Statistical significance between groups was determined by Student’s <i>t</i>-test. ***<i>P</i> < 0.001, and ns represents no significant difference.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00102&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To further investigate the effects of compounds <b>12h</b> and <b>15j</b> on the efflux pump of azole-resistant <i>C. albicans</i>, rhodamine 6G (Rh6G) efflux assay was performed. Fluorescent Rh6G, a substrate of the efflux pump, can be pumped by the efflux pump outside the fungal cells after being preloaded into cells.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> The effects of compounds <b>12h</b> and <b>15j</b> on Rh6G efflux were evaluated by measuring the extracellular fluorescence intensity of Rh6G at different designated time points (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). The results indicated that the efflux of Rh6G in the FLC group was obviously higher than that in compounds <b>12h</b> and <b>15j</b> treated groups, which were consistent to the fact that FLC increased higher expression of the efflux pump than compounds <b>12h</b> and <b>15j</b>. Moreover, the decreased expression of CYP51 and efflux pump-related genes might be caused by HDAC inhibition.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Compounds <b>12h</b> and <b>15j</b> Inhibited Yeast-to-Hypha Morphological Transition and Biofilm Formation</h3><div class="NLM_p">Morphogenetic transitions between yeast and hyphae are prevalent for fungi, which is the key virulence for pathogenic fungi including <i>Candida</i> species.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Hyphal forms of fungi provide a stronger ability of invasion and adhesion to the hosts than the yeast form.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> The fungal biofilm is a highly structured and specific community where fungal cells are surrounded by a self-produced extracellular polymeric substance, which makes it difficult for antifungal agents to reach the cells, and related resistance is developed.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Meanwhile, filamentation is also an important factor of the formation of the mature biofilm. Therefore, the influences of compounds <b>12h</b> and <b>15j</b> on the yeast-to-hypha morphogenetic transitions of <i>C. albicans</i> were evaluated using the differential interference contrast (DIC) microscope with FLC as the positive drug. Compounds <b>12h</b> (8 μg/mL) and <b>15j</b> (1 μg/mL) completely inhibited the formation of hyphae. In contrast, FLC (up to 32 μg/mL) had no obvious effect on filamentation of <i>C. albicans</i> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). The inhibitory activity of compounds <b>12h</b> and <b>15j</b> against biofilms of <i>C. albicans</i> were evaluated by the 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2<i>H</i>-tetrazolium-5-carboxanilide (XTT) reduction assay with FLC as the positive drug. The results revealed that compounds <b>12h</b> and <b>15j</b> effectively and dose-dependently inhibited biofilm formation of <i>C. albicans</i>. In contrast, only 22.9% of biofilm inhibition of FLC was achieved at the high concentration (64 μg/mL). Thus, compounds <b>12h</b> and <b>15j</b> were significantly more active than FLC in inhibiting biofilm formation (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B).</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/medium/jm0c00102_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) DIC microscope photographs on filamentation of azole-resistant <i>C. albicans</i> 0304103. Compared to FLC, compounds <b>12h</b> and <b>15j</b> significantly inhibited the yeast-to-hypha morphological transition. (B) Biofilm formation (%) of <i>C. albicans</i> 0304103. Compounds <b>12h</b> and <b>15j</b> dose-dependently inhibited biofilm formation, and were stronger than FLC. (C) Expression levels of filamentation and biofilm formation-related genes relative to the blank control. Compounds <b>12h</b> (32 μg/mL) and <b>15j</b> (32 μg/mL) suppressed the expression of these genes. The latter two results were represented as the mean ± SD by three independent experiments. Statistical significance between groups was determined by Student’s <i>t</i>-test. *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00102&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To further clarify the mechanism of inhibiting yeast-to-hypha morphological transition and biofilm formation, real-time RT-PCR was performed to investigate the effects of compounds <b>12h</b> and <b>15j</b> on the expression of several hyphae and biofilm-associated genes. <i>EFG1</i>, <i>TEC1</i>, and <i>CPH1</i> encode transcription factors, which are involved in the hyphal growth and further biofilm formation.<a onclick="showRef(event, 'ref63 ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref63 ref64 ref65">(63−65)</a><i>ALS3</i> encodes cell wall adhesin and participates in the biofilm formation.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C, the four genes were downregulated after the treatment of compounds <b>12h</b> and <b>15j</b>. The results were well consistent with the fact that compounds <b>12h</b> and <b>15j</b> inhibited yeast-to-hypha morphological transition and biofilm formation.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Compounds <b>12h</b> and <b>15j</b> Displayed Potent <i>In Vivo</i> Antifungal Effects</h3><div class="NLM_p">IC, particularly azole-resistant candidiasis, is associated with high mortality.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> For the resistant <i>C. albicans</i> strains, the efficacy of azole antifungal agents is generally rather limited.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Thus, the <i>in vivo</i> antifungal efficacies of compounds <b>12h</b> and <b>15j</b> were evaluated using the IC murine model infected with clinical azole-resistant <i>C. albicans</i> isolates. The murine model was established by injection with azole-resistant <i>C. albicans</i><i>via</i> the lateral tail vein with cyclophosphamide as the immunosuppressant. Mice were assigned into six groups, which were treated by saline, compound <b>12h</b> (20 mg/kg), and compound <b>15j</b> (20 mg/kg) by intraperitoneal (IP) administration or oral (PO) administration. The treatment was performed for five days. Then, the mice were euthanized, and their kidneys were dissected, in which the left kidney was homogenized to evaluate the renal fungal burden. As shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A, the kidney fungal burden could be significantly reduced by the IP injection of compounds <b>12h</b> and <b>15j</b> at the dose of 20 mg/kg, whose log<sub>10</sub> cfu/g value was decreased from 6.89 to 4.49 (<i>P</i> < 0.001) and to 6.16 (<i>P</i> < 0.001), respectively. Similarly, significant decrease of kidney fungal burden was observed for compounds <b>12h</b> and <b>15j</b> after oral administration. Generally, compound <b>12h</b> showed better efficacy by IP injection than PO administration, whereas compound <b>15j</b> exhibited no significant difference in the two administration ways. Among these groups, compound <b>12h</b> by IP administration showed the best <i>in vivo</i> antifungal effects.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/medium/jm0c00102_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <i>In vivo</i> therapeutic efficacies of compounds <b>12h</b> and <b>15j</b> against azole-resistant <i>C. albicans</i> 0304103 infectious murine model. (A) Fungal burden of the kidney tissue. Compounds <b>12h</b> and <b>15j</b> significantly reduced the amount of <i>C. albicans</i> in the kidney. The fungal burden of the kidney (log<sub>10</sub> cfu/g) was plotted as mean ± SD. Statistical significance between groups was determined by Student’s <i>t</i>-test. ***<i>P</i> < 0.001, ns represents no significant difference. (B) Renal histological studies using PAS staining (400×). Compounds <b>12h</b> and <b>15j</b> obviously alleviated the fungal infections and inhibited filamentation <i>in vivo</i>. (C) Survival curve of compounds <b>12h</b> and <b>15j</b> in the IC murine models. Compounds <b>12h</b> and <b>15j</b> significantly extended MST of the infected mice. Statistical significance between groups was determined by the log-rank test. ***<i>P</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00102&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The right kidneys of the selected mice in each group were stained using periodic acid-Schiff (PAS) for histological studies. Evident infections were observed with abundant colonization of fungal cells, aggregation of inflammatory leukocytes and cavitation of kidney tissues for the saline group (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). After the treatment of compound <b>12h</b> or <b>15j</b>, the degree of infections was obviously alleviated. Consistently, therapeutic efficacy of the IP administration group was superior to that of the PO administration group. Additionally, in the saline group, <i>C. albicans</i> were mainly observed in the form of hyphae. In contrast, they predominantly exhibited the form of yeast in the compound-treated groups. The results were in good accordance with their <i>in vitro</i> inhibition of filamentation.</div><div class="NLM_p last">On the basis of the <i>in vivo</i> results, compounds <b>12h</b> (20 mg/kg, IP) and <b>15j</b> (20 mg/kg, IP) were further evaluated for the efficacy to extend the survival time of the infected mice. In the saline group, the median survival time (MST) was 10 days (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C). After the treatment of compound <b>12h</b> or <b>15j</b>, a prolonged survival time were observed with MST significantly increased to 20 and 16.5 days, respectively.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82134" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82134" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we designed and synthesized the first fungal CYP51/HDAC dual inhibitors for the treatment of azole-resistant <i>Candida</i> species. Most of them exhibited potent inhibitory activities against resistant fungi <i>in vitro</i>. In particular, compounds <b>12h</b> and <b>15j</b> were highly potent to treat resistant IC both <i>in vitro</i> and <i>in vivo</i>. It was observed that they were able to significantly decrease the renal fungal burden and prolong survival time in the azole-resistant IC murine models. The mechanism studies revealed that compounds <b>12h</b> and <b>15j</b> possessed antifungal activities by suppressing biosynthesis of ergosterol (CYP51 inhibition) and exerted anti-resistant profiles by downregulating the expression of CYP51 and the efflux pump (HDAC inhibition). Taken together, this proof-of-concept study provided an effective strategy to treat azole-resistant candidiasis. Further investigation of the antifungal mechanisms and structural optimization of the dual CYP51/HDAC inhibitors are currently in progress.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01480" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01480" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chemistry</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> General Methods</h4><div class="NLM_p">Column chromatography was carried out on 300–400 mesh silica gel. Thin-layer chromatography (TLC) analysis was performed using silica gel plates GF254 (Qindao Haiyang Chemical, China). NMR spectra were recorded on Bruker MSL-600 or MSL-300 with CDCl<sub>3</sub>, CD<sub>3</sub>OD, DMSO-<i>d</i><sub>6</sub> as the solvents and tetramethylsilane as the internal standard. Chemical shifts are expressed as δ values and coupling constants (<i>J</i>) are reported in hertz (Hz). Peak multiplicities are reported as the singlet (s), doublet (d), triplet (t), quadruplet (q), broad singlet (bs), and multiplet (m). The high-resolution mass spectrum (HRMS) was recorded on an API-3000 LC–MS spectrometer. The purities of the target compounds were obtained by RP-HPLC (Agilent 1260) with CH<sub>3</sub>OH/H<sub>2</sub>O (v/v, 7/3) as the mobile phase and C18 column as the stationary phase, and they are all above 95%.</div><div id="sec4_1_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> Methyl 4-(3-Cyanopropoxy)benzoate (<b>2a</b>)</h5><div class="NLM_p last">To a stirred solution of methyl 4-hydroxybenzoate (<b>1a</b>, 500 mg, 3.29 mmol, 1.0 equiv) and 4-bromobutanenitrile (730 mg, 4.93 mmol, 1.5 equiv) in DMF (20 mL), was added K<sub>2</sub>CO<sub>3</sub> (1.36 g, 9.87 mmol, 3.0 equiv). The mixture was stirred at 80 °C for 12 h. Then, the mixture was cooled to room temperature, filtered, and the filtrate was diluted with water (100 mL) and extracted with EtOAc (50 mL × 2). The combined organic layers were washed with brine (50 mL × 3), dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under the reduced pressure. The residue was purified <i>via</i> silica gel column chromatography (<i>n</i>-hexane/EtOAc, 10/1, v/v) to afford intermediate <b>2a</b> (599 mg, 83% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.99 (d, <i>J</i> = 8.8 Hz, 2H), 6.90 (d, <i>J</i> = 8.8 Hz, 2H), 4.12 (t, <i>J</i> = 5.7 Hz, 2H), 3.88 (s, 3H), 2.60 (t, <i>J</i> = 7.1 Hz, 2H), 2.21–2.09 (m, 2H).</div></div><div id="sec4_1_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> Methyl 4-(3-(1<i>H</i>-1,2,4-Triazol-3-yl)propoxy)benzoate (<b>3a</b>)</h5><div class="NLM_p">To a stirred solution of intermediate <b>2a</b> (500 mg, 2.28 mmol, 1.0 equiv) in anhydrous CH<sub>3</sub>OH (2 mL) was added 4 M HCl dioxane solution (15 mL). The mixture was stirred at room temperature for 1 h, and then, diethyl ether (100 mL) was added to the mixture. The precipitated white solid was filtered and used directly in the next step. To the stirred solution of the obtained white solid in CH<sub>3</sub>OH (20 mL), formhydrazide (151 mg, 2.51 mmol, 1.1 equiv) and Et<sub>3</sub>N (461 mg, 4.56 mmol, 2.0 equiv) were added. The mixture was stirred at room temperature for 18 h. Then, the solvent was evaporated under reduced pressure, and the residual mixture was purified <i>via</i> silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH, 80/1, v/v) to afford intermediate <b>3a</b> (316 mg, 53% yield) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.05 (s, 1H), 7.97 (d, <i>J</i> = 8.8 Hz, 2H), 6.87 (d, <i>J</i> = 8.8 Hz, 2H), 4.03 (t, <i>J</i> = 5.9 Hz, 2H), 3.89 (s, 3H), 2.93 (t, <i>J</i> = 7.4 Hz, 2H), 2.16–2.05 (m, 2H).</div><div class="NLM_p">Oxirane <b>4</b> was prepared according to the previous reported method.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><div class="NLM_p last">To a stirred solution of intermediate <b>3a</b> (800 mg, 3.06 mmol, 1.0 equiv) and oxirane <b>4</b> (1.12 g, 3.37 mmol, 1.1 equiv) in DMF (20 mL) was added K<sub>2</sub>CO<sub>3</sub> (845 mg, 6.12 mmol, 2.0 equiv). The mixture was stirred at 80 °C for 12 h, and then, the mixture was cooled to room temperature, filtered, and the filtrate was diluted with water (50 mL) and extracted with EtOAc (50 mL × 2). The combined organic layers were washed with brine (50 mL × 3), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. TLC analysis of the residual mixture indicated that the reaction produced two main products with similar <i>R</i><sub><i>f</i></sub> values. The residual mixture was purified <i>via</i> silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH, 100/1, v/v) to afford intermediate <b>5a</b> (472 mg, 31% yield) and <b>6a</b> (307 mg, 20% yield) as a pale yellow solid. Intermediate <b>5a</b> and <b>6a</b> had similar 1D-NMR, whose chemical structures were further determined by 2D-NMR (Figure S1 in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00102/suppl_file/jm0c00102_si_001.pdf" class="ext-link">Supporting Information</a>).</div></div><div id="sec4_1_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> Methyl 4-(3-(1-(2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)-1<i>H</i>-1,2,4-triazol-3-yl)propoxy)benzoate (<b>5a</b>)</h5><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.04 (s, 1H), 7.93 (d, <i>J</i> = 8.8 Hz, 2H), 7.92 (s, 1H), 7.82 (s, 1H), 7.39–7.34 (m, 1H), 6.85 (d, <i>J</i> = 8.8 Hz, 2H), 6.79–6.73 (m, 1H), 6.72–6.66 (m, 1H), 5.56 (s, 1H), 4.66 (d, <i>J</i> = 14.4 Hz, 1H), 4.65 (d, <i>J</i> = 14.4 Hz, 1H), 4.45 (d, <i>J</i> = 14.4 Hz, 1H), 4.33 (d, <i>J</i> = 14.4 Hz, 1H), 4.00–3.91 (m, 2H), 3.84 (s, 3H), 2.82 (t, <i>J</i> = 7.4 Hz, 2H), 2.16–2.10 (m, 2H).</div></div><div id="sec4_1_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> Methyl 4-(3-(1-(2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)-1<i>H</i>-1,2,4-triazol-5-yl)propoxy)benzoate (<b>6a</b>)</h5><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.11 (s, 1H), 7.97 (d, <i>J</i> = 8.9 Hz, 2H), 7.81 (s, 1H), 7.74 (s, 1H), 7.45–7.39 (m, 1H), 6.87 (d, <i>J</i> = 8.9 Hz, 2H), 6.78–6.75 (m, 1H), 6.74–6.70 (m, 1H), 5.82 (s, 1H), 4.71 (d, <i>J</i> = 14.4 Hz, 1H), 4.67 (d, <i>J</i> = 14.4 Hz, 1H), 4.58 (d, <i>J</i> = 14.4 Hz, 1H), 4.23 (d, <i>J</i> = 14.4 Hz, 1H), 4.07–3.98 (m, 2H), 3.87 (s, 3H), 2.84 (t, <i>J</i> = 7.5 Hz, 2H), 2.26–2.13 (m, 2H).</div></div><div id="sec4_1_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> 4-(3-(1-(2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)-1<i>H</i>-1,2,4-triazol-3-yl)propoxy)-<i>N</i>-hydroxybenzamide (<b>7a</b>)</h5><div class="NLM_p">To a stirred solution of hydroxyl amine hydrochloride (2.30 g, 33.1 mmol) in CH<sub>3</sub>OH (20 mL) was added KOH (2.80 g, 49.9 mmol), the mixture was stirred at 0 °C for 30 min. The precipitate was filtered off and the filtrate (freshly prepared NH<sub>2</sub>OH in CH<sub>3</sub>OH) was added dropwise to a round-bottom flask containing intermediate <b>5a</b> (250 mg, 0.502 mmol). The new mixture was stirred at room temperature for 5 h, followed by concentration under reduced pressure. Water (50 mL) was added to the residue and acidified to pH 7 by 1 M HCl. Then, the mixture was extracted with EtOAc (50 mL × 3). The combined organic layers were dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure; then, the residual mixture was purified <i>via</i> silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH, 35/1, v/v) to afford compound <b>7a</b> (198 mg, 79% yield) as a pale yellow solid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.07 (s, 1H), 8.91 (s, 1H), 8.33 (s, 1H), 8.21 (s, 1H), 7.80 (s, 1H), 7.72 (d, <i>J</i> = 8.8 Hz, 2H), 7.21–7.16 (m, 2H), 6.94 (d, <i>J</i> = 8.8 Hz, 2H), 6.87–6.83 (m, 1H), 6.35 (s, 1H), 4.74 (d, <i>J</i> = 14.5 Hz, 1H), 4.65 (d, <i>J</i> = 14.5 Hz, 1H), 4.57 (d, <i>J</i> = 14.5 Hz, 1H), 4.49 (d, <i>J</i> = 14.5 Hz, 1H), 3.96–3.91 (m, 2H), 2.64 (t, <i>J</i> = 7.3 Hz, 2H), 1.97–1.92 (m, 2H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 165.90, 164.15, 163.88 (dd, <i>J</i> = 246.6, 12.6 Hz), 162.62, 160.95 (dd, <i>J</i> = 247.2, 12.3 Hz), 152.63, 147.26, 146.95, 131.55 (dd, <i>J</i> = 8.7, 6.0 Hz), 130.4, 126.67, 125.36 (d, <i>J</i> = 12.8 Hz), 115.86, 112.66 (d, <i>J</i> = 20.4 Hz), 105.70 (t, <i>J</i> = 26.8 Hz), 75.57 (d, <i>J</i> = 4.6 Hz), 68.47, 56.67, 50.43, 29.04, 25.7. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>23</sub>H<sub>24</sub>F<sub>2</sub>N<sub>7</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 500.1852; found, 500.1852.</div><div class="NLM_p last">Compounds <b>7b</b> and <b>7c</b> were synthesized using the similar method described for the preparation of compound <b>7a</b>.</div></div><div id="sec4_1_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> 2-(4-(3-(1-(2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)-1<i>H</i>-1,2,4-triazol-3-yl)propoxy)phenyl)-<i>N</i>-hydroxyacetamide (<b>7b</b>)</h5><div class="NLM_p last">The product was obtained as a pale yellow solid in 82% yield. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.30 (s, 1H), 8.23 (s, 1H), 7.83 (s, 1H), 7.29–7.22 (m, 1H), 7.17 (d, <i>J</i> = 8.7 Hz, 2H), 6.99–6.93 (m, 1H), 6.82 (d, <i>J</i> = 8.7 Hz, 2H), 6.78–6.72 (m, 1H), 4.82 (d, <i>J</i> = 14.6 Hz, 1H), 4.77 (d, <i>J</i> = 14.6 Hz, 1H), 4.63 (d, <i>J</i> = 14.5 Hz, 1H), 4.58 (d, <i>J</i> = 14.5 Hz, 1H), 3.92–3.83 (m, 2H), 3.33 (s, 2H), 2.78 (t, <i>J</i> = 7.1 Hz, 2H), 2.08–2.03 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>26</sub>F<sub>2</sub>N<sub>7</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 514.2009; found, 514.1996.</div></div><div id="sec4_1_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> 4-(4-(1-(2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)-1<i>H</i>-1,2,4-triazol-3-yl)butoxy)-<i>N</i>-hydroxybenzamide (<b>7c</b>)</h5><div class="NLM_p last">The product was obtained as a pale yellow solid in 73% yield. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.35 (s, 1H), 8.23 (s, 1H), 7.96 (d, <i>J</i> = 8.5 Hz, 2H), 7.85 (s, 1H), 7.31–7.25 (m, 1H), 7.01–6.97 (m, 1H), 6.96 (d, <i>J</i> = 8.5 Hz, 2H), 6.81–6.75 (m, 1H), 4.84 (d, <i>J</i> = 14.6 Hz, 1H), 4.81 (d, <i>J</i> = 14.6 Hz, 1H), 4.70 (d, <i>J</i> = 14.6 Hz, 1H), 4.55 (d, <i>J</i> = 14.6 Hz, 1H), 4.01 (t, <i>J</i> = 6.2 Hz, 2H), 2.66 (t, <i>J</i> = 7.2 Hz, 2H), 1.82–1.74 (m, 2H), 1.71–1.62 (m, 2H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ 165.23, 161.81, 161.63 (dd, <i>J</i> = 249.1, 12.6 Hz), 160.44, 157.92 (dd, <i>J</i> = 246.7, 12.0 Hz), 148.84, 143.59, 143.40, 128.07 (dd, <i>J</i> = 9.2, 5.6 Hz), 126.98, 122.56, 121.26 (dd, <i>J</i> = 13.0, 2.9 Hz), 112.46, 109.37 (d, <i>J</i> = 20.8 Hz), 102.18 (t, <i>J</i> = 27.0 Hz), 72.74 (d, <i>J</i> = 4.5 Hz), 65.82, 53.65, 53.45, 26.46, 25.27, 22.72. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>26</sub>F<sub>2</sub>N<sub>7</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 514.2009; found, 514.2021.</div></div><div id="sec4_1_1_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> 4-(3-(1-(2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)-1<i>H</i>-1,2,4-triazol-5-yl)propoxy)-<i>N</i>-hydroxybenzamide (<b>8a</b>)</h5><div class="NLM_p">Compound <b>8a</b> was prepared from intermediate <b>6a</b> using the similar method as described for the synthesis of compound <b>7a</b> from intermediate <b>5a</b>. Compound <b>8a</b> was obtained in 187 mg yield. Compound <b>8a</b> (187 mg, 75% yield) was obtained as a pale yellow solid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.07 (s, 1H), 8.91 (s, 1H), 8.33 (s, 1H), 7.78 (s, 1H), 7.73 (d, <i>J</i> = 8.7 Hz, 2H), 7.72 (s, 1H), 7.22–7.16 (m, 2H), 6.97 (d, st <i>J</i> = 8.7 Hz, 2H), 6.91–6.85 (m, 1H), 6.28 (s, 1H), 4.82 (d, <i>J</i> = 14.5 Hz, 1H), 4.65 (d, <i>J</i> = 14.5 Hz, 1H), 4.60 (d, <i>J</i> = 14.7 Hz, 1H), 4.51 (d, <i>J</i> = 14.7 Hz, 1H), 4.11–4.04 (m, 2H), 2.86–2.77 (m, 2H), 2.15–2.04 (m, 2H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 165.85, 163.89 (dd, <i>J</i> = 246.3, 12.6 Hz), 162.54, 161.02 (dd, <i>J</i> = 247.2, 12.3 Hz), 158.21, 152.57, 151.63, 146.92, 131.60 (dd, <i>J</i> = 8.1, 6.4 Hz), 130.47, 126.75, 125.56 (d, <i>J</i> = 10.8 Hz), 115.90, 112.71 (d, <i>J</i> = 20.5 Hz), 105.73 (t, <i>J</i> = 27.0 Hz), 76.29 (d, <i>J</i> = 4.6 Hz), 68.56, 56.53, 55.58, 28.25, 23.40. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>23</sub>H<sub>24</sub>F<sub>2</sub>N<sub>7</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 500.1852; found, 500.1852.</div><div class="NLM_p last">Compounds <b>8b</b> and <b>8c</b> were synthesized by the similar method described for the preparation of compound <b>8a</b>.</div></div><div id="sec4_1_1_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> 2-(4-(3-(1-(2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)-1<i>H</i>-1,2,4-triazol-5-yl)propoxy)phenyl)-<i>N</i>-hydroxyacetamide (<b>8b</b>)</h5><div class="NLM_p last">The product was obtained as a pale yellow solid in 82% yield. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.32 (s, 1H), 7.80 (s, 1H), 7.75 (s, 1H), 7.33–7.28 (m, 1H), 7.19 (d, <i>J</i> = 8.6 Hz, 2H), 6.97–6.92 (m, 1H), 6.81 (d, <i>J</i> = 8.6 Hz, 2H), 6.81–6.79 (m, 1H), 4.88 (d, <i>J</i> = 14.7 Hz, 1H), 4.70 (d, <i>J</i> = 14.7 Hz, 1H), 4.69 (d, <i>J</i> = 14.5 Hz, 1H), 4.52 (d, <i>J</i> = 14.5 Hz, 1H), 3.99–3.92 (m, 2H), 3.33 (s, 2H), 2.96–2.84 (m, 2H), 2.18–2.12 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>26</sub>F<sub>2</sub>N<sub>7</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 514.2009; found, 514.2021.</div></div><div id="sec4_1_1_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> 4-(4-(1-(2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)-1<i>H</i>-1,2,4-triazol-5-yl)butoxy)-<i>N</i>-hydroxybenzamide (<b>8c</b>)</h5><div class="NLM_p">The product was obtained as a pale yellow solid in 84% yield. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.35 (s, 1H), 7.94 (d, <i>J</i> = 8.9 Hz, 2H), 7.81 (s, 1H), 7.74 (s, 1H), 7.32–7.25 (m, 1H), 7.02–6.91 (m, 1H), 6.94 (d, <i>J</i> = 8.9 Hz, 2H), 6.83–6.75 (m, 1H), 4.91 (d, <i>J</i> = 14.7 Hz, 1H), 4.73 (d, <i>J</i> = 14.7 Hz, 1H), 4.70 (d, <i>J</i> = 14.6 Hz, 1H), 4.57 (d, <i>J</i> = 14.6 Hz, 1H), 4.03 (t, <i>J</i> = 5.9 Hz, 2H), 2.80–2.70 (m, 2H), 1.93–1.86 (m, 2H), 1.86–1.76 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>26</sub>F<sub>2</sub>N<sub>7</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 514.2009; found, 514.1996.</div><div class="NLM_p last">Starting materials <b>9a–j</b> and intermediate <b>10</b> were prepared according to the previous reported method.<a onclick="showRef(event, 'ref37 ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref37 ref48 ref49 ref50">(37,48−50)</a></div></div><div id="sec4_1_1_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> Methyl 4-(3-Bromopropyl)benzoate (<b>9g</b>)</h5><div class="NLM_p last">The product was obtained as yellow liquid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.97 (d, <i>J</i> = 8.2 Hz, 2H), 7.27 (d, <i>J</i> = 8.2 Hz, 2H), 3.91 (s, 3H), 3.39 (t, <i>J</i> = 6.5 Hz, 2H), 2.84 (t, <i>J</i> = 7.4 Hz, 2H), 2.29–2.13 (m, 2H).</div></div><div id="sec4_1_1_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> Methyl 4-(4-Bromobutyl)benzoate (<b>9h</b>)</h5><div class="NLM_p last">The product was obtained as yellow liquid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.96 (d, <i>J</i> = 8.2 Hz, 2H), 7.25 (d, <i>J</i> = 8.2 Hz, 2H), 3.90 (s, 3H), 3.42 (t, <i>J</i> = 6.4 Hz, 2H), 2.70 (t, <i>J</i> = 7.3 Hz, 2H), 1.93–1.76 (m, 4H).</div></div><div id="sec4_1_1_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> Methyl 2-(4-(3-Bromopropoxy)phenyl)acetate (<b>9j</b>)</h5><div class="NLM_p last">The product was obtained as colorless oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.23 (d, <i>J</i> = 8.5 Hz, 2H), 6.89 (d, <i>J</i> = 8.5 Hz, 2H), 4.12 (t, <i>J</i> = 5.8 Hz, 2H), 3.71 (s, 3H), 3.63 (t, <i>J</i> = 6.4 Hz, 2H), 3.58 (s, 2H), 2.36–2.31 (m, <i>J</i> = 6.1 Hz, 2H).</div></div><div id="sec4_1_1_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> <i>tert</i>-Butyl Methyl(4-(5-oxo-1,5-dihydro-4<i>H</i>-1,2,4-triazol-4-yl)benzyl)carbamate (<b>10</b>)</h5><div class="NLM_p last">The product was obtained as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 10.59 (s, 1H), 7.70 (s, 1H), 7.51 (d, <i>J</i> = 8.0 Hz, 2H), 7.37 (d, <i>J</i> = 8.0 Hz, 2H), 4.45 (s, 2H), 2.81 (s, 3H), 1.48 (s, 9H).</div></div><div id="sec4_1_1_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> 4-(4-(4-(((2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)(methyl)amino)methyl)phenyl)-5-oxo-4,5-dihydro-1<i>H</i>-1,2,4-triazol-1-yl)-<i>N</i>-hydroxybutanamide (<b>12a</b>)</h5><div class="NLM_p">To a stirred solution of intermediate <b>9a</b> (297 mg, 1.64 mmol, 1.0 equiv) and intermediate <b>10</b> (500 mg, 1.64 mmol, 1.0 equiv) in DMF (10 mL) was added K<sub>2</sub>CO<sub>3</sub> (680 mg, 4.93 mmol, 3.0 equiv), the mixture was stirred at 80 °C for 2 h. After being cooled to room temperature, the mixture was filtered, and the filtrate was diluted with water (50 mL) and extracted with EtOAc (50 mL × 2). The combined organic layers were washed with brine (50 mL × 3), dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residual mixture was purified <i>via</i> silica gel column chromatography (<i>n</i>-hexane/EtOAc, 5/1, v/v) to afford intermediate <b>11a</b> (515 mg, 78% yield) as a white solid.<sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.69 (s, 1H), 7.50 (d, <i>J</i> = 7.8 Hz, 2H), 7.32 (d, <i>J</i> = 7.8 Hz, 2H), 4.43 (s, 2H), 3.91 (t, <i>J</i> = 6.7 Hz, 2H), 3.66 (s, 3H), 2.84 (s, 3H), 2.42 (t, <i>J</i> = 7.4 Hz, 2H), 2.16–2.09 (m, 2H), 1.46 (s, 9H).</div><div class="NLM_p">To a stirred solution of intermediate <b>11a</b> (500 mg, 1.24 mmol, 1.0 equiv) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was added CF<sub>3</sub>CO<sub>2</sub>H (5 mL), the mixture was stirred at room temperature for 2 h. Then solvent was removed under reduced pressure and the residue was dissolved in DMF (10 mL). Oxirane <b>4</b> (454 mg, 1.36 mmol, 1.1 equiv) and K<sub>2</sub>CO<sub>3</sub> (513 mg, 3.72 mmol, 3.0 equiv) were added into the solution, and the mixture was stirred at 80 °C for 12 h. The mixture was cooled to room temperature, filtered and the filtrate was diluted with water (50 mL) and extracted with EtOAc (50 mL × 2). The combined organic layers were washed with brine (50 mL × 3), dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residual mixture was added into the freshly prepared NH<sub>2</sub>OH solution in CH<sub>3</sub>OH. The mixture was stirred at room temperature for 5 h, and concentrated under reduced pressure. Water (50 mL) was added to the residue and acidified to pH 7 with 1 M HCl. Then, the mixture was extracted with EtOAc (50 mL × 3). The combined organic layers were dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure; then, the residual mixture was purified <i>via</i> silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH, 40/1, v/v) to afford compound <b>12a</b> (285 mg, 42% yield) as a pale yellow solid. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.29 (s, 1H), 8.16 (s, 1H), 7.74 (s, 1H), 7.57–7.52 (m, 1H), 7.51 (d, <i>J</i> = 8.5 Hz, 2H), 7.30 (d, <i>J</i> = 8.5 Hz, 2H), 6.96–6.90 (m, 1H), 6.90–6.82 (m, 1H), 4.59 (d, <i>J</i> = 14.6 Hz, 1H), 4.56 (d, <i>J</i> = 14.6 Hz, 1H), 3.88 (t, <i>J</i> = 6.6 Hz, 2H), 3.56 (s, 2H), 3.09 (d, <i>J</i> = 13.8 Hz, 1H), 2.88 (d, <i>J</i> = 13.8 Hz, 1H), 2.19 (t, <i>J</i> = 7.3 Hz, 2H), 2.15 (s, 3H), 2.12–2.07 (m, 2H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ 171.83, 164.20 (dd, <i>J</i> = 247.7, 12.2 Hz), 160.66 (dd, <i>J</i> = 246.2, 11.8 Hz), 153.71, 151.21, 146.14, 139.78, 136.47, 134.23, 131.17, 131.03 (dd, <i>J</i> = 9.1, 6.1 Hz), 127.37 (d, <i>J</i> = 12.7 Hz), 123.51, 112.09 (d, <i>J</i> = 20.8 Hz), 104.97 (t, <i>J</i> = 26.9 Hz), 75.15 (d, <i>J</i> = 5.2 Hz), 63.68, 63.13, 57.45, 45.88, 44.55, 30.78, 25.76. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>25</sub>H<sub>29</sub>F<sub>2</sub>N<sub>8</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 543.2274; found, 543.2288.</div><div class="NLM_p last">Compounds <b>12b–j</b> were synthesized using the similar method of the preparation of <b>12a</b>.</div></div><div id="sec4_1_1_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> 5-(4-(4-(((2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)(methyl)amino)methyl)phenyl)-5-oxo-4,5-dihydro-1<i>H</i>-1,2,4-triazol-1-yl)-<i>N</i>-hydroxypentanamide (<b>12b</b>)</h5><div class="NLM_p last">The product was obtained as a pale yellow solid in 47% yield. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.27 (s, 1H), 8.13 (s, 1H), 7.72 (s, 1H), 7.55–7.49 (m, 1H), 7.48 (d, <i>J</i> = 7.5 Hz, 2H), 7.28 (d, <i>J</i> = 7.5 Hz, 2H), 6.93–6.87 (m, 1H), 6.86–6.79 (m, 1H), 4.55 (s, 2H), 3.84 (t, <i>J</i> = 6.6 Hz, 2H), 3.52 (s, 2H), 3.06 (d, <i>J</i> = 13.9 Hz, 1H), 2.85 (d, <i>J</i> = 13.9 Hz, 1H), 2.14 (t, <i>J</i> = 7.4 Hz, 2H), 2.12 (s, 3H), 1.85–1.74 (m, 2H), 1.72–1.61 (m, 2H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ 169.53, 161.27 (dd, <i>J</i> = 247.4, 12.4 Hz), 157.76 (dd, <i>J</i> = 246.3, 11.8 Hz), 150.74, 148.28, 143.22, 137.06, 133.43, 131.28, 128.22, 128.11 (d, <i>J</i> = 9.0 Hz), 124.51 (dd, <i>J</i> = 12.9, 3.2 Hz), 120.55, 109.14 (d, <i>J</i> = 20.8 Hz), 102.03 (t, <i>J</i> = 26.9 Hz), 72.32 (d, <i>J</i> = 5.3 Hz), 60.81, 60.37, 54.56, 43.11, 41.64, 30.21, 26.06, 20.74. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>26</sub>H<sub>31</sub>F<sub>2</sub>N<sub>8</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 557.2431; found, 557.2443.</div></div><div id="sec4_1_1_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> 6-(4-(4-(((2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)(methyl)amino)methyl)phenyl)-5-oxo-4,5-dihydro-1<i>H</i>-1,2,4-triazol-1-yl)-<i>N</i>-hydroxyhexanamide (<b>12c</b>)</h5><div class="NLM_p last">The product was obtained as a pale yellow solid in 49% yield. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.31 (s, 1H), 8.17 (s, 1H), 7.74 (s, 1H), 7.55–7.51 (m, 1H), 7.50 (d, <i>J</i> = 8.4 Hz, 2H), 7.29 (d, <i>J</i> = 8.4 Hz, 2H), 6.93–6.88 (m, 1H), 6.88–6.81 (m, 1H), 4.58 (s, 2H), 3.84 (t, <i>J</i> = 6.9 Hz, 2H), 3.56 (d, <i>J</i> = 13.5 Hz, 1H), 3.53 (d, <i>J</i> = 13.5 Hz, 1H), 3.09 (d, <i>J</i> = 13.8 Hz, 1H), 2.88 (d, <i>J</i> = 13.8 Hz, 1H), 2.11 (t, <i>J</i> = 7.4 Hz, 2H), 1.83–1.75 (m, 2H), 1.72–1.65 (m, 2H), 1.43–1.36 (m, 2H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ 171.30, 162.75 (dd, <i>J</i> = 247.6, 12.3 Hz), 159.24 (dd, <i>J</i> = 246.5, 11.8 Hz), 152.21, 149.78, 144.71, 138.50, 134.84, 132.78, 129.71, 129.62 (dd, <i>J</i> = 9.2, 6.5 Hz), 125.99 (dd, <i>J</i> = 12.7, 3.1 Hz), 122.04, 110.64 (d, <i>J</i> = 20.6 Hz), 103.53 (t, <i>J</i> = 26.9 Hz), 73.80 (d, <i>J</i> = 5.3 Hz), 62.29, 61.87, 56.06 (d, <i>J</i> = 4.4 Hz), 44.95, 43.13, 32.17, 27.79, 25.59, 24.80. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>27</sub>H<sub>33</sub>F<sub>2</sub>N<sub>8</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 571.2587; found, 571.2601.</div></div><div id="sec4_1_1_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> 7-(4-(4-(((2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)(methyl)amino)methyl)phenyl)-5-oxo-4,5-dihydro-1<i>H</i>-1,2,4-triazol-1-yl)-<i>N</i>-hydroxyheptanamide (<b>12d</b>)</h5><div class="NLM_p last">The product was obtained as a pale yellow solid in 55% yield. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.31 (s, 1H), 8.18 (s, 1H), 7.74 (s, 1H), 7.56–7.52 (m, 1H), 7.50 (d, <i>J</i> = 8.3 Hz, 2H), 7.30 (d, <i>J</i> = 8.3 Hz, 2H), 6.94–6.88 (m, 1H), 6.88–6.83 (m, 1H), 4.58 (s, 2H), 3.83 (t, <i>J</i> = 6.9 Hz, 2H), 3.57 (d, <i>J</i> = 13.6 Hz, 1H), 3.54 (d, <i>J</i> = 13.6 Hz, 1H), 3.09 (d, <i>J</i> = 13.7 Hz, 1H), 2.88 (d, <i>J</i> = 13.7 Hz, 1H), 2.10 (t, <i>J</i> = 7.4 Hz, 2H), 1.83–1.75 (m, 2H), 1.71–1.60 (m, 2H), 1.42–1.36 (m, 4H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ 170.02, 161.28 (dd, <i>J</i> = 247.6, 12.2 Hz), 157.77 (dd, <i>J</i> = 246.4, 11.8 Hz), 150.75, 148.30, 143.23, 137.05, 133.36, 131.31, 128.25, 128.15 (dd, <i>J</i> = 9.4, 6.3 Hz), 124.51 (dd, <i>J</i> = 12.9, 3.2 Hz), 120.57, 109.15 (d, <i>J</i> = 18.8 Hz), 102.04 (t, <i>J</i> = 26.9 Hz), 72.33 (d, <i>J</i> = 5.3 Hz), 60.82, 60.40, 54.59 (d, <i>J</i> = 4.6 Hz), 43.52, 41.66, 30.75, 26.66, 26.50, 24.25, 23.67. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>28</sub>H<sub>35</sub>F<sub>2</sub>N<sub>8</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 585.2744; found, 585.2749.</div></div><div id="sec4_1_1_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> 8-(4-(4-(((2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)(methyl)amino)methyl)phenyl)-5-oxo-4,5-dihydro-1<i>H</i>-1,2,4-triazol-1-yl)-<i>N</i>-hydroxyoctanamide (<b>12e</b>)</h5><div class="NLM_p last">The product was obtained as a pale yellow solid in 33% yield. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.31 (s, 1H), 8.18 (s, 1H), 7.74 (s, 1H), 7.57–7.51 (m, 1H), 7.50 (d, <i>J</i> = 8.4 Hz, 2H), 7.30 (d, <i>J</i> = 8.4 Hz, 2H), 6.94–6.89 (m, 1H), 6.88–6.83 (m, 1H), 4.59 (s, 2H), 3.83 (t, <i>J</i> = 7.0 Hz, 2H), 3.56 (d, <i>J</i> = 13.7 Hz, 1H), 3.54 (d, <i>J</i> = 13.7 Hz, 1H), 3.09 (d, <i>J</i> = 13.7 Hz, 1H), 2.88 (d, <i>J</i> = 13.7 Hz, 1H), 2.15 (s, 3H), 2.09 (t, <i>J</i> = 7.4 Hz, 2H), 1.81–1.74 (m, 2H), 1.65–1.58 (m, 2H), 1.42–1.31 (m, 6H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ 171.54, 162.74 (dd, <i>J</i> = 247.6, 12.2 Hz), 159.23 (dd, <i>J</i> = 246.3, 11.9 Hz), 152.20, 149.78, 144.71, 138.49, 134.79, 132.78, 129.73, 129.62 (dd, <i>J</i> = 9.1, 6.4 Hz), 125.99 (d, <i>J</i> = 9.7 Hz), 122.01, 110.64 (d, <i>J</i> = 18.8 Hz), 103.53 (t, <i>J</i> = 26.9 Hz), 73.81 (d, <i>J</i> = 5.4 Hz), 62.30, 61.87, 56.08, 45.04, 43.15, 32.30, 28.50, 28.30, 27.71, 25.92, 25.18. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>29</sub>H<sub>37</sub>F<sub>2</sub>N<sub>8</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 599.2900; found, 599.2902.</div></div><div id="sec4_1_1_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> 9-(4-(4-(((2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)(methyl)amino)methyl)phenyl)-5-oxo-4,5-dihydro-1<i>H</i>-1,2,4-triazol-1-yl)-<i>N</i>-hydroxynonanamide (<b>12f</b>)</h5><div class="NLM_p last">The product was obtained as a pale yellow solid in 42% yield. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.31 (s, 1H), 8.64 (s, 1H), 8.42 (s, 1H), 8.30 (s, 1H), 7.76 (s, 1H), 7.55 (d, <i>J</i> = 8.4 Hz, 2H), 7.47–7.41 (m, 1H), 7.18 (d, <i>J</i> = 8.4 Hz, 2H), 7.17–7.14 (m, 1H), 7.01–6.96 (m, 1H), 5.76 (s, 1H), 4.57 (d, <i>J</i> = 14.4 Hz, 1H), 4.52 (d, <i>J</i> = 14.4 Hz, 1H), 3.72 (t, <i>J</i> = 6.8 Hz, 2H), 3.61 (d, <i>J</i> = 13.7 Hz, 1H), 3.42 (d, <i>J</i> = 13.7 Hz, 1H), 3.06 (d, <i>J</i> = 14.0 Hz, 1H), 2.76 (d, <i>J</i> = 14.0 Hz, 1H), 2.08 (s, 3H), 1.93 (t, <i>J</i> = 7.3 Hz, 2H), 1.71–1.65 (m, 2H), 1.51–1.44 (m, 2H), 1.30–1.25 (m, 8H). HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>30</sub>H<sub>39</sub>F<sub>2</sub>N<sub>8</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 613.3057; found, 613.3048.</div></div><div id="sec4_1_1_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> 4-(3-(4-(4-(((2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)(methyl)amino)methyl)phenyl)-5-oxo-4,5-dihydro-1<i>H</i>-1,2,4-triazol-1-yl)propyl)-<i>N</i>-hydroxybenzamide (<b>12g</b>)</h5><div class="NLM_p last">The product was obtained as a pale yellow solid in 30% yield. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.30 (s, 1H), 8.12 (s, 1H), 7.74 (s, 1H), 7.66 (d, <i>J</i> = 7.8 Hz, 2H), 7.57–7.50 (m, 1H), 7.46 (d, <i>J</i> = 7.8 Hz, 2H), 7.33 (d, <i>J</i> = 7.6 Hz, 2H), 7.30 (d, <i>J</i> = 7.8 Hz, 2H), 6.94–6.89 (m, 1H), 6.88–6.80 (m, 1H), 4.58 (s, 2H), 3.88 (t, <i>J</i> = 6.4 Hz, 2H), 3.55 (s, 2H), 3.08 (d, <i>J</i> = 13.6 Hz, 1H), 2.87 (d, <i>J</i> = 13.6 Hz, 1H), 2.77 (t, <i>J</i> = 7.4 Hz, 2H), 2.21–2.15 (m, 2H), 2.15 (s, 3H). HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>31</sub>H<sub>33</sub>F<sub>2</sub>N<sub>8</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 619.2587; found, 619.2575.</div></div><div id="sec4_1_1_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> 4-(4-(4-(4-(((2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)(methyl)amino)methyl)phenyl)-5-oxo-4,5-dihydro-1<i>H</i>-1,2,4-triazol-1-yl)butyl)-<i>N</i>-hydroxybenzamide (<b>12h</b>)</h5><div class="NLM_p last">The product was obtained as a pale yellow solid in 33% yield. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.06 (s, 1H), 8.90 (s, 1H), 8.35 (s, 1H), 8.23 (s, 1H), 7.69 (s, 1H), 7.60 (d, <i>J</i> = 8.1 Hz, 2H), 7.48 (d, <i>J</i> = 8.3 Hz, 2H), 7.44–7.33 (m, 1H), 7.20 (d, <i>J</i> = 8.1 Hz, 2H), 7.11 (d, <i>J</i> = 8.3 Hz, 2H), 7.10–7.05 (m, 1H), 6.93–6.87 (m, 1H), 5.70 (s, 1H), 4.49 (d, <i>J</i> = 14.3 Hz, 1H), 4.45 (d, <i>J</i> = 14.3 Hz, 1H), 3.69 (t, <i>J</i> = 6.8 Hz, 2H), 3.53 (d, <i>J</i> = 13.3 Hz, 1H), 3.34 (d, <i>J</i> = 13.3 Hz, 1H), 2.98 (d, <i>J</i> = 13.7 Hz, 1H), 2.69 (d, <i>J</i> = 13.7 Hz, 1H), 2.59 (t, <i>J</i> = 7.5 Hz, 2H), 2.00 (s, 3H), 1.67–1.58 (m, 2H), 1.58–1.49 (m, 2H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.74, 162.14 (dd, <i>J</i> = 245.2, 12.6 Hz), 159.41 (dd, <i>J</i> = 246.8, 12.1 Hz), 151.61, 150.95, 145.82, 145.39, 138.43, 135.24, 133.22, 130.85, 130.34, 129.80, 128.74, 127.39, 126.62 (d, <i>J</i> = 12.1 Hz), 121.60, 111.12 (d, <i>J</i> = 20.6 Hz), 104.19 (t, <i>J</i> = 26.7 Hz), 75.60 (d, <i>J</i> = 5.0 Hz), 63.40, 62.37, 56.38, 44.79, 43.98, 34.76, 28.16, 28.06. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>32</sub>H<sub>35</sub>F<sub>2</sub>N<sub>8</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 633.2744; found, 633.2743.</div></div><div id="sec4_1_1_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> 2-(4-(2-(4-(4-(((2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)(methyl)amino)methyl)phenyl)-5-oxo-4,5-dihydro-1<i>H</i>-1,2,4-triazol-1-yl)ethoxy)phenyl)-<i>N</i>-hydroxyacetamide (<b>12i</b>)</h5><div class="NLM_p last">The product was obtained as a pale yellow solid in 47% yield. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.29 (s, 1H), 8.15 (s, 1H), 7.72 (s, 1H), 7.54–7.48 (m, 1H), 7.47 (d, <i>J</i> = 8.4 Hz, 2H), 7.29 (d, <i>J</i> = 8.4 Hz, 2H), 7.18 (d, <i>J</i> = 8.6 Hz, 2H), 6.93–6.88 (m, 1H), 6.86 (d, <i>J</i> = 8.6 Hz, 2H), 6.85–6.82 (m, 1H), 4.57 (s, 2H), 4.32 (t, <i>J</i> = 5.4 Hz, 2H), 4.20 (t, <i>J</i> = 5.4 Hz, 2H), 3.54 (d, <i>J</i> = 13.8 Hz, 1H), 3.52 (d, <i>J</i> = 13.8 Hz, 1H), 3.32 (s, 2H), 3.07 (d, <i>J</i> = 13.7 Hz, 1H), 2.86 (d, <i>J</i> = 13.7 Hz, 1H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ 168.12, 161.27 (dd, <i>J</i> = 247.6, 12.3 Hz), 157.74 (dd, <i>J</i> = 246.6, 11.8 Hz), 156.11, 151.03, 148.30, 143.22, 136.86, 133.68, 131.26, 128.27, 128.18, 128.07, 126.10, 124.42 (d, <i>J</i> = 13.6 Hz), 120.61, 113.00, 109.17 (d, <i>J</i> = 22.5 Hz), 102.06 (t, <i>J</i> = 26.9 Hz), 72.26, 63.42, 60.32, 54.54, 46.96, 43.37, 41.64, 36.84. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>31</sub>H<sub>33</sub>F<sub>2</sub>N<sub>8</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 635.2536; found, 635.2533.</div></div><div id="sec4_1_1_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> 2-(4-(3-(4-(4-(((2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)(methyl)amino)methyl)phenyl)-5-oxo-4,5-dihydro-1<i>H</i>-1,2,4-triazol-1-yl)propoxy)phenyl)-<i>N</i>-hydroxyacetamide (<b>12j</b>)</h5><div class="NLM_p">The product was obtained as a pale yellow solid in 43% yield. <sup>1</sup>H NMR (600 MHz, DMSO): δ 10.59 (s, 1H), 8.79 (s, 1H), 8.43 (s, 1H), 8.30 (s, 1H), 7.76 (s, 1H), 7.54 (d, <i>J</i> = 8.4 Hz, 2H), 7.50–7.41 (m, 1H), 7.21–7.13 (m, 5H), 7.00–6.94 (m, 1H), 6.85 (d, <i>J</i> = 8.6 Hz, 2H), 5.75 (s, 1H), 4.57 (d, <i>J</i> = 14.2 Hz, 1H), 4.53 (d, <i>J</i> = 14.2 Hz, 1H), 4.02 (t, <i>J</i> = 6.0 Hz, 2H), 3.92 (t, <i>J</i> = 6.7 Hz, 2H), 3.60 (d, <i>J</i> = 13.4 Hz, 1H), 3.42 (d, <i>J</i> = 13.4 Hz, 1H), 3.21 (s, 2H), 3.06 (d, <i>J</i> = 13.7 Hz, 1H), 2.77 (d, <i>J</i> = 13.7 Hz, 1H), 2.17–2.10 (m, 2H), 2.08 (s, 3H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 167.85, 162.13 (dd, <i>J</i> = 245.6, 12.5 Hz), 159.40 (dd, <i>J</i> = 246.9, 12.2 Hz), 157.63, 151.62, 150.91, 145.35, 138.42, 135.31, 133.21, 130.90, 130.34, 129.78, 128.53, 126.59 (d, <i>J</i> = 12.7 Hz), 121.61, 114.73, 111.10 (d, <i>J</i> = 20.7 Hz), 104.17 (t, <i>J</i> = 26.9 Hz), 75.53 (d, <i>J</i> = 4.4 Hz), 65.32, 63.36, 62.38, 56.32, 43.96, 42.43, 38.93, 28.44. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>32</sub>H<sub>35</sub>F<sub>2</sub>N<sub>8</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 649.2693; found, 649.2696.</div><div class="NLM_p last">Starting materials <b>13a–q</b> were prepared according to the previous reported method.<a onclick="showRef(event, 'ref46 ref47 ref49'); return false;" href="javascript:void(0);" class="ref ref46 ref47 ref49">(46,47,49)</a></div></div><div id="sec4_1_1_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> Methyl 5-(4-Formylphenoxy)pentanoate (<b>13a</b>)</h5><div class="NLM_p last">The product is obtained as colorless liquid. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 9.88 (s, 1H), 7.83 (d, <i>J</i> = 8.8 Hz, 2H), 6.98 (d, <i>J</i> = 8.8 Hz, 2H), 4.06 (t, <i>J</i> = 5.9 Hz, 2H), 3.68 (s, 3H), 2.38 (t, <i>J</i> = 5.3 Hz, 2H), 1.93–1.70 (m, 4H).</div></div><div id="sec4_1_1_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> Methyl 6-(4-Formylphenoxy)hexanoate (<b>13b</b>)</h5><div class="NLM_p last">The product is obtained as colorless liquid. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 9.88 (s, 1H), 7.83 (d, <i>J</i> = 8.8 Hz, 2H), 6.99 (d, <i>J</i> = 8.8 Hz, 2H), 4.05 (t, <i>J</i> = 6.4 Hz, 2H), 3.68 (s, 3H), 2.32 (t, <i>J</i> = 7.5 Hz, 2H), 1.93–1.62 (m, 6H).</div></div><div id="sec4_1_1_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> Methyl 7-(4-Formylphenoxy)heptanoate (<b>13c</b>)</h5><div class="NLM_p last">The product is obtained as colorless liquid. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 9.88 (s, 1H), 7.83 (d, <i>J</i> = 8.8 Hz, 2H), 6.99 (d, <i>J</i> = 8.8 Hz, 2H), 4.04 (t, <i>J</i> = 6.5 Hz, 2H), 3.67 (s, 3H), 2.30 (t, <i>J</i> = 7.5 Hz, 2H), 1.86–1.54 (m, 8H).</div></div><div id="sec4_1_1_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> Methyl 8-(4-Formylphenoxy)octanoate (<b>13d</b>)</h5><div class="NLM_p last">The product is obtained as colorless liquid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 9.87 (s, 1H), 7.82 (d, <i>J</i> = 8.6 Hz, 2H), 6.98 (d, <i>J</i> = 8.6 Hz, 2H), 4.03 (t, <i>J</i> = 6.5 Hz, 2H), 3.67 (s, 3H), 2.30 (t, <i>J</i> = 6.3 Hz, 2H), 1.83–1.52 (m, 10H).</div></div><div id="sec4_1_1_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> Methyl 2-(4-(3-(4-Formylphenyl)propoxy)phenyl)acetate (<b>13e</b>)</h5><div class="NLM_p last">The product is obtained as a white solid. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 10.00 (s, 1H), 7.84 (d, <i>J</i> = 8.0 Hz, 2H), 7.40 (d, <i>J</i> = 8.0 Hz, 2H), 7.22 (d, <i>J</i> = 8.5 Hz, 2H), 6.87 (d, <i>J</i> = 8.5 Hz, 2H), 3.98 (t, <i>J</i> = 6.1 Hz, 2H), 3.68 (s, 3H), 3.58 (s, 2H), 2.93 (t, <i>J</i> = 7.5 Hz, 2H), 2.18–2.12 (m, 2H).</div></div><div id="sec4_1_1_30" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> Methyl 2-(4-(4-(4-Formylphenyl)butanamido)phenyl)acetate (<b>13h</b>)</h5><div class="NLM_p last">The product is obtained as a yellow solid. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 9.98 (s, 1H), 7.82 (d, <i>J</i> = 8.0 Hz, 2H), 7.45 (d, <i>J</i> = 8.4 Hz, 2H), 7.37 (d, <i>J</i> = 8.0 Hz, 2H), 7.23 (d, <i>J</i> = 8.4 Hz, 1H), 7.08 (s, 1H), 3.69 (s, 3H), 3.59 (s, 2H), 2.80 (t, <i>J</i> = 7.6 Hz, 2H), 2.37 (t, <i>J</i> = 7.4 Hz, 2H), 2.13–2.08 (m, 2H).</div></div><div id="sec4_1_1_31" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> Methyl 2-(4-(3-(4-Formylphenoxy)propoxy)phenyl)acetate (<b>13i</b>)</h5><div class="NLM_p last">The product is obtained as a white solid. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 9.89 (s, 1H), 8.00 (d, <i>J</i> = 8.8 Hz, 2H), 7.84 (d, <i>J</i> = 8.7 Hz, 2H), 7.02 (d, <i>J</i> = 8.7 Hz, 2H), 6.93 (d, <i>J</i> = 8.8 Hz, 2H), 4.29 (t, <i>J</i> = 6.1 Hz, 2H), 4.25 (t, <i>J</i> = 6.0 Hz, 2H), 3.89 (s, 3H), 2.41–2.31 (m, 2H).</div></div><div id="sec4_1_1_32" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> 5-(4-(((2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)(methyl)amino)methyl)phenoxy)-<i>N</i>-hydroxypentanamide (<b>15a</b>)</h5><div class="NLM_p">To a stirred solution of methyl 5-(4-formylphenoxy)pentanoate <b>13a</b> (500 mg, 2.12 mmol, 1.0 equiv), methylamine hydrochloride (214 mg, 3.17 mmol, 1.5 equiv) and Et<sub>3</sub>N (641 mg, 6.35 mmol, 3.0 equiv) in anhydrous CH<sub>3</sub>OH (20 mL) was added tetraisopropoxytitanium (1.202 g, 4.23 mmol, 2.0 equiv), and the mixture was stirred at room temperature for 12 h. Then, NaBH<sub>4</sub> (640 mg, 16.9 mmol, 8.0 equiv) was added to the mixture portion wise followed by stirring at room temperature for 30 min. The reaction was quenched by the addition of water (10 mL), and the resulting precipitate was filtered. The filtrate was diluted with water (60 mL), extracted with EtOAc (50 mL × 2), and the combined organic layer was dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to afford intermediate <b>14a</b> (493 mg, 93% yield) as a pale yellow oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.24 (d, <i>J</i> = 8.7 Hz, 2H), 6.86 (d, <i>J</i> = 8.7 Hz, 2H), 3.97 (t, <i>J</i> = 5.9 Hz, 2H), 3.70 (s, 2H), 3.69 (s, 3H), 2.45 (s, 3H), 2.41 (t, <i>J</i> = 7.0 Hz, 2H), 1.85–1.82 (m, 4H).</div><div class="NLM_p">To a stirred solution of intermediate <b>14a</b> (450 mg, 1.79 mmol, 1.0 equiv) in DMF (10 mL) was added oxirane <b>4</b> (656 mg, 1.97 mmol, 1.1 equiv) and K<sub>2</sub>CO<sub>3</sub> (741 mg, 5.37 mmol, 3.0 equiv); the mixture was stirred at 80 °C for 12 h. Then, the mixture was cooled to room temperature, filtered, and the filtrate was diluted with water (50 mL) and extracted with EtOAc (50 mL × 2). The combined organic layers were washed with brine (50 mL × 3), dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residual mixture was added into the freshly prepared NH<sub>2</sub>OH in CH<sub>3</sub>OH. The mixture was stirred at room temperature for 5 h and concentrated under reduced pressure. Water (50 mL) was added to the residue and acidified to pH 7 with 1 M HCl. Then, the mixture was extracted with EtOAc (50 mL × 3), and the combined organic layers were dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residual mixture was purified <i>via</i> silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH, 40/1, v/v) to afford compound <b>15a</b> (371 mg, 42% yield) as a pale yellow solid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.37 (s, 1H), 8.70 (s, 1H), 8.28 (s, 1H), 7.73 (s, 1H), 7.44–7.39 (m, 1H), 7.17–7.10 (m, 1H), 6.98 (d, <i>J</i> = 8.7 Hz, 2H), 6.97–6.93 (m, 1H), 6.78 (d, <i>J</i> = 8.7 Hz, 2H), 5.70 (s, 1H), 4.53 (d, <i>J</i> = 14.3 Hz, 1H), 4.48 (d, <i>J</i> = 14.3 Hz, 1H), 3.91 (t, <i>J</i> = 6.1 Hz, 2H), 3.44 (d, <i>J</i> = 13.0 Hz, 1H), 3.32 (d, <i>J</i> = 13.0 Hz, 1H), 2.96 (d, <i>J</i> = 13.7 Hz, 1H), 2.74 (d, <i>J</i> = 13.7 Hz, 1H), 2.04 (s, 3H), 2.00 (t, <i>J</i> = 7.1 Hz, 2H), 1.70–1.60 (m, 4H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 169.39, 162.11 (dd, <i>J</i> = 245.5, 12.4 Hz), 159.38 (dd, <i>J</i> = 246.8, 12.1 Hz), 158.06, 150.88, 145.33, 131.07, 130.30, 130.29, 126.71 (d, <i>J</i> = 10.3 Hz), 114.42, 111.09 (d, <i>J</i> = 20.8 Hz), 104.16 (t, <i>J</i> = 26.8 Hz), 75.35 (d, <i>J</i> = 5.3 Hz), 67.41, 63.21, 62.52, 56.32, 43.90, 32.37, 28.68, 22.26. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>30</sub>F<sub>2</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 490.2260; found, 490.2264.</div><div class="NLM_p last">Compounds <b>15b–t</b> were synthesized by the similar method described for the preparation of <b>15a</b>.</div></div><div id="sec4_1_1_33" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> 6-(4-(((2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)(methyl)amino)methyl)phenoxy)-<i>N</i>-hydroxyhexanamide (<b>15b</b>)</h5><div class="NLM_p last">The product was obtained as a pale yellow solid in 45% yield. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.31 (s, 1H), 7.74 (s, 1H), 7.56–7.49 (m, 1H), 7.06 (d, <i>J</i> = 8.5 Hz, 2H), 6.93–6.88 (m, 1H), 6.87–6.83 (m, 1H), 6.80 (d, <i>J</i> = 8.5 Hz, 2H), 4.56 (d, <i>J</i> = 14.5 Hz, 1H), 4.53 (d, <i>J</i> = 14.5 Hz, 1H), 3.94 (t, <i>J</i> = 6.3 Hz, 2H), 3.44 (d, <i>J</i> = 12.8 Hz, 1H), 3.39 (d, <i>J</i> = 14.2 Hz, 1H), 3.02 (d, <i>J</i> = 13.9 Hz, 1H), 2.90 (d, <i>J</i> = 13.7 Hz, 1H), 2.15 (t, <i>J</i> = 7.4 Hz, 2H), 2.11 (s, 3H), 1.83–1.74 (m, 2H), 1.74–1.66 (m, 2H), 1.56–1.47 (m, 2H). <sup>13</sup>C NMR (151 MHz, DMSO): δ 169.28, 162.09 (dd, <i>J</i> = 245.3, 11.9 Hz), 159.37 (dd, <i>J</i> = 246.9, 12.2 Hz), 158.06, 150.83, 145.34, 131.05, 130.29, 126.69 (d, <i>J</i> = 13.2 Hz), 114.39, 114.20, 111.06 (d, <i>J</i> = 19.7 Hz), 104.12 (t, <i>J</i> = 26.7 Hz), 75.36 (d, <i>J</i> = 5.2 Hz), 67.69, 63.19, 62.49, 56.30, 43.90, 32.55, 28.92, 25.63, 25.40. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>25</sub>H<sub>32</sub>F<sub>2</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 504.2417; found, 504.2418.</div></div><div id="sec4_1_1_34" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> 7-(4-(((2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)(methyl)amino)methyl)phenoxy)-<i>N</i>-hydroxyheptanamide (<b>15c</b>)</h5><div class="NLM_p last">The product was obtained as a pale yellow solid in 38% yield. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.31 (s, 1H), 7.74 (s, 1H), 7.56–7.49 (m, 1H), 7.06 (d, <i>J</i> = 8.5 Hz, 2H), 6.93–6.88 (m, 1H), 6.87–6.83 (m, 1H), 6.80 (d, <i>J</i> = 8.5 Hz, 2H), 4.56 (d, <i>J</i> = 14.5 Hz, 1H), 4.53 (d, <i>J</i> = 14.5 Hz, 1H), 3.94 (t, <i>J</i> = 6.3 Hz, 2H), 3.44 (d, <i>J</i> = 12.8 Hz, 1H), 3.39 (d, <i>J</i> = 14.2 Hz, 1H), 3.02 (d, <i>J</i> = 13.9 Hz, 1H), 2.90 (d, <i>J</i> = 13.7 Hz, 1H), 2.15 (t, <i>J</i> = 7.4 Hz, 2H), 2.11 (s, 3H), 1.83–1.74 (m, 2H), 1.74–1.66 (m, 2H), 1.56–1.47 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>26</sub>H<sub>34</sub>F<sub>2</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 518.2573; found, 518.2587.</div></div><div id="sec4_1_1_35" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> 8-(4-(((2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)(methyl)amino)methyl)phenoxy)-<i>N</i>-hydroxyoctanamide (<b>15d</b>)</h5><div class="NLM_p last">The product was obtained as a pale yellow solid in 38% yield. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.30 (s, 1H), 8.63 (s, 1H), 8.26 (s, 1H), 7.71 (s, 1H), 7.42–7.36 (m, 1H), 7.14–7.09 (m, 1H), 6.96 (d, <i>J</i> = 8.4 Hz, 2H), 6.95–6.89 (m, 1H), 6.76 (d, <i>J</i> = 8.4 Hz, 2H), 5.67 (s, 1H), 4.51 (d, <i>J</i> = 14.3 Hz, 1H), 4.46 (d, <i>J</i> = 14.3 Hz, 1H), 3.88 (t, <i>J</i> = 6.5 Hz, 2H), 3.42 (d, <i>J</i> = 13.1 Hz, 1H), 3.28 (<i>J</i> = 13.1 Hz, 1H), 2.94 (d, <i>J</i> = 13.6 Hz, 1H), 2.72 (d, <i>J</i> = 13.6 Hz, 1H), 2.02 (s, 3H), 1.92 (t, <i>J</i> = 7.3 Hz, 2H), 1.69–1.63 (m, 2H), 1.49–1.44 (m, 2H), 1.37–1.21 (m, 6H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ 171.56, 162.69 (dd, <i>J</i> = 247.7, 12.2 Hz), 159.20 (dd, <i>J</i> = 246.3, 12.1 Hz), 158.46, 149.71, 144.68, 130.09, 129.97, 129.55 (dd, <i>J</i> = 8.8, 6.2 Hz), 126.16 (dd, <i>J</i> = 12.8, 3.0 Hz), 113.98, 110.64 (d, <i>J</i> = 20.8 Hz), 103.54 (t, <i>J</i> = 26.8 Hz), 73.25 (d, <i>J</i> = 5.4 Hz), 67.56, 62.43, 61.55, 56.22, 43.10, 32.40, 28.96, 28.72, 28.70, 25.63, 25.30. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>27</sub>H<sub>36</sub>F<sub>2</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 532.2730; found, 532.2734.</div></div><div id="sec4_1_1_36" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> 2-(4-(3-(4-(((2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)(methyl)amino)methyl)phenyl)propoxy)phenyl)-<i>N</i>-hydroxyacetamide (<b>15e</b>)</h5><div class="NLM_p last">The product was obtained as a pale yellow solid in 37% yield. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.29 (s, 1H), 7.73 (s, 1H), 7.54–7.48 (m, 1H), 7.20 (d, <i>J</i> = 8.6 Hz, 2H), 7.13 (d, <i>J</i> = 8.0 Hz, 2H), 7.09 (d, <i>J</i> = 8.0 Hz, 2H), 6.91–6.86 (m, 1H), 6.86–6.82 (m, 1H), 6.84 (d, <i>J</i> = 8.6 Hz, 2H), 4.54 (d, <i>J</i> = 14.4 Hz, 1H), 4.52 (d, <i>J</i> = 14.4 Hz, 1H), 3.91 (t, <i>J</i> = 6.3 Hz, 2H), 3.49 (d, <i>J</i> = 12.9 Hz, 1H), 3.44 (d, <i>J</i> = 12.9 Hz, 1H), 3.34 (s, 2H), 3.03 (d, <i>J</i> = 13.7 Hz, 1H), 2.91 (d, <i>J</i> = 13.7 Hz, 1H), 2.77 (t, <i>J</i> = 7.6 Hz, 2H), 2.14 (s, 3H), 2.06–2.02 (m, 2H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ 169.79, 162.72 (dd, <i>J</i> = 247.9, 12.2 Hz), 159.21 (dd, <i>J</i> = 246.6, 11.9 Hz), 158.15, 149.71, 144.66, 140.66, 135.76, 129.67, 129.56 (dd, <i>J</i> = 9.2, 6.3 Hz), 128.96, 128.19, 126.97, 126.02 (dd, <i>J</i> = 12.8, 3.0 Hz), 114.25, 110.67 (d, <i>J</i> = 20.9 Hz), 103.56 (t, <i>J</i> = 26.8 Hz), 73.42 (d, <i>J</i> = 5.4 Hz), 66.56, 62.77, 61.72, 56.16 (d, <i>J</i> = 4.3 Hz), 43.24, 38.42, 31.36, 30.68. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>30</sub>H<sub>34</sub>F<sub>2</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 566.2573; found, 566.2585.</div></div><div id="sec4_1_1_37" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> 2-(4-(4-(4-(((2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)(methyl)amino)methyl)phenyl)butoxy)phenyl)-<i>N</i>-hydroxyacetamide (<b>15f</b>)</h5><div class="NLM_p last">The product was obtained as a pale yellow solid in 37% yield. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.29 (s, 1H), 7.72 (s, 1H), 7.56–7.47 (m, 1H), 7.19 (d, <i>J</i> = 8.4 Hz, 2H), 7.12 (d, <i>J</i> = 7.9 Hz, 2H), 7.09 (d, <i>J</i> = 7.9 Hz, 2H), 6.93–6.88 (m, 1H), 6.87–6.85 (m, 1H), 6.84 (d, <i>J</i> = 8.4 Hz, 2H), 4.55 (d, <i>J</i> = 14.4 Hz, 1H), 4.52 (d, <i>J</i> = 14.4 Hz, 1H), 4.00–3.93 (m, 2H), 3.51 (d, <i>J</i> = 12.9 Hz, 1H), 3.45 (d, <i>J</i> = 12.9 Hz, 1H), 3.33 (s, 2H), 3.04 (d, <i>J</i> = 13.8 Hz, 1H), 2.92 (d, <i>J</i> = 13.8 Hz, 1H), 2.67 (t, <i>J</i> = 6.1 Hz, 2H), 2.15 (s, 3H), 1.81–1.74 (m, 4H). HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>31</sub>H<sub>36</sub>F<sub>2</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 580.2730; found, 580.2739.</div></div><div id="sec4_1_1_38" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> 4-(4-(4-(((2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)(methyl)amino)methyl)phenyl)butanamido)-<i>N</i>-hydroxybenzamide (<b>15g</b>)</h5><div class="NLM_p last">The product was obtained as a pale yellow solid in 47% yield. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.08 (s, 1H), 10.06 (s, 1H), 8.91 (s, 1H), 8.26 (s, 1H), 7.72 (s, 1H), 7.68 (d, <i>J</i> = 8.5 Hz, 2H), 7.62 (d, <i>J</i> = 8.5 Hz, 2H), 7.44–7.37 (m, 1H), 7.14–7.09 (m, 1H), 7.06 (d, <i>J</i> = 7.8 Hz, 2H), 6.97 (d, <i>J</i> = 7.8 Hz, 2H), 6.95–6.92 (m, 1H), 5.69 (s, 1H), 4.53 (d, <i>J</i> = 14.3 Hz, 1H), 4.48 (d, <i>J</i> = 14.3 Hz, 1H), 3.48 (d, <i>J</i> = 13.2 Hz, 1H), 3.34 (d, <i>J</i> = 13.2 Hz, 1H), 2.98 (d, <i>J</i> = 13.7 Hz, 1H), 2.74 (d, <i>J</i> = 13.7 Hz, 1H), 2.56 (t, <i>J</i> = 7.5 Hz, 2H), 2.31 (t, <i>J</i> = 7.1 Hz, 2H), 2.03 (s, 3H), 1.89–1.80 (m, 2H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 171.81, 164.37, 162.10 (dd, <i>J</i> = 245.3, 12.5 Hz), 159.38 (dd, <i>J</i> = 246.9, 12.0 Hz), 150.87, 145.32, 142.24, 140.57, 136.79, 130.31, 129.11, 128.47, 128.03, 127.37, 126.68 (d, <i>J</i> = 11.2 Hz), 118.75, 111.08 (d, <i>J</i> = 20.3 Hz), 104.14 (t, <i>J</i> = 26.9 Hz), 75.42 (d, <i>J</i> = 5.3 Hz), 63.38, 62.86, 56.32, 43.98, 36.27, 34.68, 27.04. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>30</sub>H<sub>33</sub>F<sub>2</sub>N<sub>6</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 579.2526; found, 579.2527.</div></div><div id="sec4_1_1_39" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> 4-(4-(((2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)(methyl)amino)methyl)phenyl)-<i>N</i>-(4-(2-(hydroxyamino)-2-oxoethyl)phenyl)butanamide (<b>15h</b>)</h5><div class="NLM_p last">The product was obtained as a pale yellow solid in 51% yield. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.60 (bs, 1H), 9.81 (s, 1H), 8.78 (bs, 1H), 8.28 (s, 1H), 7.74 (s, 1H), 7.49 (d, <i>J</i> = 8.4 Hz, 2H), 7.45–7.40 (m, 1H), 7.15 (d, <i>J</i> = 8.4 Hz, 2H), 7.14–7.11 (m, 1H), 7.08 (d, <i>J</i> = 8.0 Hz, 2H), 6.99 (d, <i>J</i> = 8.0 Hz, 2H), 6.97–6.93 (m, 1H), 5.70 (bs, 1H), 4.54 (d, <i>J</i> = 14.3 Hz, 1H), 4.50 (d, <i>J</i> = 14.3 Hz, 1H), 3.50 (d, <i>J</i> = 13.2 Hz, 1H), 3.36 (d, <i>J</i> = 13.2 Hz, 2H), 3.21 (s, 2H), 3.00 (d, <i>J</i> = 13.7 Hz, 1H), 2.75 (d, <i>J</i> = 13.7 Hz, 1H), 2.57 (t, <i>J</i> = 7.5 Hz, 2H), 2.28 (t, <i>J</i> = 7.4 Hz, 2H), 2.05 (s, 3H), 1.89–1.82 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>31</sub>H<sub>35</sub>F<sub>2</sub>N<sub>6</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 593.2682; found, 593.2696.</div></div><div id="sec4_1_1_40" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> 4-(3-(4-(((2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)(methyl)amino)methyl)phenoxy)propoxy)-<i>N</i>-hydroxybenzamide (<b>15i</b>)</h5><div class="NLM_p last">The product was obtained as a pale yellow solid in 40% yield. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.30 (s, 1H), 7.72 (s, 1H), 7.71 (d, <i>J</i> = 8.2 Hz, 2H), 7.54–7.47 (m, 1H), 7.07 (d, <i>J</i> = 8.3 Hz, 2H), 7.01 (d, <i>J</i> = 8.2 Hz, 2H), 6.93–6.88 (m, 1H), 6.87–6.85 (m, 1H), 6.84 (d, <i>J</i> = 8.3 Hz, 2H), 4.55 (d, <i>J</i> = 14.6 Hz, 1H), 4.52 (d, <i>J</i> = 14.6 Hz, 1H), 4.24 (t, <i>J</i> = 5.9 Hz, 2H), 4.16 (t, <i>J</i> = 5.9 Hz, 2H), 3.45 (d, <i>J</i> = 12.8 Hz, 1H), 3.39 (d, <i>J</i> = 12.8 Hz, 1H), 3.01 (d, <i>J</i> = 13.7 Hz, 1H), 2.89 (d, <i>J</i> = 13.7 Hz, 1H), 2.30–2.22 (m, 2H), 2.12 (s, 3H). HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>29</sub>H<sub>32</sub>F<sub>2</sub>N<sub>5</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 568.2366; found, 568.2371.</div></div><div id="sec4_1_1_41" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> 2-(4-(3-(4-(((2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)(methyl)amino)methyl)phenoxy)propoxy)phenyl)-<i>N</i>-hydroxyacetamide (<b>15j</b>)</h5><div class="NLM_p last">The product was obtained as a pale yellow solid in 45% yield. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.59 (s, 1H), 8.78 (s, 1H), 8.28 (s, 1H), 7.73 (s, 1H), 7.44–7.38 (m, 1H), 7.15 (d, <i>J</i> = 8.3 Hz, 2H), 7.14–7.11 (m, 1H), 6.99 (d, <i>J</i> = 8.6 Hz, 2H), 6.97–6.92 (m, 1H), 6.87 (d, <i>J</i> = 8.3 Hz, 2H), 6.82 (d, <i>J</i> = 8.6 Hz, 2H), 5.70 (s, 1H), 4.53 (d, <i>J</i> = 14.4 Hz, 1H), 4.48 (d, <i>J</i> = 14.4 Hz, 1H), 4.11–4.06 (m, 4H), 3.45 (d, <i>J</i> = 13.0 Hz, 1H), 3.32 (d, <i>J</i> = 13.0 Hz, 1H), 3.19 (s, 2H), 2.96 (d, <i>J</i> = 13.7 Hz, 1H), 2.74 (d, <i>J</i> = 13.7 Hz, 1H), 2.16–2.11 (m, 2H), 2.04 (s, 3H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 167.78, 162.11 (dd, <i>J</i> = 245.5, 12.3 Hz), 159.38 (dd, <i>J</i> = 246.8, 12.3 Hz), 157.91, 157.65, 150.88, 145.33, 131.27, 130.39, 130.33, 130.25, 128.55, 126.71 (d, <i>J</i> = 10.4 Hz), 114.71, 114.48, 111.09 (d, <i>J</i> = 20.4 Hz), 104.16 (t, <i>J</i> = 26.8 Hz), 75.37 (d, <i>J</i> = 5.2 Hz), 64.69, 64.60, 63.21, 62.51, 56.34, 43.92, 38.94, 29.14. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>30</sub>H<sub>34</sub>F<sub>2</sub>N<sub>5</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 582.2523; found, 582.2528.</div></div><div id="sec4_1_1_42" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> 3-(4-(3-(4-(((2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)(methyl)amino)methyl)phenoxy)propoxy)phenyl)-<i>N</i>-hydroxypropanamide (<b>15k</b>)</h5><div class="NLM_p last">The product was obtained as a pale yellow solid in 44% yield. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.31 (s, 1H), 8.65 (bs, 1H), 8.25 (s, 1H), 7.70 (s, 1H), 7.42–7.35 (m, 1H), 7.16–7.08 (m, 1H), 7.06 (d, <i>J</i> = 8.1 Hz, 2H), 6.96 (d, <i>J</i> = 8.1 Hz, 2H), 6.94–6.87 (m, 1H), 6.81 (d, <i>J</i> = 8.2 Hz, 2H), 6.79 (d, <i>J</i> = 8.2 Hz, 2H), 5.67 (bs, 1H), 4.50 (d, <i>J</i> = 14.3 Hz, 1H), 4.45 (d, <i>J</i> = 14.3 Hz, 1H), 4.09–4.01 (m, 4H), 3.42 (d, <i>J</i> = 13.0 Hz, 1H), 3.29 (d, <i>J</i> = 13.0 Hz, 1H), 2.93 (d, <i>J</i> = 13.7 Hz, 1H), 2.74 (d, <i>J</i> = 13.7 Hz, 1H), 2.70 (t, <i>J</i> = 7.5 Hz, 2H), 2.18 (t, <i>J</i> = 7.5 Hz, 2H), 2.13–2.08 (m, 2H), 2.01 (s, 3H). HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>31</sub>H<sub>36</sub>F<sub>2</sub>N<sub>5</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 596.2697; found, 596.2677.</div></div><div id="sec4_1_1_43" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> 4-(3-(3-(((2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)(methyl)amino)methyl)phenoxy)propoxy)-<i>N</i>-hydroxybenzamide (<b>15l</b>)</h5><div class="NLM_p last">The product was obtained as a pale yellow solid in 43% yield. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.26 (s, 1H), 7.71 (s, 1H), 7.71 (d, <i>J</i> = 8.6 Hz, 2H), 7.53–7.46 (m, 1H), 7.14 (t, <i>J</i> = 7.8 Hz, 1H), 7.00 (d, <i>J</i> = 8.6 Hz, 2H), 6.91–6.85 (m, 1H), 6.84–6.80 (m, 1H), 6.80–6.76 (m, 1H), 6.72 (d, <i>J</i> = 7.5 Hz, 1H), 6.69 (s, 1H), 4.54 (d, <i>J</i> = 15.0 Hz, 1H), 4.51 (d, <i>J</i> = 15.0 Hz, 1H), 4.22 (t, <i>J</i> = 6.1 Hz, 2H), 4.11 (t, <i>J</i> = 6.1 Hz, 2H), 3.45 (d, <i>J</i> = 13.4 Hz, 1H), 3.42 (d, <i>J</i> = 13.4 Hz, 1H), 3.05 (d, <i>J</i> = 13.7 Hz, 1H), 2.84 (d, <i>J</i> = 13.7 Hz, 1H), 2.28–2.20 (m, 2H), 2.12 (s, 3H). HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>29</sub>H<sub>32</sub>F<sub>2</sub>N<sub>5</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 568.2366; found, 568.2376.</div></div><div id="sec4_1_1_44" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> 2-(4-(3-(3-(((2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)(methyl)amino)methyl)phenoxy)propoxy)phenyl)-<i>N</i>-hydroxyacetamide (<b>15m</b>)</h5><div class="NLM_p last">The product was obtained as a pale yellow solid in 42% yield. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.60 (s, 1H), 8.79 (s, 1H), 8.28 (s, 1H), 7.75 (s, 1H), 7.47–7.40 (m, 1H), 7.16 (d, <i>J</i> = 8.2 Hz, 2H), 7.15–7.12 (m, 1H), 7.12–7.10 (m, 1H), 6.98–6.92 (m, 1H), 6.88 (d, <i>J</i> = 8.2 Hz, 2H), 6.76 (dd, <i>J</i> = 8.2, 2.4 Hz, 1H), 6.65 (d, <i>J</i> = 7.5 Hz, 1H), 6.55 (s, 1H), 5.75 (s, 1H), 4.54 (d, <i>J</i> = 14.4 Hz, 1H), 4.49 (d, <i>J</i> = 14.4 Hz, 1H), 4.09 (t, <i>J</i> = 6.3 Hz, 2H), 4.01 (t, <i>J</i> = 6.2 Hz, 2H), 3.54 (d, <i>J</i> = 13.3 Hz, 1H), 3.31 (d, <i>J</i> = 13.3 Hz, 1H), 3.04 (d, <i>J</i> = 13.7 Hz, 1H), 2.72 (d, <i>J</i> = 13.7 Hz, 1H), 2.17–2.10 (m, 2H), 2.05 (s, 3H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 167.80, 162.11 (dd, <i>J</i> = 245.5, 12.5 Hz), 159.42 (dd, <i>J</i> = 246.9, 12.2 Hz), 158.85, 157.65, 150.91, 145.34, 141.23, 130.40, 130.31, 129.45, 128.55, 126.65 (d, <i>J</i> = 10.5 Hz), 121.30, 114.69, 114.65, 113.61, 111.06 (d, <i>J</i> = 20.7 Hz), 104.11 (t, <i>J</i> = 26.7 Hz), 75.65 (d, <i>J</i> = 5.1 Hz), 65.37, 64.66, 64.44, 62.95, 56.46, 44.03, 38.95, 29.17. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>30</sub>H<sub>34</sub>F<sub>2</sub>N<sub>5</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 582.2523; found, 582.2524.</div></div><div id="sec4_1_1_45" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> 3-(4-(3-(3-(((2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)(methyl)amino)methyl)phenoxy)propoxy)phenyl)-<i>N</i>-hydroxypropanamide (<b>15n</b>)</h5><div class="NLM_p last">The product was obtained as a pale yellow solid in 39% yield. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.33 (s, 1H), 8.67 (bs, 1H), 8.26 (s, 1H), 7.72 (s, 1H), 7.43–7.38 (m, 1H), 7.11–7.04 (m, 4H), 6.93–6.90 (m, 1H), 6.82 (d, <i>J</i> = 8.6 Hz, 2H), 6.74–6.70 (m, 1H), 6.64–6.59 (m, 1H), 6.55–6.51 (m, 1H), 5.72 (bs, 1H), 4.51 (d, <i>J</i> = 14.3 Hz, 1H), 4.47 (d, <i>J</i> = 14.3 Hz, 1H), 4.05 (t, <i>J</i> = 6.2 Hz, 2H), 3.98 (t, <i>J</i> = 6.2 Hz, 2H), 3.51 (d, <i>J</i> = 13.3 Hz, 1H), 3.29 (d, <i>J</i> = 13.3 Hz, 1H), 3.02 (d, <i>J</i> = 13.8 Hz, 1H), 2.72 (d, <i>J</i> = 13.8 Hz, 1H), 2.71 (t, <i>J</i> = 6.7 Hz, 2H), 2.19 (t, <i>J</i> = 6.7 Hz, 2H), 2.12–2.09 (m, 2H), 2.02 (s, 3H). HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>31</sub>H<sub>36</sub>F<sub>2</sub>N<sub>5</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 596.2679; found, 596.2692.</div></div><div id="sec4_1_1_46" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> 4-(3-(2-(((2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)(methyl)amino)methyl)phenoxy)propoxy)-<i>N</i>-hydroxybenzamide (<b>15o</b>)</h5><div class="NLM_p last">The product was obtained as a pale yellow solid in 42% yield. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.19 (s, 1H), 7.70 (d, <i>J</i> = 8.7 Hz, 2H), 7.69 (s, 1H), 7.40–7.36 (m, 1H), 7.23–7.20 (m, 1H), 7.10–7.08 (m, 1H), 7.00 (d, <i>J</i> = 8.7 Hz, 2H), 6.97–6.93 (m, 1H), 6.86–6.83 (m, 2H), 6.76–6.72 (m, 1H), 4.45 (d, <i>J</i> = 14.3 Hz, 1H), 4.40 (d, <i>J</i> = 14.3 Hz, 1H), 4.26 (t, <i>J</i> = 5.7 Hz, 2H), 4.21 (t, <i>J</i> 5.7 Hz, 2H), 3.54 (s, 2H), 2.99 (d, <i>J</i> = 13.6 Hz, 1H), 2.92 (d, <i>J</i> = 13.6 Hz, 1H), 2.34–2.30 (m, 2H), 2.02 (s, 3H). HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>29</sub>H<sub>32</sub>F<sub>2</sub>N<sub>5</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 568.2366; found, 568.2359.</div></div><div id="sec4_1_1_47" class="NLM_sec NLM_sec_level_4"><div id="ac_i67" class="anchor-spacer"></div><h5 class="article-section__title" id="_i67"> 2-(4-(3-(2-(((2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)(methyl)amino)methyl)phenoxy)propoxy)phenyl)-<i>N</i>-hydroxyacetamide (<b>15p</b>)</h5><div class="NLM_p last">The product was obtained as a pale yellow solid in 40% yield. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.21 (s, 1H), 7.70 (s, 1H), 7.45–7.40 (m, 1H), 7.26–7.22 (m, 1H), 7.21 (d, <i>J</i> = 8.5 Hz, 2H), 7.11 (d, <i>J</i> = 7.3 Hz, 1H), 7.00–6.96 (m, 1H), 6.91 (d, <i>J</i> = 8.5 Hz, 2H), 6.89–6.87 (m, 1H), 6.87–6.84 (m, 1H), 6.78 (t, <i>J</i> = 8.4 Hz, 1H), 4.48 (d, <i>J</i> = 14.6 Hz, 1H), 4.42 (d, <i>J</i> = 14.6 Hz, 1H), 4.26–4.18 (m, 4H), 3.56 (s, 2H), 3.34 (s, 2H), 3.00 (d, <i>J</i> = 13.5 Hz, 1H), 2.93 (d, <i>J</i> = 13.5 Hz, 1H), 2.34–2.29 (m, 2H), 2.03 (s, 3H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ 169.74, 162.69 (dd, <i>J</i> = 247.6, 12.3 Hz), 159.18 (dd, <i>J</i> = 246.2, 11.8 Hz), 158.09, 157.22, 149.57, 144.60, 131.09, 129.69, 129.47 (dd, <i>J</i> = 8.8, 6.5 Hz), 128.71, 127.15, 127.15, 126.24 (d, <i>J</i> = 13.1 Hz), 126.13, 120.08, 114.28, 111.46, 110.64 (d, <i>J</i> = 20.9 Hz), 103.46 (t, <i>J</i> = 26.8 Hz), 72.73 (d, <i>J</i> = 5.5 Hz), 64.44, 61.66, 58.30, 56.06, 42.76, 38.38, 29.00. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>30</sub>H<sub>34</sub>F<sub>2</sub>N<sub>5</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 582.2523; found, 582.2515.</div></div><div id="sec4_1_1_48" class="NLM_sec NLM_sec_level_4"><div id="ac_i68" class="anchor-spacer"></div><h5 class="article-section__title" id="_i68"> 3-(4-(3-(2-(((2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)(methyl)amino)methyl)phenoxy)propoxy)phenyl)-<i>N</i>-hydroxypropanamide (<b>15q</b>)</h5><div class="NLM_p last">The product was obtained as a pale yellow solid in 46% yield. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.18 (s, 1H), 7.68 (s, 1H), 7.42–7.35 (m, 1H), 7.22–7.17 (m, 1H), 7.11–7.06 (m, 3H), 6.95 (d, <i>J</i> = 8.2 Hz, 1H), 6.87–6.82 (m, 4H), 6.76–6.71 (m, 1H), 4.45 (d, <i>J</i> = 14.3 Hz, 1H), 4.39 (d, <i>J</i> = 14.3 Hz, 1H), 4.21–4.14 (m, 4H), 3.54 (s, 2H), 2.99 (d, <i>J</i> = 13.7 Hz, 1H), 2.92 (d, <i>J</i> = 13.7 Hz, 1H), 2.82 (t, <i>J</i> = 7.5 Hz, 2H), 2.31 (t, <i>J</i> = 7.6 Hz, 2H), 2.29–2.24 (m, 2H), 2.01 (s, 3H). HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>31</sub>H<sub>36</sub>F<sub>2</sub>N<sub>5</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 596.2679; found, 596.2697.</div></div><div id="sec4_1_1_49" class="NLM_sec NLM_sec_level_4"><div id="ac_i69" class="anchor-spacer"></div><h5 class="article-section__title" id="_i69"> 2-(4-(3-(4-(((2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)(ethyl)amino)methyl)phenoxy)propoxy)phenyl)-<i>N</i>-hydroxyacetamide (<b>15r</b>)</h5><div class="NLM_p last">The product was obtained as a pale yellow solid in 39% yield. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.29 (s, 1H), 7.72 (s, 1H), 7.53–7.45 (m, 1H), 7.19 (d, <i>J</i> = 8.6 Hz, 2H), 7.04 (d, <i>J</i> = 8.6 Hz, 2H), 6.92–6.89 (m, 1H), 6.88 (d, <i>J</i> = 8.6 Hz, 2H), 6.85–6.82 (m, 1H), 6.82 (d, <i>J</i> = 8.6 Hz, 2H), 4.52 (d, <i>J</i> = 14.3 Hz, 1H), 4.47 (d, <i>J</i> = 14.3 Hz, 1H), 4.16–4.11 (m, 4H), 3.44 (d, <i>J</i> = 13.2 Hz, 1H), 3.38 (d, <i>J</i> = 13.2 Hz, 1H), 3.32 (s, 2H), 3.10 (d, <i>J</i> = 14.0 Hz, 1H), 2.90 (d, <i>J</i> = 14.0 Hz, 1H), 2.44–2.36 (m, 2H), 2.23–2.17 (m, 2H), 0.89 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD): δ 168.27, 161.23 (dd, <i>J</i> = 249.0, 12.3 Hz), 157.73 (dd, <i>J</i> = 246.3, 11.6 Hz), 156.66, 148.18, 143.13, 139.12, 134.35, 128.11, 128.00, 127.40, 126.65, 125.46, 124.55 (d, <i>J</i> = 10.4 Hz), 112.74, 109.09 (d, <i>J</i> = 20.6 Hz), 101.99 (t, <i>J</i> = 26.9 Hz), 71.93 (d, <i>J</i> = 4.7 Hz), 65.05, 61.27, 60.25, 54.65, 41.70, 36.88, 29.83, 29.17, 11.55. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>31</sub>H<sub>36</sub>F<sub>2</sub>N<sub>5</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 596.2679; found, 596.2675.</div></div><div id="sec4_1_1_50" class="NLM_sec NLM_sec_level_4"><div id="ac_i70" class="anchor-spacer"></div><h5 class="article-section__title" id="_i70"> 2-(4-(3-(4-(((2-(2,4-Difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)(isopropyl)amino)methyl)phenoxy)propoxy)phenyl)-<i>N</i>-hydroxyacetamide (<b>15s</b>)</h5><div class="NLM_p last">The product was obtained as a pale yellow solid in 34% yield. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.28 (s, 1H), 7.75 (s, 1H), 7.50–7.43 (m, 1H), 7.19 (d, <i>J</i> = 8.7 Hz, 2H), 7.04 (d, <i>J</i> = 8.7 Hz, 2H), 6.92–6.89 (m, 1H), 6.88 (d, <i>J</i> = 8.7 Hz, 2H), 6.81 (d, <i>J</i> = 8.7 Hz, 2H), 6.80–6.77 (m, 1H), 4.48 (d, <i>J</i> = 14.5 Hz, 1H), 4.42 (d, <i>J</i> = 14.5 Hz, 1H), 4.16–4.11 (m, 4H), 3.38 (d, <i>J</i> = 13.3 Hz, 1H), 3.33 (d, <i>J</i> = 13.3 Hz, 1H), 3.32 (s, 2H), 3.06 (d, <i>J</i> = 14.0 Hz, 1H), 2.92 (d, <i>J</i> = 14.0 Hz, 1H), 2.70–2.64 (m, 1H), 2.24–2.17 (m, 2H), 0.91 (d, <i>J</i> = 7.0 Hz, 3H), 0.90 (d, <i>J</i> = 7.1 Hz, 3H). HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>32</sub>H<sub>38</sub>F<sub>2</sub>N<sub>5</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 610.2836; found, 610.2819.</div></div><div id="sec4_1_1_51" class="NLM_sec NLM_sec_level_4"><div id="ac_i71" class="anchor-spacer"></div><h5 class="article-section__title" id="_i71"> 2-(4-(3-(4-((Cyclopropyl(2-(2,4-difluorophenyl)-2-hydroxy-3-(1<i>H</i>-1,2,4-triazol-1-yl)propyl)amino)methyl)phenoxy)propoxy)phenyl)-<i>N</i>-hydroxyacetamide (<b>15t</b>)</h5><div class="NLM_p last">The product was obtained as a pale yellow solid in 34% yield. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.32 (s, 1H), 7.75 (s, 1H), 7.52–7.42 (m, 1H), 7.19 (d, <i>J</i> = 8.5 Hz, 2H), 6.98 (d, <i>J</i> = 8.5 Hz, 2H), 6.96–6.91 (m, 1H), 6.87 (d, <i>J</i> = 8.5 Hz, 2H), 6.85–6.81 (m, 1H), 6.80 (d, <i>J</i> = 8.5 Hz, 2H), 4.54 (d, <i>J</i> = 14.4 Hz, 1H), 4.46 (d, <i>J</i> = 14.4 Hz, 1H), 4.15–4.10 (m, 4H), 3.57 (d, <i>J</i> = 13.3 Hz, 1H), 3.46 (d, <i>J</i> = 13.3 Hz, 1H), 3.34 (d, <i>J</i> = 13.3 Hz, 1H), 3.31 (s, 2H), 3.03 (d, <i>J</i> = 13.3 Hz, 1H), 2.23–2.16 (m, 2H), 1.93–1.89 (m, 1H), 0.36–0.31 (m, 1H), 0.30–0.25 (m, 1H), 0.19–0.12 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>32</sub>H<sub>36</sub>F<sub>2</sub>N<sub>5</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 608.2679; found, 608.2671.</div></div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Strains, Culture and Agents</h3><div class="NLM_p last"><i>C. albicans</i> SC5314, <i>C. neoformans</i> H99, azole-resistant <i>C. albicans</i> (strains number: 0304103, 4108 and 7781), and azole-resistant <i>C. tropicalis</i> (strains number: 5008) were provided by Changzheng Hospital of Shanghai. They were incubated in yeast extract peptone dextrose (YPD) medium (1% yeast extract, 2% peptone and 2% dextrose) at 30 °C in a shaking (200 rpm/min) incubator. Tested compounds, FLC, ITC, VOR, and SAHA were dissolved in DMSO at 6.4 mg/mL as stock solution.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> MIC<sub>80</sub> Determination</h3><div class="NLM_p last">The MIC<sub>80</sub> values were determined using the serial dilution method according to CLSI (M27-A3). Briefly, fungal cells were harvested during the exponential growth phase and diluted to 1 × 10<sup>3</sup> cfu/mL with RPMI 1640 medium. Two-fold serial dilutions of the tested compounds prepared from stock solution were added to the fungal dilution in 96-well plates with maximum compound concentration at 64 μg/mL. The plates inoculated with <i>Candida</i> cells were incubated at 35 °C for 48 h, while those inoculated with <i>C. neoformans</i> H99 were incubated at 35 °C for 72 h. Then, the density of fungal cells in each well was detected by measuring the optical density (OD) at 630 nm with a spectrophotometer, and the inhibitory effect was calculated. Each compound was tested in triplicate.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> Sterol Composition Analysis</h3><div class="NLM_p last">A single colony of azole-resistant <i>C. albicans</i> 0304103 was picked to inoculate into 1 mL of YPD and incubated at 30 °C for 16 h; then, 50 μL of C. albicans cells culture was used to inoculate 50 mL of YPD. Meanwhile, compound <b>12h</b> (0.5 μg/mL), compound <b>15j</b> (0.5 μg/mL), FLC (0.5 μg/mL), or blank control was added into the culture to treat the <i>C. albicans</i> cells. After the cultures were incubated at 35 °C for 24 h, the <i>C. albicans</i> cells were harvested by centrifugation and saponified by 10 mL of 20% NaOH (w/v) in 90% ethanol at 80 °C for 60 min. Then, 10 mL of <i>n</i>-hexane was added to the saponification mixture to extract sterol. Then, the solvent were evaporated under reduced pressure, and the residue was dissolved by 1 mL of cyclohexane as the GC–MS sample. Finally, GC–MS was conducted to analysis the sterol composition of each group.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Whole Fungal Cell HDAC Enzymatic Assay</h3><div class="NLM_p last">The whole fungal cell HDAC enzymatic assay was performed according to the previously reported methods with further optimizations.<a onclick="showRef(event, 'ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref69 ref70">(69,70)</a> In detail, a single colony of azole-resistant <i>C. albicans</i> 0304103 was picked to inoculate into 10 mL of YPD and incubated at 30 °C for 16 h; then, the fungal cells were harvested by centrifugation. Protoplasts of the harvested cells were prepared using 60 mg of snailase and 24 μL of 2-mercaptoethanol as fungal cell wall lyase in the 6 mL of snailase reaction buffer according to the protocol from the manufacture (Rapid Yeast Genomic DNA Isolation Kit, Sangon Biotech, China). The protoplasts were harvested by centrifugation (3000 rpm) for 5 min and resuspended by 20 mL of phosphate-buffered saline (PBS). Then, 100 μL of protoplasts in PBS per well was added into 96-well transparent plates and treated with different concentrations of compound <b>12h</b>, <b>15j</b>, SAHA, and FLC at 35 °C for 12 h. Then, 10 μL of 330 μM HDAC substrate Boc-Lys(Ac)-AMC was added to each well and incubated at 37 °C for 4 h. Stop solution (100 μL) (2 mg/mL trypsin, 1% NP 40, 10 μM SAHA, 50 mM Tris-HCl (pH = 8), 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl<sub>2</sub>) were added to each well with a following incubation at 37 °C for 3 h. Finally, 100 μL of mixture of each well was transferred to a 96-well black plate correspondingly, and the fluorescence intensity of each well was measured on a fluorimeter with an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Experiments were performed in triplicate.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Whole Human Cell HDAC Enzymatic Assay</h3><div class="NLM_p last">The whole human cell HDAC enzymatic assay was performed according to the previously reported method with a few modifications.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> First, HUVEC cells were seeded into 96-well transparent plates (15,000 cells per well). After being adhered to the plate at 37 °C with 5% CO<sub>2</sub> atmosphere for 24 h, they were treated with two-fold serial dilutions of the tested compounds for 12 h. Then, 10 μL of 3.3 mM HDAC substrate Boc-Lys(Ac)-AMC was added to each well and incubated at 37 °C for 4 h. Stop solution (100 μL) (2 mg/mL trypsin, 1% NP 40, 10 μM SAHA, 50 mM Tris-HCl (pH = 8), 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl<sub>2</sub>) were added to each well with a following incubation at 37 °C for 3 h. Finally, 100 μL of mixture of each well was transferred to a 96-well black plate correspondingly, and the fluorescence intensity of each well was measured on a fluorimeter with an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Experiments were performed in triplicate.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Real-Time RT-PCR Analysis</h3><div class="NLM_p last">Azole-resistant <i>C. albicans</i> 0304103 that were harvested during the exponential growth phase were used to inoculate 10 mL of YPD. After the evaluation of different concentrations, 32 μg/mL was used because significant difference of genes could be observed without inhibiting <i>C. albicans</i> cells too strongly. Then, compound <b>12h</b> (32 μg/mL), <b>15j</b> (32 μg/mL), FLC (32 μg/mL), or blank control were added into the culture to treated the <i>C. albicans</i> cells. After the cultures were incubated at 35 °C for 16 h, total RNA of each group was isolated according to the manufacture’s protocol (Column Fungal RNAOUT, Tiandz, China), and cDNA was obtained using a RT kit (Takara Biotechnology, China). Real-time RT-PCR was performed on a LightCycler real-time PCR system (Roche Diagnostics GmbH Mannheim, Germany) using SYBR Green I as the fluorescence indicator. The experimental procedure was performed with 40 cycles. The fluorescence change of SYBR Green I was monitored during the each cycle to measure the threshold cycle (<i>C</i><sub>T</sub>). <i>ACT1</i> was used as an internal control gene. Compared with <i>ACT1</i>, relative fold change of the gene expression levels for each group were calculated using the formula 2<sup>(−ΔΔ<i>C</i><sub>T</sub>)</sup>. Real-time PCR reaction for each cDNA was performed in triplicate. The primers used in the assay are shown in Table S2 in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00102/suppl_file/jm0c00102_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> Rh6G Efflux Assay</h3><div class="NLM_p last">Azole-resistant <i>C. albicans</i> 0304103 that were harvested during the exponential growth phase were inoculated into 8 mL of YPD. Then, compound <b>12h</b> (32 μg/mL), <b>15j</b> (32 μg/mL), FLC (32 μg/mL), or blank control was added into the culture to treat the <i>C. albicans</i> cells. After the cultures were incubated at 35 °C for 16 h, <i>C. albicans</i> cells were harvested and diluted to OD at 630 nm to 0.5 (OD<sub>630</sub> = 0.5) with PBS (5 mL). Then, they were incubated at 35 °C for 2 h and Rh6G was added with final concentration of 10 μM. After further incubation at 35 °C for 30 min, <span class="smallcaps smallerCapital">d</span>-glucose was added to each group with a final concentration of 2 mM. Then, at designated time points (0, 20, 40, and 60 min), the fluorescence intensity of the supernatant (100 μL) of each group was measured on a fluorimeter with an excitation wavelength of 515 nm and an emission wavelength of 535 nm to determine the amount of extracellular Rh6G. The fluorescence intensity of each time point was measured in triplicate.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> Filamentation Assay</h3><div class="NLM_p last">The <i>in vitro</i> filamentation formation assay of compounds <b>12h</b>, <b>15j</b>, and FLC against the azole-resistant <i>C. albicans</i> 0304103 were performed according to the previously reported methods with a few modifications.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Briefly, 2 mL of fungal cells suspension (1 × 10<sup>5</sup> cfu/mL) in Spider medium was inoculated into 12-well plates, and then, different concentrations of compound were added. The plates were incubated at 37 °C for 4 h. Finally, the morphology of fungal cells in each well was recorded on an Axio observer D1-inverted microscope (Carl Zeiss, Inc., Thornwood, NY) equipped for photography.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> Biofilm Formation Assay</h3><div class="NLM_p last">The <i>in vitro</i> biofilm formation assay of compounds <b>12h</b>, <b>15j</b>, and FLC against the azole-resistant <i>C. albicans</i> 0304103 were performed according to the previously reported protocols.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Briefly, 100 μL of cell suspensions (1 × 10<sup>6</sup> cfu/mL) in RPMI 1640 medium was inoculated into the 96-well tissue culture plate, and the cells were cultured statically at 37 °C for 90 min. Then, the spent medium was aspirated, and each well was carefully washed three times with sterile PBS. Different concentrations of compound in RPMI 1640 medium were added, and the plates were further incubated at 37 °C for 24 h; finally, a semiquantitative biofilms formation rate was calculated using the XTT reduction assay. The experiment was performed in triplicate.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> <i>In Vivo</i> Antifungal Potency</h3><div class="NLM_p last">ICR female mice (4 to 6 weeks old and weighing 20–25 g) obtained from Shanghai Experimental Animal Center were fed as the experimental animals. Also, the mice were treated according to ACS guidelines on Animal Studies. Compound solution of <b>12h</b> (20 mg/kg, suspended in saline with 1.5% glycerin and 0.5% Tween 80) and <b>15j</b> (20 mg/kg, suspended in saline with 1.5% glycerin and 0.5% Tween 80) were freshly prepared before injection. The IC model was established by IP injection with a 0.2 mL of cyclophosphamide (100 mg/kg in saline) on day −1 and infected with a 0.2 mL inoculum (1 × 10<sup>5</sup> cfu) of azole-resistant <i>C. albicans</i> 0304103 by intravenous route on day 0. After 24 h, all the infectious mice were divided into six groups with four mice used for each group, and treated with saline (IP), compound <b>12h</b> (IP), compound <b>15j</b> (IP), saline (PO), compound <b>12h</b> (PO), and compound <b>15j</b> (PO), respectively, once a day for 5 days. On day 6, all the mice were euthanized and dissected, whose kidney were picked and weighed. Then, their left kidneys were homogenized in saline (1 mL), and the homogenates were diluted with saline to different concentration. The diluent homogenates were inoculated on Sabouraud’s dextrose agar medium containing a chloromycetin (100 μg/mL) plate, followed by incubation at 35 °C for 48 h. The number of colonies on each medium plate was counted to calculate the number of cfu/g of the kidney tissue and the numbers were transformed into log<sub>10</sub> units. The differences among the groups were analyzed by Student’s <i>t</i>-test. Their right kidneys were stained by PAS for histological studies.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> <i>In Vivo</i> Survival Time Assays</h3><div class="NLM_p last">The establishments of <i>C. albicans</i> infectious mice were similar to the fungal burden assays. Thirty mice were randomly and equally divided into three groups (compound <b>12h</b> group, compound <b>15j</b> group and saline group). Compound or saline were injected IP at the dose of 20 mg/kg per day for five days. The survival time of every mice were recorded for the plotting of the survive curve. The differences between groups were analyzed using the log-rank test.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i83"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00102" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46273" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46273" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00102?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00102</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Cytotoxicity of compounds <b>12h</b> and <b>15j</b> against human cell lines; primers for real-time RT-PCR; 2D-NMR of intermediates <b>5a</b> and <b>6a</b>; interactions of posaconazole and compound <b>15j</b> with CYP51; GC–MS of sterol composition; time-kill curve of compound <b>15j</b>; and spectral data and high-performance LC of the representative compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00102/suppl_file/jm0c00102_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings of the target compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00102/suppl_file/jm0c00102_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00102/suppl_file/jm0c00102_si_001.pdf">jm0c00102_si_001.pdf (8.09 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00102/suppl_file/jm0c00102_si_002.csv">jm0c00102_si_002.csv (3.95 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00102" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26453" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26453" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chunquan Sheng</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9489-804X" title="Orcid link">http://orcid.org/0000-0001-9489-804X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ef9c878a81888c9eaf9c82829ac18a8b9ac18c81"><span class="__cf_email__" data-cfemail="a4d7ccc1cac3c7d5e4d7c9c9d18ac1c0d18ac7ca">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guiyan Han</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Na Liu</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chenglan Li</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Ningxia Medical University, 1160 Shengli Street, Yinchuan 750004, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jie Tu</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhuang Li</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>G.H. and N.L. contributed equally to this work. The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare no competing financial interest.<br /></br></p></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i85">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17317" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17317" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the National Natural Science Foundation of China (grant 81725020 to C.S.), the Innovation Program of Shanghai Municipal Education Commission (grant 2019-01-07-00-07-E00073 to C.S.), and Science and Technology Commission of Shanghai Municipality (grant 17XD1404700 to C.S.).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">HIV</td><td class="NLM_def"><p class="first last">human immunodeficiency virus</p></td></tr><tr><td class="NLM_term">ICU</td><td class="NLM_def"><p class="first last">intensive care unit</p></td></tr><tr><td class="NLM_term">IFI</td><td class="NLM_def"><p class="first last">invasive fungal infection</p></td></tr><tr><td class="NLM_term">IC</td><td class="NLM_def"><p class="first last">invasive candidiasis</p></td></tr><tr><td class="NLM_term">HDACs</td><td class="NLM_def"><p class="first last">histone deacetylases</p></td></tr><tr><td class="NLM_term">FLC</td><td class="NLM_def"><p class="first last">fluconazole</p></td></tr><tr><td class="NLM_term">ITC</td><td class="NLM_def"><p class="first last">itraconazole</p></td></tr><tr><td class="NLM_term">VOR</td><td class="NLM_def"><p class="first last">voriconazole</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SRC</td><td class="NLM_def"><p class="first last">surface recognition cap</p></td></tr><tr><td class="NLM_term">ZBG</td><td class="NLM_def"><p class="first last">zinc-binding group</p></td></tr><tr><td class="NLM_term">MIC</td><td class="NLM_def"><p class="first last">minimum inhibitory concentration</p></td></tr><tr><td class="NLM_term">Et<sub>3</sub>N</td><td class="NLM_def"><p class="first last">trimethylamine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term"><i>C. alb.</i> and <i>C. albicans</i></td><td class="NLM_def"><p class="first last"><i>Candida albicans</i></p></td></tr><tr><td class="NLM_term"><i>C. tro.</i> and <i>C. tropicalis</i></td><td class="NLM_def"><p class="first last"><i>Candida tropicalis</i></p></td></tr><tr><td class="NLM_term"><i>C. neo.</i> and <i>C. neoformans</i></td><td class="NLM_def"><p class="first last"><i>Cryptococcus neoformans</i></p></td></tr><tr><td class="NLM_term">GC–MS</td><td class="NLM_def"><p class="first last">gas chromatography–mass spectrometry</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviation</p></td></tr><tr><td class="NLM_term">RT-PCR</td><td class="NLM_def"><p class="first last">reverse transcription-polymerase chain reaction</p></td></tr><tr><td class="NLM_term">Rh6G</td><td class="NLM_def"><p class="first last">rhodamine 6G</p></td></tr><tr><td class="NLM_term">DIC</td><td class="NLM_def"><p class="first last">differential interference contrast</p></td></tr><tr><td class="NLM_term">XTT</td><td class="NLM_def"><p class="first last">2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2<i>H</i>-tetrazolium-5-carboxanilide</p></td></tr><tr><td class="NLM_term">IP</td><td class="NLM_def"><p class="first last">intraperitoneal</p></td></tr><tr><td class="NLM_term">PO</td><td class="NLM_def"><p class="first last">oral</p></td></tr><tr><td class="NLM_term">PAS</td><td class="NLM_def"><p class="first last">periodic acid-Schiff</p></td></tr><tr><td class="NLM_term">MST</td><td class="NLM_def"><p class="first last">median survival time</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high-resolution mass spectrum</p></td></tr><tr><td class="NLM_term">YPD</td><td class="NLM_def"><p class="first last">yeast extract peptone dextrose</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffer saline</p></td></tr><tr><td class="NLM_term">OD</td><td class="NLM_def"><p class="first last">optical density</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i87">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31185" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31185" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 73 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miceli, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Díaz, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. A.</span></span> <span> </span><span class="NLM_article-title">Emerging opportunistic yeast infections</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">142</span>– <span class="NLM_lpage">151</span>, <span class="refDoi"> DOI: 10.1016/s1473-3099(10)70218-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1016%2FS1473-3099%2810%2970218-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=21272794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A280%3ADC%252BC3M7kvFKhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=142-151&author=M.+H.+Miceliauthor=J.+A.+D%C3%ADazauthor=S.+A.+Lee&title=Emerging+opportunistic+yeast+infections&doi=10.1016%2Fs1473-3099%2810%2970218-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging opportunistic yeast infections</span></div><div class="casAuthors">Miceli Marisa H; Diaz Jose A; Lee Samuel A</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Infectious diseases</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">142-51</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A growing population of immunosuppressed patients has resulted in increasingly frequent diagnoses of invasive fungal infections, including those caused by unusual yeasts.  The incidence of non-albicans species of Candida is increasing compared with that of Candida albicans, and several species, such as Candida glabrata and Candida krusei, may be resistant to azole antifungal therapy.  Trichosporon species are the second most common cause of fungaemia in patients with haematological malignant disease and are characterised by resistance to amphotericin and echinocandins and poor prognosis.  Rhodotorula species belong to the family Cryptococcaceae, and are a cause of catheter-related fungaemia, sepsis, and invasive disease in severely immunosuppressed patients.  An increasing number of sporadic cases of invasive fungal infections by non-neoformans cryptococci have been reported in immunocompromised hosts, especially for patients with advanced HIV infection or cancer who are undergoing transplant.  Other uncommon yeasts that can cause invasive disease in severely immunosuppressed patients include Geotrichum, Hansenula, Malassezia, and Saccharomyces.  Host immune status is a crucial determinant of the type of invasive fungal infection a patient is at risk for.  Diagnosis can be challenging and relies heavily on traditional cultures of blood and other sterile sites, although serum (1,3)-β-D-glucan testing might have an adjunctive role.  Although rare yeasts are emerging as opportunistic human pathogens, diagnosis remains challenging and treatment suboptimal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSWAubP3dADd691pGlMMoT5fW6udTcc2eatw-hf7GP_dLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7kvFKhuw%253D%253D&md5=3a92de401da3daf5656338ad744bb102</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2810%2970218-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252810%252970218-8%26sid%3Dliteratum%253Aachs%26aulast%3DMiceli%26aufirst%3DM.%2BH.%26aulast%3DD%25C3%25ADaz%26aufirst%3DJ.%2BA.%26aulast%3DLee%26aufirst%3DS.%2BA.%26atitle%3DEmerging%2520opportunistic%2520yeast%2520infections%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2011%26volume%3D11%26spage%3D142%26epage%3D151%26doi%3D10.1016%2Fs1473-3099%2810%2970218-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denning, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levitz, S. M.</span></span> <span> </span><span class="NLM_article-title">Tackling human fungal infections</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>336</i></span>,  <span class="NLM_fpage">647</span>, <span class="refDoi"> DOI: 10.1126/science.1222236</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1126%2Fscience.1222236" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=22582229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvF2jtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2012&pages=647&author=G.+D.+Brownauthor=D.+W.+Denningauthor=S.+M.+Levitz&title=Tackling+human+fungal+infections&doi=10.1126%2Fscience.1222236"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Tackling human fungal infections</span></div><div class="casAuthors">Brown, Gordon D.; Denning, David W.; Levitz, Stuart M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">6082</span>),
    <span class="NLM_cas:pages">647</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEe-AdzM8oD7Vg90H21EOLACvtfcHk0lg_bqVt--vd8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvF2jtLc%253D&md5=ad0c19c925c3821e35a52717f1cb071e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.1222236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1222236%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DG.%2BD.%26aulast%3DDenning%26aufirst%3DD.%2BW.%26aulast%3DLevitz%26aufirst%3DS.%2BM.%26atitle%3DTackling%2520human%2520fungal%2520infections%26jtitle%3DScience%26date%3D2012%26volume%3D336%26spage%3D647%26doi%3D10.1126%2Fscience.1222236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Emerging new targets for the treatment of resistant fungal infections</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5484</span>– <span class="NLM_lpage">5511</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01413</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01413" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVWlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5484-5511&author=N.+Liuauthor=J.+Tuauthor=G.+Dongauthor=Y.+Wangauthor=C.+Sheng&title=Emerging+new+targets+for+the+treatment+of+resistant+fungal+infections&doi=10.1021%2Facs.jmedchem.7b01413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging New Targets for the Treatment of Resistant Fungal Infections</span></div><div class="casAuthors">Liu, Na; Tu, Jie; Dong, Guoqiang; Wang, Yan; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5484-5511</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  With the increasing morbidity and mortality of invasive fungal infections and the emergence of severe antifungal drug resistance, new drug targets and novel antifungal agents are urgently needed.  Recently, better understanding of fungal pathogenesis has contributed to the rapid emergence of potential antifungal drug targets.  This perspective aims to provide a comprehensive review of new antifungal targets and of medicinal chem. efforts toward inhibitor discovery.  Particular focus will be placed on the druggability of the targets and their potential to treat resistant fungal infections.  Innovative strategies for the next generation of antifungal therapy, such as virulence factors, protein-protein interactions, and immune response-based proteins, will also be highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOtRgloz2VI7Vg90H21EOLACvtfcHk0lhy12iL370Vww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVWlsA%253D%253D&md5=ff2bf0c214005c9be04e3dfd8480d8da</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01413%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DTu%26aufirst%3DJ.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DEmerging%2520new%2520targets%2520for%2520the%2520treatment%2520of%2520resistant%2520fungal%2520infections%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5484%26epage%3D5511%26doi%3D10.1021%2Facs.jmedchem.7b01413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanglard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurr, S. J.</span></span> <span> </span><span class="NLM_article-title">Worldwide emergence of resistance to antifungal drugs challenges human health and food security</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>360</i></span>,  <span class="NLM_fpage">739</span>– <span class="NLM_lpage">742</span>, <span class="refDoi"> DOI: 10.1126/science.aap7999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1126%2Fscience.aap7999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=29773744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsVCgsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2018&pages=739-742&author=M.+C.+Fisherauthor=N.+J.+Hawkinsauthor=D.+Sanglardauthor=S.+J.+Gurr&title=Worldwide+emergence+of+resistance+to+antifungal+drugs+challenges+human+health+and+food+security&doi=10.1126%2Fscience.aap7999"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Worldwide emergence of resistance to antifungal drugs challenges human health and food security</span></div><div class="casAuthors">Fisher, Matthew C.; Hawkins, Nichola J.; Sanglard, Dominique; Gurr, Sarah J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue">6390</span>),
    <span class="NLM_cas:pages">739-742</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The recent rate of emergence of pathogenic fungi that are resistant to the limited no. of commonly used antifungal agents is unprecedented.  The azoles, for example, are used not only for human and animal health care and crop protection but also in antifouling coatings and timber preservation.  The ubiquity and multiple uses of azoles have hastened the independent evolution of resistance in many environments.  One consequence is an increasing risk in human health care from naturally occurring opportunistic fungal pathogens that have acquired resistance to this broad class of chems.  To avoid a global collapse in our ability to control fungal infections and to avoid crit. failures in medicine and food security, we must improve our stewardship of extant chems., promote new antifungal discovery, and leverage emerging technologies for alternative solns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolE2CwqdzBv7Vg90H21EOLACvtfcHk0lhy12iL370Vww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsVCgsbg%253D&md5=8add9de472138d5aca677fa3585ddd72</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.aap7999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aap7999%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DM.%2BC.%26aulast%3DHawkins%26aufirst%3DN.%2BJ.%26aulast%3DSanglard%26aufirst%3DD.%26aulast%3DGurr%26aufirst%3DS.%2BJ.%26atitle%3DWorldwide%2520emergence%2520of%2520resistance%2520to%2520antifungal%2520drugs%2520challenges%2520human%2520health%2520and%2520food%2520security%26jtitle%3DScience%26date%3D2018%26volume%3D360%26spage%3D739%26epage%3D742%26doi%3D10.1126%2Fscience.aap7999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perfect, J. R.</span></span> <span> </span><span class="NLM_article-title">The antifungal pipeline: a reality check</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">603</span>– <span class="NLM_lpage">616</span>, <span class="refDoi"> DOI: 10.1038/nrd.2017.46</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1038%2Fnrd.2017.46" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=28496146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC2sXns1Kisrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=603-616&author=J.+R.+Perfect&title=The+antifungal+pipeline%3A+a+reality+check&doi=10.1038%2Fnrd.2017.46"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The antifungal pipeline: a reality check</span></div><div class="casAuthors">Perfect, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">603-616</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Invasive fungal infections continue to appear in record nos. as the immunocompromised population of the world increases, owing partially to the increased no. of individuals who are infected with HIV and partially to the successful treatment of serious underlying diseases.  The effectiveness of current antifungal therapies - polyenes, flucytosine, azoles and echinocandins (as monotherapies or in combinations for prophylaxis, or as empiric, pre-emptive or specific therapies) - in the management of these infections has plateaued.  Although these drugs are clin. useful, they have several limitations, such as off-target toxicity, and drug-resistant fungi are now emerging.  New antifungals are therefore needed.  In this Review, I discuss the robust and dynamic antifungal pipeline, including results from preclin. academic efforts through to pharmaceutical industry products, and describe the targets, strategies, compds. and potential outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMkSYe01GMwLVg90H21EOLACvtfcHk0ljqk5wEhDnp3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXns1Kisrs%253D&md5=1c6fcc06db9dd97c562c0f17b1441c8d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2017.46&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2017.46%26sid%3Dliteratum%253Aachs%26aulast%3DPerfect%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520antifungal%2520pipeline%253A%2520a%2520reality%2520check%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D603%26epage%3D616%26doi%3D10.1038%2Fnrd.2017.46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denning, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gow, N. A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levitz, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netea, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, T. C.</span></span> <span> </span><span class="NLM_article-title">Hidden killers: human fungal infections</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">165rv13</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3004404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1126%2Fscitranslmed.3004404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=23253612" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=165rv13&author=G.+D.+Brownauthor=D.+W.+Denningauthor=N.+A.+R.+Gowauthor=S.+M.+Levitzauthor=M.+G.+Neteaauthor=T.+C.+White&title=Hidden+killers%3A+human+fungal+infections&doi=10.1126%2Fscitranslmed.3004404"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3004404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3004404%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DG.%2BD.%26aulast%3DDenning%26aufirst%3DD.%2BW.%26aulast%3DGow%26aufirst%3DN.%2BA.%2BR.%26aulast%3DLevitz%26aufirst%3DS.%2BM.%26aulast%3DNetea%26aufirst%3DM.%2BG.%26aulast%3DWhite%26aufirst%3DT.%2BC.%26atitle%3DHidden%2520killers%253A%2520human%2520fungal%2520infections%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D165rv13%26doi%3D10.1126%2Fscitranslmed.3004404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lien, M.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, C.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, S.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, M.-W.</span></span> <span> </span><span class="NLM_article-title">Epidemiology and risk factors for invasive fungal infections during induction chemotherapy for newly diagnosed acute myeloid leukemia: A retrospective cohort study</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>, <span class="NLM_elocation-id">e0197851</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0197851</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1371%2Fjournal.pone.0197851" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=29883443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVOmsr7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&author=M.-Y.+Lienauthor=C.-H.+Chouauthor=C.-C.+Linauthor=L.-Y.+Baiauthor=C.-F.+Chiuauthor=S.-P.+Yehauthor=M.-W.+Ho&title=Epidemiology+and+risk+factors+for+invasive+fungal+infections+during+induction+chemotherapy+for+newly+diagnosed+acute+myeloid+leukemia%3A+A+retrospective+cohort+study&doi=10.1371%2Fjournal.pone.0197851"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Epidemiology and risk factors for invasive fungal infections during induction chemotherapy for newly diagnosed acute myeloid leukemia: a retrospective cohort study</span></div><div class="casAuthors">Lien, Ming-Yu; Chou, Chia-Hui; Lin, Ching-Chan; Bai, Li-Yuan; Chiu, Chang-Fang; Yeh, Su-Peng; Ho, Mao-Wang</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e0197851/1-e0197851/11</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">This study investigated the epidemiol. and risk factors assocd. with invasive fungal infections (IFIs) during induction chemotherapy in a cohort of Taiwanese patients with newly-diagnosed acute myeloid leukemia (AML).  IFIs are a significant complication in the management of immunocompromised cancer patients; such infections are assocd. with a high incidence of morbidity and mortality, particularly in many South-Asian countries, where IFI rates are increasing.  We retrospectively analyzed IFI incidence data from 105 patients with newly diagnosed AML at a single center undergoing their first course of induction chemotherapy without primary antifungal prophylaxis between Nov. 2008 and Dec. 2014.  Of 21 cases documented as proven/provable IFIs 16 (76%) were invasive aspergillosis, 2 (10%) were mucormycosis infections, and 3 (14%) were proven yeast infections.  The lung was the most commonly affected site (n = 16; 76%); 2 patients (10%) developed fungal sinusitis.  IFI cases were more often males (P = 0.020).  In multivariate anal., patients with neutropenia lasting >30 days were more than twice as likely to develop IFI (OR, 2.24 [95% CI, 2.81-31.11], P<0.001).  We also confirmed patients with smoker and receiving parenteral nutrition during chemotherapy were significant assocd. with IFIs.  Our findings suggest that antifungal prophylaxis should be considered for patients with AML during induction chemotherapy, particularly in patients from Southeastern Asia, an area of potentially high IFI rates.  We recommend that clinicians det. which patients receiving induction chemotherapy for AML are at high risk of developing IFI, to allow for targeted therapeutic prophylaxis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2iw5KeqRuobVg90H21EOLACvtfcHk0ljqk5wEhDnp3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVOmsr7K&md5=162afec989576580df80dcc6e78544ab</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0197851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0197851%26sid%3Dliteratum%253Aachs%26aulast%3DLien%26aufirst%3DM.-Y.%26aulast%3DChou%26aufirst%3DC.-H.%26aulast%3DLin%26aufirst%3DC.-C.%26aulast%3DBai%26aufirst%3DL.-Y.%26aulast%3DChiu%26aufirst%3DC.-F.%26aulast%3DYeh%26aufirst%3DS.-P.%26aulast%3DHo%26aufirst%3DM.-W.%26atitle%3DEpidemiology%2520and%2520risk%2520factors%2520for%2520invasive%2520fungal%2520infections%2520during%2520induction%2520chemotherapy%2520for%2520newly%2520diagnosed%2520acute%2520myeloid%2520leukemia%253A%2520A%2520retrospective%2520cohort%2520study%26jtitle%3DPLoS%2520One%26date%3D2018%26volume%3D13%26doi%3D10.1371%2Fjournal.pone.0197851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Enoch, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aliyu, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micallef, C.</span></span> <span> </span><span class="NLM_article-title">The changing epidemiology of invasive fungal infections</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1508</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1007/978-1-4939-6515-1_2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1007%2F978-1-4939-6515-1_2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=27837497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktFOqtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1508&publication_year=2017&pages=17-65&author=D.+A.+Enochauthor=H.+Yangauthor=S.+H.+Aliyuauthor=C.+Micallef&title=The+changing+epidemiology+of+invasive+fungal+infections&doi=10.1007%2F978-1-4939-6515-1_2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The changing epidemiology of invasive fungal infections</span></div><div class="casAuthors">Enoch, David A.; Yang, Huina; Aliyu, Sani H.; Micallef, Christianne</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1508</span>
        (<span class="NLM_cas:issue">Human Fungal Pathogen Identification</span>),
    <span class="NLM_cas:pages">17-65</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Invasive fungal infections (IFI) are an emerging problem worldwide with invasive candidiasis and candidemia responsible for the majority of cases.  This is predominantly driven by the widespread adoption of aggressive immunosuppressive therapy among certain patient populations (e.g., chemotherapy, transplants) and the increasing use of invasive devices such as central venous catheters (CVCs).  The use of new immune modifying drugs has also opened up an entirely new spectrum of patients at risk of IFIs.  While the epidemiol. of candida infections has changed in the last decade, with a gradual shift from C. albicans to non-albicans candida (NAC) strains which may be less susceptible to azoles, these changes vary between hospitals and regions depending on the type of population risk factors and antifungal use.  In certain parts of the world, the incidence of IFI is strongly linked to the prevalence of other disease conditions and the ecol. niche for the organism; for instance cryptococcal and pneumocystis infections are particularly common in areas with a high prevalence of HIV disease.  Poorly controlled diabetes is a major risk factor for invasive mold infections.  Environmental factors and trauma also play a unique role in the epidemiol. of mold infections, with well-described hospital outbreaks linked to the use of contaminated instruments and devices.  Blastomycosis is assocd. with occupational exposure (e.g., forest rangers) and recreational activities (e.g., camping and fishing).  The true burden of IFI is probably an underestimate because of the absence of reliable diagnostics and lack of universal application.  For example, the sensitivity of most blood culture systems for detecting candida is typically 50 %.  The advent of new technol. including mol. techniques such as 18S rRNA PCR and genome sequencing is leading to an improved understanding of the epidemiol. of the less common mold and dimorphic fungal infections.  Mol. techniques are also providing a platform for improved diagnosis and management of IFI.  Many factors affect mortality in IFI, not least the underlying medical condition, choice of therapy, and the ability to achieve early source control.  For instance, mortality due to pneumocystis pneumonia in HIV-seroneg. individuals is now higher than in seropos. patients.  Of significant concern is the progressive increase in resistance to azoles and echinocandins among candida isolates, which appears to worsen the already significant mortality assocd. with invasive candidiasis.  Mortality with mold infections approaches 50 % in most studies and varies depending on the site, underlying disease and the use of antifungal agents such as echinocandins and voriconazole.  Nevertheless, mortality for most IFIs has generally fallen with advances in medical technol., improved care of CVCs, improved diagnostics, and more effective preemptive therapy and prophylaxis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGVxF8Tly92bVg90H21EOLACvtfcHk0lgoRgug1_Ls_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktFOqtL0%253D&md5=f6e93ef28407981b84ce13bdbee5c4a8</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-6515-1_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-6515-1_2%26sid%3Dliteratum%253Aachs%26aulast%3DEnoch%26aufirst%3DD.%2BA.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DAliyu%26aufirst%3DS.%2BH.%26aulast%3DMicallef%26aufirst%3DC.%26atitle%3DThe%2520changing%2520epidemiology%2520of%2520invasive%2520fungal%2520infections%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2017%26volume%3D1508%26spage%3D17%26epage%3D65%26doi%3D10.1007%2F978-1-4939-6515-1_2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cowen, L. E.</span></span> <span> </span><span class="NLM_article-title">The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">198</span>, <span class="refDoi"> DOI: 10.1038/nrmicro1835</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1038%2Fnrmicro1835" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=18246082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvFCgt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=187-198&author=L.+E.+Cowen&title=The+evolution+of+fungal+drug+resistance%3A+modulating+the+trajectory+from+genotype+to+phenotype&doi=10.1038%2Fnrmicro1835"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype</span></div><div class="casAuthors">Cowen, Leah E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">187-198</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Leah Cowen reviews the mechanisms that potentiate the evolution of fungal drug resistance, with an emphasis on the central role of the mol. chaperone heat shock protein 90 (Hsp90) in altering the relationship between genotype and phenotype in an environmentally contingent manner, which thereby 'sculpts' the course of evolution.  The emergence of drug resistance in pathogenic microorganisms provides an excellent example of microbial evolution that has had profound consequences for human health.  The widespread use of antimicrobial agents in medicine and agriculture exerts strong selection for the evolution of drug resistance.  Selection acts on the phenotypic consequences of resistance mutations, which are influenced by the genetic variation in particular genomes.  Recent studies have revealed a mechanism by which the mol. chaperone heat shock protein 90 (Hsp90) can alter the relationship between genotype and phenotype in an environmentally contingent manner, thereby 'sculpting' the course of evolution.  Harnessing Hsp90 holds great promise for treating life-threatening infectious diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSI9Z1MVuUILVg90H21EOLACvtfcHk0lgoRgug1_Ls_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvFCgt7k%253D&md5=e55ad31b236ffc2ea0a9aa427b53b006</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro1835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro1835%26sid%3Dliteratum%253Aachs%26aulast%3DCowen%26aufirst%3DL.%2BE.%26atitle%3DThe%2520evolution%2520of%2520fungal%2520drug%2520resistance%253A%2520modulating%2520the%2520trajectory%2520from%2520genotype%2520to%2520phenotype%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2008%26volume%3D6%26spage%3D187%26epage%3D198%26doi%3D10.1038%2Fnrmicro1835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kontoyiannis, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornely, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perfect, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, T. J.</span></span> <span> </span><span class="NLM_article-title">Novel agents and drug targets to meet the challenges of resistant fungi</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>216</i></span>,  <span class="NLM_fpage">S474</span>– <span class="NLM_lpage">S483</span>, <span class="refDoi"> DOI: 10.1093/infdis/jix130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1093%2Finfdis%2Fjix130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=28911042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFOkt73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=216&publication_year=2017&pages=S474-S483&author=M.+W.+McCarthyauthor=D.+P.+Kontoyiannisauthor=O.+A.+Cornelyauthor=J.+R.+Perfectauthor=T.+J.+Walsh&title=Novel+agents+and+drug+targets+to+meet+the+challenges+of+resistant+fungi&doi=10.1093%2Finfdis%2Fjix130"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Novel agents and drug targets to meet the challenges of resistant fungi</span></div><div class="casAuthors">McCarthy, Matthew W.; Kontoyiannis, Dimitrios P.; Cornely, Oliver A.; Perfect, John R.; Walsh, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">216</span>
        (<span class="NLM_cas:issue">Suppl. 3</span>),
    <span class="NLM_cas:pages">S474-S483</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">1537-6613</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The emergence of drug-resistant fungi poses a major threat to human health.  Despite advances in preventive, diagnostic, and therapeutic interventions, resistant fungal infections continue to cause significant morbidity and mortality in patients with compromised immunity, underscoring the urgent need for new antifungal agents.  In this article, we review the challenges assocd. with identifying broad-spectrum antifungal drugs and highlight novel targets that could enhance the armamentarium of agents available to treat drug-resistant invasive fungal infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs9Wx_NnqsFLVg90H21EOLACvtfcHk0ljn_gs3gXgUVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFOkt73E&md5=8f772a238efdb03473a7acf8a285eb8e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2Fjix130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252Fjix130%26sid%3Dliteratum%253Aachs%26aulast%3DMcCarthy%26aufirst%3DM.%2BW.%26aulast%3DKontoyiannis%26aufirst%3DD.%2BP.%26aulast%3DCornely%26aufirst%3DO.%2BA.%26aulast%3DPerfect%26aufirst%3DJ.%2BR.%26aulast%3DWalsh%26aufirst%3DT.%2BJ.%26atitle%3DNovel%2520agents%2520and%2520drug%2520targets%2520to%2520meet%2520the%2520challenges%2520of%2520resistant%2520fungi%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2017%26volume%3D216%26spage%3DS474%26epage%3DS483%26doi%3D10.1093%2Finfdis%2Fjix130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hospital, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Z.</span></span> <span> </span><span class="NLM_article-title">Invasive candidiasis in intensive care units in China: in vitro antifungal susceptibility in the China-SCAN study</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">162</span>– <span class="NLM_lpage">167</span>, <span class="refDoi"> DOI: 10.1093/jac/dkt330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1093%2Fjac%2Fdkt330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=24004860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFegtrfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2014&pages=162-167&author=W.+Liuauthor=J.+Tanauthor=J.+Sunauthor=Z.+Xuauthor=M.+Liauthor=Q.+Yangauthor=H.+Shaoauthor=L.+Zhangauthor=W.+Liuauthor=Z.+Wanauthor=W.+Cuiauthor=B.+Zangauthor=D.+Jiangauthor=Q.+Fangauthor=B.+Qinauthor=T.+Qinauthor=W.+Liauthor=F.+Guoauthor=D.+Liuauthor=X.+Guanauthor=K.+Yuauthor=H.+Qiuauthor=R.+Liauthor=J.+Jinauthor=Y.+Zhanauthor=X.+Qianauthor=L.+Liuauthor=X.+Zhuauthor=D.+Wangauthor=X.+Liangauthor=Y.+Feiauthor=H.+Luauthor=B.+Maauthor=D.+Zhuauthor=B.+Huauthor=J.+Linauthor=B.+Yangauthor=M.+Liauthor=C.+Dingauthor=Y.+Qinauthor=Y.+Fengauthor=H.+Zhaoauthor=S.+Zhuauthor=Q.+Caoauthor=S.+Zhouauthor=Y.+Meiauthor=X.+Zhaoauthor=Z.+Tangauthor=H.+Liangauthor=J.+Zhuauthor=Y.+Shiauthor=Y.+Xuauthor=J.+Liuauthor=L.+Yaoauthor=X.+Yangauthor=W.+Jiaauthor=R.+Zhengauthor=X.+Zhuauthor=Y.+Xuauthor=X.+Luauthor=M.+Zhaoauthor=J.+Luauthor=X.+Guanauthor=K.+Liaoauthor=D.+Wuauthor=E.+Sunauthor=X.+Linauthor=T.+Zhouauthor=J.+Xingauthor=P.+Liuauthor=D.+Chenauthor=H.+Wangauthor=X.+Wangauthor=Q.+Shiauthor=Y.+Aiauthor=M.+Zouauthor=J.+Zhouauthor=M.+Tangauthor=Q.+Songauthor=D.+Shenauthor=W.+Guoauthor=J.+Liauthor=Q.+Guoauthor=C.+Qianauthor=X.+Fengauthor=X.+Wanauthor=J.+Zhangauthor=Z.+Huauthor=J.+Zhangauthor=Y.+Wangauthor=J.+Zhangauthor=J.+Yanauthor=L.+Zhouauthor=X.+Yuauthor=P.+Jiauthor=J.+Xiongauthor=L.+Zhangauthor=Y.+Yinauthor=H.+Liuauthor=S.+Yuanauthor=J.+Zengauthor=S.+Liauthor=L.+Liauthor=J.+Yanauthor=Z.+Xiaoauthor=Z.+Hospitalauthor=C.+Wangauthor=Y.+Wangauthor=R.+Sunauthor=M.+Xuauthor=Z.+Wan&title=Invasive+candidiasis+in+intensive+care+units+in+China%3A+in+vitro+antifungal+susceptibility+in+the+China-SCAN+study&doi=10.1093%2Fjac%2Fdkt330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Invasive candidiasis in intensive care units in China: in vitro antifungal susceptibility in the China-SCAN study</span></div><div class="casAuthors">Liu, Wei; Tan, Jingwen; Sun, Jimei; Xu, Zhijiang; Li, Min; Yang, Qing; Shao, Haifeng; Zhang, Liyan; Liu, Weixia; Wan, Zhe; Cui, Wei; Zang, Bin; Jiang, Dongpo; Fang, Qiang; Qin, Bingyu; Qin, Tiehe; Li, Weiqin; Guo, Fengmei; Liu, Dawei; Guan, Xiandong; Yu, Kaijiang; Qiu, Haibo; Li, Ruoyu; Jin, Jun; Zhan, Ying; Qian, Xuefeng; Liu, Lijun; Zhu, Xueming; Wang, Difen; Liang, Xianquan; Fei, Ying; Lu, Huixia; Ma, Bing; Zhu, Duming; Hu, Bijie; Lin, Jiandong; Yang, Bin; Li, Maoqin; Ding, Chen; Qin, Yingzhi; Feng, Yongwang; Zhao, Hongsheng; Zhu, Shaopeng; Cao, Quan; Zhou, Suming; Mei, Yaning; Zhao, Xiaoqin; Tang, Zhanhong; Liang, Hongjie; Zhu, Jianhuan; Shi, Yingjiao; Xu, Yingchun; Liu, Jian; Yao, Liqiong; Yang, Xiaojun; Jia, Wei; Zheng, Ruiqiang; Zhu, Xiaoping; Xu, Yuan; Lu, Xinxin; Zhao, Mingyan; Lu, Juan; Guan, Xiangdong; Liao, Kang; Wu, Dawei; Sun, Enhua; Lin, Xifang; Zhou, Tieli; Xing, Jinyan; Liu, Pengpeng; Chen, Dechang; Wang, Hu; Wang, Xue; Shi, Qindong; Ai, Yuhang; Zou, Mingxiang; Zhou, Jianxin; Tang, Mingzhong; Song, Qing; Shen, Dingxia; Guo, Weiyuan; Li, Jianguo; Guo, Qinglian; Qian, Chuanyun; Feng, Xia; Wan, Xianyao; Zhang, Jiuzhi; Hu, Zhenjie; Zhang, Jinyan; Wang, Yongqiang; Zhang, Jianlei; Yan, Jie; Zhou, Lizhen; Yu, Xiangyou; Ji, Ping; Xiong, Jianqiong; Zhang, Lei; Yin, Yongjie; Liu, Haibo; Yuan, Shiying; Zeng, Ji; Li, Shusheng; Li, Li; Yan, Jing; Xiao, Zhen; Hospital, Zhejiang; Wang, Chunting; Wang, Yong; Sun, Rongqing; Xu, Min; Wan, Zhe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">162-167</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The objectives of this study were to det. species distribution and in vitro antifungal susceptibility of Candida isolates identified in the multicenter China-SCAN study of invasive Candida infection (ICI) in intensive care units (ICUs) across China.  Candida isolates from patients in the China-SCAN study with documented ICI were evaluated by a central lab.  Species were identified using chromogenic culture media or the API 20C AUX kit.  Susceptibility to fluconazole, voriconazole, itraconazole, caspofungin and amphotericin B was detd. using the CLSI broth microdilution method (M27-A3) and updated clin. breakpoints or epidemiol. cut-off values.  Some 389 isolates from 244 patients were analyzed.  The species identified most frequently were Candida albicans (40.1%), Candida parapsilosis (21.3%), Candida tropicalis (17.2%) and Candida glabrata (12.9%).  Rarer species such as Lodderomyces elongisporus and Candida ernobii were also identified.  Fluconazole susceptibility was evident in 85.9% (134/156) of C. albicans, 62.7% (42/67) of C. tropicalis and 48.2% (40/83) of C. parapsilosis isolates.  Susceptibility to voriconazole was ≥90% among all species.  All isolates were susceptible to amphotericin B and caspofungin except C. glabrata [86.0% (43/50) susceptible to caspofungin].  Cross-resistance between fluconazole and voriconazole was obsd. for C. parapsilosis and C. glabrata.  Conclusions Although C. albicans was the predominant single species, non-albicans species constituted >50% of isolates.  Fluconazole susceptibility was lower in most non-albicans species, indicating that fluconazole resistance should be closely monitored.  Susceptibility to voriconazole, amphotericin B and caspofungin is encouraging.  Differences between these data and those from other regions emphasize the importance of assessing regional variations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA7yZ51ezBk7Vg90H21EOLACvtfcHk0ljfzsHqYTgGnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFegtrfN&md5=601e62068a8a49bdbb95e5f601c2b525</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkt330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkt330%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DShao%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DWan%26aufirst%3DZ.%26aulast%3DCui%26aufirst%3DW.%26aulast%3DZang%26aufirst%3DB.%26aulast%3DJiang%26aufirst%3DD.%26aulast%3DFang%26aufirst%3DQ.%26aulast%3DQin%26aufirst%3DB.%26aulast%3DQin%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DGuan%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DQiu%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DZhan%26aufirst%3DY.%26aulast%3DQian%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DFei%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DMa%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DDing%26aufirst%3DC.%26aulast%3DQin%26aufirst%3DY.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DCao%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DMei%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DTang%26aufirst%3DZ.%26aulast%3DLiang%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DJia%26aufirst%3DW.%26aulast%3DZheng%26aufirst%3DR.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DGuan%26aufirst%3DX.%26aulast%3DLiao%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DXing%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DAi%26aufirst%3DY.%26aulast%3DZou%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DM.%26aulast%3DSong%26aufirst%3DQ.%26aulast%3DShen%26aufirst%3DD.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DQian%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DWan%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DJi%26aufirst%3DP.%26aulast%3DXiong%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DYin%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DYuan%26aufirst%3DS.%26aulast%3DZeng%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DHospital%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DR.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DZ.%26atitle%3DInvasive%2520candidiasis%2520in%2520intensive%2520care%2520units%2520in%2520China%253A%2520in%2520vitro%2520antifungal%2520susceptibility%2520in%2520the%2520China-SCAN%2520study%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2014%26volume%3D69%26spage%3D162%26epage%3D167%26doi%3D10.1093%2Fjac%2Fdkt330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Novel carboline derivatives as potent antifungal lead compounds: design, synthesis, and biological evaluation</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">506</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1021/ml400492t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400492t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFKht7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=506-511&author=S.+Wangauthor=Y.+Wangauthor=W.+Liuauthor=N.+Liuauthor=Y.+Zhangauthor=G.+Dongauthor=Y.+Liuauthor=Z.+Liauthor=X.+Heauthor=Z.+Miaoauthor=J.+Yaoauthor=J.+Liauthor=W.+Zhangauthor=C.+Sheng&title=Novel+carboline+derivatives+as+potent+antifungal+lead+compounds%3A+design%2C+synthesis%2C+and+biological+evaluation&doi=10.1021%2Fml400492t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Carboline Derivatives as Potent Antifungal Lead Compounds: Design, Synthesis, and Biological Evaluation</span></div><div class="casAuthors">Wang, Shengzheng; Wang, Yan; Liu, Wei; Liu, Na; Zhang, Yongqiang; Dong, Guoqiang; Liu, Yang; Li, Zhengang; He, Xiaomeng; Miao, Zhenyuan; Yao, Jianzhong; Li, Jian; Zhang, Wannian; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">506-511</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of novel antifungal carboline derivs. was designed and synthesized, which showed broad-spectrum antifungal activity.  Particularly, compd. I showed comparable in vitro antifungal activity to fluconazole without toxicity to human embryonic lung cells.  It also exhibited good fungicidal activity against both fluconazole-sensitive and -resistant Candida albicans cells and had potent inhibition activity against Candida albicans biofilm formation and hyphal growth.  Moreover, I showed good synergistic antifungal activity in combination with fluconazole (FLC) against FLC-resistant Candida species.  Preliminary mechanism studies revealed that C38 might act by inhibiting the synthesis of fungal cell wall.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEnSU799VTv7Vg90H21EOLACvtfcHk0ljpYdCOzmOkIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFKht7s%253D&md5=65a16ae4999bc93c952dcf06299dabf9</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fml400492t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400492t%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DNovel%2520carboline%2520derivatives%2520as%2520potent%2520antifungal%2520lead%2520compounds%253A%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D506%26epage%3D511%26doi%3D10.1021%2Fml400492t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Canuto, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodero, F. G.</span></span> <span> </span><span class="NLM_article-title">Antifungal drug resistance to azoles and polyenes</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">550</span>– <span class="NLM_lpage">563</span>, <span class="refDoi"> DOI: 10.1016/s1473-3099(02)00371-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1016%2FS1473-3099%2802%2900371-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=12206971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsFOjtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=550-563&author=M.+M.+Canutoauthor=F.+G.+Rodero&title=Antifungal+drug+resistance+to+azoles+and+polyenes&doi=10.1016%2Fs1473-3099%2802%2900371-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Antifungal drug resistance to azoles and polyenes</span></div><div class="casAuthors">Canuto, Mar Masia; Rodero, Felix Gutierrez</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">550-563</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Lancet Publishing Group</span>)
        </div><div class="casAbstract">A review.  There is an increased awareness of the morbidity and mortality assocd. with fungal infections caused by resistant fungi in various groups of patients.  Epidemiol. studies have identified risk factors assocd. with antifungal drug resistance.  Selection pressure due to the continuous exposure to azoles seems to have an essential role in developing resistance to fluconazole in Candida species.  Hematol. malignancies, esp. acute leukemia with severe and prolonged neutropenia, seem to be the main risk factors for acquiring deep-seated mycosis caused by resistant filamentous fungi, such us Fusarium species, Scedosporium prolificans, and Aspergillus terreus.  The still unacceptably high mortality rate assocd. with some resistant mycosis indicates that alternatives to existing therapeutic options are needed.  Potential measures to overcome antifungal resistance ranges from the development of new drugs with better antifungal activity to improving current therapeutic, strategies with the present antifungal agents.  Among the new antifungal drugs, inhibitors of beta glucan synthesis and second-generation azole and triazole derivs. have characteristics that render them potentially suitable agents against some resistant fungi.  Other strategies including the use of high doses of lipid formulations of amphotericin B, combination therapy, and adjunctive immune therapy with cytokines are under investigation.  In addn., antifungal control programs to prevent extensive and inappropriate use of antifungals may be needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopFYGU6XdLGbVg90H21EOLACvtfcHk0ljpYdCOzmOkIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsFOjtbk%253D&md5=8ae11e7fd0b420a48e1b35c833c4d27c</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2802%2900371-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252802%252900371-7%26sid%3Dliteratum%253Aachs%26aulast%3DCanuto%26aufirst%3DM.%2BM.%26aulast%3DRodero%26aufirst%3DF.%2BG.%26atitle%3DAntifungal%2520drug%2520resistance%2520to%2520azoles%2520and%2520polyenes%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2002%26volume%3D2%26spage%3D550%26epage%3D563%26doi%3D10.1016%2Fs1473-3099%2802%2900371-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, M.-J.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China</span>. <i>Res. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>166</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">161</span>, <span class="refDoi"> DOI: 10.1016/j.resmic.2015.02.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1016%2Fj.resmic.2015.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=25748216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktFOqur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2015&pages=153-161&author=J.-Y.+Liuauthor=C.+Shiauthor=Y.+Wangauthor=W.-J.+Liauthor=Y.+Zhaoauthor=M.-J.+Xiang&title=Mechanisms+of+azole+resistance+in+Candida+albicans+clinical+isolates+from+Shanghai%2C+China&doi=10.1016%2Fj.resmic.2015.02.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China</span></div><div class="casAuthors">Liu, Jin-Yan; Shi, Ce; Wang, Ying; Li, Wen-Jing; Zhao, Yue; Xiang, Ming-Jie</div><div class="citationInfo"><span class="NLM_cas:title">Research in Microbiology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">153-161</span>CODEN:
                <span class="NLM_cas:coden">RMCREW</span>;
        ISSN:<span class="NLM_cas:issn">0923-2508</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">This study was undertaken to characterize the mechanism(s) of azole resistance in clin. isolates of Candida albicans collected in Shanghai, China, focusing on the role of efflux pumps, target enzymes of fluconazole (Erg11), respiratory status and the ergosterol biosynthetic pathway.  Clin. isolates of C. albicans (n = 30) were collected from 30 different non-HIV-infected patients in four hospitals in Shanghai.  All 30 C. albicans isolates were susceptible to amphotericin B and 5-fluorocytosine.  Twelve C. albicans isolates showed resistance to at least one type of triazole antifungal.  Flow cytometry anal. of rhodamine 6G efflux showed that azole-resistant isolates had greater efflux pump activity, which was consistent with elevated levels of CDR1 and CDR2 genes that code for ABC efflux pumps.  However, we did not observe increased expression of ERG11 and MDR1 or respiratory deficiency.  Several mutations of ERG11 and TAC1 genes were detected.  The F964Y mutation in the TAC1 gene was identified for the first time.  Two main sterols, ergosterol and lanosterol, were identified by GC-MS chromatogram, and no missense mutations were found in ERG3.  Furthermore, seven amino acid substitutions in ERG11, A114S, Y132H, Y132F, K143Q, K143R, Y257H and G448E were found, by Type II spectral quant. anal., to contribute to low affinity binding between Erg11 and fluconazole.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtx1D6VffyWbVg90H21EOLACvtfcHk0lh-A796PME0MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktFOqur8%253D&md5=f831d913d329fbf301c69d94ff1e8be6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.resmic.2015.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.resmic.2015.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.-Y.%26aulast%3DShi%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DW.-J.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DXiang%26aufirst%3DM.-J.%26atitle%3DMechanisms%2520of%2520azole%2520resistance%2520in%2520Candida%2520albicans%2520clinical%2520isolates%2520from%2520Shanghai%252C%2520China%26jtitle%3DRes.%2520Microbiol.%26date%3D2015%26volume%3D166%26spage%3D153%26epage%3D161%26doi%3D10.1016%2Fj.resmic.2015.02.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seto, E.</span></span> <span> </span><span class="NLM_article-title">The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">206</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1038/nrm2346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1038%2Fnrm2346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=18292778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitlGnurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=206-218&author=X.-J.+Yangauthor=E.+Seto&title=The+Rpd3%2FHda1+family+of+lysine+deacetylases%3A+from+bacteria+and+yeast+to+mice+and+men&doi=10.1038%2Fnrm2346"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men</span></div><div class="casAuthors">Yang, Xiang-Jiao; Seto, Edward</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">206-218</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein lysine deacetylases have a pivotal role in numerous biol. processes and can be divided into the Rpd3/Hda1 and sirtuin families, each having members in diverse organisms including prokaryotes.  In vertebrates, the Rpd3/Hda1 family contains 11 members, traditionally referred to as histone deacetylases (HDAC) 1-11, which are further grouped into classes I, II and IV.  Whereas most class I HDACs are subunits of multiprotein nuclear complexes that are crucial for transcriptional repression and epigenetic landscaping, class II members regulate cytoplasmic processes or function as signal transducers that shuttle between the cytoplasm and the nucleus.  Little is known about class IV HDAC11, although its evolutionary conservation implies a fundamental role in various organisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRiVyZexxGn7Vg90H21EOLACvtfcHk0lh-A796PME0MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitlGnurk%253D&md5=f11f89567feadf9cd38b3852dc44c382</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnrm2346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2346%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.-J.%26aulast%3DSeto%26aufirst%3DE.%26atitle%3DThe%2520Rpd3%252FHda1%2520family%2520of%2520lysine%2520deacetylases%253A%2520from%2520bacteria%2520and%2520yeast%2520to%2520mice%2520and%2520men%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2008%26volume%3D9%26spage%3D206%26epage%3D218%26doi%3D10.1038%2Fnrm2346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of janus kinase 2 (JAK2) and histone deacetylase (HDAC) dual inhibitors as a novel strategy for the combinational treatment of leukemia and invasive fungal infections</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6056</span>– <span class="NLM_lpage">6074</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00393</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00393" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Snu7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6056-6074&author=Y.+Huangauthor=G.+Dongauthor=H.+Liauthor=N.+Liuauthor=W.+Zhangauthor=C.+Sheng&title=Discovery+of+janus+kinase+2+%28JAK2%29+and+histone+deacetylase+%28HDAC%29+dual+inhibitors+as+a+novel+strategy+for+the+combinational+treatment+of+leukemia+and+invasive+fungal+infections&doi=10.1021%2Facs.jmedchem.8b00393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Janus Kinase 2 (JAK2) and Histone Deacetylase (HDAC) Dual Inhibitors as a Novel Strategy for the Combinational Treatment of Leukemia and Invasive Fungal Infections</span></div><div class="casAuthors">Huang, Yahui; Dong, Guoqiang; Li, Huanqiu; Liu, Na; Zhang, Wannian; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6056-6074</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Clin., leukemia patients often suffer from the limited efficacy of chemotherapy and high risks of infection by invasive fungal pathogens.  Herein, a novel therapeutic strategy was developed in which a small mol. can simultaneously treat leukemia and invasive fungal infections (IFIs).  Novel Janus kinase 2 (JAK2) and histone deacetylase (HDAC) dual inhibitors were identified to possess potent anti-proliferative activity toward hematol. cell lines and excellent synergistic effects with fluconazole to treat resistant Candida albicans infections.  In particular, compd. I, a highly active and selective JAK2/HDAC6 dual inhibitor, showed excellent in vivo antitumor efficacy in several acute myeloid leukemia (AML) models and synergized with fluconazole for the treatment of resistant C. albicans infections.  This study highlights the therapeutic potential of JAK2/HDAC dual inhibitors in treating AML and IFIs and provides an efficient strategy for multitargeting drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3_ii7EQG1qLVg90H21EOLACvtfcHk0liiDG1XGeAwew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Snu7rN&md5=ba7cf74761120f0526ab520196e3dded</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00393%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520janus%2520kinase%25202%2520%2528JAK2%2529%2520and%2520histone%2520deacetylase%2520%2528HDAC%2529%2520dual%2520inhibitors%2520as%2520a%2520novel%2520strategy%2520for%2520the%2520combinational%2520treatment%2520of%2520leukemia%2520and%2520invasive%2520fungal%2520infections%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6056%26epage%3D6074%26doi%3D10.1021%2Facs.jmedchem.8b00393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Small molecule inhibitors simultaneously targeting cancer metabolism and epigenetics: discovery of novel nicotinamide phosphoribosyltransferase (NAMPT) and histone deacetylase (HDAC) dual inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7965</span>– <span class="NLM_lpage">7983</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00467</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00467" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVKhurrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7965-7983&author=G.+Dongauthor=W.+Chenauthor=X.+Wangauthor=X.+Yangauthor=T.+Xuauthor=P.+Wangauthor=W.+Zhangauthor=Y.+Raoauthor=C.+Miaoauthor=C.+Sheng&title=Small+molecule+inhibitors+simultaneously+targeting+cancer+metabolism+and+epigenetics%3A+discovery+of+novel+nicotinamide+phosphoribosyltransferase+%28NAMPT%29+and+histone+deacetylase+%28HDAC%29+dual+inhibitors&doi=10.1021%2Facs.jmedchem.7b00467"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Inhibitors Simultaneously Targeting Cancer Metabolism and Epigenetics: Discovery of Novel Nicotinamide Phosphoribosyltransferase (NAMPT) and Histone Deacetylase (HDAC) Dual Inhibitors</span></div><div class="casAuthors">Dong, Guoqiang; Chen, Wei; Wang, Xia; Yang, Xinglin; Xu, Tianying; Wang, Pei; Zhang, Wannian; Rao, Yu; Miao, Chaoyu; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7965-7983</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cancer metab. and epigenetics are among the most intensely pursued research areas in anticancer drug discovery.  Here we report the first small mols. that simultaneously inhibit nicotinamide phosphoribosyltransferase (NAMPT)and histone deacetylase (HDAC), two important targets of cancer metab. and epigenetics, resp.  Through iterative structure-based drug design, chem. synthesis, and biol. assays, a highly potent dual NAMPT and HDAC inhibitor was successfully identified.  Compd. 35 possessed excellent and balanced activities against both NAMPT (IC50 = 31 nM) and HDAC1 (IC50 = 55 nM).  It could effectively induce cell apoptosis and autophagy and ultimately led to cell death.  Importantly, compd. 35 showed excellent in vivo antitumor efficacy in the HCT116 xenograft model.  This proof-of-concept study demonstrates the feasibility of discovering an inhibitor targeting cancer metab. and epigenetics and provides an efficient strategy for multitarget antitumor drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9UvfGattu1rVg90H21EOLACvtfcHk0liiDG1XGeAwew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVKhurrO&md5=65df0b485cbbc169886d34ae4421f814</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00467%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DRao%26aufirst%3DY.%26aulast%3DMiao%26aufirst%3DC.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DSmall%2520molecule%2520inhibitors%2520simultaneously%2520targeting%2520cancer%2520metabolism%2520and%2520epigenetics%253A%2520discovery%2520of%2520novel%2520nicotinamide%2520phosphoribosyltransferase%2520%2528NAMPT%2529%2520and%2520histone%2520deacetylase%2520%2528HDAC%2529%2520dual%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7965%26epage%3D7983%26doi%3D10.1021%2Facs.jmedchem.7b00467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowen, L. E.</span></span> <span> </span><span class="NLM_article-title">Lysine deacetylases Hda1 and Rpd3 regulate Hsp90 function thereby governing fungal drug resistance</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">878</span>– <span class="NLM_lpage">888</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2012.08.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1016%2Fj.celrep.2012.08.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=23041319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCls7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=878-888&author=N.+Robbinsauthor=M.+D.+Leachauthor=L.+E.+Cowen&title=Lysine+deacetylases+Hda1+and+Rpd3+regulate+Hsp90+function+thereby+governing+fungal+drug+resistance&doi=10.1016%2Fj.celrep.2012.08.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Lysine deacetylases Hda1 and Rpd3 regulate Hsp90 function thereby governing fungal drug resistance</span></div><div class="casAuthors">Robbins, Nicole; Leach, Michelle D.; Cowen, Leah E.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">878-888</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The mol. chaperone Hsp90 is a hub of protein homeostasis and regulatory circuitry.  Hsp90 function is regulated by posttranslational modifications including acetylation in mammals; however, whether this regulation is conserved remains unknown.  In fungi, Hsp90 governs the evolution of drug resistance by stabilizing signal transducers.  Here, we establish that pharmacol. inhibition of lysine deacetylases (KDACs) blocks the emergence and maintenance of Hsp90-dependent resistance to the most widely deployed antifungals, the azoles, in the human fungal pathogen Candida albicans and the model yeast Saccharomyces cerevisiae.  S. cerevisiae Hsp90 is acetylated on lysine 27 and 270, and key KDACs for drug resistance are Hda1 and Rpd3.  Compromising KDACs alters stability and function of Hsp90 client proteins, including the drug-resistance regulator calcineurin.  Thus, we establish acetylation as a mechanism of posttranslational control of Hsp90 function in fungi, functional redundancy between KDACs Hda1 and Rpd3, as well as a mechanism governing fungal drug resistance with broad therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooz_5th4Mi9LVg90H21EOLACvtfcHk0li4QKpa8gDOqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCls7rI&md5=a83238283ab971d51f0c88224245f3a9</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2012.08.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2012.08.035%26sid%3Dliteratum%253Aachs%26aulast%3DRobbins%26aufirst%3DN.%26aulast%3DLeach%26aufirst%3DM.%2BD.%26aulast%3DCowen%26aufirst%3DL.%2BE.%26atitle%3DLysine%2520deacetylases%2520Hda1%2520and%2520Rpd3%2520regulate%2520Hsp90%2520function%2520thereby%2520governing%2520fungal%2520drug%2520resistance%26jtitle%3DCell%2520Rep.%26date%3D2012%26volume%3D2%26spage%3D878%26epage%3D888%26doi%3D10.1016%2Fj.celrep.2012.08.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edlind, T. D.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">3532</span>– <span class="NLM_lpage">3539</span>, <span class="refDoi"> DOI: 10.1128/aac.46.11.3532-3539.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1128%2FAAC.46.11.3532-3539.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=12384361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD38Xot1yktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2002&pages=3532-3539&author=W.+L.+Smithauthor=T.+D.+Edlind&title=Histone+deacetylase+inhibitors+enhance+Candida+albicans+sensitivity+to+azoles+and+related+antifungals%3A+correlation+with+reduction+in+CDR+and+ERG+upregulation&doi=10.1128%2Faac.46.11.3532-3539.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation</span></div><div class="casAuthors">Smith, W. Lamar; Edlind, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3532-3539</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Histone acetylation and deacetylation play important roles in eukaryotic gene regulation.  Several histone deacetylase (HDA) inhibitors have been characterized, including trichostatin A (TSA), apicidin, and sodium butyrate.  We tested their effects on Candida albicans in vitro growth, heat sensitivity, and germ tube formation; minimal effects were obsd.  However, there was a dramatic effect of TSA on C. albicans sensitivity to the azoles fluconazole, itraconazole, and miconazole.  Similar effects were obsd. with other HDA inhibitors and with the antifungals terbinafine and fenpropimorph, which target, as do azoles, enzymes in the ergosterol biosynthetic pathway.  In contrast, HDA inhibitors had minimal effect on the activities of amphotericin B, flucytosine, and echinocandin, which have unrelated targets.  Specifically, addn. of 3 μg of TSA/mL lowered the itraconazole MIC for five susceptible C. albicans isolates an av. of 2.7-fold at 24 h, but this increased to > 200-fold at 48 h.  Thus, the primary effect of TSA was a redn. in azole trailing.  TSA also enhanced itraconazole activity against Candida parapsilosis and Candida tropicalis but had no effect with four less related yeast species.  To examine the mol. basis for these effects, we studied expression of ERG genes (encoding azole and terbinafine targets) and CDR/MDR1 genes (encoding multidrug transporters) in C. albicans cells treated with fluconazole or terbinafine with or without TSA.  Both antifungals induced to various levels the expression of ERG1, ERG11, CDR1, and CDR2; addn. of TSA reduced this upregulation 50 to 100%.  This most likely explains the inhibition of azole and terbinafine trailing by TSA and, more generally, provides evidence that trailing is mediated by upregulation of target enzymes and multidrug transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4DpmS0neAOrVg90H21EOLACvtfcHk0li4QKpa8gDOqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xot1yktbc%253D&md5=8a372cf4fcb9077cf8b92c21b37792bf</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2FAAC.46.11.3532-3539.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.46.11.3532-3539.2002%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DW.%2BL.%26aulast%3DEdlind%26aufirst%3DT.%2BD.%26atitle%3DHistone%2520deacetylase%2520inhibitors%2520enhance%2520Candida%2520albicans%2520sensitivity%2520to%2520azoles%2520and%2520related%2520antifungals%253A%2520correlation%2520with%2520reduction%2520in%2520CDR%2520and%2520ERG%2520upregulation%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2002%26volume%3D46%26spage%3D3532%26epage%3D3539%26doi%3D10.1128%2Faac.46.11.3532-3539.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kmetzsch, L.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylases: Targets for antifungal drug development</span>. <i>Virulence</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">535</span>– <span class="NLM_lpage">536</span>, <span class="refDoi"> DOI: 10.1080/21505594.2015.1049807</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1080%2F21505594.2015.1049807" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=26151486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlKku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=535-536&author=L.+Kmetzsch&title=Histone+deacetylases%3A+Targets+for+antifungal+drug+development&doi=10.1080%2F21505594.2015.1049807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylases: Targets for antifungal drug development</span></div><div class="casAuthors">Kmetzsch, Livia</div><div class="citationInfo"><span class="NLM_cas:title">Virulence</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">535-536</span>CODEN:
                <span class="NLM_cas:coden">VIRUCS</span>;
        ISSN:<span class="NLM_cas:issn">2150-5608</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A review.  The interaction of pathogens and its hosts causes a drastic change in the transcriptional landscape in both cells.  Among the several mechanisms of gene regulation, transcriptional initiation is probably the main point.  In such scenario, the access of transcriptional machinery to promoter is highly regulated by post-translational modification of histones, such as acetylation, phosphorylation and others.  Inhibition of histone deacetylases is able to reduce fungal pathogens fitness during infection and, therefore, is currently being considered for the development of new antifungal therapy strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-fbI2ZYvCZ7Vg90H21EOLACvtfcHk0li4QKpa8gDOqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlKku7s%253D&md5=d9386d6e04621a0a4bf8f93f2ac4ba82</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1080%2F21505594.2015.1049807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F21505594.2015.1049807%26sid%3Dliteratum%253Aachs%26aulast%3DKmetzsch%26aufirst%3DL.%26atitle%3DHistone%2520deacetylases%253A%2520Targets%2520for%2520antifungal%2520drug%2520development%26jtitle%3DVirulence%26date%3D2015%26volume%3D6%26spage%3D535%26epage%3D536%26doi%3D10.1080%2F21505594.2015.1049807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garnaud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Champleboux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maubon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govin, J.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylases and their inhibition in Candida Species</span>. <i>Front. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1238</span>, <span class="refDoi"> DOI: 10.3389/fmicb.2016.01238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.3389%2Ffmicb.2016.01238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=27547205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A280%3ADC%252BC2szjtVKisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1238&author=C.+Garnaudauthor=M.+Champlebouxauthor=D.+Maubonauthor=M.+Cornetauthor=J.+Govin&title=Histone+deacetylases+and+their+inhibition+in+Candida+Species&doi=10.3389%2Ffmicb.2016.01238"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Histone Deacetylases and Their Inhibition in Candida Species</span></div><div class="casAuthors">Garnaud Cecile; Maubon Daniele; Cornet Muriel; Champleboux Morgane; Govin Jerome</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in microbiology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1238</span>
        ISSN:<span class="NLM_cas:issn">1664-302X</span>.
    </div><div class="casAbstract">Fungi are generally benign members of the human mucosal flora or live as saprophytes in the environment.  However, they can become pathogenic, leading to invasive and life threatening infections in vulnerable patients.  These invasive fungal infections are regarded as a major public health problem on a similar scale to tuberculosis or malaria.  Current treatment for these infections is based on only four available drug classes.  This limited therapeutic arsenal and the emergence of drug-resistant strains are a matter of concern due to the growing number of patients to be treated, and new therapeutic strategies are urgently needed.  Adaptation of fungi to drug pressure involves transcriptional regulation, in which chromatin dynamics and histone modifications play a major role.  Histone deacetylases (HDACs) remove acetyl groups from histones and actively participate in controlling stress responses.  HDAC inhibition has been shown to limit fungal development, virulence, biofilm formation, and dissemination in the infected host, while also improving the efficacy of existing antifungal drugs toward Candida spp.  In this article, we review the functional roles of HDACs and the biological effects of HDAC inhibitors on Candida spp., highlighting the correlations between their pathogenic effects in vitro and in vivo.  We focus on how HDAC inhibitors could be used to treat invasive candidiasis while also reviewing recent developments in their clinical evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSqH6RST9Bi-Ebxh97K6Vt6fW6udTcc2eZq1y3Li4XP0Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2szjtVKisw%253D%253D&md5=73b9e6f664ac8652a3220c7757952ae6</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2016.01238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2016.01238%26sid%3Dliteratum%253Aachs%26aulast%3DGarnaud%26aufirst%3DC.%26aulast%3DChampleboux%26aufirst%3DM.%26aulast%3DMaubon%26aufirst%3DD.%26aulast%3DCornet%26aufirst%3DM.%26aulast%3DGovin%26aufirst%3DJ.%26atitle%3DHistone%2520deacetylases%2520and%2520their%2520inhibition%2520in%2520Candida%2520Species%26jtitle%3DFront.%2520Microbiol.%26date%3D2016%26volume%3D7%26spage%3D1238%26doi%3D10.3389%2Ffmicb.2016.01238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.-E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.-S.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase-mediated morphological transition in Candida albicans</span>. <i>J. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">805</span>– <span class="NLM_lpage">811</span>, <span class="refDoi"> DOI: 10.1007/s12275-015-5488-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1007%2Fs12275-015-5488-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=26626350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKqs77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2015&pages=805-811&author=J.+Kimauthor=J.-E.+Leeauthor=J.-S.+Lee&title=Histone+deacetylase-mediated+morphological+transition+in+Candida+albicans&doi=10.1007%2Fs12275-015-5488-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase-mediated morphological transition in Candida albicans</span></div><div class="casAuthors">Kim, Jueun; Lee, Ji-Eun; Lee, Jung-Shin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Microbiology (Seoul, Republic of Korea)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">805-811</span>CODEN:
                <span class="NLM_cas:coden">JOMIFG</span>;
        ISSN:<span class="NLM_cas:issn">1225-8873</span>.
    
            (<span class="NLM_cas:orgname">Microbiological Society of Korea</span>)
        </div><div class="casAbstract">Candida albicans is the most common opportunistic fungal pathogen, which switches its morphol. from single-cell yeast to filament through the various signaling pathways responding to diverse environmental cues.  Various transcriptional factors such as Nrg1, Efg1, Brg1, Ssn6, and Tup1 are the key components of these signaling pathways.  Since C. albicans can regulate its transcriptional gene expressions using common eukaryotic regulatory systems, its morphol. transition by these signaling pathways could be linked to the epigenetic regulation by chromatin structure modifiers.  Histone proteins, which are crit. components of eukaryotic chromatin structure, can regulate the eukaryotic chromatin structure through their own modifications such as acetylation, methylation, phosphorylation and ubiquitylation.  Recent studies revealed that various histone modifications, esp. histone acetylation and deacetylation, participate in morphol. transition of C. albicans collaborating with well-known transcription factors in the signaling pathways.  Here, we review recent studies about chromatin-mediated morphol. transition of C. albicans focusing on the interaction between transcription factors in the signaling pathways and histone deacetylases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbiykuEydVfbVg90H21EOLACvtfcHk0lh3nRVUGEacoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKqs77O&md5=1cf37e54e429418df616741ba24ac6b5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs12275-015-5488-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12275-015-5488-3%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.-E.%26aulast%3DLee%26aufirst%3DJ.-S.%26atitle%3DHistone%2520deacetylase-mediated%2520morphological%2520transition%2520in%2520Candida%2520albicans%26jtitle%3DJ.%2520Microbiol.%26date%3D2015%26volume%3D53%26spage%3D805%26epage%3D811%26doi%3D10.1007%2Fs12275-015-5488-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamoth, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juvvadi, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbach, W. J.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase inhibition as an alternative strategy against invasive aspergillosis</span>. <i>Front. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">96</span>, <span class="refDoi"> DOI: 10.3389/fmicb.2015.00096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.3389%2Ffmicb.2015.00096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=25762988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A280%3ADC%252BC2MnjsVyqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=96&author=F.+Lamothauthor=P.+R.+Juvvadiauthor=W.+J.+Steinbach&title=Histone+deacetylase+inhibition+as+an+alternative+strategy+against+invasive+aspergillosis&doi=10.3389%2Ffmicb.2015.00096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibition as an alternative strategy against invasive aspergillosis</span></div><div class="casAuthors">Lamoth Frederic; Juvvadi Praveen R; Steinbach William J</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in microbiology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">96</span>
        ISSN:<span class="NLM_cas:issn">1664-302X</span>.
    </div><div class="casAbstract">Invasive aspergillosis (IA) is a life-threatening infection due to Aspergillus fumigatus and other Aspergillus spp.  Drugs targeting the fungal cell membrane (triazoles, amphotericin B) or cell wall (echinocandins) are currently the sole therapeutic options against IA.  Their limited efficacy and the emergence of resistance warrant the identification of new antifungal targets.  Histone deacetylases (HDACs) are enzymes responsible of the deacetylation of lysine residues of core histones, thus controlling chromatin remodeling and transcriptional activation.  HDACs also control the acetylation and activation status of multiple non-histone proteins, including the heat shock protein 90 (Hsp90), an essential molecular chaperone for fungal virulence and antifungal resistance.  This review provides an overview of the different HDACs in Aspergillus spp. as well as their respective contribution to total HDAC activity, fungal growth, stress responses, and virulence.  The potential of HDAC inhibitors, currently under development for cancer therapy, as novel alternative antifungal agents against IA is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT3AIhflCE8RpcXNb62YGmbfW6udTcc2eYkZ2D2iTVydbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnjsVyqsg%253D%253D&md5=009f225bc2913bb6e48671c019230228</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2015.00096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2015.00096%26sid%3Dliteratum%253Aachs%26aulast%3DLamoth%26aufirst%3DF.%26aulast%3DJuvvadi%26aufirst%3DP.%2BR.%26aulast%3DSteinbach%26aufirst%3DW.%2BJ.%26atitle%3DHistone%2520deacetylase%2520inhibition%2520as%2520an%2520alternative%2520strategy%2520against%2520invasive%2520aspergillosis%26jtitle%3DFront.%2520Microbiol.%26date%3D2015%26volume%3D6%26spage%3D96%26doi%3D10.3389%2Ffmicb.2015.00096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pfaller, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhomberg, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messer, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castanheira, M.</span></span> <span> </span><span class="NLM_article-title">In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species</span>. <i>Diagn. Microbiol. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">259</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1016/j.diagmicrobio.2014.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1016%2Fj.diagmicrobio.2014.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=25600842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVSnsbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2015&pages=259-263&author=M.+A.+Pfallerauthor=P.+R.+Rhombergauthor=S.+A.+Messerauthor=M.+Castanheira&title=In+vitro+activity+of+a+Hos2+deacetylase+inhibitor%2C+MGCD290%2C+in+combination+with+echinocandins+against+echinocandin-resistant+Candida+species&doi=10.1016%2Fj.diagmicrobio.2014.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species</span></div><div class="casAuthors">Pfaller, M. A.; Rhomberg, P. R.; Messer, S. A.; Castanheira, M.</div><div class="citationInfo"><span class="NLM_cas:title">Diagnostic Microbiology and Infectious Disease</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">259-263</span>CODEN:
                <span class="NLM_cas:coden">DMIDDZ</span>;
        ISSN:<span class="NLM_cas:issn">0732-8893</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">MGCD290, a Hos2 fungal histone deacetylase inhibitor, showed modest activity when tested alone (MIC range, 0.12-4 μg/mL; MIC50/90, 0.5/4 μg/mL) against Candida glabrata (n = 15; 14 fks mutants; 5 also fluconazole resistant), Candida albicans (8 fks mutants; 2 also fluconazole resistant), Candida tropicalis (4 fks mutants), and Candida krusei (3 fks mutants).  However, MGCD290 showed synergy or partial synergy for 33.3%, 30.1%, 36.7%, and 80.0% of the isolates when tested with anidulafungin, caspofungin, micafungin, and fluconazole, resp.  Favorable interactions were achieved with low concns. of MGCD290 (0.015-0.25 μg/mL), and categorical shifts were obsd. in 2 of 8 (25.0%) isolates of C. albicans and 2 of 3 (66.7%) isolates of C. krusei and in 4 of the 5 (80.0%) fluconazole-resistant isolates of C. glabrata.  MGCD290 exerts a distinctly favorable influence on the MICs of fluconazole and the echinocandins, resulting in conversion from resistance to susceptibility regardless of fks mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIr_O0BjzX4rVg90H21EOLACvtfcHk0lh3nRVUGEacoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVSnsbjL&md5=3a7550a215a89b52495ec6ebf5297bb1</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.diagmicrobio.2014.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.diagmicrobio.2014.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DPfaller%26aufirst%3DM.%2BA.%26aulast%3DRhomberg%26aufirst%3DP.%2BR.%26aulast%3DMesser%26aufirst%3DS.%2BA.%26aulast%3DCastanheira%26aufirst%3DM.%26atitle%3DIn%2520vitro%2520activity%2520of%2520a%2520Hos2%2520deacetylase%2520inhibitor%252C%2520MGCD290%252C%2520in%2520combination%2520with%2520echinocandins%2520against%2520echinocandin-resistant%2520Candida%2520species%26jtitle%3DDiagn.%2520Microbiol.%2520Infect.%2520Dis.%26date%3D2015%26volume%3D81%26spage%3D259%26epage%3D263%26doi%3D10.1016%2Fj.diagmicrobio.2014.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brandão, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derengowski, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albuquerque, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicola, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva-Pereira, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poças-Fonseca, M. J.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylases inhibitors effects on Cryptococcus neoformans major virulence phenotypes</span>. <i>Virulence</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">618</span>– <span class="NLM_lpage">630</span>, <span class="refDoi"> DOI: 10.1080/21505594.2015.1038014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1080%2F21505594.2015.1038014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=26103530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlKku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=618-630&author=F.+A.+Brand%C3%A3oauthor=L.+S.+Derengowskiauthor=P.+Albuquerqueauthor=A.+M.+Nicolaauthor=I.+Silva-Pereiraauthor=M.+J.+Po%C3%A7as-Fonseca&title=Histone+deacetylases+inhibitors+effects+on+Cryptococcus+neoformans+major+virulence+phenotypes&doi=10.1080%2F21505594.2015.1038014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylases inhibitors effects on Cryptococcus neoformans major virulence phenotypes</span></div><div class="casAuthors">Brandao, Fabiana A. S.; Derengowski, Lorena S.; Albuquerque, Patricia; Nicola, Andre M.; Silva-Pereira, Ildinete; Pocas-Fonseca, Marcio J.</div><div class="citationInfo"><span class="NLM_cas:title">Virulence</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">618-630</span>CODEN:
                <span class="NLM_cas:coden">VIRUCS</span>;
        ISSN:<span class="NLM_cas:issn">2150-5608</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Cryptococcus neoformans undergoes phenotypical changes during host infection in order to promote persistence and survival.  Studies have demonstrated that such adaptations require alterations in gene transcription networks by distinct mechanisms.  Drugs such as the histone deacetylases inhibitors (HDACi) Sodium Butyrate (NaBut) and Trichostatin A (TSA) can alter the chromatin conformation and have been used to modulate epigenetic states in the treatment of diseases such as cancer.  In this work, we have studied the effect of NaBut and TSA on the expression of C. neoformans major virulence phenotypes and on the survival rate of an animal model infected with drugs-treated yeasts.  Both drugs affected fungal growth at 37°C more intensely than at 30°C; nonetheless, drugs did not affect cell viability at the concns. we studied.  HDACi also provoked the redn. of the fungal capsule expansion.  Phospholipases enzyme activity decreased; mating process and melanin synthesis were also affected by both inhibitors.  NaBut led to an increase in the population of cells in G2/M.  Treated yeast cells, which were washed in order to remove the drugs from the culture medium prior to the inoculation in the Galleria mellonela infection model, did not cause significant difference at the host survival curve when compared to non-treated cells.  Overall, NaBut effects on the impairment of C. neoformans main virulence factors were more intense and stable than the TSA effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlYMtxsjDi4LVg90H21EOLACvtfcHk0lgWHDhDgIZVNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlKku70%253D&md5=6bb33f7a308923343af630d5d94aa1b3</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1080%2F21505594.2015.1038014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F21505594.2015.1038014%26sid%3Dliteratum%253Aachs%26aulast%3DBrand%25C3%25A3o%26aufirst%3DF.%2BA.%26aulast%3DDerengowski%26aufirst%3DL.%2BS.%26aulast%3DAlbuquerque%26aufirst%3DP.%26aulast%3DNicola%26aufirst%3DA.%2BM.%26aulast%3DSilva-Pereira%26aufirst%3DI.%26aulast%3DPo%25C3%25A7as-Fonseca%26aufirst%3DM.%2BJ.%26atitle%3DHistone%2520deacetylases%2520inhibitors%2520effects%2520on%2520Cryptococcus%2520neoformans%2520major%2520virulence%2520phenotypes%26jtitle%3DVirulence%26date%3D2015%26volume%3D6%26spage%3D618%26epage%3D630%26doi%3D10.1080%2F21505594.2015.1038014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotili, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brosch, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonetti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passariello, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palamara, A. T.</span></span> <span> </span><span class="NLM_article-title">Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1221</span>– <span class="NLM_lpage">1225</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.12.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1016%2Fj.bmcl.2006.12.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=17196388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVyjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1221-1225&author=A.+Maiauthor=D.+Rotiliauthor=S.+Massaauthor=G.+Broschauthor=G.+Simonettiauthor=C.+Passarielloauthor=A.+T.+Palamara&title=Discovery+of+uracil-based+histone+deacetylase+inhibitors+able+to+reduce+acquired+antifungal+resistance+and+trailing+growth+in+Candida+albicans&doi=10.1016%2Fj.bmcl.2006.12.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans</span></div><div class="casAuthors">Mai, Antonello; Rotili, Dante; Massa, Silvio; Brosch, Gerald; Simonetti, Giovanna; Passariello, Claudio; Palamara, Anna Teresa</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1221-1225</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Among fungal pathogens such as Candida albicans, acquired drug resistance has not been assocd. with plasmids or other transferable elements, but it is thought to involve primarily mutations and genetic or epigenetic phenomena.  This the authors to test some histone deacetylase inhibitors (HDACi) from their library, in combination with fluconazole, against C. albicans strains in vitro.  Among the tested compds., the two chloro-contg. uracil-hydroxamates 1c and 1d showed a strong redn. of the MIC values on Candida strains that show the trailing growth effect.  In this assay, 1c,d were more potent than SAHA, a well-known HDAC inhibitor, in reducing the Candida growth.  Compds. 1c,d as well as SAHA were able to inhibit the fluconazole-induced resistance induction in Candida cultures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgG2dBVCiTN7Vg90H21EOLACvtfcHk0lgWHDhDgIZVNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVyjsL8%253D&md5=459aca01b82b284070f9bfe6229aca3b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.12.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.12.028%26sid%3Dliteratum%253Aachs%26aulast%3DMai%26aufirst%3DA.%26aulast%3DRotili%26aufirst%3DD.%26aulast%3DMassa%26aufirst%3DS.%26aulast%3DBrosch%26aufirst%3DG.%26aulast%3DSimonetti%26aufirst%3DG.%26aulast%3DPassariello%26aufirst%3DC.%26aulast%3DPalamara%26aufirst%3DA.%2BT.%26atitle%3DDiscovery%2520of%2520uracil-based%2520histone%2520deacetylase%2520inhibitors%2520able%2520to%2520reduce%2520acquired%2520antifungal%2520resistance%2520and%2520trailing%2520growth%2520in%2520Candida%2520albicans%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1221%26epage%3D1225%26doi%3D10.1016%2Fj.bmcl.2006.12.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J.-U.</span></span> <span> </span><span class="NLM_article-title">Polypharmacology - foe or friend?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">8955</span>– <span class="NLM_lpage">8971</span>, <span class="refDoi"> DOI: 10.1021/jm400856t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400856t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1amtrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8955-8971&author=J.-U.+Peters&title=Polypharmacology+-+foe+or+friend%3F&doi=10.1021%2Fjm400856t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Polypharmacology - Foe or Friend?</span></div><div class="casAuthors">Peters, Jens-Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8955-8971</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Polypharmacol. describes the activity of compds. at multiple targets.  Current research focuses on two aspects of polypharmacol.: (1) unintended polypharmacol. can lead to adverse effects; (2) polypharmacol. across several disease-relevant targets can improve therapeutic efficacy, prevent drug resistance, or reduce therapeutic-target-related adverse effects.  This perspective reviews these interconnected aspects of polypharmacol.  The first part discusses the relevance of polypharmacol. for the safety of drugs, the mitigation of safety risks, and methods to identify polypharmacol. compds. early in the drug discovery process.  The second part discusses the advantages of polypharmacol. in the treatment of multigenic diseases and infections, and opportunities for drug discovery and drug repurposing.  This perspective aims to provide a balanced view on polypharmacol., which can compromise the safety of drugs, but can also confer superior efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5vnFGPfTnGLVg90H21EOLACvtfcHk0lgvIt98umXrDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1amtrnO&md5=f4aeb6efddd4bfdf4e94656303323cba</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm400856t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400856t%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DJ.-U.%26atitle%3DPolypharmacology%2520-%2520foe%2520or%2520friend%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8955%26epage%3D8971%26doi%3D10.1021%2Fjm400856t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anighoro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajorath, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rastelli, G.</span></span> <span> </span><span class="NLM_article-title">Polypharmacology: challenges and opportunities in drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">7874</span>– <span class="NLM_lpage">7887</span>, <span class="refDoi"> DOI: 10.1021/jm5006463s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5006463" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVShsL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7874-7887&author=A.+Anighoroauthor=J.+Bajorathauthor=G.+Rastelli&title=Polypharmacology%3A+challenges+and+opportunities+in+drug+discovery&doi=10.1021%2Fjm5006463s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Polypharmacology: Challenges and Opportunities in Drug Discovery</span></div><div class="casAuthors">Anighoro, Andrew; Bajorath, Jurgen; Rastelli, Giulio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7874-7887</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  At present, the legendary magic bullet, i.e., a drug with high potency and selectivity toward a specific biol. target, shares the spotlight with an emerging and alternative polypharmacol. approach.  Polypharmacol. suggests that more effective drugs can be developed by specifically modulating multiple targets.  It is generally thought that complex diseases such as cancer and central nervous system diseases may require complex therapeutic approaches.  In this respect, a drug that "hits" multiple sensitive nodes belonging to a network of interacting targets offers the potential for higher efficacy and may limit drawbacks generally arising from the use of a single-target drug or a combination of multiple drugs.  In this review, we will compare advantages and disadvantages of multitarget vs. combination therapies, discuss potential drug promiscuity arising from off-target effects, comment on drug repurposing, and introduce approaches to the computational design of multitarget drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFOTyEu80AZrVg90H21EOLACvtfcHk0lgvIt98umXrDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShsL3I&md5=5ab36c961a84462d90bc25130d90a281</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm5006463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5006463%26sid%3Dliteratum%253Aachs%26aulast%3DAnighoro%26aufirst%3DA.%26aulast%3DBajorath%26aufirst%3DJ.%26aulast%3DRastelli%26aufirst%3DG.%26atitle%3DPolypharmacology%253A%2520challenges%2520and%2520opportunities%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7874%26epage%3D7887%26doi%3D10.1021%2Fjm5006463s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Che, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">New azoles with potent antifungal activity: design, synthesis and molecular docking</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">4218</span>– <span class="NLM_lpage">4226</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2009.05.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1016%2Fj.ejmech.2009.05.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=19539408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptlertLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=4218-4226&author=X.+Cheauthor=C.+Shengauthor=W.+Wangauthor=Y.+Caoauthor=Y.+Xuauthor=H.+Jiauthor=G.+Dongauthor=Z.+Miaoauthor=J.+Yaoauthor=W.+Zhang&title=New+azoles+with+potent+antifungal+activity%3A+design%2C+synthesis+and+molecular+docking&doi=10.1016%2Fj.ejmech.2009.05.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">New azoles with potent antifungal activity: Design, synthesis and molecular docking</span></div><div class="casAuthors">Che, Xiaoying; Sheng, Chunquan; Wang, Wenya; Cao, Yongbing; Xu, Yulan; Ji, Haitao; Dong, Guoqiang; Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4218-4226</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In response to the urgent need for novel antifungal agents with improved activity and broader spectrum, computer modeling was used for rational design of novel antifungal azoles.  On the basis of the active site of lanosterol 14α-demethylase from Candida albicans (CACYP51), a series of new azoles with substituted-phenoxypropyl piperazine side chains were rationally designed and synthesized.  In vitro antifungal activity assay indicates that the new azoles show good activity against most of the tested pathogenic fungi.  Interestingly, the designed compds. are also active against an azole-resistant clin. strain.  Compared to fluconazole and itraconazole, several compds. (such as I) show higher antifungal activity and a broader spectrum, which are promising leads for the development of novel antifungal agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMhIP1RDAqCbVg90H21EOLACvtfcHk0ljd1BF-hgRGXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptlertLc%253D&md5=62f53f8f010f3382a973817243e643ee</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2009.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2009.05.018%26sid%3Dliteratum%253Aachs%26aulast%3DChe%26aufirst%3DX.%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DNew%2520azoles%2520with%2520potent%2520antifungal%2520activity%253A%2520design%252C%2520synthesis%2520and%2520molecular%2520docking%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D4218%26epage%3D4226%26doi%3D10.1016%2Fj.ejmech.2009.05.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and antifungal activity of novel triazole derivatives containing substituted 1,2,3-triazole-piperdine side chains</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">490</span>– <span class="NLM_lpage">497</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.05.079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1016%2Fj.ejmech.2014.05.079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=24934573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVCqu7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2014&pages=490-497&author=Z.+Jiangauthor=J.+Guauthor=C.+Wangauthor=S.+Wangauthor=N.+Liuauthor=Y.+Jiangauthor=G.+Dongauthor=Y.+Wangauthor=Y.+Liuauthor=J.+Yaoauthor=Z.+Miaoauthor=W.+Zhangauthor=C.+Sheng&title=Design%2C+synthesis+and+antifungal+activity+of+novel+triazole+derivatives+containing+substituted+1%2C2%2C3-triazole-piperdine+side+chains&doi=10.1016%2Fj.ejmech.2014.05.079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and antifungal activity of novel triazole derivatives containing substituted 1,2,3-triazole-piperidine side chains</span></div><div class="casAuthors">Jiang, Zhigan; Gu, Julin; Wang, Chen; Wang, Shengzheng; Liu, Na; Jiang, Yan; Dong, Guoqiang; Wang, Yan; Liu, Yang; Yao, Jianzhong; Miao, Zhenyuan; Zhang, Wannian; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">490-497</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Due to increasing incidence of invasive fungal infections and severe drug resistance to triazole antifungal agents, a series of novel antifungal triazoles with substituted triazole-piperidine side chains was designed and synthesized.  Most of the target compds. showed good inhibitory activity against a variety of clin. important fungal pathogens.  In particular, compds. I (R = Ac or OCF3) were highly active against Candida albicans and Cryptococcus neoformans with MIC values in the range of 0.125 μg/mL to 0.0125 μg/mL.  They represent promising leads for the development of new generation of triazole antifungal agents.  Mol. docking studies revealed that the target compds. interacted with CACYP51 mainly through hydrophobic and Van der Waals interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKepCqtBVuVbVg90H21EOLACvtfcHk0ljd1BF-hgRGXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVCqu7vM&md5=a67a053c579aa2daf1ef3d42f81e09ce</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.05.079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.05.079%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DGu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDesign%252C%2520synthesis%2520and%2520antifungal%2520activity%2520of%2520novel%2520triazole%2520derivatives%2520containing%2520substituted%25201%252C2%252C3-triazole-piperdine%2520side%2520chains%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D82%26spage%3D490%26epage%3D497%26doi%3D10.1016%2Fj.ejmech.2014.05.079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lü, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">Evolutionary trace analysis of CYP51 family: implication for site-directed mutagenesis and novel antifungal drug design</span>. <i>J. Mol. Model.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1007/s00894-009-0527-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1007%2Fs00894-009-0527-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=19593597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlslGisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=279-284&author=C.+Shengauthor=S.+Chenauthor=H.+Jiauthor=G.+Dongauthor=X.+Cheauthor=W.+Wangauthor=Z.+Miaoauthor=J.+Yaoauthor=J.+L%C3%BCauthor=W.+Guoauthor=W.+Zhang&title=Evolutionary+trace+analysis+of+CYP51+family%3A+implication+for+site-directed+mutagenesis+and+novel+antifungal+drug+design&doi=10.1007%2Fs00894-009-0527-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Evolutionary trace analysis of CYP51 family: implication for site-directed mutagenesis and novel antifungal drug design</span></div><div class="casAuthors">Sheng, Chunquan; Chen, Shuanghong; Ji, Haitao; Dong, Guoqiang; Che, Xiaoyin; Wang, Wenya; Miao, Zhenyuan; Yao, Jianzhong; Lu, Jiaguo; Guo, Wei; Zhang, Wannian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">279-284</span>CODEN:
                <span class="NLM_cas:coden">JMMOFK</span>;
        ISSN:<span class="NLM_cas:issn">0948-5023</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Lanosterol 14α-demethylase (CYP51) is an essential enzyme in the fungal life cycle and also an important target for the antifungal drug development.  Based on the multiple sequence alignments of CYP51 family, an evolutionary tree of the CYP51 family was constructed by the evolutionary trace (ET) method.  The identified trace residues could provide a reliable and rational guide to the design of CYP51 mutations and give more information about the detailed mechanism of substrate (drug) recognition and binding.  The reliability of ET anal. to identify residues of functional importance was validated by the reported site-directed mutagenesis studies of CYP51s.  Several residues in the active site were also validated by our mutagenesis studies.  Mapping the identified trace residues onto the active site of the modeled structure of Candida albicans CYP51 (CACYP51) may provide useful information for the design of novel antifungal agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprrMjVIO4bVLVg90H21EOLACvtfcHk0liZoKWXs8hhNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlslGisb4%253D&md5=8880c201917fd1f975d6c6c606dda812</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2Fs00894-009-0527-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00894-009-0527-9%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DChe%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DL%25C3%25BC%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DEvolutionary%2520trace%2520analysis%2520of%2520CYP51%2520family%253A%2520implication%2520for%2520site-directed%2520mutagenesis%2520and%2520novel%2520antifungal%2520drug%2520design%26jtitle%3DJ.%2520Mol.%2520Model.%26date%3D2010%26volume%3D16%26spage%3D279%26epage%3D284%26doi%3D10.1007%2Fs00894-009-0527-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lü, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">Three-dimensional model of lanosterol 14α-demethylase from Cryptococcus neoformans: active-site characterization and insights into azole binding</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3487</span>– <span class="NLM_lpage">3495</span>, <span class="refDoi"> DOI: 10.1128/aac.01630-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1128%2FAAC.01630-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=19470512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD1MXps1ygs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=3487-3495&author=C.+Shengauthor=Z.+Miaoauthor=H.+Jiauthor=J.+Yaoauthor=W.+Wangauthor=X.+Cheauthor=G.+Dongauthor=J.+L%C3%BCauthor=W.+Guoauthor=W.+Zhang&title=Three-dimensional+model+of+lanosterol+14%CE%B1-demethylase+from+Cryptococcus+neoformans%3A+active-site+characterization+and+insights+into+azole+binding&doi=10.1128%2Faac.01630-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Three-dimensional model of lanosterol 14α-demethylase from Cryptococcus neoformans: active-site characterization and insights into azole binding</span></div><div class="casAuthors">Sheng, Chunquan; Miao, Zhenyuan; Ji, Haitao; Yao, Jianzhong; Wang, Wenya; Che, Xiaoying; Dong, Guoqiang; Lu, Jiaguo; Guo, Wei; Zhang, Wannian</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3487-3495</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Cryptococcus neoformans is one of the most important causes of life-threatening fungal infections in immunocompromised patients.  Lanosterol 14α-demethylase (CYP51) is the target of azole antifungal agents.  This study describes, for the first time, the 3-dimensional model of CYP51 from Cryptococcus neoformans (CnCYP51).  The model was further refined by energy minimization and mol.-dynamics simulations.  The active site of CnCYP51 was well characterized by multiple-copy simultaneous-search calcns., and four functional regions important for rational drug design were identified.  The mode of binding of the natural substrate and azole antifungal agents with CnCYP51 was identified by flexible mol. docking.  A G484S substitution mechanism for azole resistance in CnCYP51, which might be important for the conformation of the heme environment, is suggested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-URQUj7XzzLVg90H21EOLACvtfcHk0liZoKWXs8hhNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXps1ygs74%253D&md5=94209f274d245e169873c8d576a954a0</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1128%2FAAC.01630-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01630-08%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DChe%26aufirst%3DX.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DL%25C3%25BC%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DThree-dimensional%2520model%2520of%2520lanosterol%252014%25CE%25B1-demethylase%2520from%2520Cryptococcus%2520neoformans%253A%2520active-site%2520characterization%2520and%2520insights%2520into%2520azole%2520binding%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D3487%26epage%3D3495%26doi%3D10.1128%2Faac.01630-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">Improved model of lanosterol 14α-demethylase by ligand-supported homology modeling: validation by virtual screening and azole optimization</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">390</span>– <span class="NLM_lpage">397</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200900468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1002%2Fcmdc.200900468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=20157915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslens7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=390-397&author=C.+Shengauthor=W.+Wangauthor=X.+Cheauthor=G.+Dongauthor=S.+Wangauthor=H.+Jiauthor=Z.+Miaoauthor=J.+Yaoauthor=W.+Zhang&title=Improved+model+of+lanosterol+14%CE%B1-demethylase+by+ligand-supported+homology+modeling%3A+validation+by+virtual+screening+and+azole+optimization&doi=10.1002%2Fcmdc.200900468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Improved model of lanosterol 14α-demethylase by ligand-supported homology modeling: validation by virtual screening and azole optimization</span></div><div class="casAuthors">Sheng, Chunquan; Wang, Wenya; Che, Xiaoying; Dong, Guoqiang; Wang, Shengzheng; Ji, Haitao; Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">390-397</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Lanosterol 14α-demethylase (CYP51) is an important target for antifungal drugs.  An improved three-dimensional model of CYP51 from Candida albicans (CACYP51) was constructed by ligand-supported homol. modeling and mol. dynamics simulations.  The accuracy of the constructed model was evaluated by its performance in a small-scale virtual screen.  The results show that known CYP51 inhibitors were efficiently discriminated by the model, and it performed better than our previous CACYP51 model.  The active site of CACYP51 was characterized by multiple copy simultaneous search (MCSS) calcns.  On the basis of the MCSS results, a series of novel azoles were designed and synthesized, and they showed good in vitro antifungal activity with a broad spectrum.  The MIC80 value of four of these compds. against C. albicans is 0.001 μg mL-1, indicating that they are promising leads for the discovery of novel antifungal agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvPkz8zBBmybVg90H21EOLACvtfcHk0liZoKWXs8hhNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslens7Y%253D&md5=3bcf5f8c16b66dd107ae86cfe6427816</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200900468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200900468%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DChe%26aufirst%3DX.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DImproved%2520model%2520of%2520lanosterol%252014%25CE%25B1-demethylase%2520by%2520ligand-supported%2520homology%2520modeling%253A%2520validation%2520by%2520virtual%2520screening%2520and%2520azole%2520optimization%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D390%26epage%3D397%26doi%3D10.1002%2Fcmdc.200900468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">New lead structures in antifungal drug discovery</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">733</span>– <span class="NLM_lpage">766</span>, <span class="refDoi"> DOI: 10.2174/092986711794480113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.2174%2F092986711794480113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=21182484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFyjs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=733-766&author=C.+Shengauthor=W.+Zhang&title=New+lead+structures+in+antifungal+drug+discovery&doi=10.2174%2F092986711794480113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">New lead structures in antifungal drug discovery</span></div><div class="casAuthors">Sheng, Chunquan; Zhang, Wannian</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">733-766</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  During the past two decades, the incidence of invasive fungal infections has been increasing dramatically.  Clin. available antifungal agents have several drawbacks such as limited potency and spectrum, drug related toxicity, non-optimal pharmacokinetics, and severe resistance.  There is an emergent need to develop new antifungal drugs with novel chem. structures and novel mechanism of action.  This review will focus on the most significant achievements in the discovery of antifungal lead structures within last few years.  In particular, we pay more attention on the structure-activity relationship of antifungal leads and provide perspectives for future antifungal drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg5sTIG2meTrVg90H21EOLACvtfcHk0lheHyDzLOTW2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFyjs7w%253D&md5=89308e007069c3ffb25ab8b943fc6e98</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.2174%2F092986711794480113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711794480113%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DNew%2520lead%2520structures%2520in%2520antifungal%2520drug%2520discovery%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D733%26epage%3D766%26doi%3D10.2174%2F092986711794480113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">Discovery of highly potent novel antifungal azoles by structure-based rational design</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">5965</span>– <span class="NLM_lpage">5969</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.07.144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1016%2Fj.bmcl.2009.07.144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=19748782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtF2hurnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5965-5969&author=W.+Wangauthor=C.+Shengauthor=X.+Cheauthor=H.+Jiauthor=Y.+Caoauthor=Z.+Miaoauthor=J.+Yaoauthor=W.+Zhang&title=Discovery+of+highly+potent+novel+antifungal+azoles+by+structure-based+rational+design&doi=10.1016%2Fj.bmcl.2009.07.144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of highly potent novel antifungal azoles by structure-based rational design</span></div><div class="casAuthors">Wang, Wenya; Sheng, Chunquan; Che, Xiaoying; Ji, Haitao; Cao, Yongbing; Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5965-5969</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">On the basis of the active site of lanosterol 14α-demethylase from Candida albicans (CACYP51), a series of new azoles were designed and synthesized.  All the new azoles show excellent in vitro activity against most of the tested pathogenic fungi, which represent a class of promising leads for the development of novel antifungal agents.  The MIC80 value of compds. 8c, 8i and 8n against C. albicans is 0.001 μg/mL, indicating that these compds. are more potent than fluconazole, itraconazole and voriconazole.  Flexible mol. docking was used to analyze the structure-activity relationships (SARs) of the compds.  The designed compds. interact with CACYP51 through hydrophobic, van der Waals and hydrogen-bonding interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbUjKEmrTELbVg90H21EOLACvtfcHk0lheHyDzLOTW2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtF2hurnJ&md5=373a69254b94184d2d2d43d24a1e14b5</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.07.144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.07.144%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DChe%26aufirst%3DX.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DDiscovery%2520of%2520highly%2520potent%2520novel%2520antifungal%2520azoles%2520by%2520structure-based%2520rational%2520design%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5965%26epage%3D5969%26doi%3D10.1016%2Fj.bmcl.2009.07.144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">From antidiabetic to antifungal: discovery of highly potent triazole-thiazolidinedione hybrids as novel antifungal agents</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2639</span>– <span class="NLM_lpage">2646</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201402320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1002%2Fcmdc.201402320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=25196996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVyrsb7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=2639-2646&author=S.+Wuauthor=Y.+Zhangauthor=X.+Heauthor=X.+Cheauthor=S.+Wangauthor=Y.+Liuauthor=Y.+Jiangauthor=N.+Liuauthor=G.+Dongauthor=J.+Yaoauthor=Z.+Miaoauthor=Y.+Wangauthor=W.+Zhangauthor=C.+Sheng&title=From+antidiabetic+to+antifungal%3A+discovery+of+highly+potent+triazole-thiazolidinedione+hybrids+as+novel+antifungal+agents&doi=10.1002%2Fcmdc.201402320"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">From Antidiabetic to Antifungal: Discovery of Highly Potent Triazole-Thiazolidinedione Hybrids as Novel Antifungal Agents</span></div><div class="casAuthors">Wu, Shanchao; Zhang, Yongqiang; He, Xiaomeng; Che, Xiaoying; Wang, Shengzheng; Liu, Yang; Jiang, Yan; Liu, Na; Dong, Guoqiang; Yao, Jianzhong; Miao, Zhenyuan; Wang, Yan; Zhang, Wannian; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2639-2646</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">In an attempt to discover a new generation of triazole antifungal agents, a series of triazole-thiazolidinedione hybrids I [R = Ph, 2-BrC6H4, 4-ClC6H4, etc.] were designed and synthesized by mol. hybridization of the antifungal agent fluconazole and rosiglitazone (an antidiabetic).  Most of the target compds. showed good to excellent inhibitory activity against a variety of clin. important fungal pathogens.  In particular, compds. I [R = 2,4-Cl2C6H3], I [R = 2-furyl], I [R = 3-furyl] were highly active against Candida albicans, with MIC80 values in the range of 0.03-0.15 μΜ.  Moreover, the last two compds. compds. were found to be effective against four fluconazole-resistant clin. isolates; these two compds. are particularly promising antifungal leads for further optimization.  Mol. docking studies revealed that the hydrogen bonding interactions between thiazolidinedione and CYP51 from C. albicans are important for antifungal activity.  This study also demonstrates the effectiveness of mol. hybridization in antifungal drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa2mPEjg23bbVg90H21EOLACvtfcHk0lheHyDzLOTW2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVyrsb7P&md5=1805f6c32a74cad85e6e2c8ab9bccc8c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201402320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201402320%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DChe%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DFrom%2520antidiabetic%2520to%2520antifungal%253A%2520discovery%2520of%2520highly%2520potent%2520triazole-thiazolidinedione%2520hybrids%2520as%2520novel%2520antifungal%2520agents%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D2639%26epage%3D2646%26doi%3D10.1002%2Fcmdc.201402320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lü, J.</span></span> <span> </span><span class="NLM_article-title">Structure-based optimization of azole antifungal agents by CoMFA, CoMSIA, and molecular docking</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">2512</span>– <span class="NLM_lpage">2525</span>, <span class="refDoi"> DOI: 10.1021/jm051211n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051211n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD28XislCjs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2512-2525&author=C.+Shengauthor=W.+Zhangauthor=H.+Jiauthor=M.+Zhangauthor=Y.+Songauthor=H.+Xuauthor=J.+Zhuauthor=Z.+Miaoauthor=Q.+Jiangauthor=J.+Yaoauthor=Y.+Zhouauthor=J.+Zhuauthor=J.+L%C3%BC&title=Structure-based+optimization+of+azole+antifungal+agents+by+CoMFA%2C+CoMSIA%2C+and+molecular+docking&doi=10.1021%2Fjm051211n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Optimization of Azole Antifungal Agents by CoMFA, CoMSIA, and Molecular Docking</span></div><div class="casAuthors">Sheng, Chunquan; Zhang, Wannian; Ji, Haitao; Zhang, Min; Song, Yunlong; Xu, Hui; Zhu, Jie; Miao, Zhenyuan; Jiang, Qingfen; Yao, Jianzhong; Zhou, Youjun; Zhu, Jue; Lue, Jiaguo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2512-2525</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In a continuing effort to develop highly potent azole antifungal agents, the three-dimensional quant. structure-activity relationship methods, CoMFA and CoMSIA, were applied using a set of novel azole antifungal compds.  The binding mode of the compds. at the active site of lanosterol 14α-demethylase was further explored using the flexible docking method.  Various hydrophobic, van der Waals, π-π stacking, and hydrogen bonding interactions were obsd. between the azoles and the enzyme.  Based on results from the mol. modeling, a receptor-based pharmacophore model was established to guide the rational optimization of the azole antifungal agents.  Thus, a total of 57 novel azoles were designed and synthesized by a three-step optimization process.  In vitro antifungal assay revealed that the antifungal activities of these novel azoles were greatly improved, which confirmed the reliability of the model from mol. modeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVIWFj1cTBJbVg90H21EOLACvtfcHk0lj2VyEgAefhaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XislCjs7o%253D&md5=23d45b0954032f8e294f97c8d6625c66</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm051211n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051211n%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DL%25C3%25BC%26aufirst%3DJ.%26atitle%3DStructure-based%2520optimization%2520of%2520azole%2520antifungal%2520agents%2520by%2520CoMFA%252C%2520CoMSIA%252C%2520and%2520molecular%2520docking%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2512%26epage%3D2525%26doi%3D10.1021%2Fjm051211n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Dual NAMPT/HDAC Inhibitors as a New Strategy for Multitargeting Antitumor Drug Discovery</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">34</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00414</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00414" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFOqsrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=34-38&author=W.+Chenauthor=G.+Dongauthor=Y.+Wuauthor=W.+Zhangauthor=C.+Miaoauthor=C.+Sheng&title=Dual+NAMPT%2FHDAC+Inhibitors+as+a+New+Strategy+for+Multitargeting+Antitumor+Drug+Discovery&doi=10.1021%2Facsmedchemlett.7b00414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Dual NAMPT/HDAC Inhibitors as a New Strategy for Multitargeting Antitumor Drug Discovery</span></div><div class="casAuthors">Chen, Wei; Dong, Guoqiang; Wu, Ying; Zhang, Wannian; Miao, Chaoyu; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">34-38</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel dual nicotinamide phosphoribosyltransferase (NAMPT) and histone deacetylase (HDAC) inhibitors were designed by a pharmacophore fusion approach.  The thiazolocarboxamide inhibitors were highly active for both targets.  In particular, compd. 7f (NAMPT IC50 = 15 nM, HDAC1 IC50 = 2 nM) showed potent in vivo antitumor efficacy in the HCT116 xenograft model.  The study offers a new strategy for multi-target antitumor drug discovery by simultaneously acting on cancer metab. and epigenetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeCOjvPbhLxbVg90H21EOLACvtfcHk0lj2VyEgAefhaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFOqsrjJ&md5=72fc5750e9b6d3b1a0331f1f3a8a3f5c</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00414%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DMiao%26aufirst%3DC.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDual%2520NAMPT%252FHDAC%2520Inhibitors%2520as%2520a%2520New%2520Strategy%2520for%2520Multitargeting%2520Antitumor%2520Drug%2520Discovery%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D34%26epage%3D38%26doi%3D10.1021%2Facsmedchemlett.7b00414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel indoleamine 2,3-dioxygenase 1 (IDO1) and histone deacetylase (HDAC) dual inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">312</span>– <span class="NLM_lpage">317</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00487</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00487" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmtVWrurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=312-317&author=K.+Fangauthor=G.+Dongauthor=Y.+Liauthor=S.+Heauthor=Y.+Wuauthor=S.+Wuauthor=W.+Wangauthor=C.+Sheng&title=Discovery+of+novel+indoleamine+2%2C3-dioxygenase+1+%28IDO1%29+and+histone+deacetylase+%28HDAC%29+dual+inhibitors&doi=10.1021%2Facsmedchemlett.7b00487"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) and Histone Deacetylase (HDAC) Dual Inhibitors</span></div><div class="casAuthors">Fang, Kun; Dong, Guoqiang; Li, Yu; He, Shipeng; Wu, Ying; Wu, Shanchao; Wang, Wei; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">312-317</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In order to take advantage of both immunotherapeutic and epigenetic antitumor agents, the first generation of dual indoleamine 2,3-dioxygenase 1 (IDO1) and histone deacetylase (HDAC) inhibitors were designed.  The highly active dual inhibitor 10 showed excellent and balanced activity against both IDO1 (IC50 = 69.0 nM) and HDAC1 (IC50 = 66.5 nM), whose dual targeting mechanisms were validated in cancer cells.  Compd. 10 had good pharmacokinetic profiles as an orally active antitumor agent and significantly reduced the L-kynurenine level in plasma.  In particular, it showed excellent in vivo antitumor efficacy in the murine LLC tumor model with low toxicity.  This proof-of-concept study provided a novel strategy for cancer treatment.  Compd. 10 represents a promising lead compd. for the development of novel antitumor agents and can also be used as a valuable probe to clarify the relationships and mechanisms between cancer immunotherapy and epigenetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEDqXRR2J0zrVg90H21EOLACvtfcHk0lj2VyEgAefhaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmtVWrurc%253D&md5=c808b75f03d703dc7e66798759457f4a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00487%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DK.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520novel%2520indoleamine%25202%252C3-dioxygenase%25201%2520%2528IDO1%2529%2520and%2520histone%2520deacetylase%2520%2528HDAC%2529%2520dual%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D312%26epage%3D317%26doi%3D10.1021%2Facsmedchemlett.7b00487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Small molecules simultaneously inhibiting p53-murine double minute 2 (MDM2) interaction and histone deacetylases (HDACs): discovery of novel multitargeting antitumor agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">7245</span>– <span class="NLM_lpage">7260</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00664</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00664" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlykur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=7245-7260&author=S.+Heauthor=G.+Dongauthor=S.+Wuauthor=K.+Fangauthor=Z.+Miaoauthor=W.+Wangauthor=C.+Sheng&title=Small+molecules+simultaneously+inhibiting+p53-murine+double+minute+2+%28MDM2%29+interaction+and+histone+deacetylases+%28HDACs%29%3A+discovery+of+novel+multitargeting+antitumor+agents&doi=10.1021%2Facs.jmedchem.8b00664"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecules Simultaneously Inhibiting p53-Murine Double Minute 2 (MDM2) Interaction and Histone Deacetylases (HDACs): Discovery of Novel Multitargeting Antitumor Agents</span></div><div class="casAuthors">He, Shipeng; Dong, Guoqiang; Wu, Shanchao; Fang, Kun; Miao, Zhenyuan; Wang, Wei; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7245-7260</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">P53-Murine double minute 2 (MDM2) interaction and histone deacetylases (HDACs) are important targets in antitumor drug development.  Inspired by the synergistic effects between MDM2 and HDACs, the first MDM2/HDACs dual inhibitors were identified, which showed excellent activities against both targets.  In particular, compd. 14d was proven to be a potent and orally active MDM2/HDAC dual inhibitor, whose antitumor mechanisms were validated in cancer cells.  Compd. 14d showed excellent in vivo antitumor potency in the A549 xenograft model, providing a promising lead compd. for the development of novel antitumor agents.  Also, this proof-of-concept study offers a novel and efficient strategy for multitargeting antitumor drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx94Uvm3pP8bVg90H21EOLACvtfcHk0ljpeUSdqPpdMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlykur3L&md5=68871e41ecb786e135b01742e59eec85</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00664&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00664%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DS.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DK.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DSmall%2520molecules%2520simultaneously%2520inhibiting%2520p53-murine%2520double%2520minute%25202%2520%2528MDM2%2529%2520interaction%2520and%2520histone%2520deacetylases%2520%2528HDACs%2529%253A%2520discovery%2520of%2520novel%2520multitargeting%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D7245%26epage%3D7260%26doi%3D10.1021%2Facs.jmedchem.8b00664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel dual histone deacetylase and mammalian target of rapamycin target inhibitors as a promising strategy for cancer therapy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1577</span>– <span class="NLM_lpage">1592</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01825</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01825" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC1MXovFeguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=1577-1592&author=Y.+Chenauthor=X.+Yuanauthor=W.+Zhangauthor=M.+Tangauthor=L.+Zhengauthor=F.+Wangauthor=W.+Yanauthor=S.+Yangauthor=Y.+Weiauthor=J.+Heauthor=L.+Chen&title=Discovery+of+novel+dual+histone+deacetylase+and+mammalian+target+of+rapamycin+target+inhibitors+as+a+promising+strategy+for+cancer+therapy&doi=10.1021%2Facs.jmedchem.8b01825"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Dual Histone Deacetylase and Mammalian Target of Rapamycin Target Inhibitors as a Promising Strategy for Cancer Therapy</span></div><div class="casAuthors">Chen, Yong; Yuan, Xue; Zhang, Wanhua; Tang, Minghai; Zheng, Li; Wang, Fang; Yan, Wei; Yang, Shengyong; Wei, Yuquan; He, Jun; Chen, Lijuan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1577-1592</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the present study, a series of novel dual-target histone deacetylase (HDAC) and mammalian target of rapamycin (mTOR) inhibitors were designed and synthesized using pyrimidine-pyrazolyl pharmacophore to append HDAC recognition cap and hydroxamic acid as a zinc-binding motif.  Among them, I was the optimal lead compd. with potent inhibition activities against mTOR and HDAC1 with half-maximal inhibitory concn. of 1.2 and 0.19 nM, resp.  Western blot confirmed that I could upregulate acetylation of H3 and α-tubulin and downregulate mTOR-related downstream mediators.  I could also stimulate cell cycle arrest in G0/G1 phase and induce tumor cell apoptosis.  I showed comparable antitumor activity with the combination medication in MM1S xenograft model with a tumor growth inhibitory rate of 72.5%, without causing significant loss of body wt. and toxicity.  All of the results indicated that I could be a promising dual target inhibitor for treating hematol. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ3AdehNv1ObVg90H21EOLACvtfcHk0ljpeUSdqPpdMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXovFeguw%253D%253D&md5=7a2ff5020aedb0e3c302e65d993301e6</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01825%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DYuan%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520novel%2520dual%2520histone%2520deacetylase%2520and%2520mammalian%2520target%2520of%2520rapamycin%2520target%2520inhibitors%2520as%2520a%2520promising%2520strategy%2520for%2520cancer%2520therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D1577%26epage%3D1592%26doi%3D10.1021%2Facs.jmedchem.8b01825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of 4-methyl quinazoline derivatives as anticancer agents simultaneously targeting phosphoinositide 3-kinases and histone deacetylases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">6992</span>– <span class="NLM_lpage">7014</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00390</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00390" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpvFamtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=6992-7014&author=K.+Zhangauthor=F.+Laiauthor=S.+Linauthor=M.+Jiauthor=J.+Zhangauthor=Y.+Zhangauthor=J.+Jinauthor=R.+Fuauthor=D.+Wuauthor=H.+Tianauthor=N.+Xueauthor=L.+Shengauthor=X.+Zouauthor=Y.+Liauthor=X.+Chenauthor=H.+Xu&title=Design%2C+synthesis%2C+and+biological+evaluation+of+4-methyl+quinazoline+derivatives+as+anticancer+agents+simultaneously+targeting+phosphoinositide+3-kinases+and+histone+deacetylases&doi=10.1021%2Facs.jmedchem.9b00390"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of 4-Methyl Quinazoline Derivatives as Anticancer Agents Simultaneously Targeting Phosphoinositide 3-Kinases and Histone Deacetylases</span></div><div class="casAuthors">Zhang, Kehui; Lai, Fangfang; Lin, Songwen; Ji, Ming; Zhang, Jingbo; Zhang, Yan; Jin, Jing; Fu, Rong; Wu, Deyu; Tian, Hua; Xue, Nina; Sheng, Li; Zou, Xiaowen; Li, Yan; Chen, Xiaoguang; Xu, Heng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6992-7014</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Polypharmacol. is a promising paradigm in modern drug discovery.  Herein, we have discovered a series of novel PI3K and HDAC dual inhibitors in which the hydroxamic acid moiety as the zinc binding functional group was introduced to a quinazoline-based PI3K pharmacophore through an appropriate linker.  Systematic structure-activity relationship studies resulted in lead compds. 23 (shown in graphical abstr. and duplicated as I) and 36 (II) that simultaneously inhibited PI3K and HDAC with nanomolar potencies and demonstrated favorable antiproliferative activities.  Compds. 23 and 36 efficiently modulated the expression of p-AKT and Ac-H3, arrested the cell cycle, and induced apoptosis in HCT116 cancer cells.  Following pharmacokinetic studies, 23 was further evaluated in HCT116 and HGC-27 xenograft models to show significant in vivo anticancer efficacies with tumor growth inhibitions of 45.8% (po, 150 mg/kg) and 62.6% (i.p., 30 mg/kg), resp.  Overall, this work shows promise in discovering new anticancer therapeutics by the approach of simultaneously targeting PI3K and HDAC pathways with a single mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6xLiFaGhwk7Vg90H21EOLACvtfcHk0lh42IA0VEgH7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpvFamtLg%253D&md5=de4c9a630208e49eac58dcad630adcd6</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00390%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DLai%26aufirst%3DF.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DJi%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DTian%26aufirst%3DH.%26aulast%3DXue%26aufirst%3DN.%26aulast%3DSheng%26aufirst%3DL.%26aulast%3DZou%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DH.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%25204-methyl%2520quinazoline%2520derivatives%2520as%2520anticancer%2520agents%2520simultaneously%2520targeting%2520phosphoinositide%25203-kinases%2520and%2520histone%2520deacetylases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D6992%26epage%3D7014%26doi%3D10.1021%2Facs.jmedchem.9b00390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of amide-pyridine derivatives as novel dual-target (SE, CYP51) antifungal inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2427</span>– <span class="NLM_lpage">2437</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2019.02.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1016%2Fj.bmc.2019.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=30765301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC1MXivVahur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2019&pages=2427-2437&author=B.+Sunauthor=Y.+Dongauthor=K.+Leiauthor=J.+Wangauthor=L.+Zhaoauthor=M.+Liu&title=Design%2C+synthesis+and+biological+evaluation+of+amide-pyridine+derivatives+as+novel+dual-target+%28SE%2C+CYP51%29+antifungal+inhibitors&doi=10.1016%2Fj.bmc.2019.02.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of amide-pyridine derivatives as novel dual-target (SE, CYP51) antifungal inhibitors</span></div><div class="casAuthors">Sun, Bin; Dong, Yue; Lei, Kang; Wang, Jian; Zhao, Liyu; Liu, Min</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2427-2437</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Based on the anal. of the squalene cyclooxygenase (SE) and 14α-demethylase (CYP51) inhibitors pharmacophore feature and the dual-target active sites, a series of compds. with amide-pyridine scaffolds have been designed and synthesized to treat the increasing incidence of drug-resistant fungal infections.  In vitro evaluation showed that these compds. have a certain degree of antifungal activity.  The most potent compds. 11a, 11b with MIC values in the range of 0.125-2 μg/mL had a broad-spectrum antifungal activity and exhibited excellent inhibitory activity against drug-resistant pathogenic fungi.  Preliminary mechanism studies revealed that the compd. 11b might play an antifungal role by inhibiting the activity of SE and CYP51.  Notably compds. did not show the genotoxicity through plasmid binding assay.  Finally, this study of mol. docking, ADME/T prediction and the construction of 3D QSAR model were performed.  These results can point out the direction for further optimization of the lead compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjqDxVOdtpaLVg90H21EOLACvtfcHk0lgfa1m5TRkRtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXivVahur8%253D&md5=b8fe8648e4c7e1fa2c7fe3935989741c</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2019.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2019.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DB.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DLei%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DM.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520amide-pyridine%2520derivatives%2520as%2520novel%2520dual-target%2520%2528SE%252C%2520CYP51%2529%2520antifungal%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2019%26volume%3D27%26spage%3D2427%26epage%3D2437%26doi%3D10.1016%2Fj.bmc.2019.02.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hargrove, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friggeri, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wawrzak, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoekstra, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schotzinger, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">York, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guengerich, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepesheva, G. I.</span></span> <span> </span><span class="NLM_article-title">Structural analyses of Candida albicans sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">6728</span>– <span class="NLM_lpage">6743</span>, <span class="refDoi"> DOI: 10.1074/jbc.m117.778308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1074%2Fjbc.M117.778308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=28258218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtlKlurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=6728-6743&author=T.+Y.+Hargroveauthor=L.+Friggeriauthor=Z.+Wawrzakauthor=A.+Qiauthor=W.+J.+Hoekstraauthor=R.+J.+Schotzingerauthor=J.+D.+Yorkauthor=F.+P.+Guengerichauthor=G.+I.+Lepesheva&title=Structural+analyses+of+Candida+albicans+sterol+14%CE%B1-demethylase+complexed+with+azole+drugs+address+the+molecular+basis+of+azole-mediated+inhibition+of+fungal+sterol+biosynthesis&doi=10.1074%2Fjbc.m117.778308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Structural analyses of Candida albicans sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis</span></div><div class="casAuthors">Hargrove, Tatiana Y.; Friggeri, Laura; Wawrzak, Zdzislaw; Qi, Aidong; Hoekstra, William J.; Schotzinger, Robert J.; York, John D.; Guengerich, F. Peter; Lepesheva, Galina I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6728-6743</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">With some advances in modern medicine (such as cancer chemotherapy, broad exposure to antibiotics, and immunosuppression), the incidence of opportunistic fungal pathogens such as Candida albicans has increased.  Cases of drug resistance among these pathogens have become more frequent, requiring the development of new drugs and a better understanding of the targeted enzymes.  Sterol 14α-demethylase (CYP51) is a cytochrome P 450 enzyme required for biosynthesis of sterols in eukaryotic cells and is the major target of clin. drugs for managing fungal pathogens, but some of the CYP51 key features important for rational drug design have remained obscure.  We report the catalytic properties, ligand-binding profiles, and inhibition of enzymic activity of C. albicans CYP51 by clin. antifungal drugs that are used systemically (fluconazole, voriconazole, ketoconazole, itraconazole, and posaconazole) and topically (miconazole and clotrimazole) and by a tetrazole-based drug candidate, VT-1161 (oteseconazole: (R)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)-1-(5-(4-(2,2,2-trifluoroethoxy)phenyl)pyridin-2-yl)propan-2-ol).  Among the compds. tested, the first-line drug fluconazole was the weakest inhibitor, whereas posaconazole and VT-1161 were the strongest CYP51 inhibitors.  We detd. the X-ray structures of C. albicans CYP51 complexes with posaconazole and VT-1161, providing a mol. mechanism for the potencies of these drugs, including the activity of VT-1161 against Candida krusei and Candida glabrata, pathogens that are intrinsically resistant to fluconazole.  Our comparative structural anal. outlines phylum-specific CYP51 features that could direct future rational development of more efficient broad-spectrum antifungals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfxQlfsadoX7Vg90H21EOLACvtfcHk0lgfa1m5TRkRtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtlKlurY%253D&md5=d1ee6d20b19d9cf7ee5eb5b1f6f11965</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M117.778308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M117.778308%26sid%3Dliteratum%253Aachs%26aulast%3DHargrove%26aufirst%3DT.%2BY.%26aulast%3DFriggeri%26aufirst%3DL.%26aulast%3DWawrzak%26aufirst%3DZ.%26aulast%3DQi%26aufirst%3DA.%26aulast%3DHoekstra%26aufirst%3DW.%2BJ.%26aulast%3DSchotzinger%26aufirst%3DR.%2BJ.%26aulast%3DYork%26aufirst%3DJ.%2BD.%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26aulast%3DLepesheva%26aufirst%3DG.%2BI.%26atitle%3DStructural%2520analyses%2520of%2520Candida%2520albicans%2520sterol%252014%25CE%25B1-demethylase%2520complexed%2520with%2520azole%2520drugs%2520address%2520the%2520molecular%2520basis%2520of%2520azole-mediated%2520inhibition%2520of%2520fungal%2520sterol%2520biosynthesis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26spage%3D6728%26epage%3D6743%26doi%3D10.1074%2Fjbc.m117.778308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tandon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lown, J. W.</span></span> <span> </span><span class="NLM_article-title">Synthesis of geometrically constrained unsymmetrical bis(polyamides) related to the antiviral distamycin</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>2000</i></span>,  <span class="NLM_fpage">2095</span>– <span class="NLM_lpage">2103</span>, <span class="refDoi"> DOI: 10.1002/1099-0690(200006)2000:11<2095::aid-ejoc2095>3.0.co;2-j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1002%2F1099-0690%28200006%292000%3A11%3C2095%3A%3AAID-EJOC2095%3E3.0.CO%3B2-J" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2000&publication_year=2000&pages=2095-2103&author=S.+K.+Sharmaauthor=M.+Tandonauthor=J.+W.+Lown&title=Synthesis+of+geometrically+constrained+unsymmetrical+bis%28polyamides%29+related+to+the+antiviral+distamycin&doi=10.1002%2F1099-0690%28200006%292000%3A11%3C2095%3A%3Aaid-ejoc2095%3E3.0.co%3B2-j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1002%2F1099-0690%28200006%292000%3A11%3C2095%3A%3AAID-EJOC2095%3E3.0.CO%3B2-J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1099-0690%2528200006%25292000%253A11%253C2095%253A%253AAID-EJOC2095%253E3.0.CO%253B2-J%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DS.%2BK.%26aulast%3DTandon%26aufirst%3DM.%26aulast%3DLown%26aufirst%3DJ.%2BW.%26atitle%3DSynthesis%2520of%2520geometrically%2520constrained%2520unsymmetrical%2520bis%2528polyamides%2529%2520related%2520to%2520the%2520antiviral%2520distamycin%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2000%26volume%3D2000%26spage%3D2095%26epage%3D2103%26doi%3D10.1002%2F1099-0690%28200006%292000%3A11%3C2095%3A%3Aaid-ejoc2095%3E3.0.co%3B2-j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dolles, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunesch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinelli, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatonnet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohse, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittmann, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabissi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, M.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships and computational investigations into the development of potent and balanced dual-acting butyrylcholinesterase inhibitors and human cannabinoid receptor 2 ligands with pro-cognitive in vivo profiles</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1646</span>– <span class="NLM_lpage">1663</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01760</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01760" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1Sqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1646-1663&author=D.+Dollesauthor=M.+Hoffmannauthor=S.+Guneschauthor=O.+Marinelliauthor=J.+M%C3%B6llerauthor=G.+Santoniauthor=A.+Chatonnetauthor=M.+J.+Lohseauthor=H.-J.+Wittmannauthor=A.+Strasserauthor=M.+Nabissiauthor=T.+Mauriceauthor=M.+Decker&title=Structure-activity+relationships+and+computational+investigations+into+the+development+of+potent+and+balanced+dual-acting+butyrylcholinesterase+inhibitors+and+human+cannabinoid+receptor+2+ligands+with+pro-cognitive+in+vivo+profiles&doi=10.1021%2Facs.jmedchem.7b01760"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships and Computational Investigations into the Development of Potent and Balanced Dual-Acting Butyrylcholinesterase Inhibitors and Human Cannabinoid Receptor 2 Ligands with Pro-Cognitive in Vivo Profiles</span></div><div class="casAuthors">Dolles, Dominik; Hoffmann, Matthias; Gunesch, Sandra; Marinelli, Oliviero; Moeller, Jan; Santoni, Giorgio; Chatonnet, Arnaud; Lohse, Martin J.; Wittmann, Hans-Joachim; Strasser, Andrea; Nabissi, Massimo; Maurice, Tangui; Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1646-1663</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The enzyme butyrylcholinesterase (BChE) and the human cannabinoid receptor 2 (hCB2R) represent promising targets for pharmacotherapy in the later stages of Alzheimer's disease.  The authors merged pharmacophores for both targets into small benzimidazole-based mols., investigated SARs, and identified several dual-acting ligands with a balanced affinity/inhibitory activity and an excellent selectivity over both hCB1R and hAChE.  A homol. model for the hCB2R was developed based on the hCB1R crystal structure and used for mol. dynamics studies to investigate binding modes.  In vitro studies proved hCB2R agonism.  Unwanted μ-opioid receptor affinity could be designed out.  One well-balanced dual-acting and selective hBChE inhibitor/hCB2R agonist showed superior in vivo activity over the lead CB2 agonist with regards to cognition improvement.  The data shows the possibility to combine a small mol. with selective and balanced GPCR-activity/enzyme inhibition and in vivo activity for the therapy of AD and may help to rationalize the development of other dual-acting ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgCAoLm6nAVbVg90H21EOLACvtfcHk0lgW7I7-OddUlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1Sqsbo%253D&md5=49e8e68c2c9a023b872e2522fad6e78c</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01760%26sid%3Dliteratum%253Aachs%26aulast%3DDolles%26aufirst%3DD.%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DGunesch%26aufirst%3DS.%26aulast%3DMarinelli%26aufirst%3DO.%26aulast%3DM%25C3%25B6ller%26aufirst%3DJ.%26aulast%3DSantoni%26aufirst%3DG.%26aulast%3DChatonnet%26aufirst%3DA.%26aulast%3DLohse%26aufirst%3DM.%2BJ.%26aulast%3DWittmann%26aufirst%3DH.-J.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DNabissi%26aufirst%3DM.%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DStructure-activity%2520relationships%2520and%2520computational%2520investigations%2520into%2520the%2520development%2520of%2520potent%2520and%2520balanced%2520dual-acting%2520butyrylcholinesterase%2520inhibitors%2520and%2520human%2520cannabinoid%2520receptor%25202%2520ligands%2520with%2520pro-cognitive%2520in%2520vivo%2520profiles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D1646%26epage%3D1663%26doi%3D10.1021%2Facs.jmedchem.7b01760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baek, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryeom, H.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, T.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y.</span></span> <span> </span><span class="NLM_article-title">Gadolinium complex of 1,4,7,10-tetraazacyclododecane-1,4,7-trisacetic acid (DO3A)-ethoxybenzyl (EOB) conjugate as a new macrocyclic hepatobiliary MRI contrast agent</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4861</span>– <span class="NLM_lpage">4868</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00060</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00060" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotFOksrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4861-4868&author=A.+R.+Baekauthor=H.-K.+Kimauthor=S.+Parkauthor=G.+H.+Leeauthor=H.+J.+Kangauthor=J.-C.+Jungauthor=J.-S.+Parkauthor=H.-K.+Ryeomauthor=T.-J.+Kimauthor=Y.+Chang&title=Gadolinium+complex+of+1%2C4%2C7%2C10-tetraazacyclododecane-1%2C4%2C7-trisacetic+acid+%28DO3A%29-ethoxybenzyl+%28EOB%29+conjugate+as+a+new+macrocyclic+hepatobiliary+MRI+contrast+agent&doi=10.1021%2Facs.jmedchem.7b00060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Gadolinium Complex of 1,4,7,10-Tetraazacyclododecane-1,4,7-trisacetic Acid (DO3A)-Ethoxybenzyl (EOB) Conjugate as a New Macrocyclic Hepatobiliary MRI Contrast Agent</span></div><div class="casAuthors">Baek, Ah Rum; Kim, Hee-Kyung; Park, Subin; Lee, Gang Ho; Kang, Hyo Jeung; Jung, Jae-Chang; Park, Joon-Suk; Ryeom, Hun-Kyu; Kim, Tae-Jeong; Chang, Yongmin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4861-4868</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report the synthesis of a macrocyclic Gd chelate based on a 1,4,7,10-tetraazacyclododecane-1,4,7-tri(acetic acid) (DO3A) coordination cage bearing an ethoxybenzyl (EOB) moiety and discuss its use as a T1 hepatobiliary magnetic resonance imaging (MRI) contrast agent.  The new macrocyclic liver agent shows high chelation stability and high r1 relaxivity compared with linear-type Gd chelates, which are the current clin. approved liver agents.  The authors' macrocyclic, liver-specific Gd chelate was evaluated in vivo through biodistribution anal. and liver MRI, which demonstrated its high tumor detection sensitivity and suggested that the new Gd complex is a promising contrast agent for liver cancer imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrn561cNDW8L7Vg90H21EOLACvtfcHk0lgW7I7-OddUlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotFOksrg%253D&md5=da55cff094d5cc8655ca191648c66379</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00060%26sid%3Dliteratum%253Aachs%26aulast%3DBaek%26aufirst%3DA.%2BR.%26aulast%3DKim%26aufirst%3DH.-K.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DG.%2BH.%26aulast%3DKang%26aufirst%3DH.%2BJ.%26aulast%3DJung%26aufirst%3DJ.-C.%26aulast%3DPark%26aufirst%3DJ.-S.%26aulast%3DRyeom%26aufirst%3DH.-K.%26aulast%3DKim%26aufirst%3DT.-J.%26aulast%3DChang%26aufirst%3DY.%26atitle%3DGadolinium%2520complex%2520of%25201%252C4%252C7%252C10-tetraazacyclododecane-1%252C4%252C7-trisacetic%2520acid%2520%2528DO3A%2529-ethoxybenzyl%2520%2528EOB%2529%2520conjugate%2520as%2520a%2520new%2520macrocyclic%2520hepatobiliary%2520MRI%2520contrast%2520agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4861%26epage%3D4868%26doi%3D10.1021%2Facs.jmedchem.7b00060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Minkenberg, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Rijn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florusse, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boekhoven, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, M. C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koper, G. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eelkema, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Esch, J. H.</span></span> <span> </span><span class="NLM_article-title">Responsive vesicles from dynamic covalent surfactants</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">3421</span>– <span class="NLM_lpage">3424</span>, <span class="refDoi"> DOI: 10.1002/anie.201007401</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1002%2Fanie.201007401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWmtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=3421-3424&author=C.+B.+Minkenbergauthor=F.+Liauthor=P.+van+Rijnauthor=L.+Florusseauthor=J.+Boekhovenauthor=M.+C.+A.+Stuartauthor=G.+J.+M.+Koperauthor=R.+Eelkemaauthor=J.+H.+van+Esch&title=Responsive+vesicles+from+dynamic+covalent+surfactants&doi=10.1002%2Fanie.201007401"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Responsive Vesicles from Dynamic Covalent Surfactants</span></div><div class="casAuthors">Minkenberg, Christophe B.; Li, Feng; van Rijn, Patrick; Florusse, Louw; Boekhoven, Job; Stuart, Marc C. A.; Koper, Ger J. M.; Eelkema, Rienk; van Esch, Jan H.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3421-3424, S3421/1-S3421/9</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Incorporation of dynamic covalent bonds in vesicle-forming surfactants leads to the formation of responsive vesicles, which can be switched back and forth between the bilayer state and the isotropic soln. using either diln. or a change in the pH value as external stimuli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjNi5c4TiAGbVg90H21EOLACvtfcHk0lggpvtvOh7uqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWmtbo%253D&md5=8b310f009f030266815b0baf4dde44b0</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Fanie.201007401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201007401%26sid%3Dliteratum%253Aachs%26aulast%3DMinkenberg%26aufirst%3DC.%2BB.%26aulast%3DLi%26aufirst%3DF.%26aulast%3Dvan%2BRijn%26aufirst%3DP.%26aulast%3DFlorusse%26aufirst%3DL.%26aulast%3DBoekhoven%26aufirst%3DJ.%26aulast%3DStuart%26aufirst%3DM.%2BC.%2BA.%26aulast%3DKoper%26aufirst%3DG.%2BJ.%2BM.%26aulast%3DEelkema%26aufirst%3DR.%26aulast%3Dvan%2BEsch%26aufirst%3DJ.%2BH.%26atitle%3DResponsive%2520vesicles%2520from%2520dynamic%2520covalent%2520surfactants%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26spage%3D3421%26epage%3D3424%26doi%3D10.1002%2Fanie.201007401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakash, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narasimhaswamy, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis and characterization of two phenyl ring core-based thiophene mesogens</span>. <i>Mol. Cryst. Liq. Cryst.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>582</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1080/15421406.2013.790635</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1080%2F15421406.2013.790635" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKqsbzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=582&publication_year=2013&pages=1-14&author=M.+K.+Reddyauthor=K.+S.+Reddyauthor=M.+Prakashauthor=T.+Narasimhaswamy&title=Synthesis+and+characterization+of+two+phenyl+ring+core-based+thiophene+mesogens&doi=10.1080%2F15421406.2013.790635"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Characterization of Two Phenyl Ring Core-Based Thiophene Mesogens</span></div><div class="casAuthors">Reddy, M. Kesava; Reddy, K. Subramanyam; Prakash, M.; Narasimhaswamy, T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Crystals and Liquid Crystals</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">582</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-14</span>CODEN:
                <span class="NLM_cas:coden">MCLCD8</span>;
        ISSN:<span class="NLM_cas:issn">1542-1406</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Novel thiophene mesogens built with two Ph ring core and alkoxy terminal chains are synthesized by multistep route.  The Ph ring core is connected to thiophene by ester unit at (a) 2-position and (b) 3-position to yield 2-series of mesogens.  The structural characterization of them is accomplished by using spectroscopy tools and the mesophase characteristics are evaluated by HOPM and DSC.  The 13C chem. shifts of representative mesogens calcd. from DFT by quantum chem. calcns. are compared with exptl. 13C chem. shifts and further utilized for structural assignment of core unit carbons.  A good agreement between calcd. and exptl. values is noticed.  An enantiotropic nematic phase is confirmed for all the mesogens and accordingly threaded nematic texture in HOPM is obsd. and is supported by DSC transition enthalpy values.  The mesophase as well as thermal stabilities of the mesogens are discussed with ref. to terminal chain length and position of the linking unit on thiophene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNbLPtWV7QCLVg90H21EOLACvtfcHk0lggpvtvOh7uqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKqsbzF&md5=878a1fa6834fc35e99770fec2f864c8c</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1080%2F15421406.2013.790635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15421406.2013.790635%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DM.%2BK.%26aulast%3DReddy%26aufirst%3DK.%2BS.%26aulast%3DPrakash%26aufirst%3DM.%26aulast%3DNarasimhaswamy%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520characterization%2520of%2520two%2520phenyl%2520ring%2520core-based%2520thiophene%2520mesogens%26jtitle%3DMol.%2520Cryst.%2520Liq.%2520Cryst.%26date%3D2013%26volume%3D582%26spage%3D1%26epage%3D14%26doi%3D10.1080%2F15421406.2013.790635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of highly potent triazole antifungal derivatives by heterocycle-benzene bioisosteric replacement</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">16</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2013.04.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1016%2Fj.ejmech.2013.04.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=23643831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptFKrsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2013&pages=16-22&author=Z.+Jiangauthor=Y.+Wangauthor=W.+Wangauthor=S.+Wangauthor=B.+Xuauthor=G.+Fanauthor=G.+Dongauthor=Y.+Liuauthor=J.+Yaoauthor=Z.+Miaoauthor=W.+Zhangauthor=C.+Sheng&title=Discovery+of+highly+potent+triazole+antifungal+derivatives+by+heterocycle-benzene+bioisosteric+replacement&doi=10.1016%2Fj.ejmech.2013.04.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of highly potent triazole antifungal derivatives by heterocycle-benzene bioisosteric replacement</span></div><div class="casAuthors">Jiang, Zhigan; Wang, Yan; Wang, Wenya; Wang, Shengzheng; Xu, Bo; Fan, Guorong; Dong, Guoqiang; Liu, Yang; Yao, Jianzhong; Miao, Zhenyuan; Zhang, Wannian; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16-22</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">On the basis of the authors' previously discovered triazole antifungal lead compds., heterocycle-benzene bioisosteric replacement was used to improve their pharmacokinetic profile.  The designed new triazole derivs. have good antifungal activity toward a wide range of pathogenic fungi.  Their binding mode with the target enzyme was clarified by mol. docking.  The MIC value of the highly potent compd. 1-(4-(benzo[d]thiazol-2-yl-methyl)piperazin-1-yl)-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol against Candida albicans, Candida tropicalis, and Cryptococcus neoformans is 0.016 μg/mL, 0.004 μg/mL, and 0.016 μg/mL, resp.  Moreover, preliminary pharmacokinetic studies revealed that it showed improved oral absorption as compared to the lead compd. iodiconazole and deserved for further evaluations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokqjgNHIDbnrVg90H21EOLACvtfcHk0lgwHDoC1HRKyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptFKrsr8%253D&md5=249e0d7052d65311920552e1ae0372a2</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.04.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.04.025%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DFan%26aufirst%3DG.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520highly%2520potent%2520triazole%2520antifungal%2520derivatives%2520by%2520heterocycle-benzene%2520bioisosteric%2520replacement%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D64%26spage%3D16%26epage%3D22%26doi%3D10.1016%2Fj.ejmech.2013.04.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Clinical
and Laboratory Standards
Institute</span>.  <i>Reference Method for Broth
Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard-Third
Edition M27-A3</i>, <span class="NLM_year">2008</span>; Vol.  <span class="NLM_volume">28</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=Clinical%0Aand+Laboratory+Standards%0AInstitute&title=Reference+Method+for+Broth%0ADilution+Antifungal+Susceptibility+Testing+of+Yeasts.+Approved+Standard-Third%0AEdition+M27-A3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DReference%2520Method%2520for%2520Broth%250ADilution%2520Antifungal%2520Susceptibility%2520Testing%2520of%2520Yeasts.%2520Approved%2520Standard-Third%250AEdition%2520M27-A3%26date%3D2008%26volume%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barker, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crisp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiederhold, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bareither, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckstein, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbuch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, P. D.</span></span> <span> </span><span class="NLM_article-title">Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">376</span>– <span class="NLM_lpage">385</span>, <span class="refDoi"> DOI: 10.1093/jac/dkh336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1093%2Fjac%2Fdkh336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=15201233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnt1WisLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2004&pages=376-385&author=K.+S.+Barkerauthor=S.+Crispauthor=N.+Wiederholdauthor=R.+E.+Lewisauthor=B.+Bareitherauthor=J.+Ecksteinauthor=R.+Barbuchauthor=M.+Bardauthor=P.+D.+Rogers&title=Genome-wide+expression+profiling+reveals+genes+associated+with+amphotericin+B+and+fluconazole+resistance+in+experimentally+induced+antifungal+resistant+isolates+of+Candida+albicans&doi=10.1093%2Fjac%2Fdkh336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans</span></div><div class="casAuthors">Barker, Katherine S.; Crisp, Sarah; Wiederhold, Nathan; Lewis, Russell E.; Bareither, Bart; Eckstein, James; Barbuch, Robert; Bard, Martin; Rogers, P. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">376-385</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objectives: The aim of this study was to identify changes in the gene expression profile of Candida albicans assocd. with the acquisition of exptl. induced resistance to amphotericin B and fluconazole.  Methods: C. albicans SC5314 was passed in increasing concns. of amphotericin B to generate isolate SC5314-AR.  Susceptibility testing by Etest revealed SC5314-AR to be highly resistant to both amphotericin B and fluconazole.  The gene expression profile of SC5314-AR was compared with that of SC5314 using DNA microarray anal.  Sterol compn. was detd. for both strains.  Results: Upon examn. of MICs of antifungal compds., it was found that SC5314-AR was resistant to both amphotericin B and fluconazole.  By microarray anal. a total of 134 genes were differentially expressed, that is up-regulated or down-regulated by at least 50%, in SC5314-AR.  In addn. to the cell stress genes DDR48 and RTA2, the ergosterol biosynthesis genes ERG5, ERG6 and ERG25 were up-regulated.  Several histone genes, protein synthesis genes and energy generation genes were down-regulated.  Sterol anal. revealed the prevalence of sterol intermediates eburicol and lanosterol in SC5314-AR, whereas ergosterol was the predominant sterol in SC5314.  Conclusion: Along with changes in expression of these ergosterol biosynthesis genes was the accumulation of sterol intermediates in the resistant strain, which would account for the decreased affinity of amphotericin B for membrane sterols and a decreased requirement for lanosterol demethylase activity in membrane sterol prodn.  Furthermore, other genes are implicated as having a potential role in the polyene and azole antifungal resistant phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLFsttZhPI_LVg90H21EOLACvtfcHk0liGFgClcTXimA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnt1WisLo%253D&md5=a343151092e702ec2276bae2eb5762aa</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkh336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkh336%26sid%3Dliteratum%253Aachs%26aulast%3DBarker%26aufirst%3DK.%2BS.%26aulast%3DCrisp%26aufirst%3DS.%26aulast%3DWiederhold%26aufirst%3DN.%26aulast%3DLewis%26aufirst%3DR.%2BE.%26aulast%3DBareither%26aufirst%3DB.%26aulast%3DEckstein%26aufirst%3DJ.%26aulast%3DBarbuch%26aufirst%3DR.%26aulast%3DBard%26aufirst%3DM.%26aulast%3DRogers%26aufirst%3DP.%2BD.%26atitle%3DGenome-wide%2520expression%2520profiling%2520reveals%2520genes%2520associated%2520with%2520amphotericin%2520B%2520and%2520fluconazole%2520resistance%2520in%2520experimentally%2520induced%2520antifungal%2520resistant%2520isolates%2520of%2520Candida%2520albicans%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2004%26volume%3D54%26spage%3D376%26epage%3D385%26doi%3D10.1093%2Fjac%2Fdkh336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.</span></span> <span> </span><span class="NLM_article-title">Structure-based rational screening of novel hit compounds with structural diversity for cytochrome P450 sterol 14α-demethylase from Penicillium digitatum</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">317</span>– <span class="NLM_lpage">325</span>, <span class="refDoi"> DOI: 10.1021/ci900425t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci900425t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvFWhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=317-325&author=Q.+Zhangauthor=D.+Liauthor=P.+Weiauthor=J.+Zhangauthor=J.+Wanauthor=Y.+Renauthor=Z.+Chenauthor=D.+Liuauthor=Z.+Yuauthor=L.+Feng&title=Structure-based+rational+screening+of+novel+hit+compounds+with+structural+diversity+for+cytochrome+P450+sterol+14%CE%B1-demethylase+from+Penicillium+digitatum&doi=10.1021%2Fci900425t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Rational Screening of Novel Hit Compounds with Structural Diversity for Cytochrome P450 Sterol 14α-Demethylase from Penicillium digitatum</span></div><div class="casAuthors">Zhang, Qingye; Li, Ding; Wei, Pei; Zhang, Jie; Wan, Jian; Ren, Yangliang; Chen, Zhigang; Liu, Deli; Yu, Ziniu; Feng, Lingling</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">317-325</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cytochrome P 450 sterol 14α-demethylases (CYP51s) are essential enzymes in sterol biosynthesis and well-known as the target of antifungal drugs.  All fungal CYP51s are integral membrane proteins, making structural and biophys. characterization more challenging.  The X-ray crystallog. structure of CYP51 isolated from Mycobacterium tuberculosis (MT-CYP51) is the unique reported one hitherto.  In the present study, a homol. modeling three-dimensional structure of CYP51 from Penicillium digitatum (PD-CYP51) was generated by CPHmodels, in which the accuracy of sequence alignment could be improved by taking into account further structural conservation information, using MT-CYP51 as the template.  Interaction mechanism between the active site of PD-CYP51 and its inhibitors were further investigated by mol. dynamics simulating and mol. docking.  With the effective docking process and interaction anal. information, structure-based virtual screening was performed to pick out the thirty new potential inhibiting compds. with structural diversity by using a new virtual screening strategy including Flex-Pharm/PMF/GOLD//FlexX/PMF/GOLD mol. docking procedures, and finally, seven new hit compds. out of SPECs database with potent inhibitory ability were validated by bioaffinity assays at enzyme level and on P. digitatum in vitro.  The pos. results indicated that all modeling strategies and screening processes presented in the current study are an encouraging way in search of novel lead compds. with structural diversity for the specifically individual fungal CYP51s of both plants and human pathogens in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjLVnlQqSnLLVg90H21EOLACvtfcHk0liGFgClcTXimA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvFWhuw%253D%253D&md5=20748311280af2036154ac49f44c0533</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fci900425t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci900425t%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DWei%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DJ.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DFeng%26aufirst%3DL.%26atitle%3DStructure-based%2520rational%2520screening%2520of%2520novel%2520hit%2520compounds%2520with%2520structural%2520diversity%2520for%2520cytochrome%2520P450%2520sterol%252014%25CE%25B1-demethylase%2520from%2520Penicillium%2520digitatum%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D317%26epage%3D325%26doi%3D10.1021%2Fci900425t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thamban
Chandrika, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shrestha, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsodikov, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garneau-Tsodikova, S.</span></span> <span> </span><span class="NLM_article-title">Alkylated piperazines and piperazine-azole hybrids as antifungal agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">158</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01138</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01138" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFyrtLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=158-173&author=N.+Thamban%0AChandrikaauthor=S.+K.+Shresthaauthor=H.+X.+Ngoauthor=O.+V.+Tsodikovauthor=K.+C.+Howardauthor=S.+Garneau-Tsodikova&title=Alkylated+piperazines+and+piperazine-azole+hybrids+as+antifungal+agents&doi=10.1021%2Facs.jmedchem.7b01138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Alkylated Piperazines and Piperazine-Azole Hybrids as Antifungal Agents</span></div><div class="casAuthors">Thamban Chandrika, Nishad; Shrestha, Sanjib K.; Ngo, Huy X.; Tsodikov, Oleg V.; Howard, Kaitlind C.; Garneau-Tsodikova, Sylvie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">158-173</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The extensive use of fluconazole (FLC) and other azole drugs has caused the emergence and rise of azole-resistant fungi.  The fungistatic nature of FLC in combination with toxicity concerns have resulted in an increased demand for new azole antifungal agents.  Herein, we report the synthesis and antifungal activity of novel alkylated piperazines and alkylated piperazine-azole hybrids, their time-kill studies, their hemolytic activity against murine erythrocytes, as well as their cytotoxicity against mammalian cells.  Many of these mols. exhibited broad-spectrum activity against all tested fungal strains, with excellent min. inhibitory concn. (MIC) values against non-albicans Candida and Aspergillus strains.  The most promising compds. were found to be less hemolytic than the FDA-approved antifungal agent voriconazole (VOR).  Finally, we demonstrate that the synthetic alkylated piperazine-azole hybrids do not function by fungal membrane disruption, but instead by disruption of the ergosterol biosynthetic pathway via inhibition of the 14α-demethylase enzyme present in fungal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_maYeDMRUULVg90H21EOLACvtfcHk0lgu7wiuSwrZFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFyrtLfP&md5=2e7c24c4345936afa5c12d80c78f18cc</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01138%26sid%3Dliteratum%253Aachs%26aulast%3DThamban%2BChandrika%26aufirst%3DN.%26aulast%3DShrestha%26aufirst%3DS.%2BK.%26aulast%3DNgo%26aufirst%3DH.%2BX.%26aulast%3DTsodikov%26aufirst%3DO.%2BV.%26aulast%3DHoward%26aufirst%3DK.%2BC.%26aulast%3DGarneau-Tsodikova%26aufirst%3DS.%26atitle%3DAlkylated%2520piperazines%2520and%2520piperazine-azole%2520hybrids%2520as%2520antifungal%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D158%26epage%3D173%26doi%3D10.1021%2Facs.jmedchem.7b01138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guillon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logé, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagniez, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferchaud-Roucher, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duflos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pape, P. L.</span></span> <span> </span><span class="NLM_article-title">Synthesis and in vitro antifungal evaluation of 2-(2,4-difluorophenyl)-1-[(1H-indol-3-ylmethyl)methylamino]-3-(1H-1,2,4-triazol-1 -yl)propan-2-ols</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">261</span>– <span class="NLM_lpage">269</span>, <span class="refDoi"> DOI: 10.3109/14756366.2010.503607</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.3109%2F14756366.2010.503607" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=20695753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjt1Wisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2011&pages=261-269&author=R.+Guillonauthor=C.+Log%C3%A9author=F.+Pagniezauthor=V.+Ferchaud-Roucherauthor=M.+Duflosauthor=C.+Picotauthor=P.+L.+Pape&title=Synthesis+and+in+vitro+antifungal+evaluation+of+2-%282%2C4-difluorophenyl%29-1-%5B%281H-indol-3-ylmethyl%29methylamino%5D-3-%281H-1%2C2%2C4-triazol-1+-yl%29propan-2-ols&doi=10.3109%2F14756366.2010.503607"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro antifungal evaluation of 2-(2,4-difluorophenyl)-1-[(1H-indol-3-ylmethyl)methylamino]-3-(1H-1,2,4-triazol-1-yl)propan-2-ols</span></div><div class="casAuthors">Guillon, Remi; Loge, Cedric; Pagniez, Fabrice; Ferchaud-Roucher, Veronique; Duflos, Muriel; Picot, Carine; Le Pape, Patrice</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">261-269</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Previous studies, based on the design of 1-[(1H-indol-5-ylmethyl)amino]-2-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as antifungal agents, were extended to the identification of new indol-3-ylmethylamino derivs.  The majority of these compds. exhibited antifungal activity against a Candida albicans strain (min. inhibitory concns. ranging from 199.0 to 381.0 ng/mL) suggesting an inhibition of 14α-demethylase by sterol anal. studies, but are weaker inhibitors compared to their indol-5-ylmethylamino analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosr_pdGRENerVg90H21EOLACvtfcHk0lgu7wiuSwrZFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjt1Wisr8%253D&md5=8e4c4a3b1c56c5159ecc3c7998b666ce</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.3109%2F14756366.2010.503607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2010.503607%26sid%3Dliteratum%253Aachs%26aulast%3DGuillon%26aufirst%3DR.%26aulast%3DLog%25C3%25A9%26aufirst%3DC.%26aulast%3DPagniez%26aufirst%3DF.%26aulast%3DFerchaud-Roucher%26aufirst%3DV.%26aulast%3DDuflos%26aufirst%3DM.%26aulast%3DPicot%26aufirst%3DC.%26aulast%3DPape%26aufirst%3DP.%2BL.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520antifungal%2520evaluation%2520of%25202-%25282%252C4-difluorophenyl%2529-1-%255B%25281H-indol-3-ylmethyl%2529methylamino%255D-3-%25281H-1%252C2%252C4-triazol-1%2520-yl%2529propan-2-ols%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2011%26volume%3D26%26spage%3D261%26epage%3D269%26doi%3D10.3109%2F14756366.2010.503607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S. S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podust, L. M.</span></span> <span> </span><span class="NLM_article-title">A nonazole CYP51 inhibitor cures Chagas’ disease in a mouse model of acute infection</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2480</span>– <span class="NLM_lpage">2488</span>, <span class="refDoi"> DOI: 10.1128/aac.00281-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1128%2FAAC.00281-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=20385875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1Ohu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=2480-2488&author=P.+S.+Doyleauthor=C.-K.+Chenauthor=J.+B.+Johnstonauthor=S.+D.+Hopkinsauthor=S.+S.+F.+Leungauthor=M.+P.+Jacobsonauthor=J.+C.+Engelauthor=J.+H.+McKerrowauthor=L.+M.+Podust&title=A+nonazole+CYP51+inhibitor+cures+Chagas%E2%80%99+disease+in+a+mouse+model+of+acute+infection&doi=10.1128%2Faac.00281-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">A nonazole CYP51 inhibitor cures Chagas' disease in a mouse model of acute infection</span></div><div class="casAuthors">Doyle, Patricia S.; Chen, Chiung-Kuang; Johnston, Jonathan B.; Hopkins, Stephanie D.; Leung, Siegfried S. F.; Jacobson, Matthew P.; Engel, Juan C.; McKerrow, James H.; Podust, Larissa M.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2480-2488</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Chagas' disease, the leading cause of heart failure in Latin America, is caused by the kinetoplastid protozoan Trypanosoma cruzi.  The sterols of T. cruzi resemble those of fungi, both in compn. and in biosynthesis.  Azole inhibitors of sterol 14α-demethylase (CYP51) successfully treat fungal infections in humans, and efforts to adapt the success of antifungal azoles posaconazole and ravuconazole as second-use agents for Chagas' disease are under way.  However, to address concerns about the use of azoles for Chagas' disease, including drug resistance and cost, the rational design of nonazole CYP51 inhibitors can provide promising alternative drug chemotypes.  We report the curative effect of the nonazole CYP51 inhibitor LP10 in an acute mouse model of T. cruzi infection.  Mice treated with an oral dose of 40 mg LP10/kg of body wt. twice a day (BID) for 30 days, initiated 24 h postinfection, showed no signs of acute disease and had histol. normal tissues after 6 mo.  A very stringent test of cure showed that 4/5 mice had neg. PCR results for T. cruzi, and parasites were amplified by hemoculture in only two treated mice.  These results compare favorably with those reported for posaconazole.  Electron microscopy and gas chromatog.-mass spectrometry (GC-MS) anal. of sterol compn. confirmed that treatment with LP10 blocked the 14α-demethylation step and induced breakdown of parasite cell membranes, culminating in severe ultrastructural and morphol. alterations and death of the clin. relevant amastigote stage of the parasite.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ-K-iYD6LBbVg90H21EOLACvtfcHk0lgu7wiuSwrZFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1Ohu7s%253D&md5=cd28b1ca30614162c4fbaaba28511650</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1128%2FAAC.00281-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00281-10%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DP.%2BS.%26aulast%3DChen%26aufirst%3DC.-K.%26aulast%3DJohnston%26aufirst%3DJ.%2BB.%26aulast%3DHopkins%26aufirst%3DS.%2BD.%26aulast%3DLeung%26aufirst%3DS.%2BS.%2BF.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DEngel%26aufirst%3DJ.%2BC.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DPodust%26aufirst%3DL.%2BM.%26atitle%3DA%2520nonazole%2520CYP51%2520inhibitor%2520cures%2520Chagas%25E2%2580%2599%2520disease%2520in%2520a%2520mouse%2520model%2520of%2520acute%2520infection%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D2480%26epage%3D2488%26doi%3D10.1128%2Faac.00281-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kontoyiannis, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R. E.</span></span> <span> </span><span class="NLM_article-title">Antifungal drug resistance of pathogenic fungi</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>359</i></span>,  <span class="NLM_fpage">1135</span>– <span class="NLM_lpage">1144</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(02)08162-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1016%2FS0140-6736%2802%2908162-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=11943280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1ehsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=2002&pages=1135-1144&author=D.+P.+Kontoyiannisauthor=R.+E.+Lewis&title=Antifungal+drug+resistance+of+pathogenic+fungi&doi=10.1016%2Fs0140-6736%2802%2908162-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Antifungal drug resistance of pathogenic fungi</span></div><div class="casAuthors">Kontoyiannis, Dimitrios P.; Lewis, Russell E.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">359</span>
        (<span class="NLM_cas:issue">9312</span>),
    <span class="NLM_cas:pages">1135-1144</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Lancet Publishing Group</span>)
        </div><div class="casAbstract">A review.  Pathogenic fungi have many complex mechanisms of resistance to antifungal drugs.  Information about the clin., cellular, and mol. factors contributing to antifungal-drug resistance continues to accumulate.  The authors critically review the diagnosis, epidemiol., and mechanisms of antifungal drug resistance of pathogenic fungi.  Better understanding of this resistance should assist in developing better detection strategies for preventing and treating refractory mycoses in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1dW784KCr5rVg90H21EOLACvtfcHk0lgfS8T8i6OcJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1ehsLs%253D&md5=80210f3ec3e1dccea49e2427118218a6</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2802%2908162-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252802%252908162-X%26sid%3Dliteratum%253Aachs%26aulast%3DKontoyiannis%26aufirst%3DD.%2BP.%26aulast%3DLewis%26aufirst%3DR.%2BE.%26atitle%3DAntifungal%2520drug%2520resistance%2520of%2520pathogenic%2520fungi%26jtitle%3DLancet%26date%3D2002%26volume%3D359%26spage%3D1135%26epage%3D1144%26doi%3D10.1016%2Fs0140-6736%2802%2908162-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arendrup, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, T. F.</span></span> <span> </span><span class="NLM_article-title">Multidrug-resistant candida: epidemiology, molecular mechanisms, and treatment</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>216</i></span>,  <span class="NLM_fpage">S445</span>– <span class="NLM_lpage">S451</span>, <span class="refDoi"> DOI: 10.1093/infdis/jix131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1093%2Finfdis%2Fjix131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=28911043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFOkt7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=216&publication_year=2017&pages=S445-S451&author=M.+C.+Arendrupauthor=T.+F.+Patterson&title=Multidrug-resistant+candida%3A+epidemiology%2C+molecular+mechanisms%2C+and+treatment&doi=10.1093%2Finfdis%2Fjix131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug-resistant Candida: epidemiology, molecular mechanisms, and treatment</span></div><div class="casAuthors">Arendrup, Maiken Cavling; Patterson, Thomas F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">216</span>
        (<span class="NLM_cas:issue">Suppl. 3</span>),
    <span class="NLM_cas:pages">S445-S451</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">1537-6613</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Invasive Candida infections remain an important cause of morbidity and mortality, esp. in hospitalized and immunocompromised or critically ill patients.  A limited no. of antifungal agents from only a few drug classes are available to treat patients with these serious infections.  Resistance can be either intrinsic or acquired.  Resistance mechanisms are not exchanged between Candida; thus, acquired resistance either emerges in response to an antifungal selection pressure in the individual patient or, more rarely, occur due to horizontal transmission of resistant strains between patients.  Although multidrug resistance is uncommon, increasing reports of multidrug resistance to the azoles, echinocandins, and polyenes have occurred in several Candida species, most notably Candida glabrata and more recently Candida auris.  Drivers are overall antifungal use, subtherapeutic drug levels at sites of infection/ colonization, drug sequestration in the biofilm matrix, and, in the setting of outbreaks, suboptimal infection control.  Moreover, recent research suggests that DNA mismatch repair gene mutations may facilitate acquisition of resistance mutations in C. glabrata specifically.  Diagnosis of antifungal-resistant Candida infections is crit. to the successful management of patients with these infections.  Redn. of unnecessary use of antifungals via antifungal stewardship is crit. to limit multidrug resistance emergence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqedB5dIDze6rVg90H21EOLACvtfcHk0lgfS8T8i6OcJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFOkt7zF&md5=c6d777b6835af212887b07485e2c114a</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2Fjix131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252Fjix131%26sid%3Dliteratum%253Aachs%26aulast%3DArendrup%26aufirst%3DM.%2BC.%26aulast%3DPatterson%26aufirst%3DT.%2BF.%26atitle%3DMultidrug-resistant%2520candida%253A%2520epidemiology%252C%2520molecular%2520mechanisms%252C%2520and%2520treatment%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2017%26volume%3D216%26spage%3DS445%26epage%3DS451%26doi%3D10.1093%2Finfdis%2Fjix131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niimi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harding, D. R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parshot, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lun, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decottignies, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niimi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cannon, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goffeau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monk, B. C.</span></span> <span> </span><span class="NLM_article-title">Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a D-octapeptide derivative</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1256</span>– <span class="NLM_lpage">1271</span>, <span class="refDoi"> DOI: 10.1128/aac.48.4.1256-1271.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1128%2FAAC.48.4.1256-1271.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=15047528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtVKqsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=1256-1271&author=K.+Niimiauthor=D.+R.+K.+Hardingauthor=R.+Parshotauthor=A.+Kingauthor=D.+J.+Lunauthor=A.+Decottigniesauthor=M.+Niimiauthor=S.+Linauthor=R.+D.+Cannonauthor=A.+Goffeauauthor=B.+C.+Monk&title=Chemosensitization+of+fluconazole+resistance+in+Saccharomyces+cerevisiae+and+pathogenic+fungi+by+a+D-octapeptide+derivative&doi=10.1128%2Faac.48.4.1256-1271.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a D-octapeptide derivative</span></div><div class="casAuthors">Niimi, K.; Harding, D. R. K.; Parshot, R.; King, A.; Lun, D. J.; Decottignies, A.; Niimi, M.; Lin, S.; Cannon, R. D.; Goffeau, A.; Monk, B. C.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1256-1271</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Hyperexpression of the S. cerevisiae multidrug ATP-binding cassette (ABC) transporter Pdr5p was driven by the pdr1-3 mutation in the Pdr1p transcriptional regulator in a strain (AD/PDR5+) with deletions of 5 other ABC-type multidrug efflux pumps.  The strain had high-level fluconazole (FLC) resistance (MIC, 600 μg/mL), and plasma membrane fractions showed oligomycin-sensitive ATPase activity ≤5-fold higher than that shown by fractions from an isogenic PDR5-null mutant (FLC MIC, 0.94 μg/mL).  In vitro inhibition of the Pdr5p ATPase activity and chemosensitization of cells to FLC allowed the systematic screening of a 1.8-million-member designer D-octapeptide combinatorial library for surface-active Pdr5p antagonists with modest toxicity against yeast cells.  Library deconvolution identified the 4-methoxy-2,3,6-trimethylbenzenesulfonyl-substituted D-octapeptide KN20 as a potent Pdr5p ATPase inhibitor (concn. of drug causing 50% inhibition of enzyme activity [IC50], 4 μM) which chemosensitized AD/PDR5+ to FLC, itraconazole, and ketoconazole.  It also inhibited the ATPase activity of other ABC transporters, such as Candida albicans Cdr1p (IC50, 30 μM) and Cdr2p (IC50, 2 μM), and chemosensitized clin. isolates of pathogenic Candida spp. and S. cerevisiae strains that heterologously hyperexpressed either ABC-type multidrug efflux pumps, the C. albicans major facilitator superfamily-type drug transporter BenRp, or the FLC drug target lanosterol 14α-demethylase (Erg11p).  Although KN20 also inhibited the S. cerevisiae plasma membrane proton pump Pma1p (IC50, 1 μM), the peptide concns. required for chemosensitization made yeast cells permeable to rhodamine 6G.  KN20 therefore appears to indirectly chemosensitize cells to FLC by a nonlethal permeabilization of the fungal plasma membrane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_Glg2Lzb-yLVg90H21EOLACvtfcHk0lgfS8T8i6OcJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtVKqsrs%253D&md5=80a29376a7856176a73cec97eb3ce27e</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1128%2FAAC.48.4.1256-1271.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.48.4.1256-1271.2004%26sid%3Dliteratum%253Aachs%26aulast%3DNiimi%26aufirst%3DK.%26aulast%3DHarding%26aufirst%3DD.%2BR.%2BK.%26aulast%3DParshot%26aufirst%3DR.%26aulast%3DKing%26aufirst%3DA.%26aulast%3DLun%26aufirst%3DD.%2BJ.%26aulast%3DDecottignies%26aufirst%3DA.%26aulast%3DNiimi%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DCannon%26aufirst%3DR.%2BD.%26aulast%3DGoffeau%26aufirst%3DA.%26aulast%3DMonk%26aufirst%3DB.%2BC.%26atitle%3DChemosensitization%2520of%2520fluconazole%2520resistance%2520in%2520Saccharomyces%2520cerevisiae%2520and%2520pathogenic%2520fungi%2520by%2520a%2520D-octapeptide%2520derivative%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D1256%26epage%3D1271%26doi%3D10.1128%2Faac.48.4.1256-1271.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumamoto, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinces, M. D.</span></span> <span> </span><span class="NLM_article-title">Contributions of hyphae and hypha-co-regulated genes to Candida albicans virulence</span>. <i>Cell. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1546</span>– <span class="NLM_lpage">1554</span>, <span class="refDoi"> DOI: 10.1111/j.1462-5822.2005.00616.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1111%2Fj.1462-5822.2005.00616.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=16207242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFGkt7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=1546-1554&author=C.+A.+Kumamotoauthor=M.+D.+Vinces&title=Contributions+of+hyphae+and+hypha-co-regulated+genes+to+Candida+albicans+virulence&doi=10.1111%2Fj.1462-5822.2005.00616.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Contributions of hyphae and hypha-co-regulated genes to Candida albicans virulence</span></div><div class="casAuthors">Kumamoto, Carol A.; Vinces, Marcelo D.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Microbiology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1546-1554</span>CODEN:
                <span class="NLM_cas:coden">CEMIF5</span>;
        ISSN:<span class="NLM_cas:issn">1462-5814</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The fascinating ability of Candida albicans to undergo dramatic changes in cellular morphol. has invited speculation that this plasticity in form contributes to the virulence of the organism.  Mol. genetic analyses have confirmed this hypothesis and further demonstrated that genes that govern cellular morphol. are co-regulated with genes encoding conventional virulence factors such as proteases and adhesins.  The transcriptional regulatory networks of C. albicans thus ensure that hyphae are produced concomitantly with virulence factors, resulting in cells that are adapted for invading the tissues of an immunocompromised host.  Hyphae are able to exert mech. force, aiding penetration of epithelial surfaces, and hyphae damage endothelial cells, aiding escape of C. albicans from the host bloodstream into deeper tissue.  Hyphal morphogenesis is thus an integral part of the overall virulence strategy of C. albicans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMN0NHLYd1YbVg90H21EOLACvtfcHk0lgKayxS9O8tyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFGkt7vP&md5=bdc4095d0da44bfcf6ec265fd798e89d</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1111%2Fj.1462-5822.2005.00616.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1462-5822.2005.00616.x%26sid%3Dliteratum%253Aachs%26aulast%3DKumamoto%26aufirst%3DC.%2BA.%26aulast%3DVinces%26aufirst%3DM.%2BD.%26atitle%3DContributions%2520of%2520hyphae%2520and%2520hypha-co-regulated%2520genes%2520to%2520Candida%2520albicans%2520virulence%26jtitle%3DCell.%2520Microbiol.%26date%3D2005%26volume%3D7%26spage%3D1546%26epage%3D1554%26doi%3D10.1111%2Fj.1462-5822.2005.00616.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saville, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzell, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryant, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fretzen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monreal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solberg, E. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteagudo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Ribot, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milne, G. T.</span></span> <span> </span><span class="NLM_article-title">Inhibition of filamentation can be used to treat disseminated candidiasis</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">3312</span>– <span class="NLM_lpage">3316</span>, <span class="refDoi"> DOI: 10.1128/aac.00628-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1128%2FAAC.00628-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=17005810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVylsbvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=3312-3316&author=S.+P.+Savilleauthor=A.+L.+Lazzellauthor=A.+P.+Bryantauthor=A.+Fretzenauthor=A.+Monrealauthor=E.+O.+Solbergauthor=C.+Monteagudoauthor=J.+L.+Lopez-Ribotauthor=G.+T.+Milne&title=Inhibition+of+filamentation+can+be+used+to+treat+disseminated+candidiasis&doi=10.1128%2Faac.00628-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of filamentation can be used to treat disseminated candidiasis</span></div><div class="casAuthors">Saville, Stephen P.; Lazzell, Anna L.; Bryant, Alexander P.; Fretzen, Angelika; Monreal, Alex; Solberg, Erik O.; Monteagudo, Carlos; Lopez-Ribot, Jose L.; Milne, G. Todd</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3312-3316</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Candida albicans remains the leading causative agent of invasive fungal infection.  Although the importance of filamentation in C. albicans pathogenesis has been extensively investigated, in vivo studies to date have been unable to dissect the role of this developmental process in the establishment of infection vs. the development of active disease as characterized by damage to the host leading to mortality.  To address this issue, we genetically engineered a C. albicans tet-NRG1 strain in which filamentation and virulence can be modulated both in vitro and in vivo simply by the presence or absence of doxycycline (DOX): this strain enabled us, in a prior study, to demonstrate that yeast-form cells were able to infect the deep organs but caused no disease unless filamentation (induced by the addn. of DOX) was allowed to occur.  In the present study, we examd. whether inhibiting filamentation (by withdrawing the DOX) at 24 or 48 h postinfection could serve as an effective therapeutic intervention against candidiasis.  The results obtained indicate that DOX removal led to an alteration in the morphol. of the infecting fungal cells and a dramatic increase in survival, but as with conventional antifungal drug therapy regimens, mortality rates increased markedly the longer this intervention was delayed.  These observations reinforce the importance of invasive filamentous growth in causing the damage to the host and the lethality assocd. with active disease and suggest this process could be fruitfully targeted for the development of new antifungal agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoGINnT2eTmLVg90H21EOLACvtfcHk0lgKayxS9O8tyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVylsbvL&md5=62b8140867261cf304c8d0518553eb4d</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1128%2FAAC.00628-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00628-06%26sid%3Dliteratum%253Aachs%26aulast%3DSaville%26aufirst%3DS.%2BP.%26aulast%3DLazzell%26aufirst%3DA.%2BL.%26aulast%3DBryant%26aufirst%3DA.%2BP.%26aulast%3DFretzen%26aufirst%3DA.%26aulast%3DMonreal%26aufirst%3DA.%26aulast%3DSolberg%26aufirst%3DE.%2BO.%26aulast%3DMonteagudo%26aufirst%3DC.%26aulast%3DLopez-Ribot%26aufirst%3DJ.%2BL.%26aulast%3DMilne%26aufirst%3DG.%2BT.%26atitle%3DInhibition%2520of%2520filamentation%2520can%2520be%2520used%2520to%2520treat%2520disseminated%2520candidiasis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D3312%26epage%3D3316%26doi%3D10.1128%2Faac.00628-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Tackling fungal resistance by biofilm inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2193</span>– <span class="NLM_lpage">2211</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01203</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01203" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC2sXis12jsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2193-2211&author=S.+Wuauthor=Y.+Wangauthor=N.+Liuauthor=G.+Dongauthor=C.+Sheng&title=Tackling+fungal+resistance+by+biofilm+inhibitors&doi=10.1021%2Facs.jmedchem.6b01203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Tackling Fungal Resistance by Biofilm Inhibitors</span></div><div class="casAuthors">Wu, Shanchao; Wang, Yan; Liu, Na; Dong, Guoqiang; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2193-2211</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The high incidence and mortality of invasive fungal infections and serious drug resistance have become a global public health issue.  The ability of fungal cells to form biofilms is an important reason for the emergence of severe resistance to most clin. available antifungal agents.  Targeting fungal biofilm formation by small mols. represents a promising new strategy for the development of novel antifungal agents.  This perspective will provide a comprehensive review of fungal biofilm inhibitors.  In particular, discovery strategies, chem. structures, antibiofilm/antifungal activities and structure-activity relationship studies will be discussed.  Development of inhibitors to treat biofilm-related resistant fungal infections is a new yet clin. unexploited paradigm, and there is still a long way to go to clin. application.  Better understanding of fungal biofilms in combination with systematic drug discovery efforts will pave the way for potential clin. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeZ6BRDEnjE7Vg90H21EOLACvtfcHk0lgKayxS9O8tyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXis12jsA%253D%253D&md5=7a0290b1463fb2c848493bd50d09c0ee</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01203%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DTackling%2520fungal%2520resistance%2520by%2520biofilm%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2193%26epage%3D2211%26doi%3D10.1021%2Facs.jmedchem.6b01203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stoldt, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonneborn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuker, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, J. F.</span></span> <span> </span><span class="NLM_article-title">Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1982</span>– <span class="NLM_lpage">1991</span>, <span class="refDoi"> DOI: 10.1093/emboj/16.8.1982</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1093%2Femboj%2F16.8.1982" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=9155024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADyaK2sXjt1WksL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=1982-1991&author=V.+R.+Stoldtauthor=A.+Sonnebornauthor=C.+E.+Leukerauthor=J.+F.+Ernst&title=Efg1p%2C+an+essential+regulator+of+morphogenesis+of+the+human+pathogen+Candida+albicans%2C+is+a+member+of+a+conserved+class+of+bHLH+proteins+regulating+morphogenetic+processes+in+fungi&doi=10.1093%2Femboj%2F16.8.1982"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi</span></div><div class="casAuthors">Stoldt, Volker R.; Sonneborn, Anja; Leuker, Christoph E.; Ernst, Joachim F.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1982-1991</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">We identified a gene of the fungal pathogen Candida albicans, designated EFG1, whose high-level expression stimulates pseudohyphal morphogenesis in the yeast Saccharomyces cerevisiae.  In a central region the deduced Efg1 protein is highly homologous to the StuA and Phd1/Sok2 proteins that regulate morphogenesis of Aspergillus nidulans and S. cerevisiae, resp.  The core of the conserved region is homologous to the basic helix-loop-helix (bHLH) motif of eukaryotic transcription factors, specifically to the human Myc and Max proteins.  Fungal-specific residues in the bHLH domain include the substitution of an invariant glutamate, responsible for target (E-box) specificity, by a threonine residue.  During hyphal induction EFG1 transcript levels decline to low levels; downregulation is effected at the level of transcriptional initiation as shown by a EFG1 promoter-LAC4 fusion.  A strain carrying one disrupted EFG1 allele and one EFG1 allele under the control of the glucose-repressible PCK1 promoter forms rod-like, pseudohyphal cells, but is unable to form true hyphae on glucose-contg. media.  Overexpression of EFG1 in C. albicans leads to enhanced filamentous growth in the form of extended pseudohyphae in liq. and on solid media.  The results suggest that Efg1p has a dual role as a transcriptional activator and repressor, whose balanced activity is essential for yeast, pseudohyphal and hyphal morphogenesis of C. albicans.  Functional analogies between Efg1p and Myc are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKgZx5C4RGDbVg90H21EOLACvtfcHk0lhnNCI3l3jrCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjt1WksL0%253D&md5=212b347be9858b7e6378539e50bec2cf</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F16.8.1982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F16.8.1982%26sid%3Dliteratum%253Aachs%26aulast%3DStoldt%26aufirst%3DV.%2BR.%26aulast%3DSonneborn%26aufirst%3DA.%26aulast%3DLeuker%26aufirst%3DC.%2BE.%26aulast%3DErnst%26aufirst%3DJ.%2BF.%26atitle%3DEfg1p%252C%2520an%2520essential%2520regulator%2520of%2520morphogenesis%2520of%2520the%2520human%2520pathogen%2520Candida%2520albicans%252C%2520is%2520a%2520member%2520of%2520a%2520conserved%2520class%2520of%2520bHLH%2520proteins%2520regulating%2520morphogenetic%2520processes%2520in%2520fungi%26jtitle%3DEMBO%2520J.%26date%3D1997%26volume%3D16%26spage%3D1982%26epage%3D1991%26doi%3D10.1093%2Femboj%2F16.8.1982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biswas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Datta, A.</span></span> <span> </span><span class="NLM_article-title">N-acetylglucosamine-inducible CaGAP1 encodes a general amino acid permease which co-ordinates external nitrogen source response and morphogenesis in Candida albicans</span>. <i>Microbiology</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>149</i></span>,  <span class="NLM_fpage">2597</span>– <span class="NLM_lpage">2608</span>, <span class="refDoi"> DOI: 10.1099/mic.0.26215-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1099%2Fmic.0.26215-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=12949183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnslGnsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2003&pages=2597-2608&author=S.+Biswasauthor=M.+Royauthor=A.+Datta&title=N-acetylglucosamine-inducible+CaGAP1+encodes+a+general+amino+acid+permease+which+co-ordinates+external+nitrogen+source+response+and+morphogenesis+in+Candida+albicans&doi=10.1099%2Fmic.0.26215-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">N-acetylglucosamine-inducible CaGAP1 encodes a general amino acid permease which co-ordinates external nitrogen source response and morphogenesis in Candida albicans</span></div><div class="casAuthors">Biswas, Subhrajit; Roy, Monideepa; Datta, Asis</div><div class="citationInfo"><span class="NLM_cas:title">Microbiology (Reading, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2597-2608</span>CODEN:
                <span class="NLM_cas:coden">MROBEO</span>;
        ISSN:<span class="NLM_cas:issn">1350-0872</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">Candida albicans is able to grow in a variety of reversible morphol. forms (yeast, pseudohyphal and hyphal) in response to various environmental signals, noteworthy among them being N-acetylglucosamine (GlcNAc).  The gene CaGAP1, homologous to GAP1, which encodes the general amino acid permease from Saccharomyces cerevisiae, was isolated on the basis of its induction by GlcNAc through differential screening of a C. albicans genomic library.  The gene could functionally complement an S. cerevisiae gap1 mutant by rendering it susceptible to the toxic amino acid analog mimosine in minimal proline media.  As in S. cerevisiae, mutation of the CaGAP1 gene had an effect on citrulline uptake in C. albicans.  Northern anal. showed that GlcNAc-induced expression of CaGAP1 was further enhanced in synthetic minimal media supplemented with single amino acids (glutamate, proline and glutamine) or urea (without amino acids) but repressed in minimal ammonium media.  Induction of CaGAP1 expression by GlcNAc was nullified in C. albicans deleted for the transcription factor CPH1 and the hyphal regulator RAS1, indicating the involvement of Cph1p-dependent Ras1p signalling in CaGAP1 expression.  A homozygous mutant of this gene showed defective hyphal formation in solid hyphal-inducing media and exhibited less hyphal clumps when induced by GlcNAc.  Alteration of morphol. and short filamentation under nitrogen-starvation conditions in the heterozygous mutant suggested that CaGAP1 affects morphogenesis in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosiEvDEvT3oLVg90H21EOLACvtfcHk0lhnNCI3l3jrCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnslGnsbw%253D&md5=a12dcd38cfa3caf77ce598bd49c58e46</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1099%2Fmic.0.26215-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fmic.0.26215-0%26sid%3Dliteratum%253Aachs%26aulast%3DBiswas%26aufirst%3DS.%26aulast%3DRoy%26aufirst%3DM.%26aulast%3DDatta%26aufirst%3DA.%26atitle%3DN-acetylglucosamine-inducible%2520CaGAP1%2520encodes%2520a%2520general%2520amino%2520acid%2520permease%2520which%2520co-ordinates%2520external%2520nitrogen%2520source%2520response%2520and%2520morphogenesis%2520in%2520Candida%2520albicans%26jtitle%3DMicrobiology%26date%3D2003%26volume%3D149%26spage%3D2597%26epage%3D2608%26doi%3D10.1099%2Fmic.0.26215-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lane, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span> <span> </span><span class="NLM_article-title">The basic helix-loop-helix transcription factor Cph2 regulates hyphal development in Candida albicans partly via TEC1</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">6418</span>– <span class="NLM_lpage">6428</span>, <span class="refDoi"> DOI: 10.1128/mcb.21.19.6418-6428.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1128%2FMCB.21.19.6418-6428.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=11533231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmvFGhsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=6418-6428&author=S.+Laneauthor=S.+Zhouauthor=T.+Panauthor=Q.+Daiauthor=H.+Liu&title=The+basic+helix-loop-helix+transcription+factor+Cph2+regulates+hyphal+development+in+Candida+albicans+partly+via+TEC1&doi=10.1128%2Fmcb.21.19.6418-6428.2001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">The basic helix-loop-helix transcription factor Cph2 regulates hyphal development in Candida albicans partly via Tec1</span></div><div class="casAuthors">Lane, Shelley; Zhou, Song; Pan, Ting; Dai, Qian; Liu, Haoping</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6418-6428</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Candida albicans undergoes a morphogenetic switch from budding yeast to hyphal growth form in response to a variety of stimuli and growth conditions.  Multiple signaling pathways, including a Cph1-mediated mitogen-activated protein kinase pathway and an Efg1-mediated cAMP/protein kinase A pathway, regulate the transition.  Here we report the identification of a basic helix-loop-helix transcription factor of the Myc subfamily (Cph2) by its ability to promote pseudohyphal growth in Saccharomyces cerevisiae.  Like sterol response element binding protein 1, Cph2 has a Tyr instead of a conserved Arg in the basic DNA binding region.  Cph2 regulates hyphal development in C. albicans, as cph2/cph2 mutant strains show medium-specific impairment in hyphal development and in the induction of hypha-specific genes.  However, many hypha-specific genes do not have potential Cph2 binding sites in their upstream regions.  Interestingly, upstream sequences of all known hypha-specific genes are found to contain potential binding sites for Tec1, a regulator of hyphal development.  Northern anal. shows that TEC1 transcription is highest in the medium in which cph2/cph2 displays a defect in hyphal development, and Cph2 is necessary for this transcriptional induction of TEC1.  In vitro gel mobility shift expts. show that Cph2 directly binds to the two sterol regulatory element 1-like elements upstream of TEC1.  Furthermore, the ectopic expression of TEC1 suppresses the defect of cph2/cph2 in hyphal development.  Therefore, the function of Cph2 in hyphal transcription is mediated, in part, through Tec1.  We further show that this function of Cph2 is independent of the Cph1- and Efg1-mediated pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_NVWYjyz1CLVg90H21EOLACvtfcHk0lhnNCI3l3jrCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmvFGhsL4%253D&md5=155552fad624314912eb3d2caccf9bec</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1128%2FMCB.21.19.6418-6428.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.21.19.6418-6428.2001%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DT.%26aulast%3DDai%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DH.%26atitle%3DThe%2520basic%2520helix-loop-helix%2520transcription%2520factor%2520Cph2%2520regulates%2520hyphal%2520development%2520in%2520Candida%2520albicans%2520partly%2520via%2520TEC1%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2001%26volume%3D21%26spage%3D6418%26epage%3D6428%26doi%3D10.1128%2Fmcb.21.19.6418-6428.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheppard, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeaman, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welch, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, Q. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filler, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waring, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, J. E.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Functional and structural diversity in the Als protein family of Candida albicans</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">30480</span>– <span class="NLM_lpage">30489</span>, <span class="refDoi"> DOI: 10.1074/jbc.m401929200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1074%2Fjbc.M401929200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=15128742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsFKhsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=30480-30489&author=D.+C.+Sheppardauthor=M.+R.+Yeamanauthor=W.+H.+Welchauthor=Q.+T.+Phanauthor=Y.+Fuauthor=A.+S.+Ibrahimauthor=S.+G.+Fillerauthor=M.+Zhangauthor=A.+J.+Waringauthor=J.+E.+Edwards&title=Functional+and+structural+diversity+in+the+Als+protein+family+of+Candida+albicans&doi=10.1074%2Fjbc.m401929200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Functional and Structural Diversity in the Als Protein Family of Candida albicans</span></div><div class="casAuthors">Sheppard, Donald C.; Yeaman, Michael R.; Welch, William H.; Phan, Quynh T.; Fu, Yue; Ibrahim, Ashraf S.; Filler, Scott G.; Zhang, Mason; Waring, Alan J.; Edwards, John E., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">30480-30489</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The human fungal pathogen Candida albicans colonizes and invades a wide range of host tissues.  Adherence to host constituents plays an important role in this process.  Two members of the C. albicans Als protein family (Als1p and Als5p) have been found to mediate adherence; however, the functions of other members of this family are unknown.  In this study, members of the ALS gene family were cloned and expressed in Saccharomyces cerevisiae to characterize their individual functions.  Distinct Als proteins conferred distinct adherence profiles to diverse host substrates.  Using chimeric Als5p-Als6p constructs, the regions mediating substrate-specific adherence were localized to the N-terminal domains in Als proteins.  Interestingly, a subset of Als proteins also mediated endothelial cell invasion, a previously unknown function of this family.  Consistent with these results, homol. modeling revealed that Als members contain anti-parallel β-sheet motifs interposed by extended regions, homologous to adhesins or invasins of the Ig superfamily.  This finding was confirmed using CD and Fourier transform IR spectrometric anal. of the N-terminal domain of Als1p.  Specific regions of amino acid hypervariability were found among the N-terminal domains of Als proteins, and energy-based models predicted similarities and differences in the N-terminal domains that probably govern the diverse function of Als family members.  Collectively, these results indicate that the structural and functional diversity within the Als family provides C. albicans with an array of cell wall proteins capable of recognizing and interacting with a wide range of host constituents during infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF70gkXSCYCbVg90H21EOLACvtfcHk0lgYbudRlVlvfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsFKhsr8%253D&md5=c1b7191906d3320bbf361d6a6c19b7b2</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M401929200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M401929200%26sid%3Dliteratum%253Aachs%26aulast%3DSheppard%26aufirst%3DD.%2BC.%26aulast%3DYeaman%26aufirst%3DM.%2BR.%26aulast%3DWelch%26aufirst%3DW.%2BH.%26aulast%3DPhan%26aufirst%3DQ.%2BT.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DIbrahim%26aufirst%3DA.%2BS.%26aulast%3DFiller%26aufirst%3DS.%2BG.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DWaring%26aufirst%3DA.%2BJ.%26aulast%3DEdwards%26aufirst%3DJ.%2BE.%26atitle%3DFunctional%2520and%2520structural%2520diversity%2520in%2520the%2520Als%2520protein%2520family%2520of%2520Candida%2520albicans%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D30480%26epage%3D30489%26doi%3D10.1074%2Fjbc.m401929200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitman, J.</span></span> <span> </span><span class="NLM_article-title">Epigenetic mechanisms of drug resistance in fungi</span>. <i>Fungal Genet. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">103253</span>, <span class="refDoi"> DOI: 10.1016/j.fgb.2019.103253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1016%2Fj.fgb.2019.103253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=31325489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVCgsb%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2019&pages=103253&author=Z.+Changauthor=V.+Yadavauthor=S.+C.+Leeauthor=J.+Heitman&title=Epigenetic+mechanisms+of+drug+resistance+in+fungi&doi=10.1016%2Fj.fgb.2019.103253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic mechanisms of drug resistance in fungi</span></div><div class="casAuthors">Chang, Zanetta; Yadav, Vikas; Lee, Soo Chan; Heitman, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Fungal Genetics and Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103253</span>CODEN:
                <span class="NLM_cas:coden">FGBIFV</span>;
        ISSN:<span class="NLM_cas:issn">1087-1845</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The emergence of drug-resistant fungi poses a continuously increasing threat to human health.  Despite advances in preventive care and diagnostics, resistant fungi continue to cause significant mortality, esp. in immunocompromised patients.  Therapeutic resources are further limited by current usage of only four major classes of antifungal drugs.  Resistance against these drugs has already been obsd. in pathogenic fungi requiring the development of much needed newer antifungal drugs.  Epigenetic changes such as DNA or chromatin modifications alter gene expression levels in response to certain stimuli, including interaction with the host in the case of fungal pathogens.  These changes can confer resistance to drugs by altering the expression of target genes or genes encoding drug efflux pumps.  Multiple pathogens share many of these epigenetic pathways; thus, targeting epigenetic pathways might also identify drug target candidates for the development of broad-spectrum antifungal drugs.  In this review, we discuss the importance of epigenetic pathways in mediating drug resistance in fungi as well as in the development of anti-fungal drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUsc8iIa_pi7Vg90H21EOLACvtfcHk0lh2oz3lYp6F6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVCgsb%252FM&md5=86dbb4c9a50787f348efe0b5b9c47891</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.fgb.2019.103253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fgb.2019.103253%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DZ.%26aulast%3DYadav%26aufirst%3DV.%26aulast%3DLee%26aufirst%3DS.%2BC.%26aulast%3DHeitman%26aufirst%3DJ.%26atitle%3DEpigenetic%2520mechanisms%2520of%2520drug%2520resistance%2520in%2520fungi%26jtitle%3DFungal%2520Genet.%2520Biol.%26date%3D2019%26volume%3D132%26spage%3D103253%26doi%3D10.1016%2Fj.fgb.2019.103253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eldesouky, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salama, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazbun, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayhoub, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seleem, M. N.</span></span> <span> </span><span class="NLM_article-title">Ospemifene displays broad-spectrum synergistic interactions with itraconazole through potent interference with fungal efflux activities</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">6089</span>, <span class="refDoi"> DOI: 10.1038/s41598-020-62976-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1038%2Fs41598-020-62976-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=32269301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmvFGnurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=6089&author=H.+E.+Eldesoukyauthor=E.+A.+Salamaauthor=T.+R.+Hazbunauthor=A.+S.+Mayhoubauthor=M.+N.+Seleem&title=Ospemifene+displays+broad-spectrum+synergistic+interactions+with+itraconazole+through+potent+interference+with+fungal+efflux+activities&doi=10.1038%2Fs41598-020-62976-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Ospemifene displays broad-spectrum synergistic interactions with itraconazole through potent interference with fungal efflux activities</span></div><div class="casAuthors">Eldesouky, Hassan E.; Salama, Ehab A.; Hazbun, Tony R.; Mayhoub, Abdelrahman S.; Seleem, Mohamed N.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">6089</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: Azole antifungals are vital therapeutic options for treating invasive mycotic infections.  However, the emergence of azole-resistant isolates combined with limited therapeutic options presents a growing challenge in medical mycol.  To address this issue, we utilized microdilution checkerboard assays to evaluate nine stilbene compds. for their ability to interact synergistically with azole drugs, particularly against azole-resistant fungal isolates.  Ospemifene displayed the most potent azole chemosensitizing activity, and its combination with itraconazole displayed broad-spectrum synergistic interactions against Candida albicans, Candida auris, Cryptococcus neoformans, and Aspergillus fumigatus (ΣFICI = 0.05-0.50).  Addnl., in a Caenorhabditis elegans infection model, the ospemifene-itraconazole combination significantly reduced fungal CFU burdens in infected nematodes by ∼75-96%.  Nile Red efflux assays and RT-qPCR anal. suggest ospemifene interferes directly with fungal efflux systems, thus permitting entry of azole drugs into fungal cells.  This study identifies ospemifene as a novel antifungal adjuvant that augments the antifungal activity of itraconazole against a broad range of fungal pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouk_EemTj2RrVg90H21EOLACvtfcHk0lh2oz3lYp6F6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmvFGnurg%253D&md5=6fee184868288f722fb2fe1319ea27d4</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2Fs41598-020-62976-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-020-62976-y%26sid%3Dliteratum%253Aachs%26aulast%3DEldesouky%26aufirst%3DH.%2BE.%26aulast%3DSalama%26aufirst%3DE.%2BA.%26aulast%3DHazbun%26aufirst%3DT.%2BR.%26aulast%3DMayhoub%26aufirst%3DA.%2BS.%26aulast%3DSeleem%26aufirst%3DM.%2BN.%26atitle%3DOspemifene%2520displays%2520broad-spectrum%2520synergistic%2520interactions%2520with%2520itraconazole%2520through%2520potent%2520interference%2520with%2520fungal%2520efflux%2520activities%26jtitle%3DSci.%2520Rep.%26date%3D2020%26volume%3D10%26spage%3D6089%26doi%3D10.1038%2Fs41598-020-62976-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Georgopapadakou, N.</span>; <span class="NLM_string-name">Hu, W.</span>; <span class="NLM_string-name">Campeol, N.</span>; <span class="NLM_string-name">Bedard, J.</span>; <span class="NLM_string-name">Deziel, R.</span>; <span class="NLM_string-name">Ajamian, A.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase inhibitors for enhanceing activity of antifungal agents</span>. U.S. Patent <span class="NLM_patent">0,197,550 A1</span>, Aug 23, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=N.+Georgopapadakou&author=W.+Hu&author=N.+Campeol&author=J.+Bedard&author=R.+Deziel&author=A.+Ajamian&title=Histone+deacetylase+inhibitors+for+enhanceing+activity+of+antifungal+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGeorgopapadakou%26aufirst%3DN.%26atitle%3DHistone%2520deacetylase%2520inhibitors%2520for%2520enhanceing%2520activity%2520of%2520antifungal%2520agents%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sridharan, R.</span>; <span class="NLM_string-name">Selvakumar, T. P.</span>; <span class="NLM_string-name">Maneesh, P. S.</span>; <span class="NLM_string-name">Gopalan, B.</span>; <span class="NLM_string-name">Solanki, S. S.</span>; <span class="NLM_string-name">Bharathimohan, K.</span>; <span class="NLM_string-name">Virendra, K. D.</span>; <span class="NLM_string-name">Vinoth, C. N.</span>; <span class="NLM_string-name">Karthikeyan, G.</span>; <span class="NLM_string-name">Shridhar, N.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase inhibitors for treatment of fungal infections</span>. <span class="NLM_patent">WO 058582 A1</span>, May 19, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=R.+Sridharan&author=T.+P.+Selvakumar&author=P.+S.+Maneesh&author=B.+Gopalan&author=S.+S.+Solanki&author=K.+Bharathimohan&author=K.+D.+Virendra&author=C.+N.+Vinoth&author=G.+Karthikeyan&author=N.+Shridhar&title=Histone+deacetylase+inhibitors+for+treatment+of+fungal+infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSridharan%26aufirst%3DR.%26atitle%3DHistone%2520deacetylase%2520inhibitors%2520for%2520treatment%2520of%2520fungal%2520infections%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonfils, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalita, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubay, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siu, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carducci, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martell, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besterman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span> <span> </span><span class="NLM_article-title">Evaluation of the pharmacodynamic effects of MGCD0103 from preclinical models to human using a novel HDAC enzyme assay</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">3441</span>– <span class="NLM_lpage">3449</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.ccr-07-4427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1158%2F1078-0432.CCR-07-4427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=18519775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmslygsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=3441-3449&author=C.+Bonfilsauthor=A.+Kalitaauthor=M.+Dubayauthor=L.+L.+Siuauthor=M.+A.+Carducciauthor=G.+Reidauthor=R.+E.+Martellauthor=J.+M.+Bestermanauthor=Z.+Li&title=Evaluation+of+the+pharmacodynamic+effects+of+MGCD0103+from+preclinical+models+to+human+using+a+novel+HDAC+enzyme+assay&doi=10.1158%2F1078-0432.ccr-07-4427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the Pharmacodynamic Effects of MGCD0103 from Preclinical Models to Human Using a Novel HDAC Enzyme Assay</span></div><div class="casAuthors">Bonfils, Claire; Kalita, Ann; Dubay, Marja; Siu, Lillian L.; Carducci, Michael A.; Reid, Gregory; Martell, Robert E.; Besterman, Jeffrey M.; Li, Zuomei</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3441-3449</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The pharmacodynamic properties of MGCD0103, an isotype-selective inhibitor of histone deacetylase (HDAC), were evaluated in preclin. models and patients with a novel whole-cell HDAC enzyme assay.  Exptl. Design: Boc-Lys(.vepsiln.-Ac)-AMC, a HDAC substrate with fluorescent readout, was found to be cell permeable and was used to monitor MGCD0103-mediated HDAC inhibition in cultured cancer cells in vitro, in peripheral WBC ex vivo, in mice in vivo, and in human patients.  RESULTS: MGCD0103 inhibited HDAC activity in several human cancer cell lines in vitro and in human peripheral WBC ex vivo in a dose-dependent manner.  Unlike suberoylanilide hydroxamic acid, the HDAC inhibitory activity of MGCD0103 was time dependent and sustained for at least 24 h following drug removal in peripheral WBC ex vivo.  Inhibitory activity of MGCD0103 was sustained for at least 8 h in vivo in mice and 48 h in patients with solid tumors.  HDAC inhibitory activity of MGCD0103 in peripheral WBC correlated with induction of histone acetylation in blood and in implanted tumors in mice.  In cancer patients, sustained pharmacodynamic effect of MGCD0103 was visualized only by dose-dependent enzyme inhibition in peripheral WBC but not by histone acetylation anal.  CONCLUSIONS: This study shows that MGCD0103 has sustained pharmacodynamic effects that can be monitored both in vitro and in vivo with a cell-based HDAC enzyme assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrReZVYYRQ0YbVg90H21EOLACvtfcHk0lh2oz3lYp6F6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmslygsbk%253D&md5=29b048a8a7c72caa67b9e68e5604e1df</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-4427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-4427%26sid%3Dliteratum%253Aachs%26aulast%3DBonfils%26aufirst%3DC.%26aulast%3DKalita%26aufirst%3DA.%26aulast%3DDubay%26aufirst%3DM.%26aulast%3DSiu%26aufirst%3DL.%2BL.%26aulast%3DCarducci%26aufirst%3DM.%2BA.%26aulast%3DReid%26aufirst%3DG.%26aulast%3DMartell%26aufirst%3DR.%2BE.%26aulast%3DBesterman%26aufirst%3DJ.%2BM.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DEvaluation%2520of%2520the%2520pharmacodynamic%2520effects%2520of%2520MGCD0103%2520from%2520preclinical%2520models%2520to%2520human%2520using%2520a%2520novel%2520HDAC%2520enzyme%2520assay%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D3441%26epage%3D3449%26doi%3D10.1158%2F1078-0432.ccr-07-4427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzell, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHardy, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saville, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Ribot, J. L.</span></span> <span> </span><span class="NLM_article-title">Development of anti-virulence approaches for candidiasis via a novel series of small-molecule inhibitors of Candida albicans filamentation</span>. <i>mBio</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e01991</span> <span class="refDoi"> DOI: 10.1128/mbio.01991-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1128%2FmBio.01991-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=29208749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVKmtLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&author=J.+A.+Romoauthor=C.+G.+Pierceauthor=A.+K.+Chaturvediauthor=A.+L.+Lazzellauthor=S.+F.+McHardyauthor=S.+P.+Savilleauthor=J.+L.+Lopez-Ribot&title=Development+of+anti-virulence+approaches+for+candidiasis+via+a+novel+series+of+small-molecule+inhibitors+of+Candida+albicans+filamentation&doi=10.1128%2Fmbio.01991-17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Development of anti-virulence approaches for candidiasis via a novel series of small-molecule inhibitors of Candida albicans filamentation</span></div><div class="casAuthors">Romo, Jesus A.; Pierce, Christopher G.; Chaturvedi, Ashok K.; Lazzell, Anna L.; McHardy, Stanton F.; Saville, Stephen P.; Lopez-Ribot, Jose L.</div><div class="citationInfo"><span class="NLM_cas:title">mBio</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e01991-17/1-e01991-17/16</span>CODEN:
                <span class="NLM_cas:coden">MBIOCL</span>;
        ISSN:<span class="NLM_cas:issn">2150-7511</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Candida albicans remains the main etiol. agent of candidiasis, the most common fungal infection and now the third most frequent infection in U.S. hospitals.  The scarcity of antifungal agents and their limited efficacy contribute to the unacceptably high morbidity and mortality rates assocd. with these infections.  The yeast-to-hypha transition represents the main virulence factor assocd. with the pathogenesis of C. albicans infections.  In addn., filamentation is pivotal for robust biofilm development, which represents another major virulence factor for candidiasis and further complicates treatment.  Targeting pathogenic mechanisms rather than growth represents an attractive yet clin. unexploited approach in the development of novel antifungal agents.  Here, we performed large-scale phenotypic screening assays with 30,000 drug-like small-mol. compds. within ChemBridge's DIVERSet chem. library in order to identify small-mol. inhibitors of C. albicans filamentation, and our efforts led to the identification of a novel series of bioactive compds. with a common biaryl amide core structure.  The leading compd. of this series, N-[3-(allyloxy)-phenyl]-4-methoxybenzamide, was able to prevent filamentation under all liq. and solid medium conditions tested, suggesting that it impacts a common core component of the cellular machinery that mediates hypha formation under different environmental conditions.  In addn. to filamentation, this compd. also inhibited C. albicans biofilm formation.  This leading compd. also demonstrated in vivo activity in clin. relevant murine models of invasive and oral candidiasis.  Overall, our results indicate that compds. within this series represent promising candidates for the development of novel anti-virulence approaches to combat C. albicans infections.  IMPORTANCE Since fungi are eukaryotes, there is a limited no. of fungusspecific targets and, as a result, the antifungal arsenal is exceedingly small.  Furthermore, the efficacy of antifungal treatment is compromised by toxicity and development of resistance.  As a consequence, fungal infections carry high morbidity and mortality rates, and there is an urgent but unmet need for novel antifungal agents.  One appealing strategy for antifungal drug development is to target pathogenetic mechanisms assocd. with infection.  In Candida albicans, one of the most common pathogenic fungi, morphogenetic transitions between yeast cells and filamentous hyphae represent a key virulence factor assocd. with the ability of fungal cells to invade tissues, cause damage, and form biofilms.  Here, we describe and characterize a novel small-mol. compd. capable of inhibiting C. albicans filamentation both in vitro and in vivo; as such, this compd. represents a leading candidate for the development of anti-virulence therapies against candidiasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqGPhBx3db77Vg90H21EOLACvtfcHk0libq3WyhHBNww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVKmtLjI&md5=6f14fbe603e993cc98c5364557f39440</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1128%2FmBio.01991-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.01991-17%26sid%3Dliteratum%253Aachs%26aulast%3DRomo%26aufirst%3DJ.%2BA.%26aulast%3DPierce%26aufirst%3DC.%2BG.%26aulast%3DChaturvedi%26aufirst%3DA.%2BK.%26aulast%3DLazzell%26aufirst%3DA.%2BL.%26aulast%3DMcHardy%26aufirst%3DS.%2BF.%26aulast%3DSaville%26aufirst%3DS.%2BP.%26aulast%3DLopez-Ribot%26aufirst%3DJ.%2BL.%26atitle%3DDevelopment%2520of%2520anti-virulence%2520approaches%2520for%2520candidiasis%2520via%2520a%2520novel%2520series%2520of%2520small-molecule%2520inhibitors%2520of%2520Candida%2520albicans%2520filamentation%26jtitle%3DmBio%26date%3D2017%26volume%3D8%26doi%3D10.1128%2Fmbio.01991-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">The discovery of novel antifungal scaffolds by structural simplification of the natural product sampangine</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">14648</span>– <span class="NLM_lpage">14651</span>, <span class="refDoi"> DOI: 10.1039/c5cc05699c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1039%2Fc5cc05699c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=26289663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlSnu7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2015&pages=14648-14651&author=Z.+Jiangauthor=N.+Liuauthor=D.+Huauthor=G.+Dongauthor=Z.+Miaoauthor=J.+Yaoauthor=H.+Heauthor=Y.+Jiangauthor=W.+Zhangauthor=Y.+Wangauthor=C.+Sheng&title=The+discovery+of+novel+antifungal+scaffolds+by+structural+simplification+of+the+natural+product+sampangine&doi=10.1039%2Fc5cc05699c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of novel antifungal scaffolds by structural simplification of the natural product sampangine</span></div><div class="casAuthors">Jiang, Zhigan; Liu, Na; Hu, Dandan; Dong, Guoqiang; Miao, Zhenyuan; Yao, Jianzhong; He, Haiying; Jiang, Yuanying; Zhang, Wannian; Wang, Yan; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">78</span>),
    <span class="NLM_cas:pages">14648-14651</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Natural products are important sources of therapeutic drugs.  However, it is a challenge to simplify the structure of natural products without decreasing the biol. activity.  Here we provide the first example of the successful simplification of an antifungal natural product.  Starting from sampangine, two novel simplified scaffolds with excellent antifungal activity were discovered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDQRLoWYoyu7Vg90H21EOLACvtfcHk0libq3WyhHBNww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlSnu7vO&md5=82161572e5e8a6dcd2db7bb3e2f5e7e3</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1039%2Fc5cc05699c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc5cc05699c%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DHu%26aufirst%3DD.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DThe%2520discovery%2520of%2520novel%2520antifungal%2520scaffolds%2520by%2520structural%2520simplification%2520of%2520the%2520natural%2520product%2520sampangine%26jtitle%3DChem.%2520Commun.%26date%3D2015%26volume%3D51%26spage%3D14648%26epage%3D14651%26doi%3D10.1039%2Fc5cc05699c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 14 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Wanzhen Yang, Jie Tu, Changjin Ji, Zhuang Li, Guiyan Han, Na Liu, Jian Li, <span class="NLM_string-name hlFld-ContribAuthor">Chunquan Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Piperidol Derivatives for Combinational Treatment of Azole-Resistant Candidiasis. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2021,</strong> <em>7 </em>
                                    (3)
                                     , 650-660. <a href="https://doi.org/10.1021/acsinfecdis.0c00849" title="DOI URL">https://doi.org/10.1021/acsinfecdis.0c00849</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.0c00849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.0c00849%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DDiscovery%252Bof%252BPiperidol%252BDerivatives%252Bfor%252BCombinational%252BTreatment%252Bof%252BAzole-Resistant%252BCandidiasis%26aulast%3DYang%26aufirst%3DWanzhen%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D02122020%26date%3D16022021%26volume%3D7%26issue%3D3%26spage%3D650%26epage%3D660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhuang Li, Jie Tu, Guiyan Han, Na Liu, <span class="NLM_string-name hlFld-ContribAuthor">Chunquan Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Carboline Fungal Histone Deacetylase (HDAC) Inhibitors for Combinational Treatment of Azole-Resistant Candidiasis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (2)
                                     , 1116-1126. <a href="https://doi.org/10.1021/acs.jmedchem.0c01763" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01763</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01763%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BCarboline%252BFungal%252BHistone%252BDeacetylase%252B%252528HDAC%252529%252BInhibitors%252Bfor%252BCombinational%252BTreatment%252Bof%252BAzole-Resistant%252BCandidiasis%26aulast%3DLi%26aufirst%3DZhuang%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D07102020%26date%3D27122020%26volume%3D64%26issue%3D2%26spage%3D1116%26epage%3D1126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wei Liu, Lin Yuan, <span class="NLM_string-name hlFld-ContribAuthor">Shengzheng Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (21)
                                     , 12429-12459. <a href="https://doi.org/10.1021/acs.jmedchem.0c00748" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00748</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00748%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BProgress%252Bin%252Bthe%252BDiscovery%252Bof%252BAntifungal%252BAgents%252BTargeting%252Bthe%252BCell%252BWall%26aulast%3DLiu%26aufirst%3DWei%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D04052020%26date%3D04082020%26date%3D21072020%26volume%3D63%26issue%3D21%26spage%3D12429%26epage%3D12459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan-Fei  Sui</span>, <span class="hlFld-ContribAuthor ">Mohammad Fawad  Ansari</span>, <span class="hlFld-ContribAuthor ">Bo  Fang</span>, <span class="hlFld-ContribAuthor ">Shao-Lin  Zhang</span>, <span class="hlFld-ContribAuthor ">Cheng-He  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel purinylthiazolylethanone derivatives as anti-Candida albicans agents through possible multifaceted mechanisms. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>221 </em>, 113557. <a href="https://doi.org/10.1016/j.ejmech.2021.113557" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113557</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113557%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Bpurinylthiazolylethanone%252Bderivatives%252Bas%252Banti-Candida%252Balbicans%252Bagents%252Bthrough%252Bpossible%252Bmultifaceted%252Bmechanisms%26aulast%3DSui%26aufirst%3DYan-Fei%26date%3D2021%26volume%3D221%26spage%3D113557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tianbao  Zhu</span>, <span class="hlFld-ContribAuthor ">Xi  Chen</span>, <span class="hlFld-ContribAuthor ">Chenglan  Li</span>, <span class="hlFld-ContribAuthor ">Jie  Tu</span>, <span class="hlFld-ContribAuthor ">Na  Liu</span>, <span class="hlFld-ContribAuthor ">Defeng  Xu</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Lanosterol 14α-demethylase (CYP51)/histone deacetylase (HDAC) dual inhibitors for treatment of Candida tropicalis and Cryptococcus neoformans infections. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>221 </em>, 113524. <a href="https://doi.org/10.1016/j.ejmech.2021.113524" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113524</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113524&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113524%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLanosterol%252B14%2525CE%2525B1-demethylase%252B%252528CYP51%252529%25252Fhistone%252Bdeacetylase%252B%252528HDAC%252529%252Bdual%252Binhibitors%252Bfor%252Btreatment%252Bof%252BCandida%252Btropicalis%252Band%252BCryptococcus%252Bneoformans%252Binfections%26aulast%3DZhu%26aufirst%3DTianbao%26date%3D2021%26volume%3D221%26spage%3D113524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aleksandra  Kuplińska</span>, <span class="hlFld-ContribAuthor ">Kamila  Rząd</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular targets for antifungals in amino acid and protein biosynthetic pathways. </span><span class="cited-content_cbyCitation_journal-name">Amino Acids</span><span> <strong>2021,</strong> <em>53 </em>
                                    (7)
                                     , 961-991. <a href="https://doi.org/10.1007/s00726-021-03007-6" title="DOI URL">https://doi.org/10.1007/s00726-021-03007-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00726-021-03007-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00726-021-03007-6%26sid%3Dliteratum%253Aachs%26jtitle%3DAmino%2520Acids%26atitle%3DMolecular%252Btargets%252Bfor%252Bantifungals%252Bin%252Bamino%252Bacid%252Band%252Bprotein%252Bbiosynthetic%252Bpathways%26aulast%3DKupli%25C5%2584ska%26aufirst%3DAleksandra%26date%3D2021%26date%3D2021%26volume%3D53%26issue%3D7%26spage%3D961%26epage%3D991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying  Chen</span>, <span class="hlFld-ContribAuthor ">Yi‐Dong  Zhou</span>, <span class="hlFld-ContribAuthor ">Pablo  Laborda</span>, <span class="hlFld-ContribAuthor ">Hai‐Lin  Wang</span>, <span class="hlFld-ContribAuthor ">Rui  Wang</span>, <span class="hlFld-ContribAuthor ">Xian  Chen</span>, <span class="hlFld-ContribAuthor ">Feng‐Quan  Liu</span>, <span class="hlFld-ContribAuthor ">Dong‐Jing  Yang</span>, <span class="hlFld-ContribAuthor ">Su‐Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Xin‐Chi  Shi</span>, <span class="hlFld-ContribAuthor ">Pedro  Laborda</span>. </span><span class="cited-content_cbyCitation_article-title">Mode of action and efficacy of quinolinic acid for the control of
              
                Ceratocystis fimbriata
              
              on sweet potato. </span><span class="cited-content_cbyCitation_journal-name">Pest Management Science</span><span> <strong>2021,</strong> <em>76 </em><a href="https://doi.org/10.1002/ps.6495" title="DOI URL">https://doi.org/10.1002/ps.6495</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ps.6495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fps.6495%26sid%3Dliteratum%253Aachs%26jtitle%3DPest%2520Management%2520Science%26atitle%3DMode%252Bof%252Baction%252Band%252Befficacy%252Bof%252Bquinolinic%252Bacid%252Bfor%252Bthe%252Bcontrol%252Bof%252BCeratocystis%252Bfimbriata%252Bon%252Bsweet%252Bpotato%26aulast%3DChen%26aufirst%3DYing%26date%3D2021%26date%3D2021%26volume%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan‐Fei  Sui</span>, <span class="hlFld-ContribAuthor ">Mohammad Fawad  Ansari</span>, <span class="hlFld-ContribAuthor ">Cheng‐He  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrimidinetrione‐imidazoles as a Unique Structural Type of Potential Agents towards
              Candida Albicans
              : Design, Synthesis and Biological Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – An Asian Journal</span><span> <strong>2021,</strong> <em>16 </em>
                                    (11)
                                     , 1417-1429. <a href="https://doi.org/10.1002/asia.202100146" title="DOI URL">https://doi.org/10.1002/asia.202100146</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/asia.202100146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fasia.202100146%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520An%2520Asian%2520Journal%26atitle%3DPyrimidinetrione%2525E2%252580%252590imidazoles%252Bas%252Ba%252BUnique%252BStructural%252BType%252Bof%252BPotential%252BAgents%252Btowards%252BCandida%252BAlbicans%252B%25253A%252BDesign%25252C%252BSynthesis%252Band%252BBiological%252BEvaluation%26aulast%3DSui%26aufirst%3DYan%25E2%2580%2590Fei%26date%3D2021%26date%3D2021%26volume%3D16%26issue%3D11%26spage%3D1417%26epage%3D1429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rui  Yuan</span>, <span class="hlFld-ContribAuthor ">Jie  Tu</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>, <span class="hlFld-ContribAuthor ">Xi  Chen</span>, <span class="hlFld-ContribAuthor ">Na  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of Hsp90 Inhibitor Ganetespib on Inhibition of Azole-Resistant Candida albicans. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Microbiology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fmicb.2021.680382" title="DOI URL">https://doi.org/10.3389/fmicb.2021.680382</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmicb.2021.680382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmicb.2021.680382%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Microbiology%26atitle%3DEffects%252Bof%252BHsp90%252BInhibitor%252BGanetespib%252Bon%252BInhibition%252Bof%252BAzole-Resistant%252BCandida%252Balbicans%26aulast%3DYuan%26aufirst%3DRui%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arshdeep  Singh</span>, <span class="hlFld-ContribAuthor ">Ting-Yu  Chang</span>, <span class="hlFld-ContribAuthor ">Navdeep  Kaur</span>, <span class="hlFld-ContribAuthor ">Kai-Cheng  Hsu</span>, <span class="hlFld-ContribAuthor ">Yun  Yen</span>, <span class="hlFld-ContribAuthor ">Tony Eight  Lin</span>, <span class="hlFld-ContribAuthor ">Mei-Jung  Lai</span>, <span class="hlFld-ContribAuthor ">Sung-Bau  Lee</span>, <span class="hlFld-ContribAuthor ">Jing-Ping  Liou</span>. </span><span class="cited-content_cbyCitation_article-title">CAP rigidification of MS-275 and chidamide leads to enhanced antiproliferative effects mediated through HDAC1, 2 and tubulin polymerization inhibition. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>215 </em>, 113169. <a href="https://doi.org/10.1016/j.ejmech.2021.113169" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113169</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113169%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCAP%252Brigidification%252Bof%252BMS-275%252Band%252Bchidamide%252Bleads%252Bto%252Benhanced%252Bantiproliferative%252Beffects%252Bmediated%252Bthrough%252BHDAC1%25252C%252B2%252Band%252Btubulin%252Bpolymerization%252Binhibition%26aulast%3DSingh%26aufirst%3DArshdeep%26date%3D2021%26volume%3D215%26spage%3D113169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qinsheng  Sun</span>, <span class="hlFld-ContribAuthor ">Qiuzi  Dai</span>, <span class="hlFld-ContribAuthor ">Cunlong  Zhang</span>, <span class="hlFld-ContribAuthor ">Yan  Chen</span>, <span class="hlFld-ContribAuthor ">Lei  Zhao</span>, <span class="hlFld-ContribAuthor ">Zigao  Yuan</span>, <span class="hlFld-ContribAuthor ">Yuyang  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and antitumor evaluations of nucleoside base hydroxamic acid derivatives as DNMT and HDAC dual inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2021,</strong> <em>59 </em><a href="https://doi.org/10.1016/j.cclet.2021.02.004" title="DOI URL">https://doi.org/10.1016/j.cclet.2021.02.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2021.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2021.02.004%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bantitumor%252Bevaluations%252Bof%252Bnucleoside%252Bbase%252Bhydroxamic%252Bacid%252Bderivatives%252Bas%252BDNMT%252Band%252BHDAC%252Bdual%252Binhibitors%26aulast%3DSun%26aufirst%3DQinsheng%26date%3D2021%26volume%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yunfei  An</span>, <span class="hlFld-ContribAuthor ">Yue  Dong</span>, <span class="hlFld-ContribAuthor ">Min  Liu</span>, <span class="hlFld-ContribAuthor ">Jun  Han</span>, <span class="hlFld-ContribAuthor ">Liyu  Zhao</span>, <span class="hlFld-ContribAuthor ">Bin  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Novel naphthylamide derivatives as dual-target antifungal inhibitors: Design, synthesis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>210 </em>, 112991. <a href="https://doi.org/10.1016/j.ejmech.2020.112991" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112991</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112991%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bnaphthylamide%252Bderivatives%252Bas%252Bdual-target%252Bantifungal%252Binhibitors%25253A%252BDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%26aulast%3DAn%26aufirst%3DYunfei%26date%3D2021%26volume%3D210%26spage%3D112991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huanran  Sun</span>, <span class="hlFld-ContribAuthor ">Jiaqi  Song</span>, <span class="hlFld-ContribAuthor ">Mingming  Sun</span>, <span class="hlFld-ContribAuthor ">Changliang  Shan</span>. </span><span class="cited-content_cbyCitation_article-title">Histone deacetylase inhibitors (HDACi), the ongoing epigenetic agents to enhance chemotherapy sensitization. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 25-39. <a href="https://doi.org/10.1016/B978-0-12-823684-0.00014-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-823684-0.00014-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-823684-0.00014-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-823684-0.00014-1%26sid%3Dliteratum%253Aachs%26atitle%3DHistone%252Bdeacetylase%252Binhibitors%252B%252528HDACi%252529%25252C%252Bthe%252Bongoing%252Bepigenetic%252Bagents%252Bto%252Benhance%252Bchemotherapy%252Bsensitization%26aulast%3DSun%26aufirst%3DHuanran%26date%3D2021%26spage%3D25%26epage%3D39%26pub%3DElsevier%26atitle%3DEpigenetic%252BRegulation%252Bin%252BOvercoming%252BChemoresistance%26date%3D2021%26volume%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammad  Shafiei</span>, <span class="hlFld-ContribAuthor ">Lee  Peyton</span>, <span class="hlFld-ContribAuthor ">Mehrnoosh  Hashemzadeh</span>, <span class="hlFld-ContribAuthor ">Alireza  Foroumadi</span>. </span><span class="cited-content_cbyCitation_article-title">History of the development of antifungal azoles: A review on structures, SAR, and mechanism of action. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>104 </em>, 104240. <a href="https://doi.org/10.1016/j.bioorg.2020.104240" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104240</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104240%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DHistory%252Bof%252Bthe%252Bdevelopment%252Bof%252Bantifungal%252Bazoles%25253A%252BA%252Breview%252Bon%252Bstructures%25252C%252BSAR%25252C%252Band%252Bmechanism%252Bof%252Baction%26aulast%3DShafiei%26aufirst%3DMohammad%26date%3D2020%26volume%3D104%26spage%3D104240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/medium/jm0c00102_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00102&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/medium/jm0c00102_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design rationale of CYP51/HDAC dual inhibitors. (A) Chemical structures of azole antifungal agents; (B) chemical structure and binding mode of posaconazole (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5SFA">5SFA</a>); (C) design of CYP51/HDAC dual inhibitors by pharmacophore fusion.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00102&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/medium/jm0c00102_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00102&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 12 h, yield 75–83%; (b) (i) 4 M HCl in dioxane, anhydrous CH<sub>3</sub>OH, rt, 1 h; (ii) HCONHNH<sub>2</sub>, Et<sub>3</sub>N, CH<sub>3</sub>OH, rt, 18 h, yield 45–59%; (c) K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 12 h, yield 16–31%; (d) NH<sub>2</sub>OH·HCl, KOH, CH<sub>3</sub>OH, rt, 5 h, yield 73–84%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/medium/jm0c00102_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00102&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 2 h, yield 63–84%; (b) (i) 50% TFA in anhydrous CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h; (ii) K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 12 h; (iii) NH<sub>2</sub>OH·HCl, KOH, CH<sub>3</sub>OH, rt, 5 h, yield 30–55%.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/medium/jm0c00102_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00102&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) RNH<sub>2</sub>·HCl, Ti (<i>i</i>-propoxyl)<sub>4</sub>, Et<sub>3</sub>N, anhydrous CH<sub>3</sub>OH, rt, 12 h; (ii) NaBH<sub>4</sub>, rt, 30 min, yield 84–96%; (b) (i) K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 12 h; (ii) NH<sub>2</sub>OH·HCl, KOH, CH<sub>3</sub>OH, rt, 5 h, yield 34–56%.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/medium/jm0c00102_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Relative expression levels of azole-resistance related genes of <i>C. albicans</i> 0304103 after the treatment of FLC, compounds <b>12h</b> and <b>15j</b> at the concentration of 32 μg/mL for 16 h. Relative fold changes represent changes in the expression levels of the treated group as compared with the blank control. (B) Extracellular fluorescence intensity of Rh6G treated by compounds <b>12h</b>, <b>15j</b>, and FLC. These results were represented as the mean ± standard deviation using three dependent experiments. Statistical significance between groups was determined by Student’s <i>t</i>-test. ***<i>P</i> < 0.001, and ns represents no significant difference.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00102&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/medium/jm0c00102_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) DIC microscope photographs on filamentation of azole-resistant <i>C. albicans</i> 0304103. Compared to FLC, compounds <b>12h</b> and <b>15j</b> significantly inhibited the yeast-to-hypha morphological transition. (B) Biofilm formation (%) of <i>C. albicans</i> 0304103. Compounds <b>12h</b> and <b>15j</b> dose-dependently inhibited biofilm formation, and were stronger than FLC. (C) Expression levels of filamentation and biofilm formation-related genes relative to the blank control. Compounds <b>12h</b> (32 μg/mL) and <b>15j</b> (32 μg/mL) suppressed the expression of these genes. The latter two results were represented as the mean ± SD by three independent experiments. Statistical significance between groups was determined by Student’s <i>t</i>-test. *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00102&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/medium/jm0c00102_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <i>In vivo</i> therapeutic efficacies of compounds <b>12h</b> and <b>15j</b> against azole-resistant <i>C. albicans</i> 0304103 infectious murine model. (A) Fungal burden of the kidney tissue. Compounds <b>12h</b> and <b>15j</b> significantly reduced the amount of <i>C. albicans</i> in the kidney. The fungal burden of the kidney (log<sub>10</sub> cfu/g) was plotted as mean ± SD. Statistical significance between groups was determined by Student’s <i>t</i>-test. ***<i>P</i> < 0.001, ns represents no significant difference. (B) Renal histological studies using PAS staining (400×). Compounds <b>12h</b> and <b>15j</b> obviously alleviated the fungal infections and inhibited filamentation <i>in vivo</i>. (C) Survival curve of compounds <b>12h</b> and <b>15j</b> in the IC murine models. Compounds <b>12h</b> and <b>15j</b> significantly extended MST of the infected mice. Statistical significance between groups was determined by the log-rank test. ***<i>P</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00102/20200520/images/large/jm0c00102_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00102&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i87">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46510" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46510" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 73 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miceli, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Díaz, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. A.</span></span> <span> </span><span class="NLM_article-title">Emerging opportunistic yeast infections</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">142</span>– <span class="NLM_lpage">151</span>, <span class="refDoi"> DOI: 10.1016/s1473-3099(10)70218-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1016%2FS1473-3099%2810%2970218-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=21272794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A280%3ADC%252BC3M7kvFKhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=142-151&author=M.+H.+Miceliauthor=J.+A.+D%C3%ADazauthor=S.+A.+Lee&title=Emerging+opportunistic+yeast+infections&doi=10.1016%2Fs1473-3099%2810%2970218-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging opportunistic yeast infections</span></div><div class="casAuthors">Miceli Marisa H; Diaz Jose A; Lee Samuel A</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Infectious diseases</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">142-51</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A growing population of immunosuppressed patients has resulted in increasingly frequent diagnoses of invasive fungal infections, including those caused by unusual yeasts.  The incidence of non-albicans species of Candida is increasing compared with that of Candida albicans, and several species, such as Candida glabrata and Candida krusei, may be resistant to azole antifungal therapy.  Trichosporon species are the second most common cause of fungaemia in patients with haematological malignant disease and are characterised by resistance to amphotericin and echinocandins and poor prognosis.  Rhodotorula species belong to the family Cryptococcaceae, and are a cause of catheter-related fungaemia, sepsis, and invasive disease in severely immunosuppressed patients.  An increasing number of sporadic cases of invasive fungal infections by non-neoformans cryptococci have been reported in immunocompromised hosts, especially for patients with advanced HIV infection or cancer who are undergoing transplant.  Other uncommon yeasts that can cause invasive disease in severely immunosuppressed patients include Geotrichum, Hansenula, Malassezia, and Saccharomyces.  Host immune status is a crucial determinant of the type of invasive fungal infection a patient is at risk for.  Diagnosis can be challenging and relies heavily on traditional cultures of blood and other sterile sites, although serum (1,3)-β-D-glucan testing might have an adjunctive role.  Although rare yeasts are emerging as opportunistic human pathogens, diagnosis remains challenging and treatment suboptimal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSWAubP3dADd691pGlMMoT5fW6udTcc2eZut33_24l4b7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7kvFKhuw%253D%253D&md5=3a92de401da3daf5656338ad744bb102</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2810%2970218-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252810%252970218-8%26sid%3Dliteratum%253Aachs%26aulast%3DMiceli%26aufirst%3DM.%2BH.%26aulast%3DD%25C3%25ADaz%26aufirst%3DJ.%2BA.%26aulast%3DLee%26aufirst%3DS.%2BA.%26atitle%3DEmerging%2520opportunistic%2520yeast%2520infections%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2011%26volume%3D11%26spage%3D142%26epage%3D151%26doi%3D10.1016%2Fs1473-3099%2810%2970218-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denning, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levitz, S. M.</span></span> <span> </span><span class="NLM_article-title">Tackling human fungal infections</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>336</i></span>,  <span class="NLM_fpage">647</span>, <span class="refDoi"> DOI: 10.1126/science.1222236</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1126%2Fscience.1222236" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=22582229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvF2jtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2012&pages=647&author=G.+D.+Brownauthor=D.+W.+Denningauthor=S.+M.+Levitz&title=Tackling+human+fungal+infections&doi=10.1126%2Fscience.1222236"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Tackling human fungal infections</span></div><div class="casAuthors">Brown, Gordon D.; Denning, David W.; Levitz, Stuart M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">6082</span>),
    <span class="NLM_cas:pages">647</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEe-AdzM8oD7Vg90H21EOLACvtfcHk0liC1Ke-ztng3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvF2jtLc%253D&md5=ad0c19c925c3821e35a52717f1cb071e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.1222236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1222236%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DG.%2BD.%26aulast%3DDenning%26aufirst%3DD.%2BW.%26aulast%3DLevitz%26aufirst%3DS.%2BM.%26atitle%3DTackling%2520human%2520fungal%2520infections%26jtitle%3DScience%26date%3D2012%26volume%3D336%26spage%3D647%26doi%3D10.1126%2Fscience.1222236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Emerging new targets for the treatment of resistant fungal infections</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5484</span>– <span class="NLM_lpage">5511</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01413</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01413" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVWlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5484-5511&author=N.+Liuauthor=J.+Tuauthor=G.+Dongauthor=Y.+Wangauthor=C.+Sheng&title=Emerging+new+targets+for+the+treatment+of+resistant+fungal+infections&doi=10.1021%2Facs.jmedchem.7b01413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging New Targets for the Treatment of Resistant Fungal Infections</span></div><div class="casAuthors">Liu, Na; Tu, Jie; Dong, Guoqiang; Wang, Yan; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5484-5511</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  With the increasing morbidity and mortality of invasive fungal infections and the emergence of severe antifungal drug resistance, new drug targets and novel antifungal agents are urgently needed.  Recently, better understanding of fungal pathogenesis has contributed to the rapid emergence of potential antifungal drug targets.  This perspective aims to provide a comprehensive review of new antifungal targets and of medicinal chem. efforts toward inhibitor discovery.  Particular focus will be placed on the druggability of the targets and their potential to treat resistant fungal infections.  Innovative strategies for the next generation of antifungal therapy, such as virulence factors, protein-protein interactions, and immune response-based proteins, will also be highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOtRgloz2VI7Vg90H21EOLACvtfcHk0liC1Ke-ztng3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVWlsA%253D%253D&md5=ff2bf0c214005c9be04e3dfd8480d8da</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01413%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DTu%26aufirst%3DJ.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DEmerging%2520new%2520targets%2520for%2520the%2520treatment%2520of%2520resistant%2520fungal%2520infections%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5484%26epage%3D5511%26doi%3D10.1021%2Facs.jmedchem.7b01413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanglard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurr, S. J.</span></span> <span> </span><span class="NLM_article-title">Worldwide emergence of resistance to antifungal drugs challenges human health and food security</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>360</i></span>,  <span class="NLM_fpage">739</span>– <span class="NLM_lpage">742</span>, <span class="refDoi"> DOI: 10.1126/science.aap7999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1126%2Fscience.aap7999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=29773744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsVCgsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2018&pages=739-742&author=M.+C.+Fisherauthor=N.+J.+Hawkinsauthor=D.+Sanglardauthor=S.+J.+Gurr&title=Worldwide+emergence+of+resistance+to+antifungal+drugs+challenges+human+health+and+food+security&doi=10.1126%2Fscience.aap7999"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Worldwide emergence of resistance to antifungal drugs challenges human health and food security</span></div><div class="casAuthors">Fisher, Matthew C.; Hawkins, Nichola J.; Sanglard, Dominique; Gurr, Sarah J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue">6390</span>),
    <span class="NLM_cas:pages">739-742</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The recent rate of emergence of pathogenic fungi that are resistant to the limited no. of commonly used antifungal agents is unprecedented.  The azoles, for example, are used not only for human and animal health care and crop protection but also in antifouling coatings and timber preservation.  The ubiquity and multiple uses of azoles have hastened the independent evolution of resistance in many environments.  One consequence is an increasing risk in human health care from naturally occurring opportunistic fungal pathogens that have acquired resistance to this broad class of chems.  To avoid a global collapse in our ability to control fungal infections and to avoid crit. failures in medicine and food security, we must improve our stewardship of extant chems., promote new antifungal discovery, and leverage emerging technologies for alternative solns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolE2CwqdzBv7Vg90H21EOLACvtfcHk0ljNYLKHzsWGSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsVCgsbg%253D&md5=8add9de472138d5aca677fa3585ddd72</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.aap7999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aap7999%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DM.%2BC.%26aulast%3DHawkins%26aufirst%3DN.%2BJ.%26aulast%3DSanglard%26aufirst%3DD.%26aulast%3DGurr%26aufirst%3DS.%2BJ.%26atitle%3DWorldwide%2520emergence%2520of%2520resistance%2520to%2520antifungal%2520drugs%2520challenges%2520human%2520health%2520and%2520food%2520security%26jtitle%3DScience%26date%3D2018%26volume%3D360%26spage%3D739%26epage%3D742%26doi%3D10.1126%2Fscience.aap7999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perfect, J. R.</span></span> <span> </span><span class="NLM_article-title">The antifungal pipeline: a reality check</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">603</span>– <span class="NLM_lpage">616</span>, <span class="refDoi"> DOI: 10.1038/nrd.2017.46</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1038%2Fnrd.2017.46" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=28496146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC2sXns1Kisrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=603-616&author=J.+R.+Perfect&title=The+antifungal+pipeline%3A+a+reality+check&doi=10.1038%2Fnrd.2017.46"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The antifungal pipeline: a reality check</span></div><div class="casAuthors">Perfect, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">603-616</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Invasive fungal infections continue to appear in record nos. as the immunocompromised population of the world increases, owing partially to the increased no. of individuals who are infected with HIV and partially to the successful treatment of serious underlying diseases.  The effectiveness of current antifungal therapies - polyenes, flucytosine, azoles and echinocandins (as monotherapies or in combinations for prophylaxis, or as empiric, pre-emptive or specific therapies) - in the management of these infections has plateaued.  Although these drugs are clin. useful, they have several limitations, such as off-target toxicity, and drug-resistant fungi are now emerging.  New antifungals are therefore needed.  In this Review, I discuss the robust and dynamic antifungal pipeline, including results from preclin. academic efforts through to pharmaceutical industry products, and describe the targets, strategies, compds. and potential outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMkSYe01GMwLVg90H21EOLACvtfcHk0ljNYLKHzsWGSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXns1Kisrs%253D&md5=1c6fcc06db9dd97c562c0f17b1441c8d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2017.46&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2017.46%26sid%3Dliteratum%253Aachs%26aulast%3DPerfect%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520antifungal%2520pipeline%253A%2520a%2520reality%2520check%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D603%26epage%3D616%26doi%3D10.1038%2Fnrd.2017.46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denning, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gow, N. A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levitz, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netea, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, T. C.</span></span> <span> </span><span class="NLM_article-title">Hidden killers: human fungal infections</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">165rv13</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3004404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1126%2Fscitranslmed.3004404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=23253612" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=165rv13&author=G.+D.+Brownauthor=D.+W.+Denningauthor=N.+A.+R.+Gowauthor=S.+M.+Levitzauthor=M.+G.+Neteaauthor=T.+C.+White&title=Hidden+killers%3A+human+fungal+infections&doi=10.1126%2Fscitranslmed.3004404"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3004404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3004404%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DG.%2BD.%26aulast%3DDenning%26aufirst%3DD.%2BW.%26aulast%3DGow%26aufirst%3DN.%2BA.%2BR.%26aulast%3DLevitz%26aufirst%3DS.%2BM.%26aulast%3DNetea%26aufirst%3DM.%2BG.%26aulast%3DWhite%26aufirst%3DT.%2BC.%26atitle%3DHidden%2520killers%253A%2520human%2520fungal%2520infections%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D165rv13%26doi%3D10.1126%2Fscitranslmed.3004404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lien, M.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, C.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, S.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, M.-W.</span></span> <span> </span><span class="NLM_article-title">Epidemiology and risk factors for invasive fungal infections during induction chemotherapy for newly diagnosed acute myeloid leukemia: A retrospective cohort study</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>, <span class="NLM_elocation-id">e0197851</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0197851</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1371%2Fjournal.pone.0197851" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=29883443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVOmsr7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&author=M.-Y.+Lienauthor=C.-H.+Chouauthor=C.-C.+Linauthor=L.-Y.+Baiauthor=C.-F.+Chiuauthor=S.-P.+Yehauthor=M.-W.+Ho&title=Epidemiology+and+risk+factors+for+invasive+fungal+infections+during+induction+chemotherapy+for+newly+diagnosed+acute+myeloid+leukemia%3A+A+retrospective+cohort+study&doi=10.1371%2Fjournal.pone.0197851"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Epidemiology and risk factors for invasive fungal infections during induction chemotherapy for newly diagnosed acute myeloid leukemia: a retrospective cohort study</span></div><div class="casAuthors">Lien, Ming-Yu; Chou, Chia-Hui; Lin, Ching-Chan; Bai, Li-Yuan; Chiu, Chang-Fang; Yeh, Su-Peng; Ho, Mao-Wang</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e0197851/1-e0197851/11</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">This study investigated the epidemiol. and risk factors assocd. with invasive fungal infections (IFIs) during induction chemotherapy in a cohort of Taiwanese patients with newly-diagnosed acute myeloid leukemia (AML).  IFIs are a significant complication in the management of immunocompromised cancer patients; such infections are assocd. with a high incidence of morbidity and mortality, particularly in many South-Asian countries, where IFI rates are increasing.  We retrospectively analyzed IFI incidence data from 105 patients with newly diagnosed AML at a single center undergoing their first course of induction chemotherapy without primary antifungal prophylaxis between Nov. 2008 and Dec. 2014.  Of 21 cases documented as proven/provable IFIs 16 (76%) were invasive aspergillosis, 2 (10%) were mucormycosis infections, and 3 (14%) were proven yeast infections.  The lung was the most commonly affected site (n = 16; 76%); 2 patients (10%) developed fungal sinusitis.  IFI cases were more often males (P = 0.020).  In multivariate anal., patients with neutropenia lasting >30 days were more than twice as likely to develop IFI (OR, 2.24 [95% CI, 2.81-31.11], P<0.001).  We also confirmed patients with smoker and receiving parenteral nutrition during chemotherapy were significant assocd. with IFIs.  Our findings suggest that antifungal prophylaxis should be considered for patients with AML during induction chemotherapy, particularly in patients from Southeastern Asia, an area of potentially high IFI rates.  We recommend that clinicians det. which patients receiving induction chemotherapy for AML are at high risk of developing IFI, to allow for targeted therapeutic prophylaxis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2iw5KeqRuobVg90H21EOLACvtfcHk0ljNYLKHzsWGSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVOmsr7K&md5=162afec989576580df80dcc6e78544ab</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0197851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0197851%26sid%3Dliteratum%253Aachs%26aulast%3DLien%26aufirst%3DM.-Y.%26aulast%3DChou%26aufirst%3DC.-H.%26aulast%3DLin%26aufirst%3DC.-C.%26aulast%3DBai%26aufirst%3DL.-Y.%26aulast%3DChiu%26aufirst%3DC.-F.%26aulast%3DYeh%26aufirst%3DS.-P.%26aulast%3DHo%26aufirst%3DM.-W.%26atitle%3DEpidemiology%2520and%2520risk%2520factors%2520for%2520invasive%2520fungal%2520infections%2520during%2520induction%2520chemotherapy%2520for%2520newly%2520diagnosed%2520acute%2520myeloid%2520leukemia%253A%2520A%2520retrospective%2520cohort%2520study%26jtitle%3DPLoS%2520One%26date%3D2018%26volume%3D13%26doi%3D10.1371%2Fjournal.pone.0197851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Enoch, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aliyu, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micallef, C.</span></span> <span> </span><span class="NLM_article-title">The changing epidemiology of invasive fungal infections</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1508</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1007/978-1-4939-6515-1_2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1007%2F978-1-4939-6515-1_2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=27837497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktFOqtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1508&publication_year=2017&pages=17-65&author=D.+A.+Enochauthor=H.+Yangauthor=S.+H.+Aliyuauthor=C.+Micallef&title=The+changing+epidemiology+of+invasive+fungal+infections&doi=10.1007%2F978-1-4939-6515-1_2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The changing epidemiology of invasive fungal infections</span></div><div class="casAuthors">Enoch, David A.; Yang, Huina; Aliyu, Sani H.; Micallef, Christianne</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1508</span>
        (<span class="NLM_cas:issue">Human Fungal Pathogen Identification</span>),
    <span class="NLM_cas:pages">17-65</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Invasive fungal infections (IFI) are an emerging problem worldwide with invasive candidiasis and candidemia responsible for the majority of cases.  This is predominantly driven by the widespread adoption of aggressive immunosuppressive therapy among certain patient populations (e.g., chemotherapy, transplants) and the increasing use of invasive devices such as central venous catheters (CVCs).  The use of new immune modifying drugs has also opened up an entirely new spectrum of patients at risk of IFIs.  While the epidemiol. of candida infections has changed in the last decade, with a gradual shift from C. albicans to non-albicans candida (NAC) strains which may be less susceptible to azoles, these changes vary between hospitals and regions depending on the type of population risk factors and antifungal use.  In certain parts of the world, the incidence of IFI is strongly linked to the prevalence of other disease conditions and the ecol. niche for the organism; for instance cryptococcal and pneumocystis infections are particularly common in areas with a high prevalence of HIV disease.  Poorly controlled diabetes is a major risk factor for invasive mold infections.  Environmental factors and trauma also play a unique role in the epidemiol. of mold infections, with well-described hospital outbreaks linked to the use of contaminated instruments and devices.  Blastomycosis is assocd. with occupational exposure (e.g., forest rangers) and recreational activities (e.g., camping and fishing).  The true burden of IFI is probably an underestimate because of the absence of reliable diagnostics and lack of universal application.  For example, the sensitivity of most blood culture systems for detecting candida is typically 50 %.  The advent of new technol. including mol. techniques such as 18S rRNA PCR and genome sequencing is leading to an improved understanding of the epidemiol. of the less common mold and dimorphic fungal infections.  Mol. techniques are also providing a platform for improved diagnosis and management of IFI.  Many factors affect mortality in IFI, not least the underlying medical condition, choice of therapy, and the ability to achieve early source control.  For instance, mortality due to pneumocystis pneumonia in HIV-seroneg. individuals is now higher than in seropos. patients.  Of significant concern is the progressive increase in resistance to azoles and echinocandins among candida isolates, which appears to worsen the already significant mortality assocd. with invasive candidiasis.  Mortality with mold infections approaches 50 % in most studies and varies depending on the site, underlying disease and the use of antifungal agents such as echinocandins and voriconazole.  Nevertheless, mortality for most IFIs has generally fallen with advances in medical technol., improved care of CVCs, improved diagnostics, and more effective preemptive therapy and prophylaxis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGVxF8Tly92bVg90H21EOLACvtfcHk0liZYVGCQWjUeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktFOqtL0%253D&md5=f6e93ef28407981b84ce13bdbee5c4a8</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-6515-1_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-6515-1_2%26sid%3Dliteratum%253Aachs%26aulast%3DEnoch%26aufirst%3DD.%2BA.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DAliyu%26aufirst%3DS.%2BH.%26aulast%3DMicallef%26aufirst%3DC.%26atitle%3DThe%2520changing%2520epidemiology%2520of%2520invasive%2520fungal%2520infections%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2017%26volume%3D1508%26spage%3D17%26epage%3D65%26doi%3D10.1007%2F978-1-4939-6515-1_2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cowen, L. E.</span></span> <span> </span><span class="NLM_article-title">The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">198</span>, <span class="refDoi"> DOI: 10.1038/nrmicro1835</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1038%2Fnrmicro1835" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=18246082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvFCgt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=187-198&author=L.+E.+Cowen&title=The+evolution+of+fungal+drug+resistance%3A+modulating+the+trajectory+from+genotype+to+phenotype&doi=10.1038%2Fnrmicro1835"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype</span></div><div class="casAuthors">Cowen, Leah E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">187-198</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Leah Cowen reviews the mechanisms that potentiate the evolution of fungal drug resistance, with an emphasis on the central role of the mol. chaperone heat shock protein 90 (Hsp90) in altering the relationship between genotype and phenotype in an environmentally contingent manner, which thereby 'sculpts' the course of evolution.  The emergence of drug resistance in pathogenic microorganisms provides an excellent example of microbial evolution that has had profound consequences for human health.  The widespread use of antimicrobial agents in medicine and agriculture exerts strong selection for the evolution of drug resistance.  Selection acts on the phenotypic consequences of resistance mutations, which are influenced by the genetic variation in particular genomes.  Recent studies have revealed a mechanism by which the mol. chaperone heat shock protein 90 (Hsp90) can alter the relationship between genotype and phenotype in an environmentally contingent manner, thereby 'sculpting' the course of evolution.  Harnessing Hsp90 holds great promise for treating life-threatening infectious diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSI9Z1MVuUILVg90H21EOLACvtfcHk0liZYVGCQWjUeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvFCgt7k%253D&md5=e55ad31b236ffc2ea0a9aa427b53b006</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro1835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro1835%26sid%3Dliteratum%253Aachs%26aulast%3DCowen%26aufirst%3DL.%2BE.%26atitle%3DThe%2520evolution%2520of%2520fungal%2520drug%2520resistance%253A%2520modulating%2520the%2520trajectory%2520from%2520genotype%2520to%2520phenotype%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2008%26volume%3D6%26spage%3D187%26epage%3D198%26doi%3D10.1038%2Fnrmicro1835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kontoyiannis, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornely, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perfect, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, T. J.</span></span> <span> </span><span class="NLM_article-title">Novel agents and drug targets to meet the challenges of resistant fungi</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>216</i></span>,  <span class="NLM_fpage">S474</span>– <span class="NLM_lpage">S483</span>, <span class="refDoi"> DOI: 10.1093/infdis/jix130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1093%2Finfdis%2Fjix130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=28911042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFOkt73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=216&publication_year=2017&pages=S474-S483&author=M.+W.+McCarthyauthor=D.+P.+Kontoyiannisauthor=O.+A.+Cornelyauthor=J.+R.+Perfectauthor=T.+J.+Walsh&title=Novel+agents+and+drug+targets+to+meet+the+challenges+of+resistant+fungi&doi=10.1093%2Finfdis%2Fjix130"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Novel agents and drug targets to meet the challenges of resistant fungi</span></div><div class="casAuthors">McCarthy, Matthew W.; Kontoyiannis, Dimitrios P.; Cornely, Oliver A.; Perfect, John R.; Walsh, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">216</span>
        (<span class="NLM_cas:issue">Suppl. 3</span>),
    <span class="NLM_cas:pages">S474-S483</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">1537-6613</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The emergence of drug-resistant fungi poses a major threat to human health.  Despite advances in preventive, diagnostic, and therapeutic interventions, resistant fungal infections continue to cause significant morbidity and mortality in patients with compromised immunity, underscoring the urgent need for new antifungal agents.  In this article, we review the challenges assocd. with identifying broad-spectrum antifungal drugs and highlight novel targets that could enhance the armamentarium of agents available to treat drug-resistant invasive fungal infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs9Wx_NnqsFLVg90H21EOLACvtfcHk0liZYVGCQWjUeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFOkt73E&md5=8f772a238efdb03473a7acf8a285eb8e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2Fjix130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252Fjix130%26sid%3Dliteratum%253Aachs%26aulast%3DMcCarthy%26aufirst%3DM.%2BW.%26aulast%3DKontoyiannis%26aufirst%3DD.%2BP.%26aulast%3DCornely%26aufirst%3DO.%2BA.%26aulast%3DPerfect%26aufirst%3DJ.%2BR.%26aulast%3DWalsh%26aufirst%3DT.%2BJ.%26atitle%3DNovel%2520agents%2520and%2520drug%2520targets%2520to%2520meet%2520the%2520challenges%2520of%2520resistant%2520fungi%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2017%26volume%3D216%26spage%3DS474%26epage%3DS483%26doi%3D10.1093%2Finfdis%2Fjix130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hospital, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Z.</span></span> <span> </span><span class="NLM_article-title">Invasive candidiasis in intensive care units in China: in vitro antifungal susceptibility in the China-SCAN study</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">162</span>– <span class="NLM_lpage">167</span>, <span class="refDoi"> DOI: 10.1093/jac/dkt330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1093%2Fjac%2Fdkt330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=24004860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFegtrfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2014&pages=162-167&author=W.+Liuauthor=J.+Tanauthor=J.+Sunauthor=Z.+Xuauthor=M.+Liauthor=Q.+Yangauthor=H.+Shaoauthor=L.+Zhangauthor=W.+Liuauthor=Z.+Wanauthor=W.+Cuiauthor=B.+Zangauthor=D.+Jiangauthor=Q.+Fangauthor=B.+Qinauthor=T.+Qinauthor=W.+Liauthor=F.+Guoauthor=D.+Liuauthor=X.+Guanauthor=K.+Yuauthor=H.+Qiuauthor=R.+Liauthor=J.+Jinauthor=Y.+Zhanauthor=X.+Qianauthor=L.+Liuauthor=X.+Zhuauthor=D.+Wangauthor=X.+Liangauthor=Y.+Feiauthor=H.+Luauthor=B.+Maauthor=D.+Zhuauthor=B.+Huauthor=J.+Linauthor=B.+Yangauthor=M.+Liauthor=C.+Dingauthor=Y.+Qinauthor=Y.+Fengauthor=H.+Zhaoauthor=S.+Zhuauthor=Q.+Caoauthor=S.+Zhouauthor=Y.+Meiauthor=X.+Zhaoauthor=Z.+Tangauthor=H.+Liangauthor=J.+Zhuauthor=Y.+Shiauthor=Y.+Xuauthor=J.+Liuauthor=L.+Yaoauthor=X.+Yangauthor=W.+Jiaauthor=R.+Zhengauthor=X.+Zhuauthor=Y.+Xuauthor=X.+Luauthor=M.+Zhaoauthor=J.+Luauthor=X.+Guanauthor=K.+Liaoauthor=D.+Wuauthor=E.+Sunauthor=X.+Linauthor=T.+Zhouauthor=J.+Xingauthor=P.+Liuauthor=D.+Chenauthor=H.+Wangauthor=X.+Wangauthor=Q.+Shiauthor=Y.+Aiauthor=M.+Zouauthor=J.+Zhouauthor=M.+Tangauthor=Q.+Songauthor=D.+Shenauthor=W.+Guoauthor=J.+Liauthor=Q.+Guoauthor=C.+Qianauthor=X.+Fengauthor=X.+Wanauthor=J.+Zhangauthor=Z.+Huauthor=J.+Zhangauthor=Y.+Wangauthor=J.+Zhangauthor=J.+Yanauthor=L.+Zhouauthor=X.+Yuauthor=P.+Jiauthor=J.+Xiongauthor=L.+Zhangauthor=Y.+Yinauthor=H.+Liuauthor=S.+Yuanauthor=J.+Zengauthor=S.+Liauthor=L.+Liauthor=J.+Yanauthor=Z.+Xiaoauthor=Z.+Hospitalauthor=C.+Wangauthor=Y.+Wangauthor=R.+Sunauthor=M.+Xuauthor=Z.+Wan&title=Invasive+candidiasis+in+intensive+care+units+in+China%3A+in+vitro+antifungal+susceptibility+in+the+China-SCAN+study&doi=10.1093%2Fjac%2Fdkt330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Invasive candidiasis in intensive care units in China: in vitro antifungal susceptibility in the China-SCAN study</span></div><div class="casAuthors">Liu, Wei; Tan, Jingwen; Sun, Jimei; Xu, Zhijiang; Li, Min; Yang, Qing; Shao, Haifeng; Zhang, Liyan; Liu, Weixia; Wan, Zhe; Cui, Wei; Zang, Bin; Jiang, Dongpo; Fang, Qiang; Qin, Bingyu; Qin, Tiehe; Li, Weiqin; Guo, Fengmei; Liu, Dawei; Guan, Xiandong; Yu, Kaijiang; Qiu, Haibo; Li, Ruoyu; Jin, Jun; Zhan, Ying; Qian, Xuefeng; Liu, Lijun; Zhu, Xueming; Wang, Difen; Liang, Xianquan; Fei, Ying; Lu, Huixia; Ma, Bing; Zhu, Duming; Hu, Bijie; Lin, Jiandong; Yang, Bin; Li, Maoqin; Ding, Chen; Qin, Yingzhi; Feng, Yongwang; Zhao, Hongsheng; Zhu, Shaopeng; Cao, Quan; Zhou, Suming; Mei, Yaning; Zhao, Xiaoqin; Tang, Zhanhong; Liang, Hongjie; Zhu, Jianhuan; Shi, Yingjiao; Xu, Yingchun; Liu, Jian; Yao, Liqiong; Yang, Xiaojun; Jia, Wei; Zheng, Ruiqiang; Zhu, Xiaoping; Xu, Yuan; Lu, Xinxin; Zhao, Mingyan; Lu, Juan; Guan, Xiangdong; Liao, Kang; Wu, Dawei; Sun, Enhua; Lin, Xifang; Zhou, Tieli; Xing, Jinyan; Liu, Pengpeng; Chen, Dechang; Wang, Hu; Wang, Xue; Shi, Qindong; Ai, Yuhang; Zou, Mingxiang; Zhou, Jianxin; Tang, Mingzhong; Song, Qing; Shen, Dingxia; Guo, Weiyuan; Li, Jianguo; Guo, Qinglian; Qian, Chuanyun; Feng, Xia; Wan, Xianyao; Zhang, Jiuzhi; Hu, Zhenjie; Zhang, Jinyan; Wang, Yongqiang; Zhang, Jianlei; Yan, Jie; Zhou, Lizhen; Yu, Xiangyou; Ji, Ping; Xiong, Jianqiong; Zhang, Lei; Yin, Yongjie; Liu, Haibo; Yuan, Shiying; Zeng, Ji; Li, Shusheng; Li, Li; Yan, Jing; Xiao, Zhen; Hospital, Zhejiang; Wang, Chunting; Wang, Yong; Sun, Rongqing; Xu, Min; Wan, Zhe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">162-167</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The objectives of this study were to det. species distribution and in vitro antifungal susceptibility of Candida isolates identified in the multicenter China-SCAN study of invasive Candida infection (ICI) in intensive care units (ICUs) across China.  Candida isolates from patients in the China-SCAN study with documented ICI were evaluated by a central lab.  Species were identified using chromogenic culture media or the API 20C AUX kit.  Susceptibility to fluconazole, voriconazole, itraconazole, caspofungin and amphotericin B was detd. using the CLSI broth microdilution method (M27-A3) and updated clin. breakpoints or epidemiol. cut-off values.  Some 389 isolates from 244 patients were analyzed.  The species identified most frequently were Candida albicans (40.1%), Candida parapsilosis (21.3%), Candida tropicalis (17.2%) and Candida glabrata (12.9%).  Rarer species such as Lodderomyces elongisporus and Candida ernobii were also identified.  Fluconazole susceptibility was evident in 85.9% (134/156) of C. albicans, 62.7% (42/67) of C. tropicalis and 48.2% (40/83) of C. parapsilosis isolates.  Susceptibility to voriconazole was ≥90% among all species.  All isolates were susceptible to amphotericin B and caspofungin except C. glabrata [86.0% (43/50) susceptible to caspofungin].  Cross-resistance between fluconazole and voriconazole was obsd. for C. parapsilosis and C. glabrata.  Conclusions Although C. albicans was the predominant single species, non-albicans species constituted >50% of isolates.  Fluconazole susceptibility was lower in most non-albicans species, indicating that fluconazole resistance should be closely monitored.  Susceptibility to voriconazole, amphotericin B and caspofungin is encouraging.  Differences between these data and those from other regions emphasize the importance of assessing regional variations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA7yZ51ezBk7Vg90H21EOLACvtfcHk0lg-1Ntprwbt5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFegtrfN&md5=601e62068a8a49bdbb95e5f601c2b525</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkt330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkt330%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DShao%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DWan%26aufirst%3DZ.%26aulast%3DCui%26aufirst%3DW.%26aulast%3DZang%26aufirst%3DB.%26aulast%3DJiang%26aufirst%3DD.%26aulast%3DFang%26aufirst%3DQ.%26aulast%3DQin%26aufirst%3DB.%26aulast%3DQin%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DGuan%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DQiu%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DZhan%26aufirst%3DY.%26aulast%3DQian%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DFei%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DMa%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DDing%26aufirst%3DC.%26aulast%3DQin%26aufirst%3DY.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DCao%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DMei%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DTang%26aufirst%3DZ.%26aulast%3DLiang%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DJia%26aufirst%3DW.%26aulast%3DZheng%26aufirst%3DR.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DGuan%26aufirst%3DX.%26aulast%3DLiao%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DXing%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DAi%26aufirst%3DY.%26aulast%3DZou%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DM.%26aulast%3DSong%26aufirst%3DQ.%26aulast%3DShen%26aufirst%3DD.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DQ.%26aulast%3DQian%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DWan%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DJi%26aufirst%3DP.%26aulast%3DXiong%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DYin%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DYuan%26aufirst%3DS.%26aulast%3DZeng%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DHospital%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DR.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DZ.%26atitle%3DInvasive%2520candidiasis%2520in%2520intensive%2520care%2520units%2520in%2520China%253A%2520in%2520vitro%2520antifungal%2520susceptibility%2520in%2520the%2520China-SCAN%2520study%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2014%26volume%3D69%26spage%3D162%26epage%3D167%26doi%3D10.1093%2Fjac%2Fdkt330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Novel carboline derivatives as potent antifungal lead compounds: design, synthesis, and biological evaluation</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">506</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1021/ml400492t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400492t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFKht7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=506-511&author=S.+Wangauthor=Y.+Wangauthor=W.+Liuauthor=N.+Liuauthor=Y.+Zhangauthor=G.+Dongauthor=Y.+Liuauthor=Z.+Liauthor=X.+Heauthor=Z.+Miaoauthor=J.+Yaoauthor=J.+Liauthor=W.+Zhangauthor=C.+Sheng&title=Novel+carboline+derivatives+as+potent+antifungal+lead+compounds%3A+design%2C+synthesis%2C+and+biological+evaluation&doi=10.1021%2Fml400492t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Carboline Derivatives as Potent Antifungal Lead Compounds: Design, Synthesis, and Biological Evaluation</span></div><div class="casAuthors">Wang, Shengzheng; Wang, Yan; Liu, Wei; Liu, Na; Zhang, Yongqiang; Dong, Guoqiang; Liu, Yang; Li, Zhengang; He, Xiaomeng; Miao, Zhenyuan; Yao, Jianzhong; Li, Jian; Zhang, Wannian; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">506-511</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of novel antifungal carboline derivs. was designed and synthesized, which showed broad-spectrum antifungal activity.  Particularly, compd. I showed comparable in vitro antifungal activity to fluconazole without toxicity to human embryonic lung cells.  It also exhibited good fungicidal activity against both fluconazole-sensitive and -resistant Candida albicans cells and had potent inhibition activity against Candida albicans biofilm formation and hyphal growth.  Moreover, I showed good synergistic antifungal activity in combination with fluconazole (FLC) against FLC-resistant Candida species.  Preliminary mechanism studies revealed that C38 might act by inhibiting the synthesis of fungal cell wall.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEnSU799VTv7Vg90H21EOLACvtfcHk0ljIzNFFPb3jkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFKht7s%253D&md5=65a16ae4999bc93c952dcf06299dabf9</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fml400492t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400492t%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DNovel%2520carboline%2520derivatives%2520as%2520potent%2520antifungal%2520lead%2520compounds%253A%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D506%26epage%3D511%26doi%3D10.1021%2Fml400492t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Canuto, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodero, F. G.</span></span> <span> </span><span class="NLM_article-title">Antifungal drug resistance to azoles and polyenes</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">550</span>– <span class="NLM_lpage">563</span>, <span class="refDoi"> DOI: 10.1016/s1473-3099(02)00371-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1016%2FS1473-3099%2802%2900371-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=12206971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsFOjtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=550-563&author=M.+M.+Canutoauthor=F.+G.+Rodero&title=Antifungal+drug+resistance+to+azoles+and+polyenes&doi=10.1016%2Fs1473-3099%2802%2900371-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Antifungal drug resistance to azoles and polyenes</span></div><div class="casAuthors">Canuto, Mar Masia; Rodero, Felix Gutierrez</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Infectious Diseases</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">550-563</span>CODEN:
                <span class="NLM_cas:coden">LIDABP</span>;
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    
            (<span class="NLM_cas:orgname">Lancet Publishing Group</span>)
        </div><div class="casAbstract">A review.  There is an increased awareness of the morbidity and mortality assocd. with fungal infections caused by resistant fungi in various groups of patients.  Epidemiol. studies have identified risk factors assocd. with antifungal drug resistance.  Selection pressure due to the continuous exposure to azoles seems to have an essential role in developing resistance to fluconazole in Candida species.  Hematol. malignancies, esp. acute leukemia with severe and prolonged neutropenia, seem to be the main risk factors for acquiring deep-seated mycosis caused by resistant filamentous fungi, such us Fusarium species, Scedosporium prolificans, and Aspergillus terreus.  The still unacceptably high mortality rate assocd. with some resistant mycosis indicates that alternatives to existing therapeutic options are needed.  Potential measures to overcome antifungal resistance ranges from the development of new drugs with better antifungal activity to improving current therapeutic, strategies with the present antifungal agents.  Among the new antifungal drugs, inhibitors of beta glucan synthesis and second-generation azole and triazole derivs. have characteristics that render them potentially suitable agents against some resistant fungi.  Other strategies including the use of high doses of lipid formulations of amphotericin B, combination therapy, and adjunctive immune therapy with cytokines are under investigation.  In addn., antifungal control programs to prevent extensive and inappropriate use of antifungals may be needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopFYGU6XdLGbVg90H21EOLACvtfcHk0ljIzNFFPb3jkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsFOjtbk%253D&md5=8ae11e7fd0b420a48e1b35c833c4d27c</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2802%2900371-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252802%252900371-7%26sid%3Dliteratum%253Aachs%26aulast%3DCanuto%26aufirst%3DM.%2BM.%26aulast%3DRodero%26aufirst%3DF.%2BG.%26atitle%3DAntifungal%2520drug%2520resistance%2520to%2520azoles%2520and%2520polyenes%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2002%26volume%3D2%26spage%3D550%26epage%3D563%26doi%3D10.1016%2Fs1473-3099%2802%2900371-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, M.-J.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China</span>. <i>Res. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>166</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">161</span>, <span class="refDoi"> DOI: 10.1016/j.resmic.2015.02.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1016%2Fj.resmic.2015.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=25748216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktFOqur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2015&pages=153-161&author=J.-Y.+Liuauthor=C.+Shiauthor=Y.+Wangauthor=W.-J.+Liauthor=Y.+Zhaoauthor=M.-J.+Xiang&title=Mechanisms+of+azole+resistance+in+Candida+albicans+clinical+isolates+from+Shanghai%2C+China&doi=10.1016%2Fj.resmic.2015.02.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China</span></div><div class="casAuthors">Liu, Jin-Yan; Shi, Ce; Wang, Ying; Li, Wen-Jing; Zhao, Yue; Xiang, Ming-Jie</div><div class="citationInfo"><span class="NLM_cas:title">Research in Microbiology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">153-161</span>CODEN:
                <span class="NLM_cas:coden">RMCREW</span>;
        ISSN:<span class="NLM_cas:issn">0923-2508</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">This study was undertaken to characterize the mechanism(s) of azole resistance in clin. isolates of Candida albicans collected in Shanghai, China, focusing on the role of efflux pumps, target enzymes of fluconazole (Erg11), respiratory status and the ergosterol biosynthetic pathway.  Clin. isolates of C. albicans (n = 30) were collected from 30 different non-HIV-infected patients in four hospitals in Shanghai.  All 30 C. albicans isolates were susceptible to amphotericin B and 5-fluorocytosine.  Twelve C. albicans isolates showed resistance to at least one type of triazole antifungal.  Flow cytometry anal. of rhodamine 6G efflux showed that azole-resistant isolates had greater efflux pump activity, which was consistent with elevated levels of CDR1 and CDR2 genes that code for ABC efflux pumps.  However, we did not observe increased expression of ERG11 and MDR1 or respiratory deficiency.  Several mutations of ERG11 and TAC1 genes were detected.  The F964Y mutation in the TAC1 gene was identified for the first time.  Two main sterols, ergosterol and lanosterol, were identified by GC-MS chromatogram, and no missense mutations were found in ERG3.  Furthermore, seven amino acid substitutions in ERG11, A114S, Y132H, Y132F, K143Q, K143R, Y257H and G448E were found, by Type II spectral quant. anal., to contribute to low affinity binding between Erg11 and fluconazole.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtx1D6VffyWbVg90H21EOLACvtfcHk0ljIzNFFPb3jkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktFOqur8%253D&md5=f831d913d329fbf301c69d94ff1e8be6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.resmic.2015.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.resmic.2015.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.-Y.%26aulast%3DShi%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DW.-J.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DXiang%26aufirst%3DM.-J.%26atitle%3DMechanisms%2520of%2520azole%2520resistance%2520in%2520Candida%2520albicans%2520clinical%2520isolates%2520from%2520Shanghai%252C%2520China%26jtitle%3DRes.%2520Microbiol.%26date%3D2015%26volume%3D166%26spage%3D153%26epage%3D161%26doi%3D10.1016%2Fj.resmic.2015.02.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seto, E.</span></span> <span> </span><span class="NLM_article-title">The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">206</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1038/nrm2346</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1038%2Fnrm2346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=18292778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitlGnurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=206-218&author=X.-J.+Yangauthor=E.+Seto&title=The+Rpd3%2FHda1+family+of+lysine+deacetylases%3A+from+bacteria+and+yeast+to+mice+and+men&doi=10.1038%2Fnrm2346"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men</span></div><div class="casAuthors">Yang, Xiang-Jiao; Seto, Edward</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">206-218</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein lysine deacetylases have a pivotal role in numerous biol. processes and can be divided into the Rpd3/Hda1 and sirtuin families, each having members in diverse organisms including prokaryotes.  In vertebrates, the Rpd3/Hda1 family contains 11 members, traditionally referred to as histone deacetylases (HDAC) 1-11, which are further grouped into classes I, II and IV.  Whereas most class I HDACs are subunits of multiprotein nuclear complexes that are crucial for transcriptional repression and epigenetic landscaping, class II members regulate cytoplasmic processes or function as signal transducers that shuttle between the cytoplasm and the nucleus.  Little is known about class IV HDAC11, although its evolutionary conservation implies a fundamental role in various organisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRiVyZexxGn7Vg90H21EOLACvtfcHk0ljGvPIEKqqk-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitlGnurk%253D&md5=f11f89567feadf9cd38b3852dc44c382</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnrm2346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2346%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.-J.%26aulast%3DSeto%26aufirst%3DE.%26atitle%3DThe%2520Rpd3%252FHda1%2520family%2520of%2520lysine%2520deacetylases%253A%2520from%2520bacteria%2520and%2520yeast%2520to%2520mice%2520and%2520men%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2008%26volume%3D9%26spage%3D206%26epage%3D218%26doi%3D10.1038%2Fnrm2346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of janus kinase 2 (JAK2) and histone deacetylase (HDAC) dual inhibitors as a novel strategy for the combinational treatment of leukemia and invasive fungal infections</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6056</span>– <span class="NLM_lpage">6074</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00393</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00393" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Snu7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6056-6074&author=Y.+Huangauthor=G.+Dongauthor=H.+Liauthor=N.+Liuauthor=W.+Zhangauthor=C.+Sheng&title=Discovery+of+janus+kinase+2+%28JAK2%29+and+histone+deacetylase+%28HDAC%29+dual+inhibitors+as+a+novel+strategy+for+the+combinational+treatment+of+leukemia+and+invasive+fungal+infections&doi=10.1021%2Facs.jmedchem.8b00393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Janus Kinase 2 (JAK2) and Histone Deacetylase (HDAC) Dual Inhibitors as a Novel Strategy for the Combinational Treatment of Leukemia and Invasive Fungal Infections</span></div><div class="casAuthors">Huang, Yahui; Dong, Guoqiang; Li, Huanqiu; Liu, Na; Zhang, Wannian; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6056-6074</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Clin., leukemia patients often suffer from the limited efficacy of chemotherapy and high risks of infection by invasive fungal pathogens.  Herein, a novel therapeutic strategy was developed in which a small mol. can simultaneously treat leukemia and invasive fungal infections (IFIs).  Novel Janus kinase 2 (JAK2) and histone deacetylase (HDAC) dual inhibitors were identified to possess potent anti-proliferative activity toward hematol. cell lines and excellent synergistic effects with fluconazole to treat resistant Candida albicans infections.  In particular, compd. I, a highly active and selective JAK2/HDAC6 dual inhibitor, showed excellent in vivo antitumor efficacy in several acute myeloid leukemia (AML) models and synergized with fluconazole for the treatment of resistant C. albicans infections.  This study highlights the therapeutic potential of JAK2/HDAC dual inhibitors in treating AML and IFIs and provides an efficient strategy for multitargeting drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3_ii7EQG1qLVg90H21EOLACvtfcHk0ljGvPIEKqqk-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Snu7rN&md5=ba7cf74761120f0526ab520196e3dded</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00393%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520janus%2520kinase%25202%2520%2528JAK2%2529%2520and%2520histone%2520deacetylase%2520%2528HDAC%2529%2520dual%2520inhibitors%2520as%2520a%2520novel%2520strategy%2520for%2520the%2520combinational%2520treatment%2520of%2520leukemia%2520and%2520invasive%2520fungal%2520infections%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6056%26epage%3D6074%26doi%3D10.1021%2Facs.jmedchem.8b00393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Small molecule inhibitors simultaneously targeting cancer metabolism and epigenetics: discovery of novel nicotinamide phosphoribosyltransferase (NAMPT) and histone deacetylase (HDAC) dual inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7965</span>– <span class="NLM_lpage">7983</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00467</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00467" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVKhurrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7965-7983&author=G.+Dongauthor=W.+Chenauthor=X.+Wangauthor=X.+Yangauthor=T.+Xuauthor=P.+Wangauthor=W.+Zhangauthor=Y.+Raoauthor=C.+Miaoauthor=C.+Sheng&title=Small+molecule+inhibitors+simultaneously+targeting+cancer+metabolism+and+epigenetics%3A+discovery+of+novel+nicotinamide+phosphoribosyltransferase+%28NAMPT%29+and+histone+deacetylase+%28HDAC%29+dual+inhibitors&doi=10.1021%2Facs.jmedchem.7b00467"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Inhibitors Simultaneously Targeting Cancer Metabolism and Epigenetics: Discovery of Novel Nicotinamide Phosphoribosyltransferase (NAMPT) and Histone Deacetylase (HDAC) Dual Inhibitors</span></div><div class="casAuthors">Dong, Guoqiang; Chen, Wei; Wang, Xia; Yang, Xinglin; Xu, Tianying; Wang, Pei; Zhang, Wannian; Rao, Yu; Miao, Chaoyu; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7965-7983</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cancer metab. and epigenetics are among the most intensely pursued research areas in anticancer drug discovery.  Here we report the first small mols. that simultaneously inhibit nicotinamide phosphoribosyltransferase (NAMPT)and histone deacetylase (HDAC), two important targets of cancer metab. and epigenetics, resp.  Through iterative structure-based drug design, chem. synthesis, and biol. assays, a highly potent dual NAMPT and HDAC inhibitor was successfully identified.  Compd. 35 possessed excellent and balanced activities against both NAMPT (IC50 = 31 nM) and HDAC1 (IC50 = 55 nM).  It could effectively induce cell apoptosis and autophagy and ultimately led to cell death.  Importantly, compd. 35 showed excellent in vivo antitumor efficacy in the HCT116 xenograft model.  This proof-of-concept study demonstrates the feasibility of discovering an inhibitor targeting cancer metab. and epigenetics and provides an efficient strategy for multitarget antitumor drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9UvfGattu1rVg90H21EOLACvtfcHk0ljGvPIEKqqk-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVKhurrO&md5=65df0b485cbbc169886d34ae4421f814</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00467%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DRao%26aufirst%3DY.%26aulast%3DMiao%26aufirst%3DC.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DSmall%2520molecule%2520inhibitors%2520simultaneously%2520targeting%2520cancer%2520metabolism%2520and%2520epigenetics%253A%2520discovery%2520of%2520novel%2520nicotinamide%2520phosphoribosyltransferase%2520%2528NAMPT%2529%2520and%2520histone%2520deacetylase%2520%2528HDAC%2529%2520dual%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7965%26epage%3D7983%26doi%3D10.1021%2Facs.jmedchem.7b00467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowen, L. E.</span></span> <span> </span><span class="NLM_article-title">Lysine deacetylases Hda1 and Rpd3 regulate Hsp90 function thereby governing fungal drug resistance</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">878</span>– <span class="NLM_lpage">888</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2012.08.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1016%2Fj.celrep.2012.08.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=23041319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCls7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=878-888&author=N.+Robbinsauthor=M.+D.+Leachauthor=L.+E.+Cowen&title=Lysine+deacetylases+Hda1+and+Rpd3+regulate+Hsp90+function+thereby+governing+fungal+drug+resistance&doi=10.1016%2Fj.celrep.2012.08.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Lysine deacetylases Hda1 and Rpd3 regulate Hsp90 function thereby governing fungal drug resistance</span></div><div class="casAuthors">Robbins, Nicole; Leach, Michelle D.; Cowen, Leah E.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">878-888</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The mol. chaperone Hsp90 is a hub of protein homeostasis and regulatory circuitry.  Hsp90 function is regulated by posttranslational modifications including acetylation in mammals; however, whether this regulation is conserved remains unknown.  In fungi, Hsp90 governs the evolution of drug resistance by stabilizing signal transducers.  Here, we establish that pharmacol. inhibition of lysine deacetylases (KDACs) blocks the emergence and maintenance of Hsp90-dependent resistance to the most widely deployed antifungals, the azoles, in the human fungal pathogen Candida albicans and the model yeast Saccharomyces cerevisiae.  S. cerevisiae Hsp90 is acetylated on lysine 27 and 270, and key KDACs for drug resistance are Hda1 and Rpd3.  Compromising KDACs alters stability and function of Hsp90 client proteins, including the drug-resistance regulator calcineurin.  Thus, we establish acetylation as a mechanism of posttranslational control of Hsp90 function in fungi, functional redundancy between KDACs Hda1 and Rpd3, as well as a mechanism governing fungal drug resistance with broad therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooz_5th4Mi9LVg90H21EOLACvtfcHk0lhEj5X7tZOLqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCls7rI&md5=a83238283ab971d51f0c88224245f3a9</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2012.08.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2012.08.035%26sid%3Dliteratum%253Aachs%26aulast%3DRobbins%26aufirst%3DN.%26aulast%3DLeach%26aufirst%3DM.%2BD.%26aulast%3DCowen%26aufirst%3DL.%2BE.%26atitle%3DLysine%2520deacetylases%2520Hda1%2520and%2520Rpd3%2520regulate%2520Hsp90%2520function%2520thereby%2520governing%2520fungal%2520drug%2520resistance%26jtitle%3DCell%2520Rep.%26date%3D2012%26volume%3D2%26spage%3D878%26epage%3D888%26doi%3D10.1016%2Fj.celrep.2012.08.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edlind, T. D.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">3532</span>– <span class="NLM_lpage">3539</span>, <span class="refDoi"> DOI: 10.1128/aac.46.11.3532-3539.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1128%2FAAC.46.11.3532-3539.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=12384361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD38Xot1yktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2002&pages=3532-3539&author=W.+L.+Smithauthor=T.+D.+Edlind&title=Histone+deacetylase+inhibitors+enhance+Candida+albicans+sensitivity+to+azoles+and+related+antifungals%3A+correlation+with+reduction+in+CDR+and+ERG+upregulation&doi=10.1128%2Faac.46.11.3532-3539.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation</span></div><div class="casAuthors">Smith, W. Lamar; Edlind, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3532-3539</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Histone acetylation and deacetylation play important roles in eukaryotic gene regulation.  Several histone deacetylase (HDA) inhibitors have been characterized, including trichostatin A (TSA), apicidin, and sodium butyrate.  We tested their effects on Candida albicans in vitro growth, heat sensitivity, and germ tube formation; minimal effects were obsd.  However, there was a dramatic effect of TSA on C. albicans sensitivity to the azoles fluconazole, itraconazole, and miconazole.  Similar effects were obsd. with other HDA inhibitors and with the antifungals terbinafine and fenpropimorph, which target, as do azoles, enzymes in the ergosterol biosynthetic pathway.  In contrast, HDA inhibitors had minimal effect on the activities of amphotericin B, flucytosine, and echinocandin, which have unrelated targets.  Specifically, addn. of 3 μg of TSA/mL lowered the itraconazole MIC for five susceptible C. albicans isolates an av. of 2.7-fold at 24 h, but this increased to > 200-fold at 48 h.  Thus, the primary effect of TSA was a redn. in azole trailing.  TSA also enhanced itraconazole activity against Candida parapsilosis and Candida tropicalis but had no effect with four less related yeast species.  To examine the mol. basis for these effects, we studied expression of ERG genes (encoding azole and terbinafine targets) and CDR/MDR1 genes (encoding multidrug transporters) in C. albicans cells treated with fluconazole or terbinafine with or without TSA.  Both antifungals induced to various levels the expression of ERG1, ERG11, CDR1, and CDR2; addn. of TSA reduced this upregulation 50 to 100%.  This most likely explains the inhibition of azole and terbinafine trailing by TSA and, more generally, provides evidence that trailing is mediated by upregulation of target enzymes and multidrug transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4DpmS0neAOrVg90H21EOLACvtfcHk0lhEj5X7tZOLqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xot1yktbc%253D&md5=8a372cf4fcb9077cf8b92c21b37792bf</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2FAAC.46.11.3532-3539.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.46.11.3532-3539.2002%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DW.%2BL.%26aulast%3DEdlind%26aufirst%3DT.%2BD.%26atitle%3DHistone%2520deacetylase%2520inhibitors%2520enhance%2520Candida%2520albicans%2520sensitivity%2520to%2520azoles%2520and%2520related%2520antifungals%253A%2520correlation%2520with%2520reduction%2520in%2520CDR%2520and%2520ERG%2520upregulation%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2002%26volume%3D46%26spage%3D3532%26epage%3D3539%26doi%3D10.1128%2Faac.46.11.3532-3539.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kmetzsch, L.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylases: Targets for antifungal drug development</span>. <i>Virulence</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">535</span>– <span class="NLM_lpage">536</span>, <span class="refDoi"> DOI: 10.1080/21505594.2015.1049807</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1080%2F21505594.2015.1049807" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=26151486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlKku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=535-536&author=L.+Kmetzsch&title=Histone+deacetylases%3A+Targets+for+antifungal+drug+development&doi=10.1080%2F21505594.2015.1049807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylases: Targets for antifungal drug development</span></div><div class="casAuthors">Kmetzsch, Livia</div><div class="citationInfo"><span class="NLM_cas:title">Virulence</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">535-536</span>CODEN:
                <span class="NLM_cas:coden">VIRUCS</span>;
        ISSN:<span class="NLM_cas:issn">2150-5608</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A review.  The interaction of pathogens and its hosts causes a drastic change in the transcriptional landscape in both cells.  Among the several mechanisms of gene regulation, transcriptional initiation is probably the main point.  In such scenario, the access of transcriptional machinery to promoter is highly regulated by post-translational modification of histones, such as acetylation, phosphorylation and others.  Inhibition of histone deacetylases is able to reduce fungal pathogens fitness during infection and, therefore, is currently being considered for the development of new antifungal therapy strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-fbI2ZYvCZ7Vg90H21EOLACvtfcHk0lhEj5X7tZOLqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlKku7s%253D&md5=d9386d6e04621a0a4bf8f93f2ac4ba82</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1080%2F21505594.2015.1049807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F21505594.2015.1049807%26sid%3Dliteratum%253Aachs%26aulast%3DKmetzsch%26aufirst%3DL.%26atitle%3DHistone%2520deacetylases%253A%2520Targets%2520for%2520antifungal%2520drug%2520development%26jtitle%3DVirulence%26date%3D2015%26volume%3D6%26spage%3D535%26epage%3D536%26doi%3D10.1080%2F21505594.2015.1049807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garnaud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Champleboux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maubon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govin, J.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylases and their inhibition in Candida Species</span>. <i>Front. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1238</span>, <span class="refDoi"> DOI: 10.3389/fmicb.2016.01238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.3389%2Ffmicb.2016.01238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=27547205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A280%3ADC%252BC2szjtVKisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1238&author=C.+Garnaudauthor=M.+Champlebouxauthor=D.+Maubonauthor=M.+Cornetauthor=J.+Govin&title=Histone+deacetylases+and+their+inhibition+in+Candida+Species&doi=10.3389%2Ffmicb.2016.01238"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Histone Deacetylases and Their Inhibition in Candida Species</span></div><div class="casAuthors">Garnaud Cecile; Maubon Daniele; Cornet Muriel; Champleboux Morgane; Govin Jerome</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in microbiology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1238</span>
        ISSN:<span class="NLM_cas:issn">1664-302X</span>.
    </div><div class="casAbstract">Fungi are generally benign members of the human mucosal flora or live as saprophytes in the environment.  However, they can become pathogenic, leading to invasive and life threatening infections in vulnerable patients.  These invasive fungal infections are regarded as a major public health problem on a similar scale to tuberculosis or malaria.  Current treatment for these infections is based on only four available drug classes.  This limited therapeutic arsenal and the emergence of drug-resistant strains are a matter of concern due to the growing number of patients to be treated, and new therapeutic strategies are urgently needed.  Adaptation of fungi to drug pressure involves transcriptional regulation, in which chromatin dynamics and histone modifications play a major role.  Histone deacetylases (HDACs) remove acetyl groups from histones and actively participate in controlling stress responses.  HDAC inhibition has been shown to limit fungal development, virulence, biofilm formation, and dissemination in the infected host, while also improving the efficacy of existing antifungal drugs toward Candida spp.  In this article, we review the functional roles of HDACs and the biological effects of HDAC inhibitors on Candida spp., highlighting the correlations between their pathogenic effects in vitro and in vivo.  We focus on how HDAC inhibitors could be used to treat invasive candidiasis while also reviewing recent developments in their clinical evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSqH6RST9Bi-Ebxh97K6Vt6fW6udTcc2ebD5ead-e89ibntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2szjtVKisw%253D%253D&md5=73b9e6f664ac8652a3220c7757952ae6</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2016.01238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2016.01238%26sid%3Dliteratum%253Aachs%26aulast%3DGarnaud%26aufirst%3DC.%26aulast%3DChampleboux%26aufirst%3DM.%26aulast%3DMaubon%26aufirst%3DD.%26aulast%3DCornet%26aufirst%3DM.%26aulast%3DGovin%26aufirst%3DJ.%26atitle%3DHistone%2520deacetylases%2520and%2520their%2520inhibition%2520in%2520Candida%2520Species%26jtitle%3DFront.%2520Microbiol.%26date%3D2016%26volume%3D7%26spage%3D1238%26doi%3D10.3389%2Ffmicb.2016.01238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.-E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.-S.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase-mediated morphological transition in Candida albicans</span>. <i>J. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">805</span>– <span class="NLM_lpage">811</span>, <span class="refDoi"> DOI: 10.1007/s12275-015-5488-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1007%2Fs12275-015-5488-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=26626350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKqs77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2015&pages=805-811&author=J.+Kimauthor=J.-E.+Leeauthor=J.-S.+Lee&title=Histone+deacetylase-mediated+morphological+transition+in+Candida+albicans&doi=10.1007%2Fs12275-015-5488-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase-mediated morphological transition in Candida albicans</span></div><div class="casAuthors">Kim, Jueun; Lee, Ji-Eun; Lee, Jung-Shin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Microbiology (Seoul, Republic of Korea)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">805-811</span>CODEN:
                <span class="NLM_cas:coden">JOMIFG</span>;
        ISSN:<span class="NLM_cas:issn">1225-8873</span>.
    
            (<span class="NLM_cas:orgname">Microbiological Society of Korea</span>)
        </div><div class="casAbstract">Candida albicans is the most common opportunistic fungal pathogen, which switches its morphol. from single-cell yeast to filament through the various signaling pathways responding to diverse environmental cues.  Various transcriptional factors such as Nrg1, Efg1, Brg1, Ssn6, and Tup1 are the key components of these signaling pathways.  Since C. albicans can regulate its transcriptional gene expressions using common eukaryotic regulatory systems, its morphol. transition by these signaling pathways could be linked to the epigenetic regulation by chromatin structure modifiers.  Histone proteins, which are crit. components of eukaryotic chromatin structure, can regulate the eukaryotic chromatin structure through their own modifications such as acetylation, methylation, phosphorylation and ubiquitylation.  Recent studies revealed that various histone modifications, esp. histone acetylation and deacetylation, participate in morphol. transition of C. albicans collaborating with well-known transcription factors in the signaling pathways.  Here, we review recent studies about chromatin-mediated morphol. transition of C. albicans focusing on the interaction between transcription factors in the signaling pathways and histone deacetylases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbiykuEydVfbVg90H21EOLACvtfcHk0libBwoWSPw3wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKqs77O&md5=1cf37e54e429418df616741ba24ac6b5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs12275-015-5488-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12275-015-5488-3%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.-E.%26aulast%3DLee%26aufirst%3DJ.-S.%26atitle%3DHistone%2520deacetylase-mediated%2520morphological%2520transition%2520in%2520Candida%2520albicans%26jtitle%3DJ.%2520Microbiol.%26date%3D2015%26volume%3D53%26spage%3D805%26epage%3D811%26doi%3D10.1007%2Fs12275-015-5488-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamoth, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juvvadi, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbach, W. J.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase inhibition as an alternative strategy against invasive aspergillosis</span>. <i>Front. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">96</span>, <span class="refDoi"> DOI: 10.3389/fmicb.2015.00096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.3389%2Ffmicb.2015.00096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=25762988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A280%3ADC%252BC2MnjsVyqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=96&author=F.+Lamothauthor=P.+R.+Juvvadiauthor=W.+J.+Steinbach&title=Histone+deacetylase+inhibition+as+an+alternative+strategy+against+invasive+aspergillosis&doi=10.3389%2Ffmicb.2015.00096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibition as an alternative strategy against invasive aspergillosis</span></div><div class="casAuthors">Lamoth Frederic; Juvvadi Praveen R; Steinbach William J</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in microbiology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">96</span>
        ISSN:<span class="NLM_cas:issn">1664-302X</span>.
    </div><div class="casAbstract">Invasive aspergillosis (IA) is a life-threatening infection due to Aspergillus fumigatus and other Aspergillus spp.  Drugs targeting the fungal cell membrane (triazoles, amphotericin B) or cell wall (echinocandins) are currently the sole therapeutic options against IA.  Their limited efficacy and the emergence of resistance warrant the identification of new antifungal targets.  Histone deacetylases (HDACs) are enzymes responsible of the deacetylation of lysine residues of core histones, thus controlling chromatin remodeling and transcriptional activation.  HDACs also control the acetylation and activation status of multiple non-histone proteins, including the heat shock protein 90 (Hsp90), an essential molecular chaperone for fungal virulence and antifungal resistance.  This review provides an overview of the different HDACs in Aspergillus spp. as well as their respective contribution to total HDAC activity, fungal growth, stress responses, and virulence.  The potential of HDAC inhibitors, currently under development for cancer therapy, as novel alternative antifungal agents against IA is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT3AIhflCE8RpcXNb62YGmbfW6udTcc2ebsQxESJ2eTkrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnjsVyqsg%253D%253D&md5=009f225bc2913bb6e48671c019230228</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2015.00096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2015.00096%26sid%3Dliteratum%253Aachs%26aulast%3DLamoth%26aufirst%3DF.%26aulast%3DJuvvadi%26aufirst%3DP.%2BR.%26aulast%3DSteinbach%26aufirst%3DW.%2BJ.%26atitle%3DHistone%2520deacetylase%2520inhibition%2520as%2520an%2520alternative%2520strategy%2520against%2520invasive%2520aspergillosis%26jtitle%3DFront.%2520Microbiol.%26date%3D2015%26volume%3D6%26spage%3D96%26doi%3D10.3389%2Ffmicb.2015.00096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pfaller, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhomberg, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messer, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castanheira, M.</span></span> <span> </span><span class="NLM_article-title">In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species</span>. <i>Diagn. Microbiol. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">259</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1016/j.diagmicrobio.2014.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1016%2Fj.diagmicrobio.2014.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=25600842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVSnsbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2015&pages=259-263&author=M.+A.+Pfallerauthor=P.+R.+Rhombergauthor=S.+A.+Messerauthor=M.+Castanheira&title=In+vitro+activity+of+a+Hos2+deacetylase+inhibitor%2C+MGCD290%2C+in+combination+with+echinocandins+against+echinocandin-resistant+Candida+species&doi=10.1016%2Fj.diagmicrobio.2014.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species</span></div><div class="casAuthors">Pfaller, M. A.; Rhomberg, P. R.; Messer, S. A.; Castanheira, M.</div><div class="citationInfo"><span class="NLM_cas:title">Diagnostic Microbiology and Infectious Disease</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">259-263</span>CODEN:
                <span class="NLM_cas:coden">DMIDDZ</span>;
        ISSN:<span class="NLM_cas:issn">0732-8893</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">MGCD290, a Hos2 fungal histone deacetylase inhibitor, showed modest activity when tested alone (MIC range, 0.12-4 μg/mL; MIC50/90, 0.5/4 μg/mL) against Candida glabrata (n = 15; 14 fks mutants; 5 also fluconazole resistant), Candida albicans (8 fks mutants; 2 also fluconazole resistant), Candida tropicalis (4 fks mutants), and Candida krusei (3 fks mutants).  However, MGCD290 showed synergy or partial synergy for 33.3%, 30.1%, 36.7%, and 80.0% of the isolates when tested with anidulafungin, caspofungin, micafungin, and fluconazole, resp.  Favorable interactions were achieved with low concns. of MGCD290 (0.015-0.25 μg/mL), and categorical shifts were obsd. in 2 of 8 (25.0%) isolates of C. albicans and 2 of 3 (66.7%) isolates of C. krusei and in 4 of the 5 (80.0%) fluconazole-resistant isolates of C. glabrata.  MGCD290 exerts a distinctly favorable influence on the MICs of fluconazole and the echinocandins, resulting in conversion from resistance to susceptibility regardless of fks mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIr_O0BjzX4rVg90H21EOLACvtfcHk0libBwoWSPw3wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVSnsbjL&md5=3a7550a215a89b52495ec6ebf5297bb1</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.diagmicrobio.2014.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.diagmicrobio.2014.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DPfaller%26aufirst%3DM.%2BA.%26aulast%3DRhomberg%26aufirst%3DP.%2BR.%26aulast%3DMesser%26aufirst%3DS.%2BA.%26aulast%3DCastanheira%26aufirst%3DM.%26atitle%3DIn%2520vitro%2520activity%2520of%2520a%2520Hos2%2520deacetylase%2520inhibitor%252C%2520MGCD290%252C%2520in%2520combination%2520with%2520echinocandins%2520against%2520echinocandin-resistant%2520Candida%2520species%26jtitle%3DDiagn.%2520Microbiol.%2520Infect.%2520Dis.%26date%3D2015%26volume%3D81%26spage%3D259%26epage%3D263%26doi%3D10.1016%2Fj.diagmicrobio.2014.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brandão, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derengowski, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albuquerque, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicola, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva-Pereira, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poças-Fonseca, M. J.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylases inhibitors effects on Cryptococcus neoformans major virulence phenotypes</span>. <i>Virulence</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">618</span>– <span class="NLM_lpage">630</span>, <span class="refDoi"> DOI: 10.1080/21505594.2015.1038014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1080%2F21505594.2015.1038014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=26103530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlKku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=618-630&author=F.+A.+Brand%C3%A3oauthor=L.+S.+Derengowskiauthor=P.+Albuquerqueauthor=A.+M.+Nicolaauthor=I.+Silva-Pereiraauthor=M.+J.+Po%C3%A7as-Fonseca&title=Histone+deacetylases+inhibitors+effects+on+Cryptococcus+neoformans+major+virulence+phenotypes&doi=10.1080%2F21505594.2015.1038014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylases inhibitors effects on Cryptococcus neoformans major virulence phenotypes</span></div><div class="casAuthors">Brandao, Fabiana A. S.; Derengowski, Lorena S.; Albuquerque, Patricia; Nicola, Andre M.; Silva-Pereira, Ildinete; Pocas-Fonseca, Marcio J.</div><div class="citationInfo"><span class="NLM_cas:title">Virulence</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">618-630</span>CODEN:
                <span class="NLM_cas:coden">VIRUCS</span>;
        ISSN:<span class="NLM_cas:issn">2150-5608</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Cryptococcus neoformans undergoes phenotypical changes during host infection in order to promote persistence and survival.  Studies have demonstrated that such adaptations require alterations in gene transcription networks by distinct mechanisms.  Drugs such as the histone deacetylases inhibitors (HDACi) Sodium Butyrate (NaBut) and Trichostatin A (TSA) can alter the chromatin conformation and have been used to modulate epigenetic states in the treatment of diseases such as cancer.  In this work, we have studied the effect of NaBut and TSA on the expression of C. neoformans major virulence phenotypes and on the survival rate of an animal model infected with drugs-treated yeasts.  Both drugs affected fungal growth at 37°C more intensely than at 30°C; nonetheless, drugs did not affect cell viability at the concns. we studied.  HDACi also provoked the redn. of the fungal capsule expansion.  Phospholipases enzyme activity decreased; mating process and melanin synthesis were also affected by both inhibitors.  NaBut led to an increase in the population of cells in G2/M.  Treated yeast cells, which were washed in order to remove the drugs from the culture medium prior to the inoculation in the Galleria mellonela infection model, did not cause significant difference at the host survival curve when compared to non-treated cells.  Overall, NaBut effects on the impairment of C. neoformans main virulence factors were more intense and stable than the TSA effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlYMtxsjDi4LVg90H21EOLACvtfcHk0lhyzWl83fCkdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlKku70%253D&md5=6bb33f7a308923343af630d5d94aa1b3</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1080%2F21505594.2015.1038014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F21505594.2015.1038014%26sid%3Dliteratum%253Aachs%26aulast%3DBrand%25C3%25A3o%26aufirst%3DF.%2BA.%26aulast%3DDerengowski%26aufirst%3DL.%2BS.%26aulast%3DAlbuquerque%26aufirst%3DP.%26aulast%3DNicola%26aufirst%3DA.%2BM.%26aulast%3DSilva-Pereira%26aufirst%3DI.%26aulast%3DPo%25C3%25A7as-Fonseca%26aufirst%3DM.%2BJ.%26atitle%3DHistone%2520deacetylases%2520inhibitors%2520effects%2520on%2520Cryptococcus%2520neoformans%2520major%2520virulence%2520phenotypes%26jtitle%3DVirulence%26date%3D2015%26volume%3D6%26spage%3D618%26epage%3D630%26doi%3D10.1080%2F21505594.2015.1038014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotili, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brosch, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonetti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passariello, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palamara, A. T.</span></span> <span> </span><span class="NLM_article-title">Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1221</span>– <span class="NLM_lpage">1225</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.12.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1016%2Fj.bmcl.2006.12.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=17196388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVyjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1221-1225&author=A.+Maiauthor=D.+Rotiliauthor=S.+Massaauthor=G.+Broschauthor=G.+Simonettiauthor=C.+Passarielloauthor=A.+T.+Palamara&title=Discovery+of+uracil-based+histone+deacetylase+inhibitors+able+to+reduce+acquired+antifungal+resistance+and+trailing+growth+in+Candida+albicans&doi=10.1016%2Fj.bmcl.2006.12.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans</span></div><div class="casAuthors">Mai, Antonello; Rotili, Dante; Massa, Silvio; Brosch, Gerald; Simonetti, Giovanna; Passariello, Claudio; Palamara, Anna Teresa</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1221-1225</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Among fungal pathogens such as Candida albicans, acquired drug resistance has not been assocd. with plasmids or other transferable elements, but it is thought to involve primarily mutations and genetic or epigenetic phenomena.  This the authors to test some histone deacetylase inhibitors (HDACi) from their library, in combination with fluconazole, against C. albicans strains in vitro.  Among the tested compds., the two chloro-contg. uracil-hydroxamates 1c and 1d showed a strong redn. of the MIC values on Candida strains that show the trailing growth effect.  In this assay, 1c,d were more potent than SAHA, a well-known HDAC inhibitor, in reducing the Candida growth.  Compds. 1c,d as well as SAHA were able to inhibit the fluconazole-induced resistance induction in Candida cultures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgG2dBVCiTN7Vg90H21EOLACvtfcHk0lhyzWl83fCkdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVyjsL8%253D&md5=459aca01b82b284070f9bfe6229aca3b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.12.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.12.028%26sid%3Dliteratum%253Aachs%26aulast%3DMai%26aufirst%3DA.%26aulast%3DRotili%26aufirst%3DD.%26aulast%3DMassa%26aufirst%3DS.%26aulast%3DBrosch%26aufirst%3DG.%26aulast%3DSimonetti%26aufirst%3DG.%26aulast%3DPassariello%26aufirst%3DC.%26aulast%3DPalamara%26aufirst%3DA.%2BT.%26atitle%3DDiscovery%2520of%2520uracil-based%2520histone%2520deacetylase%2520inhibitors%2520able%2520to%2520reduce%2520acquired%2520antifungal%2520resistance%2520and%2520trailing%2520growth%2520in%2520Candida%2520albicans%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1221%26epage%3D1225%26doi%3D10.1016%2Fj.bmcl.2006.12.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peters, J.-U.</span></span> <span> </span><span class="NLM_article-title">Polypharmacology - foe or friend?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">8955</span>– <span class="NLM_lpage">8971</span>, <span class="refDoi"> DOI: 10.1021/jm400856t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400856t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1amtrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8955-8971&author=J.-U.+Peters&title=Polypharmacology+-+foe+or+friend%3F&doi=10.1021%2Fjm400856t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Polypharmacology - Foe or Friend?</span></div><div class="casAuthors">Peters, Jens-Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8955-8971</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Polypharmacol. describes the activity of compds. at multiple targets.  Current research focuses on two aspects of polypharmacol.: (1) unintended polypharmacol. can lead to adverse effects; (2) polypharmacol. across several disease-relevant targets can improve therapeutic efficacy, prevent drug resistance, or reduce therapeutic-target-related adverse effects.  This perspective reviews these interconnected aspects of polypharmacol.  The first part discusses the relevance of polypharmacol. for the safety of drugs, the mitigation of safety risks, and methods to identify polypharmacol. compds. early in the drug discovery process.  The second part discusses the advantages of polypharmacol. in the treatment of multigenic diseases and infections, and opportunities for drug discovery and drug repurposing.  This perspective aims to provide a balanced view on polypharmacol., which can compromise the safety of drugs, but can also confer superior efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5vnFGPfTnGLVg90H21EOLACvtfcHk0lhyzWl83fCkdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1amtrnO&md5=f4aeb6efddd4bfdf4e94656303323cba</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm400856t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400856t%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DJ.-U.%26atitle%3DPolypharmacology%2520-%2520foe%2520or%2520friend%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8955%26epage%3D8971%26doi%3D10.1021%2Fjm400856t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anighoro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajorath, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rastelli, G.</span></span> <span> </span><span class="NLM_article-title">Polypharmacology: challenges and opportunities in drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">7874</span>– <span class="NLM_lpage">7887</span>, <span class="refDoi"> DOI: 10.1021/jm5006463s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5006463" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVShsL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7874-7887&author=A.+Anighoroauthor=J.+Bajorathauthor=G.+Rastelli&title=Polypharmacology%3A+challenges+and+opportunities+in+drug+discovery&doi=10.1021%2Fjm5006463s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Polypharmacology: Challenges and Opportunities in Drug Discovery</span></div><div class="casAuthors">Anighoro, Andrew; Bajorath, Jurgen; Rastelli, Giulio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7874-7887</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  At present, the legendary magic bullet, i.e., a drug with high potency and selectivity toward a specific biol. target, shares the spotlight with an emerging and alternative polypharmacol. approach.  Polypharmacol. suggests that more effective drugs can be developed by specifically modulating multiple targets.  It is generally thought that complex diseases such as cancer and central nervous system diseases may require complex therapeutic approaches.  In this respect, a drug that "hits" multiple sensitive nodes belonging to a network of interacting targets offers the potential for higher efficacy and may limit drawbacks generally arising from the use of a single-target drug or a combination of multiple drugs.  In this review, we will compare advantages and disadvantages of multitarget vs. combination therapies, discuss potential drug promiscuity arising from off-target effects, comment on drug repurposing, and introduce approaches to the computational design of multitarget drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFOTyEu80AZrVg90H21EOLACvtfcHk0lhTtcWM7SrhJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShsL3I&md5=5ab36c961a84462d90bc25130d90a281</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm5006463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5006463%26sid%3Dliteratum%253Aachs%26aulast%3DAnighoro%26aufirst%3DA.%26aulast%3DBajorath%26aufirst%3DJ.%26aulast%3DRastelli%26aufirst%3DG.%26atitle%3DPolypharmacology%253A%2520challenges%2520and%2520opportunities%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7874%26epage%3D7887%26doi%3D10.1021%2Fjm5006463s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Che, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">New azoles with potent antifungal activity: design, synthesis and molecular docking</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">4218</span>– <span class="NLM_lpage">4226</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2009.05.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1016%2Fj.ejmech.2009.05.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=19539408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptlertLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=4218-4226&author=X.+Cheauthor=C.+Shengauthor=W.+Wangauthor=Y.+Caoauthor=Y.+Xuauthor=H.+Jiauthor=G.+Dongauthor=Z.+Miaoauthor=J.+Yaoauthor=W.+Zhang&title=New+azoles+with+potent+antifungal+activity%3A+design%2C+synthesis+and+molecular+docking&doi=10.1016%2Fj.ejmech.2009.05.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">New azoles with potent antifungal activity: Design, synthesis and molecular docking</span></div><div class="casAuthors">Che, Xiaoying; Sheng, Chunquan; Wang, Wenya; Cao, Yongbing; Xu, Yulan; Ji, Haitao; Dong, Guoqiang; Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4218-4226</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In response to the urgent need for novel antifungal agents with improved activity and broader spectrum, computer modeling was used for rational design of novel antifungal azoles.  On the basis of the active site of lanosterol 14α-demethylase from Candida albicans (CACYP51), a series of new azoles with substituted-phenoxypropyl piperazine side chains were rationally designed and synthesized.  In vitro antifungal activity assay indicates that the new azoles show good activity against most of the tested pathogenic fungi.  Interestingly, the designed compds. are also active against an azole-resistant clin. strain.  Compared to fluconazole and itraconazole, several compds. (such as I) show higher antifungal activity and a broader spectrum, which are promising leads for the development of novel antifungal agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMhIP1RDAqCbVg90H21EOLACvtfcHk0lhTtcWM7SrhJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptlertLc%253D&md5=62f53f8f010f3382a973817243e643ee</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2009.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2009.05.018%26sid%3Dliteratum%253Aachs%26aulast%3DChe%26aufirst%3DX.%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DNew%2520azoles%2520with%2520potent%2520antifungal%2520activity%253A%2520design%252C%2520synthesis%2520and%2520molecular%2520docking%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D4218%26epage%3D4226%26doi%3D10.1016%2Fj.ejmech.2009.05.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and antifungal activity of novel triazole derivatives containing substituted 1,2,3-triazole-piperdine side chains</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">490</span>– <span class="NLM_lpage">497</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.05.079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1016%2Fj.ejmech.2014.05.079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=24934573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVCqu7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2014&pages=490-497&author=Z.+Jiangauthor=J.+Guauthor=C.+Wangauthor=S.+Wangauthor=N.+Liuauthor=Y.+Jiangauthor=G.+Dongauthor=Y.+Wangauthor=Y.+Liuauthor=J.+Yaoauthor=Z.+Miaoauthor=W.+Zhangauthor=C.+Sheng&title=Design%2C+synthesis+and+antifungal+activity+of+novel+triazole+derivatives+containing+substituted+1%2C2%2C3-triazole-piperdine+side+chains&doi=10.1016%2Fj.ejmech.2014.05.079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and antifungal activity of novel triazole derivatives containing substituted 1,2,3-triazole-piperidine side chains</span></div><div class="casAuthors">Jiang, Zhigan; Gu, Julin; Wang, Chen; Wang, Shengzheng; Liu, Na; Jiang, Yan; Dong, Guoqiang; Wang, Yan; Liu, Yang; Yao, Jianzhong; Miao, Zhenyuan; Zhang, Wannian; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">490-497</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Due to increasing incidence of invasive fungal infections and severe drug resistance to triazole antifungal agents, a series of novel antifungal triazoles with substituted triazole-piperidine side chains was designed and synthesized.  Most of the target compds. showed good inhibitory activity against a variety of clin. important fungal pathogens.  In particular, compds. I (R = Ac or OCF3) were highly active against Candida albicans and Cryptococcus neoformans with MIC values in the range of 0.125 μg/mL to 0.0125 μg/mL.  They represent promising leads for the development of new generation of triazole antifungal agents.  Mol. docking studies revealed that the target compds. interacted with CACYP51 mainly through hydrophobic and Van der Waals interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKepCqtBVuVbVg90H21EOLACvtfcHk0lhTtcWM7SrhJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVCqu7vM&md5=a67a053c579aa2daf1ef3d42f81e09ce</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.05.079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.05.079%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DGu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDesign%252C%2520synthesis%2520and%2520antifungal%2520activity%2520of%2520novel%2520triazole%2520derivatives%2520containing%2520substituted%25201%252C2%252C3-triazole-piperdine%2520side%2520chains%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D82%26spage%3D490%26epage%3D497%26doi%3D10.1016%2Fj.ejmech.2014.05.079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lü, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">Evolutionary trace analysis of CYP51 family: implication for site-directed mutagenesis and novel antifungal drug design</span>. <i>J. Mol. Model.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1007/s00894-009-0527-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1007%2Fs00894-009-0527-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=19593597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlslGisb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=279-284&author=C.+Shengauthor=S.+Chenauthor=H.+Jiauthor=G.+Dongauthor=X.+Cheauthor=W.+Wangauthor=Z.+Miaoauthor=J.+Yaoauthor=J.+L%C3%BCauthor=W.+Guoauthor=W.+Zhang&title=Evolutionary+trace+analysis+of+CYP51+family%3A+implication+for+site-directed+mutagenesis+and+novel+antifungal+drug+design&doi=10.1007%2Fs00894-009-0527-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Evolutionary trace analysis of CYP51 family: implication for site-directed mutagenesis and novel antifungal drug design</span></div><div class="casAuthors">Sheng, Chunquan; Chen, Shuanghong; Ji, Haitao; Dong, Guoqiang; Che, Xiaoyin; Wang, Wenya; Miao, Zhenyuan; Yao, Jianzhong; Lu, Jiaguo; Guo, Wei; Zhang, Wannian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">279-284</span>CODEN:
                <span class="NLM_cas:coden">JMMOFK</span>;
        ISSN:<span class="NLM_cas:issn">0948-5023</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Lanosterol 14α-demethylase (CYP51) is an essential enzyme in the fungal life cycle and also an important target for the antifungal drug development.  Based on the multiple sequence alignments of CYP51 family, an evolutionary tree of the CYP51 family was constructed by the evolutionary trace (ET) method.  The identified trace residues could provide a reliable and rational guide to the design of CYP51 mutations and give more information about the detailed mechanism of substrate (drug) recognition and binding.  The reliability of ET anal. to identify residues of functional importance was validated by the reported site-directed mutagenesis studies of CYP51s.  Several residues in the active site were also validated by our mutagenesis studies.  Mapping the identified trace residues onto the active site of the modeled structure of Candida albicans CYP51 (CACYP51) may provide useful information for the design of novel antifungal agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprrMjVIO4bVLVg90H21EOLACvtfcHk0liH0sXXS2Gxrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlslGisb4%253D&md5=8880c201917fd1f975d6c6c606dda812</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2Fs00894-009-0527-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00894-009-0527-9%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DChe%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DL%25C3%25BC%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DEvolutionary%2520trace%2520analysis%2520of%2520CYP51%2520family%253A%2520implication%2520for%2520site-directed%2520mutagenesis%2520and%2520novel%2520antifungal%2520drug%2520design%26jtitle%3DJ.%2520Mol.%2520Model.%26date%3D2010%26volume%3D16%26spage%3D279%26epage%3D284%26doi%3D10.1007%2Fs00894-009-0527-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lü, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">Three-dimensional model of lanosterol 14α-demethylase from Cryptococcus neoformans: active-site characterization and insights into azole binding</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3487</span>– <span class="NLM_lpage">3495</span>, <span class="refDoi"> DOI: 10.1128/aac.01630-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1128%2FAAC.01630-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=19470512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD1MXps1ygs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=3487-3495&author=C.+Shengauthor=Z.+Miaoauthor=H.+Jiauthor=J.+Yaoauthor=W.+Wangauthor=X.+Cheauthor=G.+Dongauthor=J.+L%C3%BCauthor=W.+Guoauthor=W.+Zhang&title=Three-dimensional+model+of+lanosterol+14%CE%B1-demethylase+from+Cryptococcus+neoformans%3A+active-site+characterization+and+insights+into+azole+binding&doi=10.1128%2Faac.01630-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Three-dimensional model of lanosterol 14α-demethylase from Cryptococcus neoformans: active-site characterization and insights into azole binding</span></div><div class="casAuthors">Sheng, Chunquan; Miao, Zhenyuan; Ji, Haitao; Yao, Jianzhong; Wang, Wenya; Che, Xiaoying; Dong, Guoqiang; Lu, Jiaguo; Guo, Wei; Zhang, Wannian</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3487-3495</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Cryptococcus neoformans is one of the most important causes of life-threatening fungal infections in immunocompromised patients.  Lanosterol 14α-demethylase (CYP51) is the target of azole antifungal agents.  This study describes, for the first time, the 3-dimensional model of CYP51 from Cryptococcus neoformans (CnCYP51).  The model was further refined by energy minimization and mol.-dynamics simulations.  The active site of CnCYP51 was well characterized by multiple-copy simultaneous-search calcns., and four functional regions important for rational drug design were identified.  The mode of binding of the natural substrate and azole antifungal agents with CnCYP51 was identified by flexible mol. docking.  A G484S substitution mechanism for azole resistance in CnCYP51, which might be important for the conformation of the heme environment, is suggested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-URQUj7XzzLVg90H21EOLACvtfcHk0liH0sXXS2Gxrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXps1ygs74%253D&md5=94209f274d245e169873c8d576a954a0</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1128%2FAAC.01630-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01630-08%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DChe%26aufirst%3DX.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DL%25C3%25BC%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DThree-dimensional%2520model%2520of%2520lanosterol%252014%25CE%25B1-demethylase%2520from%2520Cryptococcus%2520neoformans%253A%2520active-site%2520characterization%2520and%2520insights%2520into%2520azole%2520binding%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D3487%26epage%3D3495%26doi%3D10.1128%2Faac.01630-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">Improved model of lanosterol 14α-demethylase by ligand-supported homology modeling: validation by virtual screening and azole optimization</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">390</span>– <span class="NLM_lpage">397</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200900468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1002%2Fcmdc.200900468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=20157915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslens7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=390-397&author=C.+Shengauthor=W.+Wangauthor=X.+Cheauthor=G.+Dongauthor=S.+Wangauthor=H.+Jiauthor=Z.+Miaoauthor=J.+Yaoauthor=W.+Zhang&title=Improved+model+of+lanosterol+14%CE%B1-demethylase+by+ligand-supported+homology+modeling%3A+validation+by+virtual+screening+and+azole+optimization&doi=10.1002%2Fcmdc.200900468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Improved model of lanosterol 14α-demethylase by ligand-supported homology modeling: validation by virtual screening and azole optimization</span></div><div class="casAuthors">Sheng, Chunquan; Wang, Wenya; Che, Xiaoying; Dong, Guoqiang; Wang, Shengzheng; Ji, Haitao; Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">390-397</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Lanosterol 14α-demethylase (CYP51) is an important target for antifungal drugs.  An improved three-dimensional model of CYP51 from Candida albicans (CACYP51) was constructed by ligand-supported homol. modeling and mol. dynamics simulations.  The accuracy of the constructed model was evaluated by its performance in a small-scale virtual screen.  The results show that known CYP51 inhibitors were efficiently discriminated by the model, and it performed better than our previous CACYP51 model.  The active site of CACYP51 was characterized by multiple copy simultaneous search (MCSS) calcns.  On the basis of the MCSS results, a series of novel azoles were designed and synthesized, and they showed good in vitro antifungal activity with a broad spectrum.  The MIC80 value of four of these compds. against C. albicans is 0.001 μg mL-1, indicating that they are promising leads for the discovery of novel antifungal agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvPkz8zBBmybVg90H21EOLACvtfcHk0liH0sXXS2Gxrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslens7Y%253D&md5=3bcf5f8c16b66dd107ae86cfe6427816</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200900468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200900468%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DChe%26aufirst%3DX.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DImproved%2520model%2520of%2520lanosterol%252014%25CE%25B1-demethylase%2520by%2520ligand-supported%2520homology%2520modeling%253A%2520validation%2520by%2520virtual%2520screening%2520and%2520azole%2520optimization%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D390%26epage%3D397%26doi%3D10.1002%2Fcmdc.200900468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">New lead structures in antifungal drug discovery</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">733</span>– <span class="NLM_lpage">766</span>, <span class="refDoi"> DOI: 10.2174/092986711794480113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.2174%2F092986711794480113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=21182484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFyjs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=733-766&author=C.+Shengauthor=W.+Zhang&title=New+lead+structures+in+antifungal+drug+discovery&doi=10.2174%2F092986711794480113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">New lead structures in antifungal drug discovery</span></div><div class="casAuthors">Sheng, Chunquan; Zhang, Wannian</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">733-766</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  During the past two decades, the incidence of invasive fungal infections has been increasing dramatically.  Clin. available antifungal agents have several drawbacks such as limited potency and spectrum, drug related toxicity, non-optimal pharmacokinetics, and severe resistance.  There is an emergent need to develop new antifungal drugs with novel chem. structures and novel mechanism of action.  This review will focus on the most significant achievements in the discovery of antifungal lead structures within last few years.  In particular, we pay more attention on the structure-activity relationship of antifungal leads and provide perspectives for future antifungal drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg5sTIG2meTrVg90H21EOLACvtfcHk0lhV5ky24g1fVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFyjs7w%253D&md5=89308e007069c3ffb25ab8b943fc6e98</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.2174%2F092986711794480113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711794480113%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DNew%2520lead%2520structures%2520in%2520antifungal%2520drug%2520discovery%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D733%26epage%3D766%26doi%3D10.2174%2F092986711794480113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">Discovery of highly potent novel antifungal azoles by structure-based rational design</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">5965</span>– <span class="NLM_lpage">5969</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.07.144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1016%2Fj.bmcl.2009.07.144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=19748782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtF2hurnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5965-5969&author=W.+Wangauthor=C.+Shengauthor=X.+Cheauthor=H.+Jiauthor=Y.+Caoauthor=Z.+Miaoauthor=J.+Yaoauthor=W.+Zhang&title=Discovery+of+highly+potent+novel+antifungal+azoles+by+structure-based+rational+design&doi=10.1016%2Fj.bmcl.2009.07.144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of highly potent novel antifungal azoles by structure-based rational design</span></div><div class="casAuthors">Wang, Wenya; Sheng, Chunquan; Che, Xiaoying; Ji, Haitao; Cao, Yongbing; Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5965-5969</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">On the basis of the active site of lanosterol 14α-demethylase from Candida albicans (CACYP51), a series of new azoles were designed and synthesized.  All the new azoles show excellent in vitro activity against most of the tested pathogenic fungi, which represent a class of promising leads for the development of novel antifungal agents.  The MIC80 value of compds. 8c, 8i and 8n against C. albicans is 0.001 μg/mL, indicating that these compds. are more potent than fluconazole, itraconazole and voriconazole.  Flexible mol. docking was used to analyze the structure-activity relationships (SARs) of the compds.  The designed compds. interact with CACYP51 through hydrophobic, van der Waals and hydrogen-bonding interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbUjKEmrTELbVg90H21EOLACvtfcHk0lhV5ky24g1fVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtF2hurnJ&md5=373a69254b94184d2d2d43d24a1e14b5</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.07.144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.07.144%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DChe%26aufirst%3DX.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DDiscovery%2520of%2520highly%2520potent%2520novel%2520antifungal%2520azoles%2520by%2520structure-based%2520rational%2520design%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5965%26epage%3D5969%26doi%3D10.1016%2Fj.bmcl.2009.07.144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">From antidiabetic to antifungal: discovery of highly potent triazole-thiazolidinedione hybrids as novel antifungal agents</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2639</span>– <span class="NLM_lpage">2646</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201402320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1002%2Fcmdc.201402320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=25196996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVyrsb7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=2639-2646&author=S.+Wuauthor=Y.+Zhangauthor=X.+Heauthor=X.+Cheauthor=S.+Wangauthor=Y.+Liuauthor=Y.+Jiangauthor=N.+Liuauthor=G.+Dongauthor=J.+Yaoauthor=Z.+Miaoauthor=Y.+Wangauthor=W.+Zhangauthor=C.+Sheng&title=From+antidiabetic+to+antifungal%3A+discovery+of+highly+potent+triazole-thiazolidinedione+hybrids+as+novel+antifungal+agents&doi=10.1002%2Fcmdc.201402320"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">From Antidiabetic to Antifungal: Discovery of Highly Potent Triazole-Thiazolidinedione Hybrids as Novel Antifungal Agents</span></div><div class="casAuthors">Wu, Shanchao; Zhang, Yongqiang; He, Xiaomeng; Che, Xiaoying; Wang, Shengzheng; Liu, Yang; Jiang, Yan; Liu, Na; Dong, Guoqiang; Yao, Jianzhong; Miao, Zhenyuan; Wang, Yan; Zhang, Wannian; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2639-2646</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">In an attempt to discover a new generation of triazole antifungal agents, a series of triazole-thiazolidinedione hybrids I [R = Ph, 2-BrC6H4, 4-ClC6H4, etc.] were designed and synthesized by mol. hybridization of the antifungal agent fluconazole and rosiglitazone (an antidiabetic).  Most of the target compds. showed good to excellent inhibitory activity against a variety of clin. important fungal pathogens.  In particular, compds. I [R = 2,4-Cl2C6H3], I [R = 2-furyl], I [R = 3-furyl] were highly active against Candida albicans, with MIC80 values in the range of 0.03-0.15 μΜ.  Moreover, the last two compds. compds. were found to be effective against four fluconazole-resistant clin. isolates; these two compds. are particularly promising antifungal leads for further optimization.  Mol. docking studies revealed that the hydrogen bonding interactions between thiazolidinedione and CYP51 from C. albicans are important for antifungal activity.  This study also demonstrates the effectiveness of mol. hybridization in antifungal drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa2mPEjg23bbVg90H21EOLACvtfcHk0lhV5ky24g1fVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVyrsb7P&md5=1805f6c32a74cad85e6e2c8ab9bccc8c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201402320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201402320%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DChe%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DFrom%2520antidiabetic%2520to%2520antifungal%253A%2520discovery%2520of%2520highly%2520potent%2520triazole-thiazolidinedione%2520hybrids%2520as%2520novel%2520antifungal%2520agents%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D2639%26epage%3D2646%26doi%3D10.1002%2Fcmdc.201402320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lü, J.</span></span> <span> </span><span class="NLM_article-title">Structure-based optimization of azole antifungal agents by CoMFA, CoMSIA, and molecular docking</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">2512</span>– <span class="NLM_lpage">2525</span>, <span class="refDoi"> DOI: 10.1021/jm051211n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051211n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD28XislCjs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2512-2525&author=C.+Shengauthor=W.+Zhangauthor=H.+Jiauthor=M.+Zhangauthor=Y.+Songauthor=H.+Xuauthor=J.+Zhuauthor=Z.+Miaoauthor=Q.+Jiangauthor=J.+Yaoauthor=Y.+Zhouauthor=J.+Zhuauthor=J.+L%C3%BC&title=Structure-based+optimization+of+azole+antifungal+agents+by+CoMFA%2C+CoMSIA%2C+and+molecular+docking&doi=10.1021%2Fjm051211n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Optimization of Azole Antifungal Agents by CoMFA, CoMSIA, and Molecular Docking</span></div><div class="casAuthors">Sheng, Chunquan; Zhang, Wannian; Ji, Haitao; Zhang, Min; Song, Yunlong; Xu, Hui; Zhu, Jie; Miao, Zhenyuan; Jiang, Qingfen; Yao, Jianzhong; Zhou, Youjun; Zhu, Jue; Lue, Jiaguo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2512-2525</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In a continuing effort to develop highly potent azole antifungal agents, the three-dimensional quant. structure-activity relationship methods, CoMFA and CoMSIA, were applied using a set of novel azole antifungal compds.  The binding mode of the compds. at the active site of lanosterol 14α-demethylase was further explored using the flexible docking method.  Various hydrophobic, van der Waals, π-π stacking, and hydrogen bonding interactions were obsd. between the azoles and the enzyme.  Based on results from the mol. modeling, a receptor-based pharmacophore model was established to guide the rational optimization of the azole antifungal agents.  Thus, a total of 57 novel azoles were designed and synthesized by a three-step optimization process.  In vitro antifungal assay revealed that the antifungal activities of these novel azoles were greatly improved, which confirmed the reliability of the model from mol. modeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVIWFj1cTBJbVg90H21EOLACvtfcHk0ljpSxzUc1UTyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XislCjs7o%253D&md5=23d45b0954032f8e294f97c8d6625c66</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm051211n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051211n%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DL%25C3%25BC%26aufirst%3DJ.%26atitle%3DStructure-based%2520optimization%2520of%2520azole%2520antifungal%2520agents%2520by%2520CoMFA%252C%2520CoMSIA%252C%2520and%2520molecular%2520docking%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2512%26epage%3D2525%26doi%3D10.1021%2Fjm051211n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Dual NAMPT/HDAC Inhibitors as a New Strategy for Multitargeting Antitumor Drug Discovery</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">34</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00414</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00414" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFOqsrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=34-38&author=W.+Chenauthor=G.+Dongauthor=Y.+Wuauthor=W.+Zhangauthor=C.+Miaoauthor=C.+Sheng&title=Dual+NAMPT%2FHDAC+Inhibitors+as+a+New+Strategy+for+Multitargeting+Antitumor+Drug+Discovery&doi=10.1021%2Facsmedchemlett.7b00414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Dual NAMPT/HDAC Inhibitors as a New Strategy for Multitargeting Antitumor Drug Discovery</span></div><div class="casAuthors">Chen, Wei; Dong, Guoqiang; Wu, Ying; Zhang, Wannian; Miao, Chaoyu; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">34-38</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel dual nicotinamide phosphoribosyltransferase (NAMPT) and histone deacetylase (HDAC) inhibitors were designed by a pharmacophore fusion approach.  The thiazolocarboxamide inhibitors were highly active for both targets.  In particular, compd. 7f (NAMPT IC50 = 15 nM, HDAC1 IC50 = 2 nM) showed potent in vivo antitumor efficacy in the HCT116 xenograft model.  The study offers a new strategy for multi-target antitumor drug discovery by simultaneously acting on cancer metab. and epigenetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeCOjvPbhLxbVg90H21EOLACvtfcHk0ljpSxzUc1UTyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFOqsrjJ&md5=72fc5750e9b6d3b1a0331f1f3a8a3f5c</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00414%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DMiao%26aufirst%3DC.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDual%2520NAMPT%252FHDAC%2520Inhibitors%2520as%2520a%2520New%2520Strategy%2520for%2520Multitargeting%2520Antitumor%2520Drug%2520Discovery%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D34%26epage%3D38%26doi%3D10.1021%2Facsmedchemlett.7b00414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel indoleamine 2,3-dioxygenase 1 (IDO1) and histone deacetylase (HDAC) dual inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">312</span>– <span class="NLM_lpage">317</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00487</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00487" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmtVWrurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=312-317&author=K.+Fangauthor=G.+Dongauthor=Y.+Liauthor=S.+Heauthor=Y.+Wuauthor=S.+Wuauthor=W.+Wangauthor=C.+Sheng&title=Discovery+of+novel+indoleamine+2%2C3-dioxygenase+1+%28IDO1%29+and+histone+deacetylase+%28HDAC%29+dual+inhibitors&doi=10.1021%2Facsmedchemlett.7b00487"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) and Histone Deacetylase (HDAC) Dual Inhibitors</span></div><div class="casAuthors">Fang, Kun; Dong, Guoqiang; Li, Yu; He, Shipeng; Wu, Ying; Wu, Shanchao; Wang, Wei; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">312-317</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In order to take advantage of both immunotherapeutic and epigenetic antitumor agents, the first generation of dual indoleamine 2,3-dioxygenase 1 (IDO1) and histone deacetylase (HDAC) inhibitors were designed.  The highly active dual inhibitor 10 showed excellent and balanced activity against both IDO1 (IC50 = 69.0 nM) and HDAC1 (IC50 = 66.5 nM), whose dual targeting mechanisms were validated in cancer cells.  Compd. 10 had good pharmacokinetic profiles as an orally active antitumor agent and significantly reduced the L-kynurenine level in plasma.  In particular, it showed excellent in vivo antitumor efficacy in the murine LLC tumor model with low toxicity.  This proof-of-concept study provided a novel strategy for cancer treatment.  Compd. 10 represents a promising lead compd. for the development of novel antitumor agents and can also be used as a valuable probe to clarify the relationships and mechanisms between cancer immunotherapy and epigenetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEDqXRR2J0zrVg90H21EOLACvtfcHk0ljpSxzUc1UTyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmtVWrurc%253D&md5=c808b75f03d703dc7e66798759457f4a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00487%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DK.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520novel%2520indoleamine%25202%252C3-dioxygenase%25201%2520%2528IDO1%2529%2520and%2520histone%2520deacetylase%2520%2528HDAC%2529%2520dual%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D312%26epage%3D317%26doi%3D10.1021%2Facsmedchemlett.7b00487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Small molecules simultaneously inhibiting p53-murine double minute 2 (MDM2) interaction and histone deacetylases (HDACs): discovery of novel multitargeting antitumor agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">7245</span>– <span class="NLM_lpage">7260</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00664</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00664" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlykur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=7245-7260&author=S.+Heauthor=G.+Dongauthor=S.+Wuauthor=K.+Fangauthor=Z.+Miaoauthor=W.+Wangauthor=C.+Sheng&title=Small+molecules+simultaneously+inhibiting+p53-murine+double+minute+2+%28MDM2%29+interaction+and+histone+deacetylases+%28HDACs%29%3A+discovery+of+novel+multitargeting+antitumor+agents&doi=10.1021%2Facs.jmedchem.8b00664"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecules Simultaneously Inhibiting p53-Murine Double Minute 2 (MDM2) Interaction and Histone Deacetylases (HDACs): Discovery of Novel Multitargeting Antitumor Agents</span></div><div class="casAuthors">He, Shipeng; Dong, Guoqiang; Wu, Shanchao; Fang, Kun; Miao, Zhenyuan; Wang, Wei; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7245-7260</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">P53-Murine double minute 2 (MDM2) interaction and histone deacetylases (HDACs) are important targets in antitumor drug development.  Inspired by the synergistic effects between MDM2 and HDACs, the first MDM2/HDACs dual inhibitors were identified, which showed excellent activities against both targets.  In particular, compd. 14d was proven to be a potent and orally active MDM2/HDAC dual inhibitor, whose antitumor mechanisms were validated in cancer cells.  Compd. 14d showed excellent in vivo antitumor potency in the A549 xenograft model, providing a promising lead compd. for the development of novel antitumor agents.  Also, this proof-of-concept study offers a novel and efficient strategy for multitargeting antitumor drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx94Uvm3pP8bVg90H21EOLACvtfcHk0lhZa2-8BKX-5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlykur3L&md5=68871e41ecb786e135b01742e59eec85</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00664&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00664%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DS.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DK.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DSmall%2520molecules%2520simultaneously%2520inhibiting%2520p53-murine%2520double%2520minute%25202%2520%2528MDM2%2529%2520interaction%2520and%2520histone%2520deacetylases%2520%2528HDACs%2529%253A%2520discovery%2520of%2520novel%2520multitargeting%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D7245%26epage%3D7260%26doi%3D10.1021%2Facs.jmedchem.8b00664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel dual histone deacetylase and mammalian target of rapamycin target inhibitors as a promising strategy for cancer therapy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1577</span>– <span class="NLM_lpage">1592</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01825</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01825" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC1MXovFeguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=1577-1592&author=Y.+Chenauthor=X.+Yuanauthor=W.+Zhangauthor=M.+Tangauthor=L.+Zhengauthor=F.+Wangauthor=W.+Yanauthor=S.+Yangauthor=Y.+Weiauthor=J.+Heauthor=L.+Chen&title=Discovery+of+novel+dual+histone+deacetylase+and+mammalian+target+of+rapamycin+target+inhibitors+as+a+promising+strategy+for+cancer+therapy&doi=10.1021%2Facs.jmedchem.8b01825"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Dual Histone Deacetylase and Mammalian Target of Rapamycin Target Inhibitors as a Promising Strategy for Cancer Therapy</span></div><div class="casAuthors">Chen, Yong; Yuan, Xue; Zhang, Wanhua; Tang, Minghai; Zheng, Li; Wang, Fang; Yan, Wei; Yang, Shengyong; Wei, Yuquan; He, Jun; Chen, Lijuan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1577-1592</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the present study, a series of novel dual-target histone deacetylase (HDAC) and mammalian target of rapamycin (mTOR) inhibitors were designed and synthesized using pyrimidine-pyrazolyl pharmacophore to append HDAC recognition cap and hydroxamic acid as a zinc-binding motif.  Among them, I was the optimal lead compd. with potent inhibition activities against mTOR and HDAC1 with half-maximal inhibitory concn. of 1.2 and 0.19 nM, resp.  Western blot confirmed that I could upregulate acetylation of H3 and α-tubulin and downregulate mTOR-related downstream mediators.  I could also stimulate cell cycle arrest in G0/G1 phase and induce tumor cell apoptosis.  I showed comparable antitumor activity with the combination medication in MM1S xenograft model with a tumor growth inhibitory rate of 72.5%, without causing significant loss of body wt. and toxicity.  All of the results indicated that I could be a promising dual target inhibitor for treating hematol. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ3AdehNv1ObVg90H21EOLACvtfcHk0lhZa2-8BKX-5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXovFeguw%253D%253D&md5=7a2ff5020aedb0e3c302e65d993301e6</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01825%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DYuan%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520novel%2520dual%2520histone%2520deacetylase%2520and%2520mammalian%2520target%2520of%2520rapamycin%2520target%2520inhibitors%2520as%2520a%2520promising%2520strategy%2520for%2520cancer%2520therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D1577%26epage%3D1592%26doi%3D10.1021%2Facs.jmedchem.8b01825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of 4-methyl quinazoline derivatives as anticancer agents simultaneously targeting phosphoinositide 3-kinases and histone deacetylases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">6992</span>– <span class="NLM_lpage">7014</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00390</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00390" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpvFamtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=6992-7014&author=K.+Zhangauthor=F.+Laiauthor=S.+Linauthor=M.+Jiauthor=J.+Zhangauthor=Y.+Zhangauthor=J.+Jinauthor=R.+Fuauthor=D.+Wuauthor=H.+Tianauthor=N.+Xueauthor=L.+Shengauthor=X.+Zouauthor=Y.+Liauthor=X.+Chenauthor=H.+Xu&title=Design%2C+synthesis%2C+and+biological+evaluation+of+4-methyl+quinazoline+derivatives+as+anticancer+agents+simultaneously+targeting+phosphoinositide+3-kinases+and+histone+deacetylases&doi=10.1021%2Facs.jmedchem.9b00390"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of 4-Methyl Quinazoline Derivatives as Anticancer Agents Simultaneously Targeting Phosphoinositide 3-Kinases and Histone Deacetylases</span></div><div class="casAuthors">Zhang, Kehui; Lai, Fangfang; Lin, Songwen; Ji, Ming; Zhang, Jingbo; Zhang, Yan; Jin, Jing; Fu, Rong; Wu, Deyu; Tian, Hua; Xue, Nina; Sheng, Li; Zou, Xiaowen; Li, Yan; Chen, Xiaoguang; Xu, Heng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6992-7014</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Polypharmacol. is a promising paradigm in modern drug discovery.  Herein, we have discovered a series of novel PI3K and HDAC dual inhibitors in which the hydroxamic acid moiety as the zinc binding functional group was introduced to a quinazoline-based PI3K pharmacophore through an appropriate linker.  Systematic structure-activity relationship studies resulted in lead compds. 23 (shown in graphical abstr. and duplicated as I) and 36 (II) that simultaneously inhibited PI3K and HDAC with nanomolar potencies and demonstrated favorable antiproliferative activities.  Compds. 23 and 36 efficiently modulated the expression of p-AKT and Ac-H3, arrested the cell cycle, and induced apoptosis in HCT116 cancer cells.  Following pharmacokinetic studies, 23 was further evaluated in HCT116 and HGC-27 xenograft models to show significant in vivo anticancer efficacies with tumor growth inhibitions of 45.8% (po, 150 mg/kg) and 62.6% (i.p., 30 mg/kg), resp.  Overall, this work shows promise in discovering new anticancer therapeutics by the approach of simultaneously targeting PI3K and HDAC pathways with a single mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6xLiFaGhwk7Vg90H21EOLACvtfcHk0lhZa2-8BKX-5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpvFamtLg%253D&md5=de4c9a630208e49eac58dcad630adcd6</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00390%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DLai%26aufirst%3DF.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DJi%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DTian%26aufirst%3DH.%26aulast%3DXue%26aufirst%3DN.%26aulast%3DSheng%26aufirst%3DL.%26aulast%3DZou%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DH.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%25204-methyl%2520quinazoline%2520derivatives%2520as%2520anticancer%2520agents%2520simultaneously%2520targeting%2520phosphoinositide%25203-kinases%2520and%2520histone%2520deacetylases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D6992%26epage%3D7014%26doi%3D10.1021%2Facs.jmedchem.9b00390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of amide-pyridine derivatives as novel dual-target (SE, CYP51) antifungal inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2427</span>– <span class="NLM_lpage">2437</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2019.02.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1016%2Fj.bmc.2019.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=30765301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC1MXivVahur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2019&pages=2427-2437&author=B.+Sunauthor=Y.+Dongauthor=K.+Leiauthor=J.+Wangauthor=L.+Zhaoauthor=M.+Liu&title=Design%2C+synthesis+and+biological+evaluation+of+amide-pyridine+derivatives+as+novel+dual-target+%28SE%2C+CYP51%29+antifungal+inhibitors&doi=10.1016%2Fj.bmc.2019.02.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of amide-pyridine derivatives as novel dual-target (SE, CYP51) antifungal inhibitors</span></div><div class="casAuthors">Sun, Bin; Dong, Yue; Lei, Kang; Wang, Jian; Zhao, Liyu; Liu, Min</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2427-2437</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Based on the anal. of the squalene cyclooxygenase (SE) and 14α-demethylase (CYP51) inhibitors pharmacophore feature and the dual-target active sites, a series of compds. with amide-pyridine scaffolds have been designed and synthesized to treat the increasing incidence of drug-resistant fungal infections.  In vitro evaluation showed that these compds. have a certain degree of antifungal activity.  The most potent compds. 11a, 11b with MIC values in the range of 0.125-2 μg/mL had a broad-spectrum antifungal activity and exhibited excellent inhibitory activity against drug-resistant pathogenic fungi.  Preliminary mechanism studies revealed that the compd. 11b might play an antifungal role by inhibiting the activity of SE and CYP51.  Notably compds. did not show the genotoxicity through plasmid binding assay.  Finally, this study of mol. docking, ADME/T prediction and the construction of 3D QSAR model were performed.  These results can point out the direction for further optimization of the lead compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjqDxVOdtpaLVg90H21EOLACvtfcHk0ljHiLiWLCRTXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXivVahur8%253D&md5=b8fe8648e4c7e1fa2c7fe3935989741c</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2019.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2019.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DB.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DLei%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DM.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520amide-pyridine%2520derivatives%2520as%2520novel%2520dual-target%2520%2528SE%252C%2520CYP51%2529%2520antifungal%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2019%26volume%3D27%26spage%3D2427%26epage%3D2437%26doi%3D10.1016%2Fj.bmc.2019.02.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hargrove, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friggeri, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wawrzak, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoekstra, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schotzinger, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">York, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guengerich, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepesheva, G. I.</span></span> <span> </span><span class="NLM_article-title">Structural analyses of Candida albicans sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">6728</span>– <span class="NLM_lpage">6743</span>, <span class="refDoi"> DOI: 10.1074/jbc.m117.778308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1074%2Fjbc.M117.778308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=28258218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtlKlurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=6728-6743&author=T.+Y.+Hargroveauthor=L.+Friggeriauthor=Z.+Wawrzakauthor=A.+Qiauthor=W.+J.+Hoekstraauthor=R.+J.+Schotzingerauthor=J.+D.+Yorkauthor=F.+P.+Guengerichauthor=G.+I.+Lepesheva&title=Structural+analyses+of+Candida+albicans+sterol+14%CE%B1-demethylase+complexed+with+azole+drugs+address+the+molecular+basis+of+azole-mediated+inhibition+of+fungal+sterol+biosynthesis&doi=10.1074%2Fjbc.m117.778308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Structural analyses of Candida albicans sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis</span></div><div class="casAuthors">Hargrove, Tatiana Y.; Friggeri, Laura; Wawrzak, Zdzislaw; Qi, Aidong; Hoekstra, William J.; Schotzinger, Robert J.; York, John D.; Guengerich, F. Peter; Lepesheva, Galina I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6728-6743</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">With some advances in modern medicine (such as cancer chemotherapy, broad exposure to antibiotics, and immunosuppression), the incidence of opportunistic fungal pathogens such as Candida albicans has increased.  Cases of drug resistance among these pathogens have become more frequent, requiring the development of new drugs and a better understanding of the targeted enzymes.  Sterol 14α-demethylase (CYP51) is a cytochrome P 450 enzyme required for biosynthesis of sterols in eukaryotic cells and is the major target of clin. drugs for managing fungal pathogens, but some of the CYP51 key features important for rational drug design have remained obscure.  We report the catalytic properties, ligand-binding profiles, and inhibition of enzymic activity of C. albicans CYP51 by clin. antifungal drugs that are used systemically (fluconazole, voriconazole, ketoconazole, itraconazole, and posaconazole) and topically (miconazole and clotrimazole) and by a tetrazole-based drug candidate, VT-1161 (oteseconazole: (R)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)-1-(5-(4-(2,2,2-trifluoroethoxy)phenyl)pyridin-2-yl)propan-2-ol).  Among the compds. tested, the first-line drug fluconazole was the weakest inhibitor, whereas posaconazole and VT-1161 were the strongest CYP51 inhibitors.  We detd. the X-ray structures of C. albicans CYP51 complexes with posaconazole and VT-1161, providing a mol. mechanism for the potencies of these drugs, including the activity of VT-1161 against Candida krusei and Candida glabrata, pathogens that are intrinsically resistant to fluconazole.  Our comparative structural anal. outlines phylum-specific CYP51 features that could direct future rational development of more efficient broad-spectrum antifungals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfxQlfsadoX7Vg90H21EOLACvtfcHk0ljHiLiWLCRTXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtlKlurY%253D&md5=d1ee6d20b19d9cf7ee5eb5b1f6f11965</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M117.778308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M117.778308%26sid%3Dliteratum%253Aachs%26aulast%3DHargrove%26aufirst%3DT.%2BY.%26aulast%3DFriggeri%26aufirst%3DL.%26aulast%3DWawrzak%26aufirst%3DZ.%26aulast%3DQi%26aufirst%3DA.%26aulast%3DHoekstra%26aufirst%3DW.%2BJ.%26aulast%3DSchotzinger%26aufirst%3DR.%2BJ.%26aulast%3DYork%26aufirst%3DJ.%2BD.%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26aulast%3DLepesheva%26aufirst%3DG.%2BI.%26atitle%3DStructural%2520analyses%2520of%2520Candida%2520albicans%2520sterol%252014%25CE%25B1-demethylase%2520complexed%2520with%2520azole%2520drugs%2520address%2520the%2520molecular%2520basis%2520of%2520azole-mediated%2520inhibition%2520of%2520fungal%2520sterol%2520biosynthesis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26spage%3D6728%26epage%3D6743%26doi%3D10.1074%2Fjbc.m117.778308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tandon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lown, J. W.</span></span> <span> </span><span class="NLM_article-title">Synthesis of geometrically constrained unsymmetrical bis(polyamides) related to the antiviral distamycin</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>2000</i></span>,  <span class="NLM_fpage">2095</span>– <span class="NLM_lpage">2103</span>, <span class="refDoi"> DOI: 10.1002/1099-0690(200006)2000:11<2095::aid-ejoc2095>3.0.co;2-j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1002%2F1099-0690%28200006%292000%3A11%3C2095%3A%3AAID-EJOC2095%3E3.0.CO%3B2-J" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2000&publication_year=2000&pages=2095-2103&author=S.+K.+Sharmaauthor=M.+Tandonauthor=J.+W.+Lown&title=Synthesis+of+geometrically+constrained+unsymmetrical+bis%28polyamides%29+related+to+the+antiviral+distamycin&doi=10.1002%2F1099-0690%28200006%292000%3A11%3C2095%3A%3Aaid-ejoc2095%3E3.0.co%3B2-j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1002%2F1099-0690%28200006%292000%3A11%3C2095%3A%3AAID-EJOC2095%3E3.0.CO%3B2-J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1099-0690%2528200006%25292000%253A11%253C2095%253A%253AAID-EJOC2095%253E3.0.CO%253B2-J%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DS.%2BK.%26aulast%3DTandon%26aufirst%3DM.%26aulast%3DLown%26aufirst%3DJ.%2BW.%26atitle%3DSynthesis%2520of%2520geometrically%2520constrained%2520unsymmetrical%2520bis%2528polyamides%2529%2520related%2520to%2520the%2520antiviral%2520distamycin%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2000%26volume%3D2000%26spage%3D2095%26epage%3D2103%26doi%3D10.1002%2F1099-0690%28200006%292000%3A11%3C2095%3A%3Aaid-ejoc2095%3E3.0.co%3B2-j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dolles, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunesch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinelli, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatonnet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohse, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittmann, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabissi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, M.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships and computational investigations into the development of potent and balanced dual-acting butyrylcholinesterase inhibitors and human cannabinoid receptor 2 ligands with pro-cognitive in vivo profiles</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1646</span>– <span class="NLM_lpage">1663</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01760</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01760" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1Sqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1646-1663&author=D.+Dollesauthor=M.+Hoffmannauthor=S.+Guneschauthor=O.+Marinelliauthor=J.+M%C3%B6llerauthor=G.+Santoniauthor=A.+Chatonnetauthor=M.+J.+Lohseauthor=H.-J.+Wittmannauthor=A.+Strasserauthor=M.+Nabissiauthor=T.+Mauriceauthor=M.+Decker&title=Structure-activity+relationships+and+computational+investigations+into+the+development+of+potent+and+balanced+dual-acting+butyrylcholinesterase+inhibitors+and+human+cannabinoid+receptor+2+ligands+with+pro-cognitive+in+vivo+profiles&doi=10.1021%2Facs.jmedchem.7b01760"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships and Computational Investigations into the Development of Potent and Balanced Dual-Acting Butyrylcholinesterase Inhibitors and Human Cannabinoid Receptor 2 Ligands with Pro-Cognitive in Vivo Profiles</span></div><div class="casAuthors">Dolles, Dominik; Hoffmann, Matthias; Gunesch, Sandra; Marinelli, Oliviero; Moeller, Jan; Santoni, Giorgio; Chatonnet, Arnaud; Lohse, Martin J.; Wittmann, Hans-Joachim; Strasser, Andrea; Nabissi, Massimo; Maurice, Tangui; Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1646-1663</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The enzyme butyrylcholinesterase (BChE) and the human cannabinoid receptor 2 (hCB2R) represent promising targets for pharmacotherapy in the later stages of Alzheimer's disease.  The authors merged pharmacophores for both targets into small benzimidazole-based mols., investigated SARs, and identified several dual-acting ligands with a balanced affinity/inhibitory activity and an excellent selectivity over both hCB1R and hAChE.  A homol. model for the hCB2R was developed based on the hCB1R crystal structure and used for mol. dynamics studies to investigate binding modes.  In vitro studies proved hCB2R agonism.  Unwanted μ-opioid receptor affinity could be designed out.  One well-balanced dual-acting and selective hBChE inhibitor/hCB2R agonist showed superior in vivo activity over the lead CB2 agonist with regards to cognition improvement.  The data shows the possibility to combine a small mol. with selective and balanced GPCR-activity/enzyme inhibition and in vivo activity for the therapy of AD and may help to rationalize the development of other dual-acting ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgCAoLm6nAVbVg90H21EOLACvtfcHk0ljucEnY15ys4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1Sqsbo%253D&md5=49e8e68c2c9a023b872e2522fad6e78c</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01760%26sid%3Dliteratum%253Aachs%26aulast%3DDolles%26aufirst%3DD.%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DGunesch%26aufirst%3DS.%26aulast%3DMarinelli%26aufirst%3DO.%26aulast%3DM%25C3%25B6ller%26aufirst%3DJ.%26aulast%3DSantoni%26aufirst%3DG.%26aulast%3DChatonnet%26aufirst%3DA.%26aulast%3DLohse%26aufirst%3DM.%2BJ.%26aulast%3DWittmann%26aufirst%3DH.-J.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DNabissi%26aufirst%3DM.%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DStructure-activity%2520relationships%2520and%2520computational%2520investigations%2520into%2520the%2520development%2520of%2520potent%2520and%2520balanced%2520dual-acting%2520butyrylcholinesterase%2520inhibitors%2520and%2520human%2520cannabinoid%2520receptor%25202%2520ligands%2520with%2520pro-cognitive%2520in%2520vivo%2520profiles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D1646%26epage%3D1663%26doi%3D10.1021%2Facs.jmedchem.7b01760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baek, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryeom, H.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, T.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y.</span></span> <span> </span><span class="NLM_article-title">Gadolinium complex of 1,4,7,10-tetraazacyclododecane-1,4,7-trisacetic acid (DO3A)-ethoxybenzyl (EOB) conjugate as a new macrocyclic hepatobiliary MRI contrast agent</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4861</span>– <span class="NLM_lpage">4868</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00060</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00060" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotFOksrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4861-4868&author=A.+R.+Baekauthor=H.-K.+Kimauthor=S.+Parkauthor=G.+H.+Leeauthor=H.+J.+Kangauthor=J.-C.+Jungauthor=J.-S.+Parkauthor=H.-K.+Ryeomauthor=T.-J.+Kimauthor=Y.+Chang&title=Gadolinium+complex+of+1%2C4%2C7%2C10-tetraazacyclododecane-1%2C4%2C7-trisacetic+acid+%28DO3A%29-ethoxybenzyl+%28EOB%29+conjugate+as+a+new+macrocyclic+hepatobiliary+MRI+contrast+agent&doi=10.1021%2Facs.jmedchem.7b00060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Gadolinium Complex of 1,4,7,10-Tetraazacyclododecane-1,4,7-trisacetic Acid (DO3A)-Ethoxybenzyl (EOB) Conjugate as a New Macrocyclic Hepatobiliary MRI Contrast Agent</span></div><div class="casAuthors">Baek, Ah Rum; Kim, Hee-Kyung; Park, Subin; Lee, Gang Ho; Kang, Hyo Jeung; Jung, Jae-Chang; Park, Joon-Suk; Ryeom, Hun-Kyu; Kim, Tae-Jeong; Chang, Yongmin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4861-4868</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report the synthesis of a macrocyclic Gd chelate based on a 1,4,7,10-tetraazacyclododecane-1,4,7-tri(acetic acid) (DO3A) coordination cage bearing an ethoxybenzyl (EOB) moiety and discuss its use as a T1 hepatobiliary magnetic resonance imaging (MRI) contrast agent.  The new macrocyclic liver agent shows high chelation stability and high r1 relaxivity compared with linear-type Gd chelates, which are the current clin. approved liver agents.  The authors' macrocyclic, liver-specific Gd chelate was evaluated in vivo through biodistribution anal. and liver MRI, which demonstrated its high tumor detection sensitivity and suggested that the new Gd complex is a promising contrast agent for liver cancer imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrn561cNDW8L7Vg90H21EOLACvtfcHk0ljucEnY15ys4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotFOksrg%253D&md5=da55cff094d5cc8655ca191648c66379</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00060%26sid%3Dliteratum%253Aachs%26aulast%3DBaek%26aufirst%3DA.%2BR.%26aulast%3DKim%26aufirst%3DH.-K.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DG.%2BH.%26aulast%3DKang%26aufirst%3DH.%2BJ.%26aulast%3DJung%26aufirst%3DJ.-C.%26aulast%3DPark%26aufirst%3DJ.-S.%26aulast%3DRyeom%26aufirst%3DH.-K.%26aulast%3DKim%26aufirst%3DT.-J.%26aulast%3DChang%26aufirst%3DY.%26atitle%3DGadolinium%2520complex%2520of%25201%252C4%252C7%252C10-tetraazacyclododecane-1%252C4%252C7-trisacetic%2520acid%2520%2528DO3A%2529-ethoxybenzyl%2520%2528EOB%2529%2520conjugate%2520as%2520a%2520new%2520macrocyclic%2520hepatobiliary%2520MRI%2520contrast%2520agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4861%26epage%3D4868%26doi%3D10.1021%2Facs.jmedchem.7b00060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Minkenberg, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Rijn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florusse, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boekhoven, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, M. C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koper, G. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eelkema, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Esch, J. H.</span></span> <span> </span><span class="NLM_article-title">Responsive vesicles from dynamic covalent surfactants</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">3421</span>– <span class="NLM_lpage">3424</span>, <span class="refDoi"> DOI: 10.1002/anie.201007401</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1002%2Fanie.201007401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWmtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=3421-3424&author=C.+B.+Minkenbergauthor=F.+Liauthor=P.+van+Rijnauthor=L.+Florusseauthor=J.+Boekhovenauthor=M.+C.+A.+Stuartauthor=G.+J.+M.+Koperauthor=R.+Eelkemaauthor=J.+H.+van+Esch&title=Responsive+vesicles+from+dynamic+covalent+surfactants&doi=10.1002%2Fanie.201007401"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Responsive Vesicles from Dynamic Covalent Surfactants</span></div><div class="casAuthors">Minkenberg, Christophe B.; Li, Feng; van Rijn, Patrick; Florusse, Louw; Boekhoven, Job; Stuart, Marc C. A.; Koper, Ger J. M.; Eelkema, Rienk; van Esch, Jan H.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3421-3424, S3421/1-S3421/9</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Incorporation of dynamic covalent bonds in vesicle-forming surfactants leads to the formation of responsive vesicles, which can be switched back and forth between the bilayer state and the isotropic soln. using either diln. or a change in the pH value as external stimuli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjNi5c4TiAGbVg90H21EOLACvtfcHk0ljucEnY15ys4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWmtbo%253D&md5=8b310f009f030266815b0baf4dde44b0</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Fanie.201007401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201007401%26sid%3Dliteratum%253Aachs%26aulast%3DMinkenberg%26aufirst%3DC.%2BB.%26aulast%3DLi%26aufirst%3DF.%26aulast%3Dvan%2BRijn%26aufirst%3DP.%26aulast%3DFlorusse%26aufirst%3DL.%26aulast%3DBoekhoven%26aufirst%3DJ.%26aulast%3DStuart%26aufirst%3DM.%2BC.%2BA.%26aulast%3DKoper%26aufirst%3DG.%2BJ.%2BM.%26aulast%3DEelkema%26aufirst%3DR.%26aulast%3Dvan%2BEsch%26aufirst%3DJ.%2BH.%26atitle%3DResponsive%2520vesicles%2520from%2520dynamic%2520covalent%2520surfactants%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26spage%3D3421%26epage%3D3424%26doi%3D10.1002%2Fanie.201007401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakash, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narasimhaswamy, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis and characterization of two phenyl ring core-based thiophene mesogens</span>. <i>Mol. Cryst. Liq. Cryst.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>582</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1080/15421406.2013.790635</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1080%2F15421406.2013.790635" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKqsbzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=582&publication_year=2013&pages=1-14&author=M.+K.+Reddyauthor=K.+S.+Reddyauthor=M.+Prakashauthor=T.+Narasimhaswamy&title=Synthesis+and+characterization+of+two+phenyl+ring+core-based+thiophene+mesogens&doi=10.1080%2F15421406.2013.790635"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Characterization of Two Phenyl Ring Core-Based Thiophene Mesogens</span></div><div class="casAuthors">Reddy, M. Kesava; Reddy, K. Subramanyam; Prakash, M.; Narasimhaswamy, T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Crystals and Liquid Crystals</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">582</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-14</span>CODEN:
                <span class="NLM_cas:coden">MCLCD8</span>;
        ISSN:<span class="NLM_cas:issn">1542-1406</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Novel thiophene mesogens built with two Ph ring core and alkoxy terminal chains are synthesized by multistep route.  The Ph ring core is connected to thiophene by ester unit at (a) 2-position and (b) 3-position to yield 2-series of mesogens.  The structural characterization of them is accomplished by using spectroscopy tools and the mesophase characteristics are evaluated by HOPM and DSC.  The 13C chem. shifts of representative mesogens calcd. from DFT by quantum chem. calcns. are compared with exptl. 13C chem. shifts and further utilized for structural assignment of core unit carbons.  A good agreement between calcd. and exptl. values is noticed.  An enantiotropic nematic phase is confirmed for all the mesogens and accordingly threaded nematic texture in HOPM is obsd. and is supported by DSC transition enthalpy values.  The mesophase as well as thermal stabilities of the mesogens are discussed with ref. to terminal chain length and position of the linking unit on thiophene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNbLPtWV7QCLVg90H21EOLACvtfcHk0lj21bYlyxO3Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKqsbzF&md5=878a1fa6834fc35e99770fec2f864c8c</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1080%2F15421406.2013.790635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15421406.2013.790635%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DM.%2BK.%26aulast%3DReddy%26aufirst%3DK.%2BS.%26aulast%3DPrakash%26aufirst%3DM.%26aulast%3DNarasimhaswamy%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520characterization%2520of%2520two%2520phenyl%2520ring%2520core-based%2520thiophene%2520mesogens%26jtitle%3DMol.%2520Cryst.%2520Liq.%2520Cryst.%26date%3D2013%26volume%3D582%26spage%3D1%26epage%3D14%26doi%3D10.1080%2F15421406.2013.790635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of highly potent triazole antifungal derivatives by heterocycle-benzene bioisosteric replacement</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">16</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2013.04.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1016%2Fj.ejmech.2013.04.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=23643831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptFKrsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2013&pages=16-22&author=Z.+Jiangauthor=Y.+Wangauthor=W.+Wangauthor=S.+Wangauthor=B.+Xuauthor=G.+Fanauthor=G.+Dongauthor=Y.+Liuauthor=J.+Yaoauthor=Z.+Miaoauthor=W.+Zhangauthor=C.+Sheng&title=Discovery+of+highly+potent+triazole+antifungal+derivatives+by+heterocycle-benzene+bioisosteric+replacement&doi=10.1016%2Fj.ejmech.2013.04.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of highly potent triazole antifungal derivatives by heterocycle-benzene bioisosteric replacement</span></div><div class="casAuthors">Jiang, Zhigan; Wang, Yan; Wang, Wenya; Wang, Shengzheng; Xu, Bo; Fan, Guorong; Dong, Guoqiang; Liu, Yang; Yao, Jianzhong; Miao, Zhenyuan; Zhang, Wannian; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16-22</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">On the basis of the authors' previously discovered triazole antifungal lead compds., heterocycle-benzene bioisosteric replacement was used to improve their pharmacokinetic profile.  The designed new triazole derivs. have good antifungal activity toward a wide range of pathogenic fungi.  Their binding mode with the target enzyme was clarified by mol. docking.  The MIC value of the highly potent compd. 1-(4-(benzo[d]thiazol-2-yl-methyl)piperazin-1-yl)-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol against Candida albicans, Candida tropicalis, and Cryptococcus neoformans is 0.016 μg/mL, 0.004 μg/mL, and 0.016 μg/mL, resp.  Moreover, preliminary pharmacokinetic studies revealed that it showed improved oral absorption as compared to the lead compd. iodiconazole and deserved for further evaluations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokqjgNHIDbnrVg90H21EOLACvtfcHk0lj21bYlyxO3Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptFKrsr8%253D&md5=249e0d7052d65311920552e1ae0372a2</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.04.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.04.025%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DFan%26aufirst%3DG.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520highly%2520potent%2520triazole%2520antifungal%2520derivatives%2520by%2520heterocycle-benzene%2520bioisosteric%2520replacement%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D64%26spage%3D16%26epage%3D22%26doi%3D10.1016%2Fj.ejmech.2013.04.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Clinical
and Laboratory Standards
Institute</span>.  <i>Reference Method for Broth
Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard-Third
Edition M27-A3</i>, <span class="NLM_year">2008</span>; Vol.  <span class="NLM_volume">28</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=Clinical%0Aand+Laboratory+Standards%0AInstitute&title=Reference+Method+for+Broth%0ADilution+Antifungal+Susceptibility+Testing+of+Yeasts.+Approved+Standard-Third%0AEdition+M27-A3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DReference%2520Method%2520for%2520Broth%250ADilution%2520Antifungal%2520Susceptibility%2520Testing%2520of%2520Yeasts.%2520Approved%2520Standard-Third%250AEdition%2520M27-A3%26date%3D2008%26volume%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barker, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crisp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiederhold, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bareither, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckstein, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbuch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, P. D.</span></span> <span> </span><span class="NLM_article-title">Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">376</span>– <span class="NLM_lpage">385</span>, <span class="refDoi"> DOI: 10.1093/jac/dkh336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1093%2Fjac%2Fdkh336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=15201233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnt1WisLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2004&pages=376-385&author=K.+S.+Barkerauthor=S.+Crispauthor=N.+Wiederholdauthor=R.+E.+Lewisauthor=B.+Bareitherauthor=J.+Ecksteinauthor=R.+Barbuchauthor=M.+Bardauthor=P.+D.+Rogers&title=Genome-wide+expression+profiling+reveals+genes+associated+with+amphotericin+B+and+fluconazole+resistance+in+experimentally+induced+antifungal+resistant+isolates+of+Candida+albicans&doi=10.1093%2Fjac%2Fdkh336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans</span></div><div class="casAuthors">Barker, Katherine S.; Crisp, Sarah; Wiederhold, Nathan; Lewis, Russell E.; Bareither, Bart; Eckstein, James; Barbuch, Robert; Bard, Martin; Rogers, P. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">376-385</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objectives: The aim of this study was to identify changes in the gene expression profile of Candida albicans assocd. with the acquisition of exptl. induced resistance to amphotericin B and fluconazole.  Methods: C. albicans SC5314 was passed in increasing concns. of amphotericin B to generate isolate SC5314-AR.  Susceptibility testing by Etest revealed SC5314-AR to be highly resistant to both amphotericin B and fluconazole.  The gene expression profile of SC5314-AR was compared with that of SC5314 using DNA microarray anal.  Sterol compn. was detd. for both strains.  Results: Upon examn. of MICs of antifungal compds., it was found that SC5314-AR was resistant to both amphotericin B and fluconazole.  By microarray anal. a total of 134 genes were differentially expressed, that is up-regulated or down-regulated by at least 50%, in SC5314-AR.  In addn. to the cell stress genes DDR48 and RTA2, the ergosterol biosynthesis genes ERG5, ERG6 and ERG25 were up-regulated.  Several histone genes, protein synthesis genes and energy generation genes were down-regulated.  Sterol anal. revealed the prevalence of sterol intermediates eburicol and lanosterol in SC5314-AR, whereas ergosterol was the predominant sterol in SC5314.  Conclusion: Along with changes in expression of these ergosterol biosynthesis genes was the accumulation of sterol intermediates in the resistant strain, which would account for the decreased affinity of amphotericin B for membrane sterols and a decreased requirement for lanosterol demethylase activity in membrane sterol prodn.  Furthermore, other genes are implicated as having a potential role in the polyene and azole antifungal resistant phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLFsttZhPI_LVg90H21EOLACvtfcHk0ljFwtVrkBuB_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnt1WisLo%253D&md5=a343151092e702ec2276bae2eb5762aa</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkh336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkh336%26sid%3Dliteratum%253Aachs%26aulast%3DBarker%26aufirst%3DK.%2BS.%26aulast%3DCrisp%26aufirst%3DS.%26aulast%3DWiederhold%26aufirst%3DN.%26aulast%3DLewis%26aufirst%3DR.%2BE.%26aulast%3DBareither%26aufirst%3DB.%26aulast%3DEckstein%26aufirst%3DJ.%26aulast%3DBarbuch%26aufirst%3DR.%26aulast%3DBard%26aufirst%3DM.%26aulast%3DRogers%26aufirst%3DP.%2BD.%26atitle%3DGenome-wide%2520expression%2520profiling%2520reveals%2520genes%2520associated%2520with%2520amphotericin%2520B%2520and%2520fluconazole%2520resistance%2520in%2520experimentally%2520induced%2520antifungal%2520resistant%2520isolates%2520of%2520Candida%2520albicans%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2004%26volume%3D54%26spage%3D376%26epage%3D385%26doi%3D10.1093%2Fjac%2Fdkh336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.</span></span> <span> </span><span class="NLM_article-title">Structure-based rational screening of novel hit compounds with structural diversity for cytochrome P450 sterol 14α-demethylase from Penicillium digitatum</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">317</span>– <span class="NLM_lpage">325</span>, <span class="refDoi"> DOI: 10.1021/ci900425t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci900425t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvFWhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=317-325&author=Q.+Zhangauthor=D.+Liauthor=P.+Weiauthor=J.+Zhangauthor=J.+Wanauthor=Y.+Renauthor=Z.+Chenauthor=D.+Liuauthor=Z.+Yuauthor=L.+Feng&title=Structure-based+rational+screening+of+novel+hit+compounds+with+structural+diversity+for+cytochrome+P450+sterol+14%CE%B1-demethylase+from+Penicillium+digitatum&doi=10.1021%2Fci900425t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Rational Screening of Novel Hit Compounds with Structural Diversity for Cytochrome P450 Sterol 14α-Demethylase from Penicillium digitatum</span></div><div class="casAuthors">Zhang, Qingye; Li, Ding; Wei, Pei; Zhang, Jie; Wan, Jian; Ren, Yangliang; Chen, Zhigang; Liu, Deli; Yu, Ziniu; Feng, Lingling</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">317-325</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cytochrome P 450 sterol 14α-demethylases (CYP51s) are essential enzymes in sterol biosynthesis and well-known as the target of antifungal drugs.  All fungal CYP51s are integral membrane proteins, making structural and biophys. characterization more challenging.  The X-ray crystallog. structure of CYP51 isolated from Mycobacterium tuberculosis (MT-CYP51) is the unique reported one hitherto.  In the present study, a homol. modeling three-dimensional structure of CYP51 from Penicillium digitatum (PD-CYP51) was generated by CPHmodels, in which the accuracy of sequence alignment could be improved by taking into account further structural conservation information, using MT-CYP51 as the template.  Interaction mechanism between the active site of PD-CYP51 and its inhibitors were further investigated by mol. dynamics simulating and mol. docking.  With the effective docking process and interaction anal. information, structure-based virtual screening was performed to pick out the thirty new potential inhibiting compds. with structural diversity by using a new virtual screening strategy including Flex-Pharm/PMF/GOLD//FlexX/PMF/GOLD mol. docking procedures, and finally, seven new hit compds. out of SPECs database with potent inhibitory ability were validated by bioaffinity assays at enzyme level and on P. digitatum in vitro.  The pos. results indicated that all modeling strategies and screening processes presented in the current study are an encouraging way in search of novel lead compds. with structural diversity for the specifically individual fungal CYP51s of both plants and human pathogens in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjLVnlQqSnLLVg90H21EOLACvtfcHk0ljFwtVrkBuB_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvFWhuw%253D%253D&md5=20748311280af2036154ac49f44c0533</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fci900425t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci900425t%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DWei%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DJ.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DFeng%26aufirst%3DL.%26atitle%3DStructure-based%2520rational%2520screening%2520of%2520novel%2520hit%2520compounds%2520with%2520structural%2520diversity%2520for%2520cytochrome%2520P450%2520sterol%252014%25CE%25B1-demethylase%2520from%2520Penicillium%2520digitatum%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D317%26epage%3D325%26doi%3D10.1021%2Fci900425t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thamban
Chandrika, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shrestha, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsodikov, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garneau-Tsodikova, S.</span></span> <span> </span><span class="NLM_article-title">Alkylated piperazines and piperazine-azole hybrids as antifungal agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">158</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01138</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01138" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFyrtLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=158-173&author=N.+Thamban%0AChandrikaauthor=S.+K.+Shresthaauthor=H.+X.+Ngoauthor=O.+V.+Tsodikovauthor=K.+C.+Howardauthor=S.+Garneau-Tsodikova&title=Alkylated+piperazines+and+piperazine-azole+hybrids+as+antifungal+agents&doi=10.1021%2Facs.jmedchem.7b01138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Alkylated Piperazines and Piperazine-Azole Hybrids as Antifungal Agents</span></div><div class="casAuthors">Thamban Chandrika, Nishad; Shrestha, Sanjib K.; Ngo, Huy X.; Tsodikov, Oleg V.; Howard, Kaitlind C.; Garneau-Tsodikova, Sylvie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">158-173</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The extensive use of fluconazole (FLC) and other azole drugs has caused the emergence and rise of azole-resistant fungi.  The fungistatic nature of FLC in combination with toxicity concerns have resulted in an increased demand for new azole antifungal agents.  Herein, we report the synthesis and antifungal activity of novel alkylated piperazines and alkylated piperazine-azole hybrids, their time-kill studies, their hemolytic activity against murine erythrocytes, as well as their cytotoxicity against mammalian cells.  Many of these mols. exhibited broad-spectrum activity against all tested fungal strains, with excellent min. inhibitory concn. (MIC) values against non-albicans Candida and Aspergillus strains.  The most promising compds. were found to be less hemolytic than the FDA-approved antifungal agent voriconazole (VOR).  Finally, we demonstrate that the synthetic alkylated piperazine-azole hybrids do not function by fungal membrane disruption, but instead by disruption of the ergosterol biosynthetic pathway via inhibition of the 14α-demethylase enzyme present in fungal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_maYeDMRUULVg90H21EOLACvtfcHk0ljFwtVrkBuB_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFyrtLfP&md5=2e7c24c4345936afa5c12d80c78f18cc</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01138%26sid%3Dliteratum%253Aachs%26aulast%3DThamban%2BChandrika%26aufirst%3DN.%26aulast%3DShrestha%26aufirst%3DS.%2BK.%26aulast%3DNgo%26aufirst%3DH.%2BX.%26aulast%3DTsodikov%26aufirst%3DO.%2BV.%26aulast%3DHoward%26aufirst%3DK.%2BC.%26aulast%3DGarneau-Tsodikova%26aufirst%3DS.%26atitle%3DAlkylated%2520piperazines%2520and%2520piperazine-azole%2520hybrids%2520as%2520antifungal%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D158%26epage%3D173%26doi%3D10.1021%2Facs.jmedchem.7b01138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guillon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logé, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagniez, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferchaud-Roucher, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duflos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pape, P. L.</span></span> <span> </span><span class="NLM_article-title">Synthesis and in vitro antifungal evaluation of 2-(2,4-difluorophenyl)-1-[(1H-indol-3-ylmethyl)methylamino]-3-(1H-1,2,4-triazol-1 -yl)propan-2-ols</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">261</span>– <span class="NLM_lpage">269</span>, <span class="refDoi"> DOI: 10.3109/14756366.2010.503607</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.3109%2F14756366.2010.503607" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=20695753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjt1Wisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2011&pages=261-269&author=R.+Guillonauthor=C.+Log%C3%A9author=F.+Pagniezauthor=V.+Ferchaud-Roucherauthor=M.+Duflosauthor=C.+Picotauthor=P.+L.+Pape&title=Synthesis+and+in+vitro+antifungal+evaluation+of+2-%282%2C4-difluorophenyl%29-1-%5B%281H-indol-3-ylmethyl%29methylamino%5D-3-%281H-1%2C2%2C4-triazol-1+-yl%29propan-2-ols&doi=10.3109%2F14756366.2010.503607"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro antifungal evaluation of 2-(2,4-difluorophenyl)-1-[(1H-indol-3-ylmethyl)methylamino]-3-(1H-1,2,4-triazol-1-yl)propan-2-ols</span></div><div class="casAuthors">Guillon, Remi; Loge, Cedric; Pagniez, Fabrice; Ferchaud-Roucher, Veronique; Duflos, Muriel; Picot, Carine; Le Pape, Patrice</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">261-269</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Previous studies, based on the design of 1-[(1H-indol-5-ylmethyl)amino]-2-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as antifungal agents, were extended to the identification of new indol-3-ylmethylamino derivs.  The majority of these compds. exhibited antifungal activity against a Candida albicans strain (min. inhibitory concns. ranging from 199.0 to 381.0 ng/mL) suggesting an inhibition of 14α-demethylase by sterol anal. studies, but are weaker inhibitors compared to their indol-5-ylmethylamino analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosr_pdGRENerVg90H21EOLACvtfcHk0lhoCv002Q1z_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjt1Wisr8%253D&md5=8e4c4a3b1c56c5159ecc3c7998b666ce</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.3109%2F14756366.2010.503607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2010.503607%26sid%3Dliteratum%253Aachs%26aulast%3DGuillon%26aufirst%3DR.%26aulast%3DLog%25C3%25A9%26aufirst%3DC.%26aulast%3DPagniez%26aufirst%3DF.%26aulast%3DFerchaud-Roucher%26aufirst%3DV.%26aulast%3DDuflos%26aufirst%3DM.%26aulast%3DPicot%26aufirst%3DC.%26aulast%3DPape%26aufirst%3DP.%2BL.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520antifungal%2520evaluation%2520of%25202-%25282%252C4-difluorophenyl%2529-1-%255B%25281H-indol-3-ylmethyl%2529methylamino%255D-3-%25281H-1%252C2%252C4-triazol-1%2520-yl%2529propan-2-ols%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2011%26volume%3D26%26spage%3D261%26epage%3D269%26doi%3D10.3109%2F14756366.2010.503607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S. S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrow, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podust, L. M.</span></span> <span> </span><span class="NLM_article-title">A nonazole CYP51 inhibitor cures Chagas’ disease in a mouse model of acute infection</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2480</span>– <span class="NLM_lpage">2488</span>, <span class="refDoi"> DOI: 10.1128/aac.00281-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1128%2FAAC.00281-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=20385875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1Ohu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=2480-2488&author=P.+S.+Doyleauthor=C.-K.+Chenauthor=J.+B.+Johnstonauthor=S.+D.+Hopkinsauthor=S.+S.+F.+Leungauthor=M.+P.+Jacobsonauthor=J.+C.+Engelauthor=J.+H.+McKerrowauthor=L.+M.+Podust&title=A+nonazole+CYP51+inhibitor+cures+Chagas%E2%80%99+disease+in+a+mouse+model+of+acute+infection&doi=10.1128%2Faac.00281-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">A nonazole CYP51 inhibitor cures Chagas' disease in a mouse model of acute infection</span></div><div class="casAuthors">Doyle, Patricia S.; Chen, Chiung-Kuang; Johnston, Jonathan B.; Hopkins, Stephanie D.; Leung, Siegfried S. F.; Jacobson, Matthew P.; Engel, Juan C.; McKerrow, James H.; Podust, Larissa M.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2480-2488</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Chagas' disease, the leading cause of heart failure in Latin America, is caused by the kinetoplastid protozoan Trypanosoma cruzi.  The sterols of T. cruzi resemble those of fungi, both in compn. and in biosynthesis.  Azole inhibitors of sterol 14α-demethylase (CYP51) successfully treat fungal infections in humans, and efforts to adapt the success of antifungal azoles posaconazole and ravuconazole as second-use agents for Chagas' disease are under way.  However, to address concerns about the use of azoles for Chagas' disease, including drug resistance and cost, the rational design of nonazole CYP51 inhibitors can provide promising alternative drug chemotypes.  We report the curative effect of the nonazole CYP51 inhibitor LP10 in an acute mouse model of T. cruzi infection.  Mice treated with an oral dose of 40 mg LP10/kg of body wt. twice a day (BID) for 30 days, initiated 24 h postinfection, showed no signs of acute disease and had histol. normal tissues after 6 mo.  A very stringent test of cure showed that 4/5 mice had neg. PCR results for T. cruzi, and parasites were amplified by hemoculture in only two treated mice.  These results compare favorably with those reported for posaconazole.  Electron microscopy and gas chromatog.-mass spectrometry (GC-MS) anal. of sterol compn. confirmed that treatment with LP10 blocked the 14α-demethylation step and induced breakdown of parasite cell membranes, culminating in severe ultrastructural and morphol. alterations and death of the clin. relevant amastigote stage of the parasite.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ-K-iYD6LBbVg90H21EOLACvtfcHk0lhoCv002Q1z_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1Ohu7s%253D&md5=cd28b1ca30614162c4fbaaba28511650</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1128%2FAAC.00281-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00281-10%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DP.%2BS.%26aulast%3DChen%26aufirst%3DC.-K.%26aulast%3DJohnston%26aufirst%3DJ.%2BB.%26aulast%3DHopkins%26aufirst%3DS.%2BD.%26aulast%3DLeung%26aufirst%3DS.%2BS.%2BF.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DEngel%26aufirst%3DJ.%2BC.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DPodust%26aufirst%3DL.%2BM.%26atitle%3DA%2520nonazole%2520CYP51%2520inhibitor%2520cures%2520Chagas%25E2%2580%2599%2520disease%2520in%2520a%2520mouse%2520model%2520of%2520acute%2520infection%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D2480%26epage%3D2488%26doi%3D10.1128%2Faac.00281-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kontoyiannis, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R. E.</span></span> <span> </span><span class="NLM_article-title">Antifungal drug resistance of pathogenic fungi</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>359</i></span>,  <span class="NLM_fpage">1135</span>– <span class="NLM_lpage">1144</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(02)08162-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1016%2FS0140-6736%2802%2908162-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=11943280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1ehsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=2002&pages=1135-1144&author=D.+P.+Kontoyiannisauthor=R.+E.+Lewis&title=Antifungal+drug+resistance+of+pathogenic+fungi&doi=10.1016%2Fs0140-6736%2802%2908162-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Antifungal drug resistance of pathogenic fungi</span></div><div class="casAuthors">Kontoyiannis, Dimitrios P.; Lewis, Russell E.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">359</span>
        (<span class="NLM_cas:issue">9312</span>),
    <span class="NLM_cas:pages">1135-1144</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Lancet Publishing Group</span>)
        </div><div class="casAbstract">A review.  Pathogenic fungi have many complex mechanisms of resistance to antifungal drugs.  Information about the clin., cellular, and mol. factors contributing to antifungal-drug resistance continues to accumulate.  The authors critically review the diagnosis, epidemiol., and mechanisms of antifungal drug resistance of pathogenic fungi.  Better understanding of this resistance should assist in developing better detection strategies for preventing and treating refractory mycoses in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1dW784KCr5rVg90H21EOLACvtfcHk0lhoCv002Q1z_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1ehsLs%253D&md5=80210f3ec3e1dccea49e2427118218a6</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2802%2908162-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252802%252908162-X%26sid%3Dliteratum%253Aachs%26aulast%3DKontoyiannis%26aufirst%3DD.%2BP.%26aulast%3DLewis%26aufirst%3DR.%2BE.%26atitle%3DAntifungal%2520drug%2520resistance%2520of%2520pathogenic%2520fungi%26jtitle%3DLancet%26date%3D2002%26volume%3D359%26spage%3D1135%26epage%3D1144%26doi%3D10.1016%2Fs0140-6736%2802%2908162-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arendrup, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, T. F.</span></span> <span> </span><span class="NLM_article-title">Multidrug-resistant candida: epidemiology, molecular mechanisms, and treatment</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>216</i></span>,  <span class="NLM_fpage">S445</span>– <span class="NLM_lpage">S451</span>, <span class="refDoi"> DOI: 10.1093/infdis/jix131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1093%2Finfdis%2Fjix131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=28911043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFOkt7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=216&publication_year=2017&pages=S445-S451&author=M.+C.+Arendrupauthor=T.+F.+Patterson&title=Multidrug-resistant+candida%3A+epidemiology%2C+molecular+mechanisms%2C+and+treatment&doi=10.1093%2Finfdis%2Fjix131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug-resistant Candida: epidemiology, molecular mechanisms, and treatment</span></div><div class="casAuthors">Arendrup, Maiken Cavling; Patterson, Thomas F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">216</span>
        (<span class="NLM_cas:issue">Suppl. 3</span>),
    <span class="NLM_cas:pages">S445-S451</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">1537-6613</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Invasive Candida infections remain an important cause of morbidity and mortality, esp. in hospitalized and immunocompromised or critically ill patients.  A limited no. of antifungal agents from only a few drug classes are available to treat patients with these serious infections.  Resistance can be either intrinsic or acquired.  Resistance mechanisms are not exchanged between Candida; thus, acquired resistance either emerges in response to an antifungal selection pressure in the individual patient or, more rarely, occur due to horizontal transmission of resistant strains between patients.  Although multidrug resistance is uncommon, increasing reports of multidrug resistance to the azoles, echinocandins, and polyenes have occurred in several Candida species, most notably Candida glabrata and more recently Candida auris.  Drivers are overall antifungal use, subtherapeutic drug levels at sites of infection/ colonization, drug sequestration in the biofilm matrix, and, in the setting of outbreaks, suboptimal infection control.  Moreover, recent research suggests that DNA mismatch repair gene mutations may facilitate acquisition of resistance mutations in C. glabrata specifically.  Diagnosis of antifungal-resistant Candida infections is crit. to the successful management of patients with these infections.  Redn. of unnecessary use of antifungals via antifungal stewardship is crit. to limit multidrug resistance emergence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqedB5dIDze6rVg90H21EOLACvtfcHk0ljHXrT4K12dZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFOkt7zF&md5=c6d777b6835af212887b07485e2c114a</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2Fjix131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252Fjix131%26sid%3Dliteratum%253Aachs%26aulast%3DArendrup%26aufirst%3DM.%2BC.%26aulast%3DPatterson%26aufirst%3DT.%2BF.%26atitle%3DMultidrug-resistant%2520candida%253A%2520epidemiology%252C%2520molecular%2520mechanisms%252C%2520and%2520treatment%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2017%26volume%3D216%26spage%3DS445%26epage%3DS451%26doi%3D10.1093%2Finfdis%2Fjix131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niimi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harding, D. R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parshot, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lun, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decottignies, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niimi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cannon, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goffeau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monk, B. C.</span></span> <span> </span><span class="NLM_article-title">Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a D-octapeptide derivative</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1256</span>– <span class="NLM_lpage">1271</span>, <span class="refDoi"> DOI: 10.1128/aac.48.4.1256-1271.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1128%2FAAC.48.4.1256-1271.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=15047528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtVKqsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=1256-1271&author=K.+Niimiauthor=D.+R.+K.+Hardingauthor=R.+Parshotauthor=A.+Kingauthor=D.+J.+Lunauthor=A.+Decottigniesauthor=M.+Niimiauthor=S.+Linauthor=R.+D.+Cannonauthor=A.+Goffeauauthor=B.+C.+Monk&title=Chemosensitization+of+fluconazole+resistance+in+Saccharomyces+cerevisiae+and+pathogenic+fungi+by+a+D-octapeptide+derivative&doi=10.1128%2Faac.48.4.1256-1271.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a D-octapeptide derivative</span></div><div class="casAuthors">Niimi, K.; Harding, D. R. K.; Parshot, R.; King, A.; Lun, D. J.; Decottignies, A.; Niimi, M.; Lin, S.; Cannon, R. D.; Goffeau, A.; Monk, B. C.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1256-1271</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Hyperexpression of the S. cerevisiae multidrug ATP-binding cassette (ABC) transporter Pdr5p was driven by the pdr1-3 mutation in the Pdr1p transcriptional regulator in a strain (AD/PDR5+) with deletions of 5 other ABC-type multidrug efflux pumps.  The strain had high-level fluconazole (FLC) resistance (MIC, 600 μg/mL), and plasma membrane fractions showed oligomycin-sensitive ATPase activity ≤5-fold higher than that shown by fractions from an isogenic PDR5-null mutant (FLC MIC, 0.94 μg/mL).  In vitro inhibition of the Pdr5p ATPase activity and chemosensitization of cells to FLC allowed the systematic screening of a 1.8-million-member designer D-octapeptide combinatorial library for surface-active Pdr5p antagonists with modest toxicity against yeast cells.  Library deconvolution identified the 4-methoxy-2,3,6-trimethylbenzenesulfonyl-substituted D-octapeptide KN20 as a potent Pdr5p ATPase inhibitor (concn. of drug causing 50% inhibition of enzyme activity [IC50], 4 μM) which chemosensitized AD/PDR5+ to FLC, itraconazole, and ketoconazole.  It also inhibited the ATPase activity of other ABC transporters, such as Candida albicans Cdr1p (IC50, 30 μM) and Cdr2p (IC50, 2 μM), and chemosensitized clin. isolates of pathogenic Candida spp. and S. cerevisiae strains that heterologously hyperexpressed either ABC-type multidrug efflux pumps, the C. albicans major facilitator superfamily-type drug transporter BenRp, or the FLC drug target lanosterol 14α-demethylase (Erg11p).  Although KN20 also inhibited the S. cerevisiae plasma membrane proton pump Pma1p (IC50, 1 μM), the peptide concns. required for chemosensitization made yeast cells permeable to rhodamine 6G.  KN20 therefore appears to indirectly chemosensitize cells to FLC by a nonlethal permeabilization of the fungal plasma membrane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_Glg2Lzb-yLVg90H21EOLACvtfcHk0ljHXrT4K12dZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtVKqsrs%253D&md5=80a29376a7856176a73cec97eb3ce27e</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1128%2FAAC.48.4.1256-1271.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.48.4.1256-1271.2004%26sid%3Dliteratum%253Aachs%26aulast%3DNiimi%26aufirst%3DK.%26aulast%3DHarding%26aufirst%3DD.%2BR.%2BK.%26aulast%3DParshot%26aufirst%3DR.%26aulast%3DKing%26aufirst%3DA.%26aulast%3DLun%26aufirst%3DD.%2BJ.%26aulast%3DDecottignies%26aufirst%3DA.%26aulast%3DNiimi%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DCannon%26aufirst%3DR.%2BD.%26aulast%3DGoffeau%26aufirst%3DA.%26aulast%3DMonk%26aufirst%3DB.%2BC.%26atitle%3DChemosensitization%2520of%2520fluconazole%2520resistance%2520in%2520Saccharomyces%2520cerevisiae%2520and%2520pathogenic%2520fungi%2520by%2520a%2520D-octapeptide%2520derivative%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D1256%26epage%3D1271%26doi%3D10.1128%2Faac.48.4.1256-1271.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumamoto, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinces, M. D.</span></span> <span> </span><span class="NLM_article-title">Contributions of hyphae and hypha-co-regulated genes to Candida albicans virulence</span>. <i>Cell. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1546</span>– <span class="NLM_lpage">1554</span>, <span class="refDoi"> DOI: 10.1111/j.1462-5822.2005.00616.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1111%2Fj.1462-5822.2005.00616.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=16207242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFGkt7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=1546-1554&author=C.+A.+Kumamotoauthor=M.+D.+Vinces&title=Contributions+of+hyphae+and+hypha-co-regulated+genes+to+Candida+albicans+virulence&doi=10.1111%2Fj.1462-5822.2005.00616.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Contributions of hyphae and hypha-co-regulated genes to Candida albicans virulence</span></div><div class="casAuthors">Kumamoto, Carol A.; Vinces, Marcelo D.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Microbiology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1546-1554</span>CODEN:
                <span class="NLM_cas:coden">CEMIF5</span>;
        ISSN:<span class="NLM_cas:issn">1462-5814</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The fascinating ability of Candida albicans to undergo dramatic changes in cellular morphol. has invited speculation that this plasticity in form contributes to the virulence of the organism.  Mol. genetic analyses have confirmed this hypothesis and further demonstrated that genes that govern cellular morphol. are co-regulated with genes encoding conventional virulence factors such as proteases and adhesins.  The transcriptional regulatory networks of C. albicans thus ensure that hyphae are produced concomitantly with virulence factors, resulting in cells that are adapted for invading the tissues of an immunocompromised host.  Hyphae are able to exert mech. force, aiding penetration of epithelial surfaces, and hyphae damage endothelial cells, aiding escape of C. albicans from the host bloodstream into deeper tissue.  Hyphal morphogenesis is thus an integral part of the overall virulence strategy of C. albicans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMN0NHLYd1YbVg90H21EOLACvtfcHk0ljHXrT4K12dZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFGkt7vP&md5=bdc4095d0da44bfcf6ec265fd798e89d</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1111%2Fj.1462-5822.2005.00616.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1462-5822.2005.00616.x%26sid%3Dliteratum%253Aachs%26aulast%3DKumamoto%26aufirst%3DC.%2BA.%26aulast%3DVinces%26aufirst%3DM.%2BD.%26atitle%3DContributions%2520of%2520hyphae%2520and%2520hypha-co-regulated%2520genes%2520to%2520Candida%2520albicans%2520virulence%26jtitle%3DCell.%2520Microbiol.%26date%3D2005%26volume%3D7%26spage%3D1546%26epage%3D1554%26doi%3D10.1111%2Fj.1462-5822.2005.00616.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saville, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzell, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryant, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fretzen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monreal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solberg, E. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteagudo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Ribot, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milne, G. T.</span></span> <span> </span><span class="NLM_article-title">Inhibition of filamentation can be used to treat disseminated candidiasis</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">3312</span>– <span class="NLM_lpage">3316</span>, <span class="refDoi"> DOI: 10.1128/aac.00628-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1128%2FAAC.00628-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=17005810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVylsbvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=3312-3316&author=S.+P.+Savilleauthor=A.+L.+Lazzellauthor=A.+P.+Bryantauthor=A.+Fretzenauthor=A.+Monrealauthor=E.+O.+Solbergauthor=C.+Monteagudoauthor=J.+L.+Lopez-Ribotauthor=G.+T.+Milne&title=Inhibition+of+filamentation+can+be+used+to+treat+disseminated+candidiasis&doi=10.1128%2Faac.00628-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of filamentation can be used to treat disseminated candidiasis</span></div><div class="casAuthors">Saville, Stephen P.; Lazzell, Anna L.; Bryant, Alexander P.; Fretzen, Angelika; Monreal, Alex; Solberg, Erik O.; Monteagudo, Carlos; Lopez-Ribot, Jose L.; Milne, G. Todd</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3312-3316</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Candida albicans remains the leading causative agent of invasive fungal infection.  Although the importance of filamentation in C. albicans pathogenesis has been extensively investigated, in vivo studies to date have been unable to dissect the role of this developmental process in the establishment of infection vs. the development of active disease as characterized by damage to the host leading to mortality.  To address this issue, we genetically engineered a C. albicans tet-NRG1 strain in which filamentation and virulence can be modulated both in vitro and in vivo simply by the presence or absence of doxycycline (DOX): this strain enabled us, in a prior study, to demonstrate that yeast-form cells were able to infect the deep organs but caused no disease unless filamentation (induced by the addn. of DOX) was allowed to occur.  In the present study, we examd. whether inhibiting filamentation (by withdrawing the DOX) at 24 or 48 h postinfection could serve as an effective therapeutic intervention against candidiasis.  The results obtained indicate that DOX removal led to an alteration in the morphol. of the infecting fungal cells and a dramatic increase in survival, but as with conventional antifungal drug therapy regimens, mortality rates increased markedly the longer this intervention was delayed.  These observations reinforce the importance of invasive filamentous growth in causing the damage to the host and the lethality assocd. with active disease and suggest this process could be fruitfully targeted for the development of new antifungal agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoGINnT2eTmLVg90H21EOLACvtfcHk0lhytPhSWZ22mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVylsbvL&md5=62b8140867261cf304c8d0518553eb4d</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1128%2FAAC.00628-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00628-06%26sid%3Dliteratum%253Aachs%26aulast%3DSaville%26aufirst%3DS.%2BP.%26aulast%3DLazzell%26aufirst%3DA.%2BL.%26aulast%3DBryant%26aufirst%3DA.%2BP.%26aulast%3DFretzen%26aufirst%3DA.%26aulast%3DMonreal%26aufirst%3DA.%26aulast%3DSolberg%26aufirst%3DE.%2BO.%26aulast%3DMonteagudo%26aufirst%3DC.%26aulast%3DLopez-Ribot%26aufirst%3DJ.%2BL.%26aulast%3DMilne%26aufirst%3DG.%2BT.%26atitle%3DInhibition%2520of%2520filamentation%2520can%2520be%2520used%2520to%2520treat%2520disseminated%2520candidiasis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D3312%26epage%3D3316%26doi%3D10.1128%2Faac.00628-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Tackling fungal resistance by biofilm inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2193</span>– <span class="NLM_lpage">2211</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01203</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01203" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC2sXis12jsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2193-2211&author=S.+Wuauthor=Y.+Wangauthor=N.+Liuauthor=G.+Dongauthor=C.+Sheng&title=Tackling+fungal+resistance+by+biofilm+inhibitors&doi=10.1021%2Facs.jmedchem.6b01203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Tackling Fungal Resistance by Biofilm Inhibitors</span></div><div class="casAuthors">Wu, Shanchao; Wang, Yan; Liu, Na; Dong, Guoqiang; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2193-2211</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The high incidence and mortality of invasive fungal infections and serious drug resistance have become a global public health issue.  The ability of fungal cells to form biofilms is an important reason for the emergence of severe resistance to most clin. available antifungal agents.  Targeting fungal biofilm formation by small mols. represents a promising new strategy for the development of novel antifungal agents.  This perspective will provide a comprehensive review of fungal biofilm inhibitors.  In particular, discovery strategies, chem. structures, antibiofilm/antifungal activities and structure-activity relationship studies will be discussed.  Development of inhibitors to treat biofilm-related resistant fungal infections is a new yet clin. unexploited paradigm, and there is still a long way to go to clin. application.  Better understanding of fungal biofilms in combination with systematic drug discovery efforts will pave the way for potential clin. applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeZ6BRDEnjE7Vg90H21EOLACvtfcHk0lhytPhSWZ22mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXis12jsA%253D%253D&md5=7a0290b1463fb2c848493bd50d09c0ee</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01203%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DTackling%2520fungal%2520resistance%2520by%2520biofilm%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2193%26epage%3D2211%26doi%3D10.1021%2Facs.jmedchem.6b01203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stoldt, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonneborn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuker, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, J. F.</span></span> <span> </span><span class="NLM_article-title">Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1982</span>– <span class="NLM_lpage">1991</span>, <span class="refDoi"> DOI: 10.1093/emboj/16.8.1982</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1093%2Femboj%2F16.8.1982" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=9155024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADyaK2sXjt1WksL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=1982-1991&author=V.+R.+Stoldtauthor=A.+Sonnebornauthor=C.+E.+Leukerauthor=J.+F.+Ernst&title=Efg1p%2C+an+essential+regulator+of+morphogenesis+of+the+human+pathogen+Candida+albicans%2C+is+a+member+of+a+conserved+class+of+bHLH+proteins+regulating+morphogenetic+processes+in+fungi&doi=10.1093%2Femboj%2F16.8.1982"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi</span></div><div class="casAuthors">Stoldt, Volker R.; Sonneborn, Anja; Leuker, Christoph E.; Ernst, Joachim F.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1982-1991</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">We identified a gene of the fungal pathogen Candida albicans, designated EFG1, whose high-level expression stimulates pseudohyphal morphogenesis in the yeast Saccharomyces cerevisiae.  In a central region the deduced Efg1 protein is highly homologous to the StuA and Phd1/Sok2 proteins that regulate morphogenesis of Aspergillus nidulans and S. cerevisiae, resp.  The core of the conserved region is homologous to the basic helix-loop-helix (bHLH) motif of eukaryotic transcription factors, specifically to the human Myc and Max proteins.  Fungal-specific residues in the bHLH domain include the substitution of an invariant glutamate, responsible for target (E-box) specificity, by a threonine residue.  During hyphal induction EFG1 transcript levels decline to low levels; downregulation is effected at the level of transcriptional initiation as shown by a EFG1 promoter-LAC4 fusion.  A strain carrying one disrupted EFG1 allele and one EFG1 allele under the control of the glucose-repressible PCK1 promoter forms rod-like, pseudohyphal cells, but is unable to form true hyphae on glucose-contg. media.  Overexpression of EFG1 in C. albicans leads to enhanced filamentous growth in the form of extended pseudohyphae in liq. and on solid media.  The results suggest that Efg1p has a dual role as a transcriptional activator and repressor, whose balanced activity is essential for yeast, pseudohyphal and hyphal morphogenesis of C. albicans.  Functional analogies between Efg1p and Myc are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKgZx5C4RGDbVg90H21EOLACvtfcHk0lhytPhSWZ22mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjt1WksL0%253D&md5=212b347be9858b7e6378539e50bec2cf</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F16.8.1982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F16.8.1982%26sid%3Dliteratum%253Aachs%26aulast%3DStoldt%26aufirst%3DV.%2BR.%26aulast%3DSonneborn%26aufirst%3DA.%26aulast%3DLeuker%26aufirst%3DC.%2BE.%26aulast%3DErnst%26aufirst%3DJ.%2BF.%26atitle%3DEfg1p%252C%2520an%2520essential%2520regulator%2520of%2520morphogenesis%2520of%2520the%2520human%2520pathogen%2520Candida%2520albicans%252C%2520is%2520a%2520member%2520of%2520a%2520conserved%2520class%2520of%2520bHLH%2520proteins%2520regulating%2520morphogenetic%2520processes%2520in%2520fungi%26jtitle%3DEMBO%2520J.%26date%3D1997%26volume%3D16%26spage%3D1982%26epage%3D1991%26doi%3D10.1093%2Femboj%2F16.8.1982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biswas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Datta, A.</span></span> <span> </span><span class="NLM_article-title">N-acetylglucosamine-inducible CaGAP1 encodes a general amino acid permease which co-ordinates external nitrogen source response and morphogenesis in Candida albicans</span>. <i>Microbiology</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>149</i></span>,  <span class="NLM_fpage">2597</span>– <span class="NLM_lpage">2608</span>, <span class="refDoi"> DOI: 10.1099/mic.0.26215-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1099%2Fmic.0.26215-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=12949183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnslGnsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2003&pages=2597-2608&author=S.+Biswasauthor=M.+Royauthor=A.+Datta&title=N-acetylglucosamine-inducible+CaGAP1+encodes+a+general+amino+acid+permease+which+co-ordinates+external+nitrogen+source+response+and+morphogenesis+in+Candida+albicans&doi=10.1099%2Fmic.0.26215-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">N-acetylglucosamine-inducible CaGAP1 encodes a general amino acid permease which co-ordinates external nitrogen source response and morphogenesis in Candida albicans</span></div><div class="casAuthors">Biswas, Subhrajit; Roy, Monideepa; Datta, Asis</div><div class="citationInfo"><span class="NLM_cas:title">Microbiology (Reading, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2597-2608</span>CODEN:
                <span class="NLM_cas:coden">MROBEO</span>;
        ISSN:<span class="NLM_cas:issn">1350-0872</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">Candida albicans is able to grow in a variety of reversible morphol. forms (yeast, pseudohyphal and hyphal) in response to various environmental signals, noteworthy among them being N-acetylglucosamine (GlcNAc).  The gene CaGAP1, homologous to GAP1, which encodes the general amino acid permease from Saccharomyces cerevisiae, was isolated on the basis of its induction by GlcNAc through differential screening of a C. albicans genomic library.  The gene could functionally complement an S. cerevisiae gap1 mutant by rendering it susceptible to the toxic amino acid analog mimosine in minimal proline media.  As in S. cerevisiae, mutation of the CaGAP1 gene had an effect on citrulline uptake in C. albicans.  Northern anal. showed that GlcNAc-induced expression of CaGAP1 was further enhanced in synthetic minimal media supplemented with single amino acids (glutamate, proline and glutamine) or urea (without amino acids) but repressed in minimal ammonium media.  Induction of CaGAP1 expression by GlcNAc was nullified in C. albicans deleted for the transcription factor CPH1 and the hyphal regulator RAS1, indicating the involvement of Cph1p-dependent Ras1p signalling in CaGAP1 expression.  A homozygous mutant of this gene showed defective hyphal formation in solid hyphal-inducing media and exhibited less hyphal clumps when induced by GlcNAc.  Alteration of morphol. and short filamentation under nitrogen-starvation conditions in the heterozygous mutant suggested that CaGAP1 affects morphogenesis in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosiEvDEvT3oLVg90H21EOLACvtfcHk0lhytPhSWZ22mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnslGnsbw%253D&md5=a12dcd38cfa3caf77ce598bd49c58e46</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1099%2Fmic.0.26215-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fmic.0.26215-0%26sid%3Dliteratum%253Aachs%26aulast%3DBiswas%26aufirst%3DS.%26aulast%3DRoy%26aufirst%3DM.%26aulast%3DDatta%26aufirst%3DA.%26atitle%3DN-acetylglucosamine-inducible%2520CaGAP1%2520encodes%2520a%2520general%2520amino%2520acid%2520permease%2520which%2520co-ordinates%2520external%2520nitrogen%2520source%2520response%2520and%2520morphogenesis%2520in%2520Candida%2520albicans%26jtitle%3DMicrobiology%26date%3D2003%26volume%3D149%26spage%3D2597%26epage%3D2608%26doi%3D10.1099%2Fmic.0.26215-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lane, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span> <span> </span><span class="NLM_article-title">The basic helix-loop-helix transcription factor Cph2 regulates hyphal development in Candida albicans partly via TEC1</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">6418</span>– <span class="NLM_lpage">6428</span>, <span class="refDoi"> DOI: 10.1128/mcb.21.19.6418-6428.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1128%2FMCB.21.19.6418-6428.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=11533231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmvFGhsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=6418-6428&author=S.+Laneauthor=S.+Zhouauthor=T.+Panauthor=Q.+Daiauthor=H.+Liu&title=The+basic+helix-loop-helix+transcription+factor+Cph2+regulates+hyphal+development+in+Candida+albicans+partly+via+TEC1&doi=10.1128%2Fmcb.21.19.6418-6428.2001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">The basic helix-loop-helix transcription factor Cph2 regulates hyphal development in Candida albicans partly via Tec1</span></div><div class="casAuthors">Lane, Shelley; Zhou, Song; Pan, Ting; Dai, Qian; Liu, Haoping</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6418-6428</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Candida albicans undergoes a morphogenetic switch from budding yeast to hyphal growth form in response to a variety of stimuli and growth conditions.  Multiple signaling pathways, including a Cph1-mediated mitogen-activated protein kinase pathway and an Efg1-mediated cAMP/protein kinase A pathway, regulate the transition.  Here we report the identification of a basic helix-loop-helix transcription factor of the Myc subfamily (Cph2) by its ability to promote pseudohyphal growth in Saccharomyces cerevisiae.  Like sterol response element binding protein 1, Cph2 has a Tyr instead of a conserved Arg in the basic DNA binding region.  Cph2 regulates hyphal development in C. albicans, as cph2/cph2 mutant strains show medium-specific impairment in hyphal development and in the induction of hypha-specific genes.  However, many hypha-specific genes do not have potential Cph2 binding sites in their upstream regions.  Interestingly, upstream sequences of all known hypha-specific genes are found to contain potential binding sites for Tec1, a regulator of hyphal development.  Northern anal. shows that TEC1 transcription is highest in the medium in which cph2/cph2 displays a defect in hyphal development, and Cph2 is necessary for this transcriptional induction of TEC1.  In vitro gel mobility shift expts. show that Cph2 directly binds to the two sterol regulatory element 1-like elements upstream of TEC1.  Furthermore, the ectopic expression of TEC1 suppresses the defect of cph2/cph2 in hyphal development.  Therefore, the function of Cph2 in hyphal transcription is mediated, in part, through Tec1.  We further show that this function of Cph2 is independent of the Cph1- and Efg1-mediated pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_NVWYjyz1CLVg90H21EOLACvtfcHk0lhAmD0lnmG6rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmvFGhsL4%253D&md5=155552fad624314912eb3d2caccf9bec</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1128%2FMCB.21.19.6418-6428.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.21.19.6418-6428.2001%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DT.%26aulast%3DDai%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DH.%26atitle%3DThe%2520basic%2520helix-loop-helix%2520transcription%2520factor%2520Cph2%2520regulates%2520hyphal%2520development%2520in%2520Candida%2520albicans%2520partly%2520via%2520TEC1%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2001%26volume%3D21%26spage%3D6418%26epage%3D6428%26doi%3D10.1128%2Fmcb.21.19.6418-6428.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheppard, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeaman, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welch, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, Q. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filler, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waring, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, J. E.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Functional and structural diversity in the Als protein family of Candida albicans</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">30480</span>– <span class="NLM_lpage">30489</span>, <span class="refDoi"> DOI: 10.1074/jbc.m401929200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1074%2Fjbc.M401929200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=15128742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsFKhsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=30480-30489&author=D.+C.+Sheppardauthor=M.+R.+Yeamanauthor=W.+H.+Welchauthor=Q.+T.+Phanauthor=Y.+Fuauthor=A.+S.+Ibrahimauthor=S.+G.+Fillerauthor=M.+Zhangauthor=A.+J.+Waringauthor=J.+E.+Edwards&title=Functional+and+structural+diversity+in+the+Als+protein+family+of+Candida+albicans&doi=10.1074%2Fjbc.m401929200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Functional and Structural Diversity in the Als Protein Family of Candida albicans</span></div><div class="casAuthors">Sheppard, Donald C.; Yeaman, Michael R.; Welch, William H.; Phan, Quynh T.; Fu, Yue; Ibrahim, Ashraf S.; Filler, Scott G.; Zhang, Mason; Waring, Alan J.; Edwards, John E., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">30480-30489</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The human fungal pathogen Candida albicans colonizes and invades a wide range of host tissues.  Adherence to host constituents plays an important role in this process.  Two members of the C. albicans Als protein family (Als1p and Als5p) have been found to mediate adherence; however, the functions of other members of this family are unknown.  In this study, members of the ALS gene family were cloned and expressed in Saccharomyces cerevisiae to characterize their individual functions.  Distinct Als proteins conferred distinct adherence profiles to diverse host substrates.  Using chimeric Als5p-Als6p constructs, the regions mediating substrate-specific adherence were localized to the N-terminal domains in Als proteins.  Interestingly, a subset of Als proteins also mediated endothelial cell invasion, a previously unknown function of this family.  Consistent with these results, homol. modeling revealed that Als members contain anti-parallel β-sheet motifs interposed by extended regions, homologous to adhesins or invasins of the Ig superfamily.  This finding was confirmed using CD and Fourier transform IR spectrometric anal. of the N-terminal domain of Als1p.  Specific regions of amino acid hypervariability were found among the N-terminal domains of Als proteins, and energy-based models predicted similarities and differences in the N-terminal domains that probably govern the diverse function of Als family members.  Collectively, these results indicate that the structural and functional diversity within the Als family provides C. albicans with an array of cell wall proteins capable of recognizing and interacting with a wide range of host constituents during infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF70gkXSCYCbVg90H21EOLACvtfcHk0lhAmD0lnmG6rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsFKhsr8%253D&md5=c1b7191906d3320bbf361d6a6c19b7b2</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M401929200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M401929200%26sid%3Dliteratum%253Aachs%26aulast%3DSheppard%26aufirst%3DD.%2BC.%26aulast%3DYeaman%26aufirst%3DM.%2BR.%26aulast%3DWelch%26aufirst%3DW.%2BH.%26aulast%3DPhan%26aufirst%3DQ.%2BT.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DIbrahim%26aufirst%3DA.%2BS.%26aulast%3DFiller%26aufirst%3DS.%2BG.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DWaring%26aufirst%3DA.%2BJ.%26aulast%3DEdwards%26aufirst%3DJ.%2BE.%26atitle%3DFunctional%2520and%2520structural%2520diversity%2520in%2520the%2520Als%2520protein%2520family%2520of%2520Candida%2520albicans%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D30480%26epage%3D30489%26doi%3D10.1074%2Fjbc.m401929200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitman, J.</span></span> <span> </span><span class="NLM_article-title">Epigenetic mechanisms of drug resistance in fungi</span>. <i>Fungal Genet. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">103253</span>, <span class="refDoi"> DOI: 10.1016/j.fgb.2019.103253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1016%2Fj.fgb.2019.103253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=31325489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVCgsb%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2019&pages=103253&author=Z.+Changauthor=V.+Yadavauthor=S.+C.+Leeauthor=J.+Heitman&title=Epigenetic+mechanisms+of+drug+resistance+in+fungi&doi=10.1016%2Fj.fgb.2019.103253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic mechanisms of drug resistance in fungi</span></div><div class="casAuthors">Chang, Zanetta; Yadav, Vikas; Lee, Soo Chan; Heitman, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Fungal Genetics and Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103253</span>CODEN:
                <span class="NLM_cas:coden">FGBIFV</span>;
        ISSN:<span class="NLM_cas:issn">1087-1845</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The emergence of drug-resistant fungi poses a continuously increasing threat to human health.  Despite advances in preventive care and diagnostics, resistant fungi continue to cause significant mortality, esp. in immunocompromised patients.  Therapeutic resources are further limited by current usage of only four major classes of antifungal drugs.  Resistance against these drugs has already been obsd. in pathogenic fungi requiring the development of much needed newer antifungal drugs.  Epigenetic changes such as DNA or chromatin modifications alter gene expression levels in response to certain stimuli, including interaction with the host in the case of fungal pathogens.  These changes can confer resistance to drugs by altering the expression of target genes or genes encoding drug efflux pumps.  Multiple pathogens share many of these epigenetic pathways; thus, targeting epigenetic pathways might also identify drug target candidates for the development of broad-spectrum antifungal drugs.  In this review, we discuss the importance of epigenetic pathways in mediating drug resistance in fungi as well as in the development of anti-fungal drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUsc8iIa_pi7Vg90H21EOLACvtfcHk0lhAmD0lnmG6rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVCgsb%252FM&md5=86dbb4c9a50787f348efe0b5b9c47891</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.fgb.2019.103253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fgb.2019.103253%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DZ.%26aulast%3DYadav%26aufirst%3DV.%26aulast%3DLee%26aufirst%3DS.%2BC.%26aulast%3DHeitman%26aufirst%3DJ.%26atitle%3DEpigenetic%2520mechanisms%2520of%2520drug%2520resistance%2520in%2520fungi%26jtitle%3DFungal%2520Genet.%2520Biol.%26date%3D2019%26volume%3D132%26spage%3D103253%26doi%3D10.1016%2Fj.fgb.2019.103253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eldesouky, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salama, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazbun, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayhoub, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seleem, M. N.</span></span> <span> </span><span class="NLM_article-title">Ospemifene displays broad-spectrum synergistic interactions with itraconazole through potent interference with fungal efflux activities</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">6089</span>, <span class="refDoi"> DOI: 10.1038/s41598-020-62976-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1038%2Fs41598-020-62976-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=32269301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmvFGnurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=6089&author=H.+E.+Eldesoukyauthor=E.+A.+Salamaauthor=T.+R.+Hazbunauthor=A.+S.+Mayhoubauthor=M.+N.+Seleem&title=Ospemifene+displays+broad-spectrum+synergistic+interactions+with+itraconazole+through+potent+interference+with+fungal+efflux+activities&doi=10.1038%2Fs41598-020-62976-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Ospemifene displays broad-spectrum synergistic interactions with itraconazole through potent interference with fungal efflux activities</span></div><div class="casAuthors">Eldesouky, Hassan E.; Salama, Ehab A.; Hazbun, Tony R.; Mayhoub, Abdelrahman S.; Seleem, Mohamed N.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">6089</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: Azole antifungals are vital therapeutic options for treating invasive mycotic infections.  However, the emergence of azole-resistant isolates combined with limited therapeutic options presents a growing challenge in medical mycol.  To address this issue, we utilized microdilution checkerboard assays to evaluate nine stilbene compds. for their ability to interact synergistically with azole drugs, particularly against azole-resistant fungal isolates.  Ospemifene displayed the most potent azole chemosensitizing activity, and its combination with itraconazole displayed broad-spectrum synergistic interactions against Candida albicans, Candida auris, Cryptococcus neoformans, and Aspergillus fumigatus (ΣFICI = 0.05-0.50).  Addnl., in a Caenorhabditis elegans infection model, the ospemifene-itraconazole combination significantly reduced fungal CFU burdens in infected nematodes by ∼75-96%.  Nile Red efflux assays and RT-qPCR anal. suggest ospemifene interferes directly with fungal efflux systems, thus permitting entry of azole drugs into fungal cells.  This study identifies ospemifene as a novel antifungal adjuvant that augments the antifungal activity of itraconazole against a broad range of fungal pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouk_EemTj2RrVg90H21EOLACvtfcHk0ljc9vzTkUr_Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmvFGnurg%253D&md5=6fee184868288f722fb2fe1319ea27d4</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2Fs41598-020-62976-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-020-62976-y%26sid%3Dliteratum%253Aachs%26aulast%3DEldesouky%26aufirst%3DH.%2BE.%26aulast%3DSalama%26aufirst%3DE.%2BA.%26aulast%3DHazbun%26aufirst%3DT.%2BR.%26aulast%3DMayhoub%26aufirst%3DA.%2BS.%26aulast%3DSeleem%26aufirst%3DM.%2BN.%26atitle%3DOspemifene%2520displays%2520broad-spectrum%2520synergistic%2520interactions%2520with%2520itraconazole%2520through%2520potent%2520interference%2520with%2520fungal%2520efflux%2520activities%26jtitle%3DSci.%2520Rep.%26date%3D2020%26volume%3D10%26spage%3D6089%26doi%3D10.1038%2Fs41598-020-62976-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Georgopapadakou, N.</span>; <span class="NLM_string-name">Hu, W.</span>; <span class="NLM_string-name">Campeol, N.</span>; <span class="NLM_string-name">Bedard, J.</span>; <span class="NLM_string-name">Deziel, R.</span>; <span class="NLM_string-name">Ajamian, A.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase inhibitors for enhanceing activity of antifungal agents</span>. U.S. Patent <span class="NLM_patent">0,197,550 A1</span>, Aug 23, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=N.+Georgopapadakou&author=W.+Hu&author=N.+Campeol&author=J.+Bedard&author=R.+Deziel&author=A.+Ajamian&title=Histone+deacetylase+inhibitors+for+enhanceing+activity+of+antifungal+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGeorgopapadakou%26aufirst%3DN.%26atitle%3DHistone%2520deacetylase%2520inhibitors%2520for%2520enhanceing%2520activity%2520of%2520antifungal%2520agents%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sridharan, R.</span>; <span class="NLM_string-name">Selvakumar, T. P.</span>; <span class="NLM_string-name">Maneesh, P. S.</span>; <span class="NLM_string-name">Gopalan, B.</span>; <span class="NLM_string-name">Solanki, S. S.</span>; <span class="NLM_string-name">Bharathimohan, K.</span>; <span class="NLM_string-name">Virendra, K. D.</span>; <span class="NLM_string-name">Vinoth, C. N.</span>; <span class="NLM_string-name">Karthikeyan, G.</span>; <span class="NLM_string-name">Shridhar, N.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase inhibitors for treatment of fungal infections</span>. <span class="NLM_patent">WO 058582 A1</span>, May 19, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=R.+Sridharan&author=T.+P.+Selvakumar&author=P.+S.+Maneesh&author=B.+Gopalan&author=S.+S.+Solanki&author=K.+Bharathimohan&author=K.+D.+Virendra&author=C.+N.+Vinoth&author=G.+Karthikeyan&author=N.+Shridhar&title=Histone+deacetylase+inhibitors+for+treatment+of+fungal+infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSridharan%26aufirst%3DR.%26atitle%3DHistone%2520deacetylase%2520inhibitors%2520for%2520treatment%2520of%2520fungal%2520infections%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonfils, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalita, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubay, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siu, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carducci, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martell, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besterman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span> <span> </span><span class="NLM_article-title">Evaluation of the pharmacodynamic effects of MGCD0103 from preclinical models to human using a novel HDAC enzyme assay</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">3441</span>– <span class="NLM_lpage">3449</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.ccr-07-4427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1158%2F1078-0432.CCR-07-4427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=18519775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmslygsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=3441-3449&author=C.+Bonfilsauthor=A.+Kalitaauthor=M.+Dubayauthor=L.+L.+Siuauthor=M.+A.+Carducciauthor=G.+Reidauthor=R.+E.+Martellauthor=J.+M.+Bestermanauthor=Z.+Li&title=Evaluation+of+the+pharmacodynamic+effects+of+MGCD0103+from+preclinical+models+to+human+using+a+novel+HDAC+enzyme+assay&doi=10.1158%2F1078-0432.ccr-07-4427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the Pharmacodynamic Effects of MGCD0103 from Preclinical Models to Human Using a Novel HDAC Enzyme Assay</span></div><div class="casAuthors">Bonfils, Claire; Kalita, Ann; Dubay, Marja; Siu, Lillian L.; Carducci, Michael A.; Reid, Gregory; Martell, Robert E.; Besterman, Jeffrey M.; Li, Zuomei</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3441-3449</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The pharmacodynamic properties of MGCD0103, an isotype-selective inhibitor of histone deacetylase (HDAC), were evaluated in preclin. models and patients with a novel whole-cell HDAC enzyme assay.  Exptl. Design: Boc-Lys(.vepsiln.-Ac)-AMC, a HDAC substrate with fluorescent readout, was found to be cell permeable and was used to monitor MGCD0103-mediated HDAC inhibition in cultured cancer cells in vitro, in peripheral WBC ex vivo, in mice in vivo, and in human patients.  RESULTS: MGCD0103 inhibited HDAC activity in several human cancer cell lines in vitro and in human peripheral WBC ex vivo in a dose-dependent manner.  Unlike suberoylanilide hydroxamic acid, the HDAC inhibitory activity of MGCD0103 was time dependent and sustained for at least 24 h following drug removal in peripheral WBC ex vivo.  Inhibitory activity of MGCD0103 was sustained for at least 8 h in vivo in mice and 48 h in patients with solid tumors.  HDAC inhibitory activity of MGCD0103 in peripheral WBC correlated with induction of histone acetylation in blood and in implanted tumors in mice.  In cancer patients, sustained pharmacodynamic effect of MGCD0103 was visualized only by dose-dependent enzyme inhibition in peripheral WBC but not by histone acetylation anal.  CONCLUSIONS: This study shows that MGCD0103 has sustained pharmacodynamic effects that can be monitored both in vitro and in vivo with a cell-based HDAC enzyme assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrReZVYYRQ0YbVg90H21EOLACvtfcHk0ljc9vzTkUr_Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmslygsbk%253D&md5=29b048a8a7c72caa67b9e68e5604e1df</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-4427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-4427%26sid%3Dliteratum%253Aachs%26aulast%3DBonfils%26aufirst%3DC.%26aulast%3DKalita%26aufirst%3DA.%26aulast%3DDubay%26aufirst%3DM.%26aulast%3DSiu%26aufirst%3DL.%2BL.%26aulast%3DCarducci%26aufirst%3DM.%2BA.%26aulast%3DReid%26aufirst%3DG.%26aulast%3DMartell%26aufirst%3DR.%2BE.%26aulast%3DBesterman%26aufirst%3DJ.%2BM.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DEvaluation%2520of%2520the%2520pharmacodynamic%2520effects%2520of%2520MGCD0103%2520from%2520preclinical%2520models%2520to%2520human%2520using%2520a%2520novel%2520HDAC%2520enzyme%2520assay%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D3441%26epage%3D3449%26doi%3D10.1158%2F1078-0432.ccr-07-4427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzell, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHardy, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saville, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Ribot, J. L.</span></span> <span> </span><span class="NLM_article-title">Development of anti-virulence approaches for candidiasis via a novel series of small-molecule inhibitors of Candida albicans filamentation</span>. <i>mBio</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e01991</span> <span class="refDoi"> DOI: 10.1128/mbio.01991-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1128%2FmBio.01991-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=29208749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVKmtLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&author=J.+A.+Romoauthor=C.+G.+Pierceauthor=A.+K.+Chaturvediauthor=A.+L.+Lazzellauthor=S.+F.+McHardyauthor=S.+P.+Savilleauthor=J.+L.+Lopez-Ribot&title=Development+of+anti-virulence+approaches+for+candidiasis+via+a+novel+series+of+small-molecule+inhibitors+of+Candida+albicans+filamentation&doi=10.1128%2Fmbio.01991-17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Development of anti-virulence approaches for candidiasis via a novel series of small-molecule inhibitors of Candida albicans filamentation</span></div><div class="casAuthors">Romo, Jesus A.; Pierce, Christopher G.; Chaturvedi, Ashok K.; Lazzell, Anna L.; McHardy, Stanton F.; Saville, Stephen P.; Lopez-Ribot, Jose L.</div><div class="citationInfo"><span class="NLM_cas:title">mBio</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e01991-17/1-e01991-17/16</span>CODEN:
                <span class="NLM_cas:coden">MBIOCL</span>;
        ISSN:<span class="NLM_cas:issn">2150-7511</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Candida albicans remains the main etiol. agent of candidiasis, the most common fungal infection and now the third most frequent infection in U.S. hospitals.  The scarcity of antifungal agents and their limited efficacy contribute to the unacceptably high morbidity and mortality rates assocd. with these infections.  The yeast-to-hypha transition represents the main virulence factor assocd. with the pathogenesis of C. albicans infections.  In addn., filamentation is pivotal for robust biofilm development, which represents another major virulence factor for candidiasis and further complicates treatment.  Targeting pathogenic mechanisms rather than growth represents an attractive yet clin. unexploited approach in the development of novel antifungal agents.  Here, we performed large-scale phenotypic screening assays with 30,000 drug-like small-mol. compds. within ChemBridge's DIVERSet chem. library in order to identify small-mol. inhibitors of C. albicans filamentation, and our efforts led to the identification of a novel series of bioactive compds. with a common biaryl amide core structure.  The leading compd. of this series, N-[3-(allyloxy)-phenyl]-4-methoxybenzamide, was able to prevent filamentation under all liq. and solid medium conditions tested, suggesting that it impacts a common core component of the cellular machinery that mediates hypha formation under different environmental conditions.  In addn. to filamentation, this compd. also inhibited C. albicans biofilm formation.  This leading compd. also demonstrated in vivo activity in clin. relevant murine models of invasive and oral candidiasis.  Overall, our results indicate that compds. within this series represent promising candidates for the development of novel anti-virulence approaches to combat C. albicans infections.  IMPORTANCE Since fungi are eukaryotes, there is a limited no. of fungusspecific targets and, as a result, the antifungal arsenal is exceedingly small.  Furthermore, the efficacy of antifungal treatment is compromised by toxicity and development of resistance.  As a consequence, fungal infections carry high morbidity and mortality rates, and there is an urgent but unmet need for novel antifungal agents.  One appealing strategy for antifungal drug development is to target pathogenetic mechanisms assocd. with infection.  In Candida albicans, one of the most common pathogenic fungi, morphogenetic transitions between yeast cells and filamentous hyphae represent a key virulence factor assocd. with the ability of fungal cells to invade tissues, cause damage, and form biofilms.  Here, we describe and characterize a novel small-mol. compd. capable of inhibiting C. albicans filamentation both in vitro and in vivo; as such, this compd. represents a leading candidate for the development of anti-virulence therapies against candidiasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqGPhBx3db77Vg90H21EOLACvtfcHk0lhvXE7-cA5hrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVKmtLjI&md5=6f14fbe603e993cc98c5364557f39440</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1128%2FmBio.01991-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.01991-17%26sid%3Dliteratum%253Aachs%26aulast%3DRomo%26aufirst%3DJ.%2BA.%26aulast%3DPierce%26aufirst%3DC.%2BG.%26aulast%3DChaturvedi%26aufirst%3DA.%2BK.%26aulast%3DLazzell%26aufirst%3DA.%2BL.%26aulast%3DMcHardy%26aufirst%3DS.%2BF.%26aulast%3DSaville%26aufirst%3DS.%2BP.%26aulast%3DLopez-Ribot%26aufirst%3DJ.%2BL.%26atitle%3DDevelopment%2520of%2520anti-virulence%2520approaches%2520for%2520candidiasis%2520via%2520a%2520novel%2520series%2520of%2520small-molecule%2520inhibitors%2520of%2520Candida%2520albicans%2520filamentation%26jtitle%3DmBio%26date%3D2017%26volume%3D8%26doi%3D10.1128%2Fmbio.01991-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">The discovery of novel antifungal scaffolds by structural simplification of the natural product sampangine</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">14648</span>– <span class="NLM_lpage">14651</span>, <span class="refDoi"> DOI: 10.1039/c5cc05699c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=10.1039%2Fc5cc05699c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=26289663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlSnu7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2015&pages=14648-14651&author=Z.+Jiangauthor=N.+Liuauthor=D.+Huauthor=G.+Dongauthor=Z.+Miaoauthor=J.+Yaoauthor=H.+Heauthor=Y.+Jiangauthor=W.+Zhangauthor=Y.+Wangauthor=C.+Sheng&title=The+discovery+of+novel+antifungal+scaffolds+by+structural+simplification+of+the+natural+product+sampangine&doi=10.1039%2Fc5cc05699c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of novel antifungal scaffolds by structural simplification of the natural product sampangine</span></div><div class="casAuthors">Jiang, Zhigan; Liu, Na; Hu, Dandan; Dong, Guoqiang; Miao, Zhenyuan; Yao, Jianzhong; He, Haiying; Jiang, Yuanying; Zhang, Wannian; Wang, Yan; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">78</span>),
    <span class="NLM_cas:pages">14648-14651</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Natural products are important sources of therapeutic drugs.  However, it is a challenge to simplify the structure of natural products without decreasing the biol. activity.  Here we provide the first example of the successful simplification of an antifungal natural product.  Starting from sampangine, two novel simplified scaffolds with excellent antifungal activity were discovered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDQRLoWYoyu7Vg90H21EOLACvtfcHk0lhvXE7-cA5hrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlSnu7vO&md5=82161572e5e8a6dcd2db7bb3e2f5e7e3</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1039%2Fc5cc05699c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc5cc05699c%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DHu%26aufirst%3DD.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DThe%2520discovery%2520of%2520novel%2520antifungal%2520scaffolds%2520by%2520structural%2520simplification%2520of%2520the%2520natural%2520product%2520sampangine%26jtitle%3DChem.%2520Commun.%26date%3D2015%26volume%3D51%26spage%3D14648%26epage%3D14651%26doi%3D10.1039%2Fc5cc05699c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5SFA" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5SFA','PDB','5SFA'); return false;">PDB: 5SFA</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i83"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00102">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_70040"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00102?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00102</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Cytotoxicity of compounds <b>12h</b> and <b>15j</b> against human cell lines; primers for real-time RT-PCR; 2D-NMR of intermediates <b>5a</b> and <b>6a</b>; interactions of posaconazole and compound <b>15j</b> with CYP51; GC–MS of sterol composition; time-kill curve of compound <b>15j</b>; and spectral data and high-performance LC of the representative compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00102/suppl_file/jm0c00102_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings of the target compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00102/suppl_file/jm0c00102_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00102/suppl_file/jm0c00102_si_001.pdf">jm0c00102_si_001.pdf (8.09 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00102/suppl_file/jm0c00102_si_002.csv">jm0c00102_si_002.csv (3.95 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00102%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-10" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00102" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"667982778b20a2e2","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
